
































and" that" the" research" presented" within" is" a" result" of" my" own" efforts" and"








Chinese" hamster" ovary" cells" are" widely" used" in" the" production" of"
biopharmaceuticals" such" as"monoclonal" antibodies." Since" their" first" use" for" this"
application" in" the" 1980s"much" engineering" of"manufacturing" processes" and" the"
CHO"cell"itself"has"been"undertaken,"leading"to"increased"cell"productivity,"product"
specificity" and" overall" product" titres" and" yields."Much" CHO" cell" engineering" has"
thus" far" focused" on" increasing" transcription" and" translation" levels," with" the"








so" far" focused" on" expression" of" single" genes" or" two" genes" in" combination." Two"
engineering" strategies"were"utilised" to"engineer" the"CHO"cell" secretory"pathway"
and" enhance" CHO" cell" productivity." Firstly" a" literatureU" and" ‘omicsUdriven"
approach" was" used" to" select" genes" with" which" to" engineer" the" CHO" secretory"
pathway." Engineering" of" the" secretory" and" biosynthetic" pathways," using" single"
genes"and"multiple"genes"in"combination,"showed"that"this"approach"can"increase"
CHO"productivity"levels"through"enhancing"specific"productivity"and"overall"titre."
Secondly," directed" evolution" was" used" as" a" method" to" bring" about" myriad" fine"
global"changes"within"the"CHO"biosynthetic"and"secretory"pathways."From"these"
results"we"hypothesise" that"a"more"holistic," global"approach" to"biosynthetic"and"






After" four" years" of" study" I" now" feel" confident" that" I" could" take" on" a" research"
project"to"a"good"level."Whilst"it"may"have"been"favourable"for"this"feeling"to"occur"
previously,"in"this"respect"I"suppose"the"doctoral"training"programme"has"had"its"
desired" effect." The" following" acknowledgements" have" formed" over" the" last" four"
years." Many" times" I" have" thought" of" the" day" I" could" write" this" small" section."
Needless"to"say"it"will"probably"not"match"the"hype."
"
Sincerest" thanks" go" to" my" academic" supervisors," Prof." David" James" and" Dr."
Andrew"Peden,"for"the"opportunity"to"work"with"them,"their"project"outlook"and"







forget" one" of" many" pivotal" figures," but" special" thanks" are" due" to" those" I" have"








this" thesis" beyond" its" already" interminable" length," but" lunch" time" pool" sessions"








Finally," those" who" have" offered" me" their" unyielding" love" and" support" in"































































































































































°C"" " U" degrees"centigrade"
‘omic" " U" combination"of"transcriptomic"and"proteomic"data"
1°" " U" primary"
2°" " U" secondary"
aa" " U" amino"acids"
AAT" " U" Amino"acid"transporters"
Amp" " U" Ampicillin"
ANOVA" U" Analysis"of"variance"
AP" " U" Adaptor"protein"
APS" " U" Ammonium"persulphate"
ATF" " U" Activating"transcription"factor"
ATP" " U" Adenosine"triphosphate"
BFA" " U" Brefeldin"A"
BHK" " U" Baby"hamster"kidney"
BiP" " U" Immunoglobulin"binding"protein"
BL1" " U" emission"detection"at"530"±"30"nm"
BLAST"" U" Basic"local"alignment"search"tool"
bp" " U" base"pair(s)"
BSA" " U" Bovine"Serum"Albumin"
CATCHR" U" Complexes"associated"with"tethering"containing"helical"rods"
CD" " U" Chemically"defined"
cDNA" " U" Complementary"DNA"
CerS2" " U" Ceramide"synthase"2"
CERT" " U" Ceramide"transfer"(protein)"
CFPS" " U" Cell"free"protein"synthesis"
CHO" " U" Chinese"hamster"ovary"
CMV" " U" Cytomegalovirus"
CO2" " U" Carbon"Dioxide"
COG" " U" Conserved"oligomeric"Golgi"(complex)"
COP" " U" Coat"protein"complex"
CRISPR" U" Clustered"Regularly"Interspaced"Short"Palindromic"Repeats"
Ct" " U" Cycle"time"
CypB" " U" Cyclophilin"B"
DAG" " U" DiUacyl"glycerol"
DCJ" " U" David"James"Laboratory"group"
diH2O" " U" DeUionised"water"
DMSO" " U" DiUMethyl"Sulphoxide"
DNA" " U" Deoxyribonucleic"Acid"
DoE" " U" Design"of"experiment"
" 14"
DT" " U" Doubling"time"
DTE" " U" Difficult"to"Express"
e125" " U" Erlenmeyer"125"mL"flask"
EB" " U" Elution"Buffer"(10"mM"TrisUCl,"pH"8.5)"
eIF2α" " U" Eukaryotic"initiation"factor"2α"
ER" " U" Endoplasmic"Reticulum"
ERAD" " U" ERUassociated"protein"degradation"
ETE" " U" Easy"to"express"
ERES" " U" ER"exit"sites"
ERO1" " U" ER"oxidoreductase"
ERSE" " U" ER"stress"element"
EtOH" " U" Ethanol"
Fab" " U" Antigen"binding"fragment"(of"antibody)"
FBS" " U" Fetal"Bovine"Serum"
Fc" " U" Constant"fragment"(of"antibody)"
FDA" " U" Food"and"drug"administration"
FKPM" " U" Fragments"per"kb"of"transcript"per"million"of"mapped"reads"
FP" " U" Fluorescence"Polarisation"
FSC" " U" Forward"scatter"
G30" " U" 30"Generations"(±2)"growth"
GASE" " U" Golgi"apparatus"stress"response"element"
GBF1" " U" GolgiUspecific"Brefeldin"A"resistance"1"
GCA" " U" Golgicide"A"
GCLM" " U" GlutamateUcysteine"ligase"modifier"subunit"
gDNA" " U" Genomic"DNA"
Gen" " U" Generation"number"
GFP" " U" Green"fluorescent"protein"
GGAs" " U" GolgiUlocalising,"γUearUcontaining,"ArfUbinding"proteins"
GO" " U" Gene"ontology"
GRAS" " U" Generally"regarded"as"safe"
GRP" " U" GlucoseUregulating"protein"
GS" " U" Glutamine"synthetase"
GSH" " U" Glutathione"
HC" " U" (Mab)"Heavy"chain"
HCP" " U" Host"cell"protein"
HF" " U" High"Fidelity"
HS" " U" High"sensitivity"
HSP" " U" Heat"shock"protein"
HTS" " U" High"throughput"screening"
IF" " U" Immunofluorescence"(microscopy)"
IgG" " U" Immunoglobulin"G"monoclonal"antibody"
IRE1" " U" inositolUrequiring"enzyme"1"
IVCD" " U" Integral"of"viable"cell"density""
" 15"
Kan" " U" Kanamycin"
kDa" " U" kilodalton"
KEGG" " U" Kyoto"Encyclopedia"of"Genes"and"Genomes"
LB" " U" Luria"Bertani"(broth)"
LC" " U" (Mab)"Light"chain"
LD" " U" Lethal"Dose"
Mab" " U" Monoclonal"Antibody"
MaxiPrep" U" Maxi"DNA"preparation"kit"(Plasmid"Plus)"
MCB" " U" Master"cell"bank"
MeOH" " U" Methanol"
MGEV" " U" MultiUgene"expression"vector"
MHRA"" U" Medicines"and"Healthcare"products"Regulatory"Agency"
min(s)"" U" minute(s)"
mg" " U" milligram"
mM" " U" milimolar"
MMPs" " U" Matrix"metaloproteases"
MSX" " U" Methionine"Sulphoxamine"
MTC" " U" Multisubunit"tethering"complex"
OncoUKIT" U" Tyrosine"receptor"kinase"
PAGE" " U" Polyacrylamide"gel"electrophoresis"
PB" " U" PrestoBlue"cell"viability"reagent"
PBS" " U" Phosphate"buffered"Saline"
PC" " U" Phosphatidylcholine"
PCR" " U" Polymerase"Chain"Reaction"
PDI(A)" U" Protein"disulphide"isomerases"
PEI" " U" Polyethylenimine"
PERK" " U" PKRUlike"ER"kinase"
PFA" " U" Paraformaldehyde"
pg" " U" picograms"
PI" " U" Phosphatidylinositol"
PLG" " U" Phase"Lock"Gel"
PLL" " U" PolyULULysine"(solution)"
PM" " U" Plasma"membrane"
PRKD1" U" Protein"Kinase"D"
pSILAC" U" pulsed"stable"isotope"labeling"of"amino"acids"in"cell"culture"
PTM" " U" PostUtranslational"modification"
Qp" " U" Specific"productivity""
RIPA" " U" Radioimmunoprecipitation"assay"buffer"
RCF" " U" Relative"Centrifugal"Field"
RFU" " U" Relative"Fluorescence"Unit(s)"
RL1" " U" emission"detection"at"660"±"20"nm"
RNA" " U" Ribonucleic"Acid"
RNAUseq" U" RNA"sequencing"(transcriptomic"data)"
" 16"
rpm" " U" Revolutions"per"minute"
RTUPCR" U" Reverse"transcription"PCR"
SAMY" " U" Secreted"aUamylase"
SD" " U" Standard"deviation"
SDS" " U" sodium"dodecyl"sulphate"
SEAP" " U" Secreted"alkaline"phosphatase"
SEM" " U" Standard"error"of"the"mean."
SGMS1" U" Sphingomyelin"synthetase"
SM" " U" Sec1/Munc18"family"of"proteins"
S/MAR" U" Scaffold/Matrix"attachment"region"
SNAP" " U" Soluble"NSF"attachment"proteins"
SRP" " U" Signal"recognition"particle"
SSC" " U" Side"scatter"
STAR" " U" Stabilising"anti"repressor"element"
Stx5" " U" Syntaxin"5"
SV40e"" U" Simian"vacuolating"virus"40"(promoter)"
t& & '& time"(normally"days)"
T25" " U" 25"cm2"tissue"culture"flasks"
TAE" " U" Tris,"acetate,"EDTA"(buffer)"
TALEN" U" Transcription"activatorUlike"effector"nucleases"
TCD" " U" Total"cell"density"
TEE" " U" Transcriptional"enhancing"element"
TEMED" U" Tetramethylethylenediamine"
TFRE" " U" Transcription"factor"regulatory/response"elements"
TGN" " U" TransUGolgi"network"
TI" " U" Targeted"integration"
Tm" " U" Melting"temperature"




UCOE" " U" Ubiquitous"chromatin"opening"element"
μL" " U" microlitre"
μm" " U" micron"(micro"meter)"
μM" " U" micromolar"
UPR" " U" Unfolded"Protein"Response"
UTR" " U" Untranslated"region"
V" " U" Volts"
VEGF" " U" Vascular"endothelial"growth"factor"
VCD" " U" Viable"cell"density"
vUSNARE" U" Vesicle"(membrane"localised)"SNARE"
VSVUG" " U" VesicularUstomatis"virusUG"
WB" " U" Western"Blot(ting)"
" 17"
WCB" " U" Working"cell"bank"
WCP" " U" Whole"Cell"Protein"




































































































cell& factory& in& biotechnology,& alongside& an& introduction& to& the& secretory& pathway&
within& mammalian& cells.& It& starts& with& an& introduction& to& the& biopharmaceutical&
industry&and&how&biopharmaceuticals&are&produced.&The&CHO&cell&and&the&processes&
by& which& it& is& used& to& produce& biologics& is& introduced,& alongside& an& overview& of&
previous&engineering&approaches&that&have&been&taken&to&enhance&CHO&productivity.&






referred" to" as" a" biologic)" is" a" form" of" therapeutic" pharmaceutical" drug"





related" diseases," metabolic" and" endocrine" disorders." Recently" gene" therapies"
requiring"highUquality"nucleic"acid"have"become"more"prevalent,"with"the"DNA"or"
RNA"used"also"classed"as"a"biologic"(Ginn"et"al."2018)."To"gain"approval"for"human"






Recent"data" shows" that" sales" of" biologics" approved" for" human"use" totaled" $140"
billion" in" 2013," with" 54" biologics" approved" for" human" use" between" 2010" and"
2014." Biologic" sales" increased" 18.2%" in" 2012" compared" to" 2011," an" increase"
sevenUtimes"greater"than"the"2.5%"increase"seen"across"the"entire"pharmaceutical"
sector." The" nine" major" protein" biologic" families" comprise" of" monoclonal"
antibodies" (Mabs);" hormones;" growth" factors;" fusion" proteins;" cytokines;" antiU
coagulants;"recombinant"vaccines"and"therapeutic"enzymes"(table"1U1)."The"most"
" 21"
prevalent" protein" biologic" family" are" Mabs," with" nine" approved" by" the" FDA" in"
2017" (de" la" Torre" and" Albericio" 2018)." Mabs" accounted" for" 31%" of" worldwide"
biologic"approvals" in"the"four"years"to"2014"and"made"up"38%"($24.6"billion)"of"
total"US" biologic" sales" in" 2012" (Aggarwal" 2014;"Walsh" 2014)." By" 2014," 47"Mab"
products"had"been"approved"by"US"and"European"regulators."By"2016/2017"this"
had" increased" to"74"MabUbased"products"making"up"65.6%"of" total" recombinant"









the" 2008" global" recession" and" onUgoing" austerity" and" financial" pressures"









Monoclonal" antibodies" (Mabs;" also" known" as" Immunoglobulins," and" including"
Immunoglobulin"G;"IgG)"are"the"highest"selling"class"of"biologic"(Aggarwal"2014)."
This" is" due" to" their" specificity" to" disease" targets," their" ability" to" be" completely"
humanised"(both"resulting"in"reduced"side"effects"and"immunogenicity)"and"their"
ability"to"be"conjugated"to"another"therapeutic"agent"or"radioisotope"such"that"it"
can" be" better" targeted" or" used" for" diagnostic" purposes" (Wang" et" al." 2007)."
Antibodies"naturally"produced"within" the"body"are"proteins" that"bind"to"specific"
antigens" (via"molecular"markers" known" as" epitopes)" and" then" neutralise" them."
Mabs" are"made" by" immune" system" lymphocytes" that" alter" deepening" upon" the"




Due" to" the" large" number" of" antigens" that" can" be" present"within" a" body,"myriad"
antibodies"are" required" to" target" them."Functional"diversity"within" the"antibody"
family" is," however," based" upon" a" conserved" molecular" backbone." A" roughly" YU
shaped"molecule" comprises" of" a" constant" region" (Fc)" forming" the" base" of" the" Y,"
" 22"
with" two" variable" domains" that" bind" antigen" forming" the" top" of" the" Y" (antigen"











The" Mab" LC" and" HC" are" each" encoded" by" separate" genes," the" gene" products"
forming" an" antibody" molecule" containing" two" HCs" and" two" LCs" due" to"
glycosylation,"disulphide"bond"formation"and"their"heterogeneity."However"some"
humanised"HCs"can"fold"and"dimerise"without"the"presence"of"LC,"subverting"the"
ER’s" quality" control" system." This" process" is" dependent" upon" the" HC" variable"
domain"(Stoyle"et"al."2017)."It" is"because"of"these"complexities"in"Mab"formation"
and"modification"that"their"synthesis"outside"of"the"body"can"not"be"performed"in"
a" chemical" reaction,"with" a"mammalian" cell" required" to" complete" their" complex"






The&nine&main&classes&of&biologics&are& shown&with&a&description&of& representative&diseases& they&are&
used&to&treat.&One&specific&example&of&each&class&is&highlighted&and&the&total&sales&from&2012&for&each&


















immune" cells." Binding" to" an"
epitope" highlights" a" problem"
















Growth!Factors! Protein" that" stimulates"










A" single" protein" made" from"
two" separate" genes" fused"
together" –" e.g." an" effector"
























Blood!factors! Clotting" factor" proteins"




















Opposite" of" Blood" Factors" –"















of& the& antibody& remains&more& constant& and& activates& immune& response& through& interactions& with&





The" development" of" a" biologic" follows" a" workflow" of" target" identification;"
discovery" of" a" molecule" that" acts" upon" it" (e.g." by" phage" display," hybridoma"
discovery"techniques);"enhancement"of"the"molecule"to"improve"its"efficacy"before"
manufacturing" and" finally" testing" to" see" whether" the" molecule" can" be" massU
produced"at"a"satisfactory"scale,"cost"and"purity."With"the"complexities"of"biologics"
exceeding" those" that" can" be" achieved" by" chemical" synthesis," the"
biopharmaceutical" industry"utilises"cellular"organisms"as"factories"with"which"to"
manufacture" biologics." The" gene" encoding" a" biologic" is" inserted" into" the" chosen"
cell" by" transformation" (prokaryotes)" or" transfection" (eukaryotes)" and" the" cell"
machinery" coUopted" to"manufacture" the" recombinant" protein." Highly" producing"





Simple" prokaryotes," particularly" Escherichia& coli,& were" initially" used" for"
production" of" recombinant" proteins." They" are" well" characterised;" easy" to"
genetically"manipulate;"easy"to"culture;"fast"growing"(entire"process"lasting"up"to"
48"h);"able"to"produce"high"protein"titres"(up"to"20"g/L)"and"therefore"relatively"
inUexpensive" and" quick" as" an" expression" system" (Rosano" and" Ceccarelli" 2014)."
However,"prokaryotic"systems"have"their"limitations."They"are"unable"to"produce"
the" complex" folding" and" postUtranslational" modifications" (PTMs)" required" by"
many" highlyUspecific" biologics" (KesikUBrodacka" 2018)." Internal" aggregation" of"
recombinant"protein,"which"bacteria"can"not"fully"secrete,"can"lead"to"the"biologic"
product" being" caught" in" difficultUtoUsolubilise" inclusion" bodies," making"
downstream"recovery"of"product"labour"intensive"and"expensive."Breaking"the"cell"





‘Generally" regarded" as" safe’" [GRAS]" by" the" FDA)" produce" recombinant" proteins"
that" are" more" accurate" and" functional" than" those" from" bacteria." Yeast" contain"
more" of" the" cellular"machinery" required" to" perform" the"basic" folding" and"PTMs"
that" are" required" for" protein" stability," function" and" efficacy." At" 6U8" days" in"
duration" yeast" processes" are" longer" than" bacterial" processes," but" recombinant"
















with" animal" pathogens" and" initial" setUup" and" plant" husbandry" costs" are"
inexpensive."However"largeUscale"production"requires"long"production"times"and"
large" amounts" of" land," whilst" transgene" expression" cannot" be" consistently"
controlled"(Lomonossoff"and"D'Aoust"2016;"Rasala"and"Mayfield"2015;"Whaley"et"
al." 2011;" Yao" et" al." 2015)." Green" microalgae" have" also" been" utilised" more" for"
recombinant" protein" production" due" to" them" being" safe," scalable," easy" to"
genetically"manipulate" and" inexpensive" to" grow."Use" of" insectUbased" expression"
systems" can" produce" products" with" many" accurate" PTMs," but" not" the" desired"
complex"glycosylation"patterns"required"(KesikUBrodacka"2018)."
For" some" purposes" and" molecular" targets," the" lack" of" precise" specificity" of" a"
biologic"is"not"problematic"and"so"production"in"microbial"systems"U"both"bacteria"
and" yeast" –" are"widely" used" for" research" and" industry."However," as" drugs" have"




unable" to" produce" the" high" level" of" specificity" required" for" most" use" within"




Production" of" recombinant" proteins" in" mammalian" cells" has" increased" rapidly,"
contributing"60%"of" all" biologics"produced"by"2014" (Walsh"2014;"Wurm"2004)."
Biologic" production" in"mammalian" cells" has" been" shown" to" be" effective," though"
some"engineering"of"the"product"is"required"for"it"to"function"correctly"(Baik"et"al."
2015)."Culturing"of"a"mammalian"cell"line"engineered"to"express"a"product"allows"
production" of" highly" specific" and" functional" recombinant" proteins" which" are"
secreted" from" the" cell," making" downstream" processing" relatively" simple" and"
similar" to" that"required" for"yeast"processes."However,"mammalian"cell"culture" is"
time" consuming" and" labour" intensive,"with" a" doubling" time" of" around" 24" hours"
" 27"
and"continuous"subUculturing"or" feeding"strategies" required" to"maximise"culture"
growth." This" results" in" processes" 2U4" weeks" in" duration" (De" Jesus" and" Wurm"
2011)."In&vivo"mammalian"cells"normally"exist"as"part"of"a"tissue"structure"but"to"
attain" the" cell" densities" required" to" make" protein" production" worthwhile"
suspension" growth" is" required." Cultured" mammalian" cells" are" much" more"
susceptible" to" contamination" and" small" changes" in" growth" conditions" than"
microbial"cells."Changes"in"media"composition"and"process"control"have"increased"
mammalian"cell"growth,"survival"time"and"productivity."Genetic"engineering"of"cell"
lines" has" enhanced" the" ability" of" cells" to" produce" biologics" to" the" required"
specificity," produce" higher" titres," quicker" growth" and" better" survival" in"
suspension"culture"(Almo"and"Love"2014;"Hacker"et"al."2009)."Various"mammalian"
cell" lines" can" be" used" for" biologic"manufacture," including"mouse"myeloma" lines"
(NS0,"Sp2/0),"murine"hybridomas,"human"cell" lines"(HEK293,"HeLa,"PER.C6)"and"
baby"hamster"kidney"(BHK)"cells"(Birch"and"Racher"2006)."However,"the"Chinese"






Chinese" Hamster" Ovary" (CHO)" cells" are" the" preferred" expression" system" for"
recombinant" biologics." The" CHO" expression" platform" accounts" for" 63%" of" all"
mammalian" production" systems" and" 35.5%" of" total" biologic" production" (Walsh"
2014)." Due" to" its" role" in" industry" CHO" is"well" characterised," its" genome" having"
been"sequenced"and"published"(Lewis"et"al."2013;"Xu"et"al."2011)."However" it" is"
genetically" plastic" enough" to" be" easily" manipulated" and" transformed" with" DNA"
encoding"recombinant"proteins"such"as"biologics."Effector"genes"can"also"be"used"
to"aid"the"amplification"of"the"product"gene,"further"enhancing"biologic"production"
levels." In" optimised" fedUbatch" manufacturing" processes" cell" densities" can" reach"
10U15" million" cells" mLU1," with" specific" productivities" of" 50U60" pg/cell/day"
resulting" in" product" yields" of" 1U5" g/L" for" Mabs" and" similar" molecules" (Wurm"
2004)."More"recently"antibody"titres"have"reached"10U13"g/L"(Huang"et"al."2010)."
















can" only" reach"mg/L" titres."Many" biological,"molecular" and" process" engineering"






more" moleculeUspecific" strategies," can" improve" production" levels" by" reducing"
difficultUtoUexpress" regions" or" motifs" that" result" in" aggregation" (Hussain" et" al."
2017)."The"optimised"gene"encoding" the"biologic" is" inserted" into"a"plasmid"DNA"
vector" and" placed" under" a" strong" promoter" from" which" its" transcription" is"
activated." The" highly" transcriptionally" active" Human" Cytomegalovirus" (CMV)"










(Cacciatore"et" al." 2010)."Recently," synthetic"promoter"design"has" improved"with"
them"becoming"more"prevalent" in"cell"engineering,"allowing"a"greater"and"wider"
control" over" transcription" rates" whilst" decreasing" the" length" of" the" promoter"
region"compared"to"those"from"natural"sources"(Brown"and"James"2016;"Brown"et"
al." 2014)." Utilisation" of" natural" and" synthetic" regulatory" elements" for" RNA"
processing"(e.g."polyUA"tail;"5’"and"3’"untranslated"regions;"introns"and"splice"sites"
to" encourage"nuclear" export)" further" enhance" rates" of" gene" transcription" (Birch"
and"Racher"2006)."
1.3.1.2.$Recombinant$gene$expression$
Plasmid" vectors" (containing" the" GOI," any" required" accessory" genes," selectable"
marker(s)" and" any" requisite" untranslated" control/regulatory" elements)" are"









Polyethylenimine," PEI;" Lipofectamine™)" requires" initial" complexing" of" the" DNA"
with" the" polymer." The" complex" is" then" taken" up" by" the" cell" by" endocytosis," the"
DNA" eventually" being" delivered" to" the" nucleus" where" it" can" be" transcribed."
Polymers" (especially"PEI)" are" generally" inexpensive" and"have" little" impact"upon"
cell" growth," though" transfection" rates" can" be" moderate" (Mozley" et" al." 2014;"
Thompson"et"al."2012)."Electroporation"physically"introduces"holes"in"to"the"CHO"
cell"wall"by"passing"an"electric"shock"through"a"mixture"containing" the"cells"and"
DNA." The" DNA" is" taken" up" into" the" cell" cytoplasm" through" the" holes" before"
delivery" to" the" nucleus"where" it" is" transcribed." Transfection" rates" are" generally"
quite" high" (above" 90%)" with" cell" recovery" improving" as" culture" time" extends,"
depending" on" the" strength" and" duration" of" the" charge" (Teissie" et" al." 2005)."
Nucleofection" is" an" improved" electroporation" method" where" DNA" is" better"
delivered"to"the"cell"nucleus"(Maurisse"et"al."2010).""
CHO"cells"can"be"either"transiently"transfected"(where"plasmid"DNA"is"transcribed"
whilst" it" persists" within" the" cell" population" for" 4U6" days)," or" stably" transfected"
(where" a" plasmid" integrates" into" the" genome" and" is" selected" for)." Transient"
transfection"produces" small" amounts" of" protein" so" is" ideal" for" the" initial" testing"
and"screening"of"genes"(both"product"and"accessory)"or"characterisation"studies."
It" is"also"scalable"between"different"culture"volumes"(Abbott"et"al."2015;"Baldi"et"
al." 2007)." The" development" of" longUterm" transient" expression" techniques" has"
resulted" in" largeUscale" transient" cultures" producing" up" to" 2" g/L" antibody" titres"
(Daramola"et"al."2014;"Derouazi"et"al."2004)."Stable"transfection"is"used"for"longU
term" highUlevel" product" production." The" stable" integration" of" the" recombinant"
DNA" into" the" genome" is" maintained" by" the" application" of" selective" pressure" to"
ensure"all"surviving"cells"contain"the"plasmid"(Kraemer"et"al."2010)."
1.3.1.3$Gene$expression$and$amplification$systems!!
Producing" CHO" cell" lines"with" high" expression" levels" of" good" quality" product" is"
required" to" make" them" viable" for" the" manufacture" of" biologics." This" primarily"
requires"a"cell" line"with"a"high"copy"number"of" the"gene"of" interest" (GOI)"stably"
integrated"into"the"genome"at"a"point"with"high"activity."Amplification"of"the"gene"
produces" cell" lines" with" high" GOI" activity" levels," with" two" platforms" U"












transfected" cells"with" the"DHFR" inhibitor"methotrexate" (MTX)"will" kill" cells" not"
expressing"DHFR."With"both"the"DHFR"gene"and"GOI"present"on"the"same"vector"
this" ensures" cells" expressing" the" GOI" persevering" within" the" cell" population."
Gradually" increasing" the" concentration" of" MTX"will" ensure" only" cells" with" high"
active" copy" numbers" of" DHFR" and" the" GOI" survive," resulting" in" an" enriched"
population"of"cells"with"high"productivity"levels"(Cacciatore"et"al."2010;"Kraemer"







an" exogenous" GS" gene." Growth" of" transfected" cells" in" glutamineUfree" media,"
coupled" with" treatment" with" the" GS" inhibitor" methionine" sulfoxamine" (MSX),"
results"in"the"death"of"cell"containing"only"low"levels"of"endogenous"or"exogenous"
GS." Only" cells" containing" higher" levels" of" active" GS" survive" these" conditions,"
resulting"in"all"cells"within"the"population"expressing"the"GOI.""
Gene" amplification" can" be" performed" by" increasing" MSX" levels," with" highU
producing" cells" then" selected" (Kraemer" et" al." 2010)." The" GS" system" has" several"
advantages"over"the"DHFR"system,"as" it"does"not"require"a"mutant"host"cell" line,"
although" the" efficiency" of" cell" line" generation" can" be" enhanced" by" knocking" out"
endogenous"GS"(Fan"et"al."2012)."GS"also"facilitates"a"more"rapid"selection"process,"
shortening"the"time"required"to"develop"a"high"producing"cell"line"(Nakamura"and"
Omasa" 2015;" Noh" et" al." 2013)." Using" a" weak" promoter" (e.g." SV40e)" to" drive"
transcription"of"the"selection"gene"(GS"or"DHFR)"aids"the"amplification"process"as"
to"survive"cells"will"need"to"be"more"productive"(Ng"et"al."2007)."Utilisation"of"a"




transfection" is" required."After" transfection"cells"are"selected" to"ensure"genes"are"




to" be" monoclonal," that" is" derived" from" a" single" progenitor" cell." Recombinant"
molecule" production" from" monoclonal" cells" produces" more" reproducible"
manufacturing" process" and" biologic" product" (ICHUQ5D" 1998)." FluorescenceU
activated" cell" sorting" (FACS)," cell" printing," microfluidic" systems" and" limited"
dilution" techniques" can" all" be" used" to" separate" heterogeneous" pool" populations"





(often" automated)" systems" and" continuously" monitored" for" productivity" and"
growth" levels" to"ensure" the"bestUperforming"cell" line" is" taken" forward" for"use" in"
manufacturing" processes" (Browne" and" AlURubeai" 2007;" Lindgren" et" al." 2009;"
Rouiller" et" al." 2016)." A" pool" of" transfectants" has" a" wide" range" of" phenotypes"




as" heterochromatin." Insertion" of" a" recombinant" gene" sequence" could" also"
interrupt" essential" genes," affecting" cellular" growth" or" processes." To" reduce" this"
heterogeneity,"increase"transcriptional"activity"and"therefore"product"yields,"sight"
directed/targeted" integration" (TI)" can" be" used" to" introduce" DNA" at" a" specific"
genomic" region"with"well" defined" expression" properties" (Baumann" et" al." 2017)."
Genetic"elements" that"modify"genomic"chromatin"can"also"be"used"to"ensure"the"
GOI" is" in" a" transcriptionally" active" conformation." This" can" be" achieved" by" the"
addition" to" the" transfected" DNA" of" a" Ubiquitous" Chromatin" Opening" Element"
(UCOE);"Scaffold/Matrix"Attachment"Region" (S/MAR);"Stabilising"Anti"Repressor"
(STAR)"elements;"or"insulators"that"are"linked"to"the"GOI."These"elements"reduce"





in" a" transfected" cell" pool," reducing" cell" line" development" timelines."UCOEs"have"
been" shown" to" increase" Mab" productivity" in" CHO" cells" by" more" than" 6Ufold"
(Benton"et"al."2002;"Betts"and"Dickson"2015;"Betts"and"Dickson"2016;"Neville"et"al."
2017;"Saunders"et"al."2015).""
Even"with" targeted" integration," transfectant" pools" have" a"wide" range" of" cellular"
phenotypes." It" is"desirable" to" identify"a"singleUcell"derived"colony"with"desirable"
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growth"and"productivity"characteristics"as"quickly"as"possible."This"accelerates"the"
development" of" a" highUproducing" cell" line," allowing" product" analysis," medical"
trials"and"eventually" largeUscale"manufacture" to"occur" in"a"shortened"timeframe."
However,"behavior"of"a"cell"line"early"in"the"selection"process"does"not"necessarily"
indicate" its" behavior" in" the" final" production" process" (Porter" et" al." 2010)."
Improving"high"throughput"screening"(HTS)"techniques"at"larger"scales"is"starting"
to" improve" the" cell" selection" process" with" regards" to" comparable" performance"
across"multiple"production"scales"(Abbott"et"al."2015;"Rouiller"et"al."2016)."Once"a"
highUperforming" clone" has" been" selected" CHO" cells" are" still" susceptible" to"




the" initial" methods" used" to" enhance" titres." Bioprocess" optimisation" has" seen" a"
100Ufold"increase"in"CHO"cell"yields"of"recombinant"proteins"to"between"1U5"g/L,"
with" a" specific" cellular" productivity" (Qp)" of" 50" U" 90" pg/cell/day" (Hacker" et" al."
2009;" Wurm" 2004)." A" decrease" in" culture" temperature" during" the" stationary"
phase"of"cell"growth"can"result" in"a"coordinated"cellular"response"in"mammalian"
cells." A" combined" modulation" of" the" cell" cycle," translation," transcription" and"
metabolism" can" reduce" cell" growth," allowing" more" cellular" resources" to" be"
directed" towards" protein" production." This" then" leads" to" a" higher" specific"
productivity" and," if" performed" correctly," an" increased" overall" titre." This" is" also"
seen" in" transientlyUexpressing" cultures," with" mild" hypothermia" also" improving"
Mab"glycosylation"(AlUFageeh"et"al."2006;"Sou"et"al."2018;"Torres"et"al."2018;"Yee"et"
al."2009).""
For" downstream" purification" and" regulatory" purposes," animalUderived" products"
such" as" serum" can" not" be" used" in" manufacturing" cell" culture," despite" their"
enhancing"effects"upon"growth"and"productivity"levels"in"a"research"environment."
The"development"of"CHO"cell"lines"able"to"grow"in"serumUfree"shaken"suspension"
culture," coupled" with" the" optimisation" of" chemically" defined" (CD)" media"
conducive" to" this," has" allowed" the" removal" of" serum" from" the" manufacturing"





during" large" scale" production." Compared" to" small" researchUscale" cell" culture"
volumes,"the"large"volumes"of"liquid"culture"required"for"manufacturing"processes"
suffer" more" from" poor" mixing." This" can" lead" to" microenvironments" within" the"
bioreactor." Increasing" mixing" speeds" to" combat" these" results" in" higher" shear"
forces"which" further" impact"upon"culture"growth,"as"well" as" increasing"host" cell"
" 33"
protein" (HCP)" levels" in" the" growth"medium"which" can" pose" a" purification" issue"
(Hogwood" et" al." 2014)." Concentration" gradients" of" gas," feed" substrates" and" cell"
metabolites" can" develop," resulting" in" a" heterogeneous"mixture" and" exposure" of"
cells" to" inhibitory" environments"which" can" result" in" a" reduction" in" cell" growth,"





peroxide" and" lactate" to" reduce" oxidative" stress" on" the" culture" and" enhance"
productivity"(Ha"et"al."2018)."Addition"of"cell"cycle"inhibitors"or"histone"modifiers"
can" alter" the" transcriptomic" and" proteomic" profile" of" the" cell," resulting" in"
enhanced" productivity" (Du" et" al." 2015;" Gatti" et" al." 2007;" Yee" et" al." 2009)." The"
production" of" HCPs" during" cell" culture" provides" challenges" for" the" downstream"










Expansion" of" the" drug" development" pipeline" from" basic" Mabs" and" globular"
proteins" has" resulted" in" the" necessity" to" produce" bispecifics," antibodyUdrug"
conjugates," radioimmunoglobulins," fusion" proteins," antibody" fragments" and"
immunocytokines." Many" of" these" will" require" complex" and" specific" folding" and"
glycosylation" that" CHO" cells"may" struggle" to" perform" (Spiess" et" al." 2015;" Strohl"
2018).""
1.3.1.6.1.$Meeting$future$biologic$demand:$Production$platform$considerations.!!
Mammalian" systems" have" the" capacity" to" produce" the" drug" quantities" currently"
required" to" target" diseases" such" as" cancers" and" immune" deficiency" in" north"
American"and"western"European"markets."However"as" the"demand" for"biologics"
increases"both"within" and"without"of" these" areas," so"will" the"pressure"upon" the"








the" worldwide" CHO" manufacturing" process." For" example," a" 1" g/month" dose" of"
biologic"per"patient"for"a"total"patient"population"of"one"million"would"require"12"
metric" tons" per" annum," a" value" double" the" worldwide" CHO" manufacturing"
capacity"in"2016"(Matthews"et"al."2017).""
Without" rapid" increases" in" mammalian" cell" productivity" levels" and" capacity,"
(which"may" yet" come" about" through" ongoing" optimisation" and" improvement" of"
longUterm" perfusion" manufacturing" technologies)" an" alternative" manufacturing"
platform" capable" of" mimicking" human" postUtranslational" modifications" whilst"
producing" the" required" level" of" materials" would" have" to" be" found." Eukaryotic"
microorganisms"such"as"yeast"are"used"in"industrial"scale"protein"production"but"
are" not" currently" suitable" for" the" high" specificity" required" for" many" biologics,"
especially"with"regards"protein"folding"and"PTMs.""
It" is" in" the" engineering" out" of" nonUmammalian" PTMs," and" engineering" in" of"
mammalian" PTMs," that" the" recent" advances" in" applicability" of" powerful" geneU
editing" tools"such"as"Clustered"Regularly" Interspaced"Short"Palindromic"Repeats"





systems" (0.1%" and" 2U10%" of" production" costs" respectively)," though" there" are"




The"widening" of" drug" development" pipelines"will" require" increased" throughput"
and" speed" with" which" to" both" optimise" production" process" as" well" as" produce"
small" amounts" of" drugs" for" testing" and" trials." HTS" processes" are" becoming"
increasingly"prevalent"to"optimise"cell" line"productivity"(Arnall"et"al.,"manuscript"
in"preparation;"Mora"et"al."2018)."The"development"of"Cell"Free"Protein"Synthesis"




is" required" to" improve" glycosylation" and" disulphide" bond" formation" in" CFPS"
systems" and" expanding" these" smallUscale" processes" to" a"manufacturingUrelevant"
scale"seems"somewhat"distant.""
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With" diminishing" returns" after" more" than" 25" years" of" process" optimisation,"
genetic" engineering" of" the" CHO" cell" has" further" increased" biologic" yields" by"
improving"productivity"levels"of"the"cell" itself," improving"yields"and"allowing"the"
production"of"more"complex"biopharmaceuticals"(Fischer"et"al."2015)."Engineering"
targets" to" improve" yields" have" so" far" focused" on" enhancing" transcriptional" and"
translational" control" of" the" product" gene" (Brown" and" James" 2016)." Metabolic"
engineering" and" cellUcycle" control" has" improved" cell" growth" within" culture"
(Fussenegger" et" al." 1998)."GlycoUengineering"has" enhanced"PTMs" such" that" they"
closer" match" patterns" found" in" humans" (Chung" et" al." 2017)." Aggregation" of"
products" has" been" reduced" (Le" Fourn" et" al." 2014)," whilst" engineering" of" the"
Endoplasmic" Reticulum" (ER)" and" the" Unfolded" Protein" Response" (UPR)" has"
improved" protein" processing," reduced" protein" aggregation" within" the" cell" and"








The" mammalian" secretory" pathway" is" made" up" of" many" discrete" membraneU
bound" compartments" comprising" organelles," vesicles," secretory" tubules,"
endosomes" and" lysosomes." Biological" membranes" are" fluid" and" easily" undergo"
topological" changes" due" to" their" fluidity" and" quasiU2Udimensional" structure,"
resulting" in"membrane" scission" and" fusion" events" essential" for" intraU" and" extraU
cellular" trafficking" as" well" as" general" cell" maintenance" (Knorr" et" al." 2017)."
Processing" of" both" host" and" recombinant" proteins" takes" place" within" the"
structures."Organelles"and"vesicles"contain"both"resident"proteins,"which"remain"
in" the" compartment" and" confer" its" biochemical" function" upon" it," and" transient"
‘cargo’"proteins"passing" through" the"organelle"en&route" to" their" final"destination."
There" are" two" main" mammalian" transport" pathways" controlling" transport" in"
different"directions"within"the"cell."Retrograde"transport"moves"cargos"from"their"
current" location" U"be" it" the"cell" surface"or"a"peripheral"organelle" U" further" inside"
the" cell." Endocytosis" initiates" this" pathway" at" the" cell" surface." Anterograde"
transport" shuttles" cargo"proteins" from"within" the"ER" towards" the"extremities"of"




continuous" delivery" of" cellular" components" to" the" plasma" membrane" and" the"
exocytosis"of"extracellular" factors."Meanwhile," specific"cells"such"as"neurons"and"
endocrine/immune" cells" practice" regulated! secretion" of" specific" molecular"
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modulators" and" effectors" (e.g." neurotransmitter" release" into" the" synapse;"
hormone/antibody" release" in" to" the" blood" stream)." The" secretion" of" these"
molecules" is" not" continuous,"with" cargo" being" stored" at" a" high" concentration" in"




The" secretory" pathway" begins" with" transport" of" the" nascent" polypeptide" chain"
from" the" ribosome" into" the"ER" lumen"via" the" translocon," a"process"mediated"by"
interaction" between" the" protein’s" signal" peptide" and" the"ER’s" signal" recognition"
particles"which"mediates"docking" of" the" ribosome"at" the" translocon" (Halic" et" al."
2006)."Within"the"ER"protein"folding"and"initial"PTMs"takes"place"with"the"help"of"




Glick"and"Nakano"2009),"with" transport" to" the" transUGolgi"network" (TGN)"being"





most" cell" types" are" not" secretory" specific." In" the" case" of" secretoryUspecific" cell"
types" naïve" cells" mature" into" protein" processing" and" secreting" factories." For"
example," antibodyUsecreting" plasma" cells" mature" from" naïve" BUcells." BUcells" are"
activated" by" the" immune" system," resulting" in" their" terminal" differentiation" into"
plasma" cells," the" antibody" producing" and" secreting" factories" of" the" immune"
system." This" change" in" cell" phenotype" is" brought" about" by" a" large" increase" in"
secretory" pathway" components" resulting" in" organelle" biogenesis," increasing" ER"
and"Golgi"volumes"(figure"1U2;"Ribourtout"and"Zandecki"2015;"Shaffer"et"al."2004;"
ShapiroUShelef" and" Calame" 2005)." Plasma" cell" protein" production" capacity" has"
been"calculated"to"reach"approximately"100"pg"of"IgG"monomers"per"cell"per"day,"






plasma& cell& that& is& specialised& in& the& secretion& of& antibodies.& The& cell& size& expands& slightly& (to&







bending& and& vesicle& budding.& Upon& budding&many& coat& proteins& are& shed& (see& section& 1.4.1.1).& [2]&
Interaction& between& vesicle& and& cytoskeleton& components& mediate& transport& towards& target&
membrane&(see&section&1.4.1.3).&[3]&Tethering&and&docking&of&vesicles&to&target&membranes&provides&












This" property" allows" the" formation" and" scission" of" vesicular" and" tubular"
structures"which"are"utilised"in"intracellular"transport"and"exocytosis"(Knorr"et"al."
2017)."Despite"the"differences"between"different"organelles"and"the"proteins"that"




correct"cargo"and"effector"proteins," resulting" in" the" formation"of"a"vesicle"which"
then" buds" from" the" parent" organelle" (Faini" et" al." 2013)." A" mixture" of" directed"
transport" (utilising" the" cell’s" cytoskeleton)" and" undirected" transport" ferries" a"
vesicle" towards" its" target"membrane"(Brownhill"et"al."2009)."Here" tethering"and"
docking" ensure" correct" vesicle" targeting" and" bring" the" vesicle" and" target"
membranes" into" close" enough" proximity" that" fusion" of" the" two" occurs" and" the"
vesicle’s" contents" are" delivered" (Bao" et" al." 2018;" D'Agostino" et" al." 2017)." An"
overview"of"a"vesicle’s"lifeUcycle"is"shown"in"figure"1U3."Five"main"protein"families"
regulate" eukaryotic" vesicular" transport:" Vesicle" coat" proteins;" Rab" GTPases;"
tethers;"SNAREs"and"SNAREUregulators."All"are"conserved"across"phylogeny"from"
yeast" to"man"and"across"cell"organelles" involved" in"vesicle" trafficking"U"ER,"Golgi"
apparatus"(containing"cisU"medialU"and"transUGolgi"regions),"endosomes,"lysosomes"
and" the" PM" U" albeit" in" slightly" different" forms" (Bock" et" al." 2001)." Despite" cargo"








and" endocytic" transport." All" can" transport" proteins," lipids" and" small" molecules,"
have"a" common"ancestry"and" function" in" similar"ways" (Faini" et" al." 2013;" Jensen"
and" Schekman" 2011;" Owen" et" al." 2004)." However" the" processes" of" COPIU" and"
COPIIUmediated" vesicle" transport" are" most" relevant" to" protein" secretion" from"
mammalian"cells."Rab"GTPases"(in"their"active"GTPUbound"state)"are"recruited"to"
transport"vesicles"and" interact"with"effector"molecules"to"regulate"a"vesicle’s" life"
cycle" (Fukuda" 2008)." Rab" activity" is" controlled" by" Guanine" Exchange" Factors"




components" (MizunoUYamasaki" et" al." 2012)." Vesicle" formation" commences"with"
the"activation"of"an"adaptor"protein"(AP)"by"a"GTPase."Activated"APs"recruit"coat"
proteins" (which" themselves" can" act" as" an" extra" AP)," cargo" or" cargo" adaptors"
(which"capture"soluble"cargoes"from"the"ER"lumen)"and"vesicle"effector"proteins"
(e.g." tethers," SNAREs)" to" the" vesicle" budding" site" (Cai" et" al." 2007a)." BuildUup" of"
coat" complexes" leads" to" membrane" bending" which" eventually" results" in" the"
physical" process" of" vesicle" fission" from" the" donor" membrane" (Bethune" and"
Wieland"2018).""
1.4.1.1.1.$Cargo$selection$and$vesicle$formation$at$the$ER!!
The"COPII" coat" complex"mediates"vesicle"budding" from" the"ER"membrane"at"ER"
exit" sites" (ERES,)" with" vesicle" formation" undergoing" a" stepwise" assembly." The"
small"GTPase"Sar1"is"activated"by"the"GEF"Sec12"(Barlowe"and"Schekman"1993),"
with" Sar1UGTP" interacting" with" the" ER" membrane" and" inducing" membrane"
curvature"(Long"et"al."2010)." Increased"membrane"curvature"has"been"shown"to"
increase" Sar1UGTP’s" affinity" for" ERUmembrane" binding" and" GTPase" activity,"
creating"a"positiveUfeedback" loop" linking"Sar1"to"membrane" fission"(Hanna"et"al."
2016)."MembraneUbound" Sar1" recruits" the" COPII" inner" coat" proteins" Sec23" and"
Sec24," which" form" a" heterodimer."Whilst" Sec23" interacts" with" Sar1UGTP," Sec24"
recruits" cargo" proteins," cargo" adaptors" and" vesicle" effectors" (e.g." SNAREs" and"
tethers)" to" the" ERES," forming" a" preUbudding" complex" that" excludes" ER" resident"
proteins" (Aridor" 2018;" Miller" et" al." 2002;" Sato" and" Nakano" 2005)." The" Sec16"
protein,"believed"to"have"a"scaffold"role,"has"also"been"shown"to"mark"ERES"and"is"
required" for" COPII" vesicle" formation," being" recruited" by" Sar1" independently" of"
Sec23/24"(Sprangers"and"Rabouille"2015;"Watson"et"al."2006).""
There" are"many" different" cargo" adaptor" proteins" (APs)" that" can" be" involved" in"
vesicle" formation," either" travelling" with" their" cargo" or" merely" facilitating"
packaging"into"vesicles,"with"APs"only"interacting"with"fullyUmature"cargo"proteins"
(Barlowe" and" Helenius" 2016)." Some" specific" APs" can" expand" the" COPII" vesicle"
beyond"its"normal"size"(50"U"100"nm)"so"that"large"proteins"such"as"collagen"can"be"
accommodated"and" transported" (Gorur"et" al." 2017;" Saito"et" al." 2017;" Saito"et" al."
2014).""
The"COPII"complex"of"outer"coat"proteins,"the"Sec13USec31"dimer,"binds"the"preU





31" increases" the" hydrolysis" of" Sar1UGTP" to" inactive" Sar1UGDP," leading" to" the"
shedding" of" COPII" coat" proteins," leaving" a" membraneUbound" vesicle" in" the"
cytoplasm"(Bi"et"al."2007;"Bonifacino"and"Glick"2004;"Faini"et"al."2013;"Jensen"and"
Schekman"2011;" Saito" et" al." 2017)."Not" all" coat"proteins" are"necessarily" shed"as"
" 40"
they"have"been"shown"to"have"a"role"in"vesicle"targeting"and"tethering"(Cai"et"al."




The" COPI" coat" complex" mediates" vesicle" formation" and" budding" at" the" Golgi,"
instigating" both" intraUGolgi" and" GolgiUER" retrograde" transportation." The" latter"
process"is"involved"in"the"recycling"of"COPII"vesicle"components"to"the"ER"(Nelson"
et" al." 1998)." COPI" vesicle" formation" for" retrograde" transport" is" instigated" by"
recruitment" of" activated" AP" Arf1" GTPase" to" the" Golgi" membrane." Activation" of"
Arf1"is"carried"out"by"a"range"of"ArfUGEFs,"which"one"depending"upon"the"position"
within"the"Golgi"stack."The"ArfUGEF"GolgiUspecific"Brefeldin"A"resistance"1"(GBF1)"
is" responsible" for" regulation"of"Arf1"activation"at" the"ERUGolgi" interface" (GarciaU
Mata" et" al." 2003)." Activated" Arf1UGTP" recruits" a" preUformed" COPI" coatomer"
complex"containing"seven"subunits"to"the"Golgi"membrane"(Harakuge"et"al."1994;"
Yu" et" al." 2012)." Sorting" signals" on" cargo" proteins"mediate" their" packaging" in" to"
COPI"vesicles"through"interaction"with"COP"subunits"and"APs"(Jackson"et"al."2010;"
Yu" et" al." 2012)." Coatomer" attachment" to" the" membrane" leads" to" coatomer"




remaining" aiding" vesicle" targeting" and" tethering" (Arakel" and" Schwappach"2018;"
Bethune"and"Wieland"2018;"Faini"et"al."2013)."
1.4.1.1.2.$Cargo$loading$and$vesicle$formation$at$the$TGN$
The" Golgi" is" polarised," allowing" transport" through" the" stacks" that" make" up" the"
organelle" to"be"directed" (Allan" et" al." 2002;"Boncompain" and"Perez"2013)." Cargo"
eventually" reaches" the" transUGolgi" network" (TGN)" where" the" endocytic" and"
exocytic" pathways" converge" in" the" sorting" of" lipids" and" proteins" for" delivery" to"
their" divergent" final" destinations," including" endosomes," lysosomes," the" PM," or"
back"through"the"Golgi"stack."For"accurate"delivery,"cargo"has"to"be"packaged"into"
transport" carriers" associated" with" docking" and" transport" machinery" specific" to"
their" destination" (De" Matteis" and" Luini" 2008)." Cargo" proteins" contain" specific"
signals"(e.g."tyrosine"based;"diULeucine"motifs)"that"are"recognised"at"the"TGN"by"
APs" that" also" recruit" requisite" vesicle" components" (Bethune" and"Wieland" 2018;"
Owen"et"al."2004;"Traub"2005)."Cargo"proteins"have"been"shown"to"exit"the"TGN"in"










mediates" the" lipid" makeUup" of" the" membrane" region," with" high" DAG"
concentrations" leading" to" bending" of" the" membrane" away" from" the" lumen,"
facilitating" transport" carrier" formation" and" budding" (Bard" and" Malhotra" 2006;"
Fugmann"et"al."2007;"Graham"and"Burd"2011;"Hausser"et"al."2005)."However"some"
transport" carrier" formation"may" be" induced" by" the" presence" of" a" specific" cargo"
(Yeaman"et"al."2004)."Transport"from"the"TGN"to"the"PM"can"also"take"other"forms,"
for" example" via" the" endosome" and" its" recycling" pathway" to" the" PM;" ClathrinU
related" APs;" transport" of" ubiquitylated" proteins" by" GolgiUlocalising," γUearU






initially" shuttled" by" COPII" vesicles" for" further" sorting" (by" both" the" signal"
sequences"within"the"cargo,"and"the"difference"in"pH"between"the"ERGIC"and"ER)."
At" the" ERGIC" concentration" and" quality" control" of" cargo" is" performed" before"
subsequent"transport"to"the"Golgi"via"a"second"vesicular"transport"step"involving"
COPI" (AppenzellerUHerzog"and"Hauri"2006;"Baines"and"Zhang"2007;"BenUTekaya"
et" al." 2005)." COPI" components" localise" to" the" ERGIC" and" are" required" for" its"
formation" (Lavoie" et" al." 1999;" Oprins" et" al." 1993)." Efficient" transport" of" several"
globular" cargo" proteins" from" ERES" to" the" ERGIC" requires" a" cargoUreceptor"
complex"formed"by"the"ERGIC53"(aka"LMAN1)"and"MCFD2"proteins"that"assist"ER"
export" and" delivery" to" the" ERGIC" before" LMAN1" is" recycled" back" to" the" ER"
(Appenzeller" et" al." 1999;" Nyfeler" et" al." 2008;" Nyfeler" et" al." 2006;" Zhang" et" al."
2005)."Vesicle" fusion" leading" to"ERGIC" formation" is" also"mediated"by"vesicleUtoU




Vesicle" transit" between" organelles" relies" upon" the" cell’s" cytoskeleton" which"
comprises" of" actin" and" microtubule" filaments" and" their" associated" molecular"
motors."Vesicles"interact"with"motor"proteins"such"as"the"microtubuleUassociated"
kinesin" and" dynein" (which" are" directed" to" microtubules’" +" and" –" ends"
respectively)" and" actinUassociated" myosin." Attachment" of" vesicles" to" motor"
proteins"is"likely"mediated"by"specific"adaptor"proteins"(e.g."kinectin"with"kinesin;"
dynactin" with" dynein)," with" Rab" GTPases" also" orchestrating" motor" protein"




movement" dependent" on" microtubules" and" kinesin," as" well" as" shortUrange"
diffusiveUlike"movements"mediated" by" actin" and"myosin," suggesting" rapid" cargo"
delivery" to" the"correct"area"of"a"cell" is"directed"along"microtubule" tracks,"before"
actinUmediated"transport"to"the"vesicle’s"final"destination"(Manneville"et"al."2003)."
Vesicle"transport"can"also"be"directed"in"a"manner"independent"of"motor"proteins,"
with" actin" polymerisation" able" to" direct" vesicles" upon" their" interaction" with"
transport" complex" surface" proteins" (Khaitlina" 2014)." Cytoskeletal" components"
also" help"maintain" organelle" structure," lumenal" conditions" and" cellular" position"
(LazaroUDieguez" et" al." 2006)," whilst" the" Golgi" is" known" to" be" a" microtubule"
nucleation"site"(Brownhill"et"al."2009).""
"
Cargo" leaving" ERES" has" been" shown" to" concentrate" in" preUGolgi" intermediates"
before" moving" towards" the" Golgi" complex" along" microtubules" using" the"
microtubule" motor" complex" of" dynein/dynactin," disruption" of" which" arrests"
transport" of" a" model" cargo" protein" (Presley" et" al." 1997)." The" COPII" Sec23U24"




vesicles" to" motor" proteins" allows" the" transport" of" vesicles" along" the" polarised"
elements"of" the"cell’s"cytoskeleton,"with"motorUprotein"adaptors"also"believed"to"
have"a" role" in"motor"protein"activation" (Allan"et"al."2002;"Brownhill" et"al."2009;"
Kamal"and"Goldstein"2002).""
"
Due" to" the" short" distances" involved," transport" of" COPI" vesicles" between" Golgi"
cisternae" is" likely"diffusion"mediated."The"actin"cytoskeleton" is" likely" to"mediate"
retrograde" traffic" of" COPI" vesicles" from" the" Golgi" to" the" ER," with" many" actinU
binding"proteins"localised"to"the"Golgi"and"activated"in"response"to"the"ArfUGTPase"




at" the"TGN" interact"with"Myosin"via"a"Rab"GTPase"and"exocyst" subunit" to"direct"
transport"towards"the"PM"(Jin"et"al."2011)."Lipid,"ion"and"small"molecule"transport"
between" organelles" can" be"mediated" by" interUorganelle"membrane" contact" sites"
where" close" tethering" (but" not" full" fusion)" between" the" ER" and" PM," endosomes"
and"mitochondria"occurs"(Henne"et"al."2015;"Phillips"and"Voeltz"2016).""
1.4.1.4.$Vesicle$tethering$at$the$target$organelle$
Once" transported" to" its" target" destination" a" transport" vesicle" interacts"with" the"






2009)." This" allows" transmembrane" soluble" NUethylmaleideUsensitive" fusion"
protein" attachment"protein" receptors" (SNAREs)"present" on"both" the" vesicle" and"




the" two"membranes" (D'Agostino" et" al." 2017;" Gerst" 2003)."Much" of" the"work" on"
vesicle"tethering"mechanisms"has"been"carried"out"in"yeast"model"systems,"though"
many" components" are" conserved" in" mammalian" cells." The" role" of" tethers" has"
recently"been"shown"to"go"beyond"formation"of"a"lose"membrane"interaction,"with"
them" shown" to" play" an" essential" mechanical" role" in" the" later" stages" of" vesicle"
fusion"as"well"as"Golgi"structure"maintenance"(Brown"et"al."2011;"D'Agostino"et"al."
2017;"Spang"2017).*




of" the" Golgi." They" have" also" been" shown" to" convey" specificity" towards" vesicles"
originating" from"different" locations" (Munro" 2011;"Wong" and"Munro" 2014)." The"
two"types"of"tethering"complex"(coiledUcoil"Golgins;"large"multiUsubunit"tethering"
complexes"[MTC])"both"interact"with"SNAREs,"membrane"lipids,"coat"proteins"and"
small" GTPases" in" a" mechanism" for" vesicle" tethering" that" is" conserved" between"
family" members" (Sztul" and" Lupashin" 2006)." An" overview" of" Golgin" and" MTC"





CoiledUcoil" tethers" (also" referred" to" as" Golgins)" are" long," rodUlike" molecules"
containing" αUhelices" that" often" form" dimers." They" extend" a" significant" distance"
(theoretically"between"100"U"600"nm)"from"the"Golgi,"allowing"vesicle"capture"at"
range" and" forming" fibrous" bridges" between" inbound" vesicles," Golgi"membranes"
and"cisternae"(Cheung"and"Pfeffer"2016;"Munro"2011;"Sztul"and"Lupashin"2006;"
Witkos" and" Lowe" 2015)." In" general," a" tether’s" N" terminus" “catches”" a" vesicle"
through" interaction"with" specific"motifs," coat" subunits" or" vesicleUlocated" tethers"
whilst" being" anchored" –" either" through" peripheral" interactions"with" an" adaptor"
protein"or"via"a"membraneUintegrated"tail"anchor"U"to"the"target"membrane"at"its"
CUterminus"(Brown"et"al."2011;"Cheung"and"Pfeffer"2016;"Gillingham"and"Munro"
2016;" Guo" et" al." 2008)." The" Golgin" contains" several" RabUGTPase" binding" sites"
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which"function"in"drawing"the"vesicle"closer"to,"and"its"stabilisation"on,"the"target"
membrane," allowing" for" interaction" with" fusion" machinery" (Witkos" and" Lowe"
2017)."
Multisubunit"tethering"complexes"are"compartmentUspecific"tether"complexes"that"
promote" specific" vesicle" fusion" at" the" correct" target" destination," although" they"
function" over" shorter" distances" (up" to" 30" nm)" than" coiledUcoil" tethers." MTCs"
contain" between" three" and" ten" subunits" which" can" be" classed" as" ‘complexes"
associated"with"tethering"containing"helical"rods”"(CATCHR;"containing"long"rods"
of"stacked"helical"bundles),"or"nonUCATCHR"complexes"which"have"a"more"diverse"
subunit" composition." Despite" this" structural" difference," all" MTCs" share" similar"
protein"interactions"and"therefore"a"common"functional"mechanism"(Dubuke"and"
Munson" 2016;" Hong" and" Lev" 2014)." The" transport" protein" particle" (TRAPP)"
complexes" are"multiUsubunit" complexes"with" the" least" similarity" to" other"MTCs."
Some" subunits" having" RabUGEF" activity" and" all" TRAPP" genes" are" essential" for"
human"cell"survival."(Cai"et"al."2008;"Kim"et"al."2016).""
1.4.1.4.1.$Vesicle$tethering$at$the$ER9Golgi$interface.$$
The" majority" of" vesicle" tethering" in! ERUtoUGolgi" and" intraUGolgi" transport"
pathways" is"mediated" by" cisUGolgi" Golgins" that" interact"with" components" on" inU
coming" COPII" vesicles" from" the" ER." For" example" the" cisUGolgi" localised" GM130"
interacts"with"a"CUterminal"acidic"patch"on" the"COPII"vesicleUlocalised"coiledUcoil"
tether"P115."P115" is"well"defined"(especially" in"yeast"as" its"homologue"Uso1)"as"
essential"for"ERUGolgi"transport"and"Golgi"structure"(Alvarez"et"al."2001;"Barr"et"al."
1998;" Grabski" et" al." 2012;" Puthenveedu" and" Linstedt" 2001;" Sztul" and" Lupashin"
2006)."The"tail"of"P115"contains"four"coiledUcoils"separated"by"prolineUrich"hinges,"
allowing" flexibility" for" an" accordionUlike" collapse" towards" the" target"membrane"
(Sapperstein"et"al."1995),"whilst"interaction"with"SNAREs"is"mediated"by"the"two"
proteins’"similar"coiledUcoil"motifs"(Wang"et"al."2015b).""
Other" than" GM130UP115" interactions," CASP" is" a" GolgiUlocalised" transmembrane"
protein" related" to" the"Golgin"giantin" that" interacts"with"SNAREs" involved" in"ERU
Golgi"transport"(Gillingham"et"al."2002);"GCP60,"GMAP210"and"GolginU45"are"cisU
Golgi"located"Golgins"involved"in"ERUGolgi"transport;"and"GolginU84"likely"plays"a"
role" in" tethering" and" Golgi" structure" (Sztul" and" Lupashin" 2006)." ERUGolgi"





in" GolgiUER" retrograde" transport." DSL1" interacts" with" the" COPI" coat" and" target"
membrane" SNAREs" but" not" GTPases," unlike" other" MTCs" (Dubuke" and" Munson"






transport& vesicles.& Coiled'coil& Golgins& (e.g.& golgin'84,& '245& and& GMAP'210)& project& from& the& Golgi&
membrane,&interacting&with&incoming&transport&vesicles&(from&ER/ERGIC,&endosomes&and,&at&exposed&
cisternae& rims,& within& the& Golgi& itself)& via& N'terminal& tethering& motifs.& The& MTC& COG& complex&
mediates& intra'Golgi& transport& alongside& some& golgins.& One& COG& subdomain& is& present& on& Golgi&
membranes& and& the& other& on& incoming& vesicles.& Interaction& between& the& two& forms& a& complete&
tethering& COG& complex,& closely& tethering& the& vesicle& to& the& target& membrane.& [b]& Mechanism& of&
Golgin'mediated& vesicle& tethering.& Tether& N'terminal& interacts& with& vesicle& membrane.& Collapse& of&






"Transport" through" the" Golgi" is" mainly" by" cisternal" maturation," in" which" cisU
cisternae"mature"into"medial"then"eventually"transUcisternae."During"this"process"
COPIUvesicle" mediated" anterograde" transport" maintains" correct" enzymatic"
compartment" contents" (Spang" 2015)." Whilst" COPIUmediated" anterograde"
transport" of" smaller" cargo" does" occur" evidence" for" it" is" less" solid" than" that" for"
COPIUmediated" retrograde" transport" (Glick" and" Luini" 2011;" Glick" and" Nakano"
2009;"Papanikou"and"Glick"2014)."There"is"also"evidence"of"a"‘kissUandUrun’"model"
of"transport"through"the"Golgi,"where"temporary"direct"fusion"between"cisternae"









early" Golgi." However" this" may" suggest" a" further" role" in" ERUGolgi" transport"
(Yamasaki"et"al."2009)."The"TRAPP"complexes"are"able" to"discern"between"COPI"
and"COPII"coats,"providing"tethering"specificity"(Barrowman"et"al."2010).""
The" Conserved" Oligomeric" Golgi" (COG)" complex" is" an" eight" subunit" CATCHR"
complex,"separated"into"two"modules"that"interacts"with"small"GTPases"on"vesicle"
and"target"membranes."It"is"necessary"for"retrograde"transport"through"the"Golgi"
compartments" (Dubuke" and" Munson" 2016)." Some" Golgins" are" present" at" the"
peripheral" buds" of" the" intraUGolgi" cisternae," but" most" present" within" the" Golgi"
stack" function" in" the"maintenance" of" Golgi" structure,"with" the"Golgins"GRASP55"
and" GRASP65" specifying" in" the" cis" U"medial" Golgi" stacking" (Sztul" and" Lupashin"
2006)."Most"Golgins"present"on"the"TGN"(e.g."GolginU245,"U97,"GCC185"and"GCC88)"





However" direct" evidence" for" tethering" is" still" not" available" despite" the" exocyst"
being" the" most" extensively" studied" tether" system" (Wu" and" Guo" 2015)." The"
exocyst’s" Sec8" subunit" is" transported" to" the"PM"on" vesicles," residing" there"until"
fusion"occurs,"showing"a"separation"between"the"tethering"and"SNAREUmediated"
steps"of"vesicle" fusion"(RiveraUMolina"and"Toomre"2013)."Like"the"COG"complex,"
the"exocyst" is"made"up"of" eight" subunits" in" two"separate"modules" that" interacts"
with"lipids"and"small"GTPases"(Rab,"Rho"and"Ral"families)"on"vesicle"and"plasma"
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membranes," as"well" as"with" SM"proteins" (Dubuke" and"Munson"2016;"Hong" and"
Lev"2014;"Moore"et"al."2007)."The"Sec3"and"Exo70"subunits"interact"with"the"PM’s"
inner" leaflet"whilst" Sec15" interacts"with" the" secretory" vesicle" via" the" Sec4"RabU
GTPase."Remaining"subunits"are"able"to"form"myriad"interactions"with"each"other"
and" build" up" around" these" markers" to" create" the" tether" complex," a" process"
initiated"by"kinaseUmediated"phosphorylation"of" the"membraneUmarking"subunit"
(Liu" and" Guo" 2012;" Sztul" and" Lupashin" 2006;" Wang" et" al." 2004;" Wu" and" Guo"
2015)."
1.4.1.5.$Vesicle$fusion$at$the$target$organelle!
The" SNAREs" are" a" protein" family" containing" a" conserved" SNARE"motif" between"
60U70"residues"in"length."A"CUterminal"transmembrane"domain"associates"with"the"
membrane," whilst" a" protruding" NUterminus" interacts" with" vesicleUmounted"
SNAREs" (Wang" et" al." 2017)." The" tethering" process" allows" SNARE" proteins" on"
vesicle"and"target"membranes"to"come"into"close"proximity"(Dubuke"and"Munson"
2016)." Three" target" (t)USNARES" (also" known" as" QUSNARES" as" they" contain" a"
specific" glutamine" residue)" are" present" on" the" target"membrane,"with" 1" vesicle"
(v)USNARE" (or" RUSNARE," containing" a" specific" arginine" residue)" present" on" the"
vesicle" membrane." Both" tethers" and" vUSNARES" are" sorted" to" vesicles" alongside"
cargo"via"interactions"with"coat"adaptor"proteins"(Arakel"and"Schwappach"2018;"
Peden"et"al."2001)."Singular"SNAREs"exist"in"a"cis"conformation."Upon"both"SNARE"
types" coming" into" close" proximity" they" assemble" into" a" complete" transUSNARE"









is" only" found" in" neuronal" cells" (Latham" and"Meunier" 2007)." Yeast" studies" have"
also" shown" Sec1" positively" regulates" formation" of" SNARE" complexes" in" Golgi" to"
PM" transport" (Gerst" 2003)." Ectopic" overexpression" of" SM" proteins" in" CHO" cells"
improves"SNAREUmediated"vesicle"fusion"at"both"the"Golgi"and"PM,"increasing"cell"
secretory"capacity" (Peng"and"Fussenegger"2009b)."Tethering"complexes"are"also"
able" to" regulate" SNARE" complex" formation" (Bock" et" al." 2001;" D'Agostino" et" al."
2017;" Gerst" 2003;" Hong" and" Lev" 2014;" Malsam" and" Soellner" 2011)." Once"
membrane"fusion"and"cargo"delivery"has"occurred"SNARE"complexes"are"broken"
down,"a"process"mediated"by"proteins"such"as"NSF,"Tomosyn"and"Amisyn."These"
bind" SNAREs," displace" the" SM"proteins" and" interrupt" the" transUSNARE" complex,"
allowing" components" to" be" recycled" (Baker" and" Hughson" 2016;" Gerst" 2003)."
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Expansion" of" the" fusion" pore" can" also" induce" conversion" of" transUSNARE"
complexes"to"a"cis"formation,"aiding"SNARE"disassembly"(Suedhof"2013).**
Whilst"exocyst"tethering"components"are"restricted"to"vesicleUdocking"areas"of"the"
PM,"SNAREs"are"broadly"distributed"across" target"membranes" (Kee"et" al."1997)."
The" transportation" of" syntaxins" to" the" PM" is"mediated" by" their" transmembrane"
domain," with" SM" proteins" holding" them" in" an" inactive" conformation" during"
transport"(Salaun"et"al."2004)."The"transmembrane"domains"of"a"complete"SNARE"
quadruplex" induce" mechanical" stress" upon" the" vesicle" and" plasma"membranes,"
aiding" the"merging"of" the" two"and" the" formation"of"a" fusion"pore" (Vardjan"et"al."
2009)." It" is" SNARE" complex" formation" (and" not" vesicle" fusion)" that" is" the" rateU
limiting" step" in" the" vesicle" fusion" process" (Smith" and" Weisshaar" 2011)." An"
increase" in" SNARE" complexes" increases" the" rate" of" cargo" release" from" a" single"
pore," enabling" the" transfer" of" larger" cargo" molecules" as" both" pore" size" and"
stability" are" affected" by" SNARE" copy" number" (Bao" et" al." 2018;" Mohrmann" and"
Sorensen" 2012)." Depletion" of" both" SNAP29" or" Stx19" SNAREs" decreases" vesicle"
fusion" events" at" the" PM" (Gordon" et" al." 2010)." Actin" and"Myosin" II" have" roles" in"
regulating"the"duration"of"fusion"pore"opening"and"therefore"how"much"cargo"can"
leave"the"vesicle"during"kissUandUrun"exocytosis"events"(Aoki"et"al."2010;"Trouillon"
and"Ewing"2014)." In"PC12" cells" SNAPU25" is" expressed"more" than"10Ufold"higher"
than" Stx1," ensuring" there" is" less" chance" of" the" formation" of" an" inert" complex"








(Malsam" and" Soellner" 2011)." As" mentioned" in" section" 1.4.1.4," COPI" vesicle"
transport" is" involved" in" retrograde" transport" through" the" Golgi" as" well" as" the"
repatriation"of"ERUGolgi"transport"components"such"as"VAMP"to"the"ER"(with"most"
COPII"coat"components"being"shed"shortly"after"budding)."ClathrinUcoated"vesicles"
are" involved" in" endocytic" transport" from" the" PM" to" the" TGN" as"well" as" TGN" to"
lysosome" transport" (Bittner"et"al."2013;"Traub"2005)."A" reduction" in" the"SNARE"






Starting& from&[a],& tethering&at&a& large&distance& from&the&target&membrane& initiates&vesicle&capture,&
bringing& v'& and& t'SNAREs& into& close& proximity& and& allowing& the& formation& of& a& quaternary& trans'
SNARE& complex.& Zippering& of& the& SNAREs,& mediated& by& SM& proteins,& overcomes& the& replant& forces&









When" the" ER’s" capability" to" correctly" fold," process" and" package" nascent"
polypeptides" (both" cargo" and" resident)" is" perturbed" the" buildUup" of" unfolded"
polypeptide" chains" leads" to" ER" stress," which" eventually" induces" the" unfolded"
protein" response."The"UPR"aims" to" regain"cellular"homeostasis"and"maintain"ER"
function"by"balancing"the"load"of"incoming"protein"(by"slowing"transcription"and"
translation)"with" the" ER’s" folding" capacity" (by" increasing" ER" chaperone" levels)."
Due" to" the" increase" of" protein" levels" in" secretoryUspecific" cells" the" UPR" has" a"
central"role"in"the"normal"development"and"function"of"secreting"cells"(Moore"and"




ERUtransmembrane" receptors:" PKRUlike" ER" kinase" (PERK)," inositolUrequiring"
enzyme"1"(IRE1)"and"ATF6."All"three"can"mediate"both"ER"recovery"and"apoptotic"
responses" to"ER"stress,"albeit"at"varying" levels" (Hussain"et"al."2014;" Jaeger"et"al."
2012)." Under" normal" ER" conditions" the" ER" lumenal" domains" of" these" proteins"
interact"with"Ig"binding"protein"(BiP"or"GlucoseUregulating"protein"[GRP]"78)."BiP"





preferentially" bind" unfolded" proteins," freeing" ATF6," IRE1" and" PERK" to" be"
activated." This" initiates" ERUtoUnucleus" signaling" cascades" and" activates" the" UPR"
(Bertolotti"et"al."2000;"Gardner"et"al."2013;"Samali"et"al."2010).""
Free" from" BiP," ATF6" translocates" (through" constitutive" secretion)" to" the" Golgi"
where" it" is" cleaved," freeing" its" cytosolic" transcriptionally" active" region" so" it" can"
enter" the"nucleus"and" initiate" transcription"of"ER"molecular"chaperones,"protein"
disulphide" isomerases," CHOP" and" XBP1" (Shen" et" al." 2002)." Both" PERK" and" IRE,"
upon"being"freed"from"BiP,"oligomerise"and"are"phosphorylated"to"an"active"state"
(Chalmers" et" al." 2017;" Gardner" et" al." 2013)." Active" PERK" phosphorylates"
eukaryotic" initiation" factor" 2α" (eIF2α)" which" in" turn" attenuates" general"
translation" levels," reducing"protein" flux" to" the"ER" (Harding"et" al." 2000)."Despite"
this" general" response," activated" eIF2α" does" initiate" translation" of" ATF4," a"
transcriptional" activator" for" proUapoptotic" factors" (Gardner" et" al." 2013)." Active"
IRE1" splices" XBP1" mRNA," allowing" production" of" the" transcriptional" activator"
XBP1s" that," upon"entering" the"nucleus," activates" transcription"of"ER" chaperones"
(He"et"al."2010)."An"overview"of"the"UPR"to"ER"stress"is"shown"in"figure"1U6.""
" 51"
The" UPR" to" ER" stress" ensures" that" only" correctlyUfolded" proteins" can" travel" on"
from" the" ER," ensuring" fidelity" in" protein" structure" and" folding" (Walter" and"Ron"
2011)." Development" of" a" nonUinvasive" fluorescenceUbased" reporter" that" is"
activated"alongside"UPR"activation"allows"the"UPR"status"of"transgeneUproducing"
CHO" cells" to" be" quantified" and" monitored," showing" that" UPR" activation" is"
regulated" throughout" production" culture," that" different" producing" CHO" clones"
vary" in" the" pattern" and" timing" of" their" UPRUrelated" transcriptional" activity" and"
that" external" factors" (media" composition" and" osmolarity)" significantly" impact"
upon"UPR"activation"(Du"et"al."2013)."The"destiny"of"the"ER"is"intrinsically"linked"
to" that" of" the" Golgi." Control" of" Golgi" capacity" is" regulated" by" wider" cellular"
demands,"including"the"ER"stress"response."ER"stress"decreases"protein"transport"
to"the"Golgi,"altering"its"glycolipid"composition"(Renna"et"al."2006).""
The" ER" chaperone" HSP47" has" been" shown" to" protect" cells" from" Golgi" stressU
induced" apoptosis," although" how" remains" unclear" (Miyata" et" al." 2013)." An"




increase" in" transcription" induction" from"a" transcription" enhancing" region" called"
the"Golgi"apparatus"stress"response"element"(GASE),"which"drives"transcription"of"
GolgiUrelated"genes"including"glycosylation"enzymes,"Golgi"structural"proteins"and"
postUGolgi" vesicle" transport" factors" (Oku" et" al." 2011)." The" transcription" factor"
TFE3" has" been" identified" as" binding" the" GASE." Normally" residing" in" its"
phosphorylated" form" within" the" cytoplasm," Golgi" stress" leads" to"
dephosphorylation" of" TFE3," allowing" it" to" enter" the" nucleus" and" bind" the" GASE"
(Beckmann" et" al." 1990;" Taniguchi" et" al." 2015)." A" transcription" factor" similar" to"





An& increase& in& unfolded& protein& leads& to& it& preferentially& binding& BiP/GRP78,& disassociating& from&
IRE1,& ATF6& and& PERK.& Once& not& bound,& PERK& monomers& dimerise& and& phosphorylate& each& other,&
leading& to& phosphorylation& and& activation& of& eIF2α.& This& knocks& down& general& translation& whilst&
activating&ATF4&which& in& turn& activates& transcription& of& genes& involved& in& amino&acid&metabolism,&
redox&reactions,&protein&secretion&and&stress&response.&Over'activation&of&ATF4&can&lead&to&initiation&
of& the&apoptotic&CHOP&pathway.&Free& IRE1&molecules&dimerise&and&are&phosphorylated.&Active& IRE1&
splices& XBP1& mRNA,& producing& the& active& XBP1s& variant& which& up'regulates& transcription& of& ER&
chaperones.& BiP'free& ATF& is& free& to& translocate& (via& secretion)& to& the& Golgi& where& it& is& cleaved,&





The" engineering" and" optimisation" of" CHO" growth" conditions," manufacturing"
processes"and"media"formulation"appears"to"have"reached"a"state"of"diminishing"
returns" with" regards" to" maximising" cell" growth" and" yields" from" standard" CHO"
cells" (Wurm" 2004)." To" further" improve" CHO" cell" capacity" and" productivity" it" is"
required"to"investigate"and"work"within"the"chassis"of"the"CHO"cell"to"enhance"its"
biosynthetic"capacity."With"CHO"cells"not"being"a"specialist"protein"producing"or"
secreting" cell" line," there" is" plenty" of" scope" for" synthetic" biology" and" genetic"
engineering" strategies" to" improve" the"productivity"of" easy" to"express" (ETE)"and"
DTE" recombinant" proteins." The" biosynthetic" pathway" incorporates" the"
production,"from"a"DNA"sequence"via"mRNA"and"tRNA"to"a"nascent"protein"that"is"
translocated"into"the"ER"where"it"undergoes"folding"and"PTMs,"before"entering"the"





Engineering" of" CHO" cells" has" thus" far" focused" upon" both" synthetic" biology" and"
genetic" engineering" strategies." These" have" been" used" to" optimise" transcription"
and" translation," the" early" biosynthetic" pathway" (protein"processing," folding" and"
processing"modifications)"and"secretory"pathway"enhancement."Whilst"molecular"
mapping" of" cell" pathways" provides" a" good" knowledge" of" interactions" occurring"
within" a" cell," the" increased" availability" of" transcriptomic" and" proteomic" (‘omic)"
datasets,"of"many"different"cell"lines,"has"provided"data"to"inform"the"selection"of"
genes"with"which" to" genetically" engineer" the" cell" in" an" attempt" to" enhance" cell"
performance"(Kumar"et"al."2015;"Lewis"et"al."2016)."However," it" is"worth"noting"
that"many"synthetic"biology"and"genetic"engineering"of"CHO"cells"has"so"far"only"










A" major" factor" in" expression" of" a" recombinant" gene" is" its" copy" number" and"
transcriptional" activity." Use" of" strong" promoters," targeting" integration" of"
recombinant"genes"to"a"highly"active"part"of"the"genome"and"use"of"elements"that"
decrease" the" risk" of" epigenetic" silencing" can" all" achieve" increased" transcription"
" 54"
and"productivity" levels" (Benton"et"al."2002;"Deer"and"Allison"2004;"Koduri"et"al."
2001;"O'Callaghan"and" James"2008;" Saunders"et" al." 2015)."All" recombinant"gene"
transcription"must"start"from"a"promoter"element."In"mammalian"cell"expression"
these"are"normally"either"endogenous"or"virusUderived."Despite"the"availability"of"
the" CHO" genome" sequence," it" has" so" far" proved" difficult" to" determine" the"
regulatory"sequences" that" control"expression"of"CHO"genes," so"endogenous"CHO"




CMV" and" SV40e" are" the"most" commonly" used" due" to" their" ability" to" drive" high"
rates"of" transcription" (Brown"and" James"2016;"Chatellard"et" al." 2007)."However"




which" expression" levels" of" recombinant" genes" within" CHO" cells" can" be" tightly"
controlled"at"myriad"levels,"allowing"precision"control"of"relative"stoichiometry"of"
numerous" functional" components" (Brown" and" James" 2016)." This" allows" tighter"
control"of"gene"stoichiometry"which"has"an"effect"upon"Mab"production"from"HC"
and"LC"(Pybus"et"al."2014)."It"also"opens"up"the"possibility"of"varying"expression"
levels" of" recombinant" genes," selection" markers" and" accessory" genes." Viral"
transcription" factor" regulatory" element" (TFREs;" also" known" as" transcription"
factor" binding" sites)" used" in" CHO" cells" have" been" screened" to" determine" their"
relative" abundance." A" large" promoter" library," with" varying" levels" of"
transcriptional"efficiency,"has"been"produced"by"placing"blocks"of"TFREs"upstream"
of" a" CMV" core" promoter." Testing" of" the" promoter" blocks" effect" upon" secreted"
alkaline" phosphatase" (SEAP)" expression" levels" showed" that" in" some" cases"
synthetic" promoters" can" exceed" the" levels" seen" from" a" standard" CMV"promoter"
(Brown" et" al." 2014)." Overexpression" of" the" chromatin" regulating" transcription"




In" many" cases" productivity" levels" do" not" increase" proportionally" with" mRNA"
levels" and" transgene" copy" numbers," suggesting" translational" and" postU
translational" steps" are" limiting" in" the" production" of" recombinant" proteins"
(Hussain"et" al." 2014;" Johari" et" al." 2015)."Basic" tenants"of" translation" include" the"
use"of" an"AUG"start" codon"downstream"of" a"Kozak" sequence" that" aids" ribosome"
binding"at" the"correct"point"of" the"mRNA"sequence" (Kozak"1987)."With" the"vast"
majority"of"biologics"being"humanised"their"codon"sequence"may"not"be"optimised"
to"work"within" the"CHO"cell," resulting" in"subUoptimal" translation" levels"and"thus"
" 55"




SINEUP"RNAs" in"CHO"cells" can"promote" and"enhance" translation," increasing" the"
production"of"recombinant"protein"(Patrucco"et"al."2015)."!
1.5.1.2.$Engineering$the$CHO$cell$biosynthetic$and$secretory$pathways$
Engineering" of" improvement" of" transcriptional," translational" and" postU
translational"processes"within"the"CHO"cells,"whilst"enhancing"overall"productivity"
levels,"can"shift"synthetic"bottlenecks"from"the"nucleus"to"the"ER"and"further"along"
the" biosynthetic" pathway." This" can" result" in" the" overloading" the" secretory"





At" the" start" of" a" secreted" protein’s" lifeUcycle," signal" recognition" particles" (SRPs)"
mediate" docking" of" active" ribosomes" to" the" ER," directing" nascent" polypeptide"
chains"through"the"translocon"so"they"can"be"transported"into"the"ER"lumen"where"
the"SRP"is"removed."The"protein"folding"process"is"initiated"whilst"translocation"is"
in" progress," although" PTMs" such" as" disulphide" bond" formation" occurs" once" the"






cells" (e.g." plasma" cells)" confirms" that" the" UPR" has" a" central" role" in" the" normal"
development" and" function" of" highlyUsecreting" cells" (Moore" and" Hollien" 2012;"









coUexpression" alongside" the" ER" oxidoreductase" ERO1ULα" saw" a" 5.3U" to" 6.2Ufold"
increase" in" Mab" yield" (Cain" et" al." 2013)." The" increase" in" productivity" brought"






of" activating" transcription" factor" (ATF)" 4" resulted" in" a" 2Ufold" increase" in"
Antithrombin" II" production" levels" (Ohya" et" al." 2008)," though" ATF4," CHOP" and"
HSPA5" transient"overexpression" in"CHO"cells" saw"a"decrease" in"Mab"expression"
levels" (Rajendra" et" al." 2015)." Overexpression" of" ATF6" saw" an" upUto" 2.5Ufold"
increase" in"Mab"productivity," though" this"was"dependent"upon" the"specific"Mab."
Expression"of"the"immunoglobulin"binding"protein"(BiP),"which"is"a"UPR"marker,"
saw" a" 1.5Ufold" increase" in" Mab" titre" (Johari" et" al." 2015;" Pybus" et" al." 2014)."




Overexpression" of" ER" chaperones" and" enzymes" catalysing" processes" that" aid"
protein"folding"is"a"more"specific"way"to"enhance"the"ER’s"protein"folding"capacity."
Stable" overexpression" of"members" of" the"HSP70" family" in" baby" hamster" kidney"
(BHK)" cells" resulted" in" a" 50%" increase" in" expression" levels" of" blood" factor" VIII"
(Ishaque" et" al." 2007)." Transient" overexpression" of" Tor1a" increased" secreted"
luciferase" and" IgG4" levels" in" CHO" by" 2.5U" and" 1.4Ufold" respectively" (Josse" et" al."
2010)." Expression" of" protein" disulphide" isomerases" (PDI[A]s)" that" catalyse" the"
formation"of"disulphide"bonds"increased"Mab"production"by"up"to"37%,"depending"
upon"the"Mab"expressed"(Borth"et"al."2005;"Johari"et"al."2015;"Pybus"et"al."2014)."
The"chaperone"cyclophilin"B"(CypB)" functions" in" folding"of"PMUdirected"proteins"
including"Mabs"(Price"et"al."1994)."Its"transient"overexpression"saw"an"upUto"1.4U
fold"increase"in"Mab"titre,"again"dependent"upon"the"specific"Mab"being"expressed"
(Johari" et" al." 2015;" Pybus" et" al." 2014)." Stable" expression" of" ERO1ULα," which"
transfers"disulphide"bonds"to"PDI"saw"an"increase"in"CHO"productivity"levels"(Cain"
et"al."2013;"Hussain"et"al."2014)."Stable"coUoverexpression"of" the"ER"chaperones"
Calnexin" and" Calreticulin" saw" an" 1.9Ufold" overall" increase" in" recombinant"




Direct" expression" of" CHO" secretory" pathway" components" appears" to" have" been"
limited" to" genes" involved" in" vesicle" docking" and" fusion" at" the" target"membrane"
(see"sections"1.4.1.4"and"1.4.1.5"for"a"more"inUdepth"explanation)."Overexpression"
in"CHO"of"the"Soluble"NUethylmaleideUsensitive"fusion"protein"attachment"protein"










Modulation" of" ceramide" transport" from" the" ER" to" the" Golgi" by" stable"
overexpression"in"CHO"cells"of"an"active"version"of"the"ceramide"transport"protein"
(CERT)" saw" a" 26" U" 45%" increase" in" IgG" and" tPA" production" levels" (Florin" et" al."
2009;" Rahimpour" et" al." 2013)." Stable" expression" of" an" oncogenic" mutant" of"
tyrosine" receptor" kinase" (oncoUKIT)" increased" global" protein" synthesis" and"
improved"cell"growth"and"stress"resistance."This"resulted"in"a"highlyUproliferating"
cell"line"with"a"greater"than"2Ufold"increase"in"productivity"of"a"GFPUMab"Fc"fusion"
protein" (Mahameed" and" Tirosh" 2017)." Stable" overexpression" of" GlutamateU




that" pushing" the" level" of" intracellular" metabolites" and" signaling" molecules" can"
have" a" deleterious" effect" when" compared" to" smaller" changes." Upregulation" of"
amino"acid"transporters"(AATs)"can"enhance"the"cellular"uptake"of"specific"amino"
acids" that" are" more" prevalent" in" Mabs" than" normal" cell" processes," as" well" as"
enhancing" levels" of" amino" acids" required" for" general" CHO" housekeeping"
procedures"such"as"GSH"synthesis"and"protein"synthesis"(Geoghegan"et"al."2018)."
"
Whilst" ectopic" expression" of" genes" is" a" proven" way" to" alter" the" synthetic" and"




cell" productivity" levels," such" as" miRNA" and" CRISPR," may" provide" an" accessible"
method"of"cell"line"engineering"without"further"burdening"the"CHO"cell"(Fischer"et"










Engineering&of& the&CHO&secretory&pathway&has& so& far& focussed&on& translocation&of&nascent&proteins&





Overexpression" of" one" or"more" effector" gene(s)"may"help" produce" an" enhanced"
productivity"phenotype,"but"production"of" further"recombinant"genes"(alongside"
that" of" the" recombinant" product)" can" add" a" further"metabolic" burden" upon" the"
cell." As" such," methods" to" enhance" CHO" cell" productivity" without" the" need" for"
further" transcription" and" translation" burden" are" of" increasing" importance"
alongside" the" introduction" of" effector" genes" in" to" cells" (Fischer" et" al." 2015)."
MicroRNAs" are" small," nonUprotein" coding" mRNAs" that" are" capable" of" postU
transcriptionally" regulating" entire" mammalian" cellular" pathways" through,"
enhancing" gene" expression" through" translation" inhibition" or" destabilisation"
(Barron" et" al." 2011b)." " Stable" expression" of" microRNAs" in" CHO" cells" enhances"
process" steps" in" cell" line" development" and" significantly" increases" final" product"
yield"(Barron"et"al."2011a;"Fischer"et"al."2017).""
"
Use" of" targeted" gene" mutation" technologies" such" as" CRISPR" and" transcription"
activatorUlike" effector" nucleases" (TALENs)" can" be" used" to" knock" down" and/or"
mutate" specific" genes," the" activity" of" which" of" which" can" impact" upon" product"
quality," cell" growth" and" productivity" (Cong" et" al." 2013;" Yang" et" al." 2015)." RNA"
interference" techniques" such" as" small" interfering" RNAs," utilising" mRNAU
complementary" sequences" and" thus"blocking" its" translation," can"also"be"used" to"
knock" down" gene" expression," being" used" to" improve" apoptosis" resistance,"
glycosylation" and" cell" metabolism," increasing" specific" productivity" and" titres" as"
well"as"product"quality"(Fischer"et"al."2015;"Mori"et"al."2004;"Zhou"et"al."2011)."
"
That" the" engineering" of" some" pathways" has" positive" effects" upon" production"
levels"with"some"cells"and"products,"but"the"opposite"in"others,"suggests"that"there"
is"some" level"of" specificity"with"regards" to"engineering"strategy"and" the"cell" line"
and" model" Mab" used." However," in" the" case" of" global" transcriptional" activators"















would"only" increase" the"burden"upon" the"protein" secretory"pathway." Increasing"
mRNA" and" protein" levels" merely" shifts" any" productivity" bottleneck" limiting"
cellular" productivity" further" down" the" biosynthetic" pathway." Increased" protein"




A" biologic" may" prove" DTE" due" to" many" reasons." An" inability" for" the" complete"
molecule"to"assemble" from"its"constituent"parts;" improper"protein"chain" folding;"
improper" PTM" processing;" specific" structural" elements" or" sequences"within" the"
polypeptide" sequence" leading" to" the" formation" of" an" inactive" conformation;" or"
regions"allowing"easy"aggregation"with"other"molecules"may"occur."Many"of"these"




The" formation"of"complete"Mabs" from"constituent"heavy"and" light"chains"can"be"
affected"by" the" levels" of" these" components"within" the" cell." The" stoichiometry" of"
HC:LC"genes" transcribed"and"translated"by" the"cell"can"have"an" impact"upon"the"
formation" of" complete" Mabs," with" the" expression" levels" of" DTE" Mabs" being"
improved" by" alteration" of" the" transfected" HC:LC" gene" ratio" (Pybus" et" al." 2014;"
Strutzenberger" et" al." 1999)." Modification" of" a" protein" sequence" can" alleviate"
structural"issues"such"as"incorrect"folding"and"interactions"leading"to"aggregation."
This" can" be" streamlined" by" utilisation" of" an" engineering" strategy" based" upon"
related" proteins" that" are" easily" expressed," accelerating" the" molecular"
development"process"(Hussain"et"al."2017)."As"previously"discussed,"engineering"
of" ER" folding" and" the" UPR" through" coUexpression" of" ERUresident" molecular"
chaperones" (e.g." BiP," PDI)" or" active" UPR" transactivators" (e.g." ATF6," XBP1s)" can"
increase" biosynthetic" and" secretory" flux." Furthermore," treatment" of" cells" with"




Molecular" engineering" of" problem" biologics" is" probably" the" most" timeUefficient"
method" of" improving" DTE" expression," with" optimisation" of" each" molecule" an"
important" step" in" the" research" and" development" pipeline" (Hussain" et" al." 2017)."
Whilst" specific" hostUcell" engineering" could" be" used" to" improve" productivity,"
producing"cell" lines"bespoke"to"a"certain"molecule"would"be"a"time"and"resource"
intensive" process" starting" from" basic" principles" for" each" different" molecule."
Utilisation"of"engineering"strategies"and"HTS"systems"could"speed"up"this"process"
but" it" would" still" prove" too" lengthy" to" be" viable" in" an" industrial" environment."
However,"production"of" a" few"general" cell" lines"with"enhanced"productivity" and"
secretion" levels" of" model" recombinant" proteins" will" streamline" the" process." By"
" 61"
providing" a" chassis" cell" line(s)"with" secretory" bottlenecks" already" removed" and"
thus" having" an" already" high" secretory" capacity," engineering" of" the" protein"
production" pathway" upstream" of" this" (from" transfection" and" transcription"
through" to" glycosylation)" will" allow" for" a" more" immediate" feedUback" as" to" the"




The" CHO" cell" is" an" important" mammalian" cell" factory" that" is" well" used" in" the"
production"of"biopharmaceuticals"due" to" its" ability" to" carry"out"PTMs," relatively"
quick" growth," genetic" plasticity" and" regulatory" status." Engineering" of" CHO"
manufacturing" processes" and" more" latterly" the" CHO" cell" itself," has" resulted" in"
increased" yields" of" a" wide" range" of" recombinant" proteins." However," as" drugs"
companies" diversify," trying" to" make" more" complex" molecules" to" target" more"
complex" and"a"wider" range"of"disease" targets," there" is" still" need" to" increase" the"
capacity"of"the"overall"CHO"production"chassis.""
"
With" the" availability" and" improving" annotation" of" the" CHO" genome," as" well" as"
increasing" transcriptomic" and" proteomic" data" sets" of" both" various" CHO" strains"
and" nonUrelated" cell" lines" with" high" productivity" characteristics," there" is" an"
increasing" knowledge" as" to" how" CHO" responds" on" an" ‘omic" level" to" different"
stimuli"and"production"processes."There" is"also"a"widening"base"of"knowledge"–"
such" as" transcriptomic" and" proteomic" data" U" which" can" be" mined" to" provide"
directed"engineering"strategies"to"try"and"improve"the"productivity"levels"of"CHO"
cells." Whilst" much" elucidation" of" the" eukaryotic" secretory" pathway" has" been"
carried" out" in" yeast," many" yeast" secretory" proteins" have" close" homologues" in"




and" secretory" pathway" components" will" likely" only" result" in" the" shifting" of"
bottlenecks" elsewhere" within" these" pathways," overloading" them" elsewhere." To"
produce"CHO"cells"with"a"truly"enhanced"biosynthetic"and"secretory"phenotype"a"
more"holistic"and"global"approach"to"CHO"cell"engineering"is"required."Facilitating"






The" overall" aim" of" this" project" is" to" improve" the" productivity" phenotype" of" the"
CHO" cell" through" engineering" of" its" secretory" pathway." It" is" envisaged" that"
" 62"
expansion" of" the" CHO" secretory" pathway" (alongside" the" biosynthetic" pathway)"
will"remove"bottlenecks"that"reduce"CHO"productivity" levels." It"has"already"been"
shown" that" singleUgene" engineering" of" the" CHO" secretory" pathway" can" increase"
CHO"productivity," through"SNARE"expression"and"control,"ceramide"transport" to"
the"Golgi,"enhancing"polypeptide"translocation"into"the"ER"and"engineering"of"the"
UPR." Whilst" some" genes" have" been" coUexpressed" to" good" effect," none" of" these"
strategies" have" taken" a" multigene" approach" to" the" engineering" of" the" CHO"
secretory"pathway."This"project"aims"to"identify"new"genetic"targets"for"secretory"
pathway"engineering."These"will"be"used,"alongside"previously"used" targets," in"a"
multigene" strategy," to" engineer" the" CHO" secretory" pathway" through" direct"
overexpression" of" single" and" combinatorial" targets." Directed" evolutionary,"










Synthetase" (GS)" levels"was" provided" by"MedImmune" (Granta" Park," Cambridge)."
This"host"cell"line"(henceforth"referred"to"as"MedIUCHO)"was"used"for"the"majority"
of" cell" culture" experimental" work," with" all" other" CHO" cell" lines" derived" from" it"
during" the" course" of" the" project" (including" evolved" and" stablyUexpressing" cell"







Glutamine" (GIBCO," Invitrogen)." Cell" lines" stably" expressing" a" recombinant" DNA"
construct" were" cultured" in" CDUCHO" supplemented" with" 50" μM" Methionine"
Sulphoxamine" (MSX" –" Sigma," St." Louis,"MO," USA)" as" a" selective" agent." For" longU
term" transient" expression" studies" a" specifically" developed" cell" line" (MedIUTran)"
was"used."MedIUTran"was"maintained"in"CDUCHO"supplemented"with"25"μM"MSX"
and" 100" μg/mL" HygromycinUB." All" CHO" cell" lines," the" abbreviations" used"







Multitron" HT" (Infors," Reigate," UK)" orbital" shaking" incubators" at" 37" °C,"













knockout." Host" cell" line"

























































































plates" to" improve" gas" transfer" and" reduce" evaporation" and" crossUcontamination"
between"wells."Cells"were"shaken"at"320"rpm"with"a"25"mm"throw,"with"plates"and"
lids"held"in"place"by"a"specific"clamp"system"(Duetz,"Enzyscreen"B.V)"to"allow"the"
vigorous" orbital" shaking" required" for" optimal" cell" culture" performance." Cell"
culture" was" carried" out" in" a" MultiTron" HT" incubator" at" 37" °C," 5%" CO2" with"
humidity"maintained"at"85%"to"reduce"culture"loss"by"evaporation."
"
Batch" cultures"were" grown" for" between" 2U4" days" before" analysis" samples"were"
taken." FedUbatch" cultures" (e.g." longUterm" transient" gene" expression;" see" section"
2.5.2)"were"maintained" for" 120" h," with" a" feed" carried" out" at" 72" h" postUseeding"
when"cells"were"supplemented"with"a"1:1"mix"of"EfficientFeed™"A"and"B"(Gibco,"
Invitrogen)." The" 96Uwell" deepUwell" plate" was" covered" with" a" sterile" plastic" lid"
(Greiner" BioUOne)" and" centrifuged" at" 300" x" g" for" 5" minutes" to" pellet" cells."
Supernatant"(10%"of"initial"seeding"volume,"47.5"μL)"was"removed"and"replaced"
" 66"
with" 47.5" μL" of" efficient" feed" mix." Cells" were" resuspended" by" gentle" pipetting"













Cell" number" and" viability" level" of" cells" was" determined" by" Trypan" Blue" dye"









in" section" 2.1.2.2)" could" not" be" measured" by" ViCell" due" to" time" and" cost"
constraints." PrestoBlue®" cell" viability" reagent" (Invitrogen)" was" used" to" give" an"
indication"of" cell" viability"and" therefore" cell" growth."Whilst"not"providing"actual"
cell"concentration"levels,"PrestoBlue®"(PB)"is"a"colourimetric"assay"which"changes"
from"blue" to"pink" in" the"presence"of" cells,"providing"a" relative" fluorescence"unit"
(RFU)" measurement" relative" to" the" amount" of" viable" cells" present" within" the"
sample."From"each" culture"well," 100"μL"of" culture"medium"was" transferred" to"a"
fresh"96"shallowUwell"plate."On"each"plate"analysed,"three"blank"wells,"containing"
100"μL"of"plain"CDUCHO"medium,"were" included."To" each"well" 22.5"μL"of" roomU
temperature" PB" solution" (a" preUmixed" 1:1" PB:CDUCHO" solution)" was" added" by"







The" RFU" values" produced" by" the" plate" reader" were" normalised" to" the" average"
value"of"the"three"mediaUblank"wells"run"on"each"plate."A"sample:blank"ratio"was"
calculated"by"dividing"each"sample"value"by" the"average"blank"value."Use"of" this"
ratio," instead" of" just" subtracting" the" blank" value," allowed" for" variances" in" plate"
reader"gain"settings"between"runs,"allowing"plates"from"separate"experiments"to"
be" compared" directly." This"was" essential" for" growth" calculations." To" determine"
growth"over" a"period"of" time,"PB" samples"were" taken" at" both" the" start" and" end"
points" of" culture," from" which" IVCD" change" and" growth" rate" values" could" be"















































VCD (cells mL-1 x 106)
R2 = 0.9695

















VCD (cells mL-1 x 106)
R2 = 0.9963
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VCD (cells mL-1 x 106)
R2 = 0.9695























a" larger"working" cell"bank" (WCB)"was"produced"as" close" to" the"original"MCB"as"
possible"(minimum"four"passages"of"growth"from"previous"vial)."Each"M/WCB"vial"
contained"between"10.0" U" 15.0" x"106" cells" in"1.5"mL" freezing"media" (chilled"CDU
CHO,"7.5%"DiUMethyl"Sulphoxide"[DMSO],"Sigma)."The"required"volume"of"culture"
(to"provide"10" U" 15" x" 106" cells)"was" centrifuged" at" 130" relative" centrifugal" field"
(RCF)" for" 5" mins" and" the" supernatant" discarded." The" cell" pellet" was" gently"











cells"were" reUsuspended" in"10"mL"growth"media" (supplemented"CDUCHO)"and"a"
cell"count"carried"out."For"the"first"passage"cells"were"seeded"at"0.3"x"106"cells"mLU1"
in" 25" mL" media" in" a" e125" flask" and" grown" for" 3" days." All" further" passages"
following"the"usual"3U"or"4Uday"duration"at"a"density"of"0.2"x"106"cells"mLU1."Cells"
were" cultured" for" at" least" 4" full" passages" before" being" used" for" experimental"





130"RCF" for" 5"mins." For" endUpoint" samples" (after"which" the" cells"would" not" be"
required"for"growth),"this"process"was"carried"out"at"1000"RCF.""
2.1.7.1.$Supernatant$sample$storage$




Beyond" this" duration" sample" storage" was" at" U20" °C." All" comparative" samples"












A" growth" curve" of" the" MedIUCHO" WCB" used" for" all" experimental" work" was"
performed" so" as" to" define" cell" growth" and" better" inform" sampling" and" feeding"
strategies."Cells"were"seeded"in"50"mL"total"volume"of"growth"media"at"0.2"x"106"
cells" mLU1." Cells" were" grown" as" described" in" section" 2.1.2," with" ViCell" samples"
taken"at"daily"intervals"to"produce"a"cell"growth"curve"(figure"2U2)."Data"collected"
from"ViCell"measurements"were"used" to"calculate"various"cell"growth"metrics" to"
better" track" cell" growth" and" productivity" during" the" course" of" cell" culture." For"
these" calculations," t& represents" time" (normally" measured" in" days)," whilst" T"





The" growth" of" cell" cultures" grown" over" similar" time" periods" were" directly"
compared" by" calculating" their" specific" growth" rate" (μ" dayU1" ," equation" 2)." This"
utilised"a"culture’s"starting"VCD"(VCD"at"t=0;"Xv0),"final"VCD"(VCD"at"t=1;"Xv1)"and"
change"in"time"(Δt,"days)"to"compare"cell"growth"starting"at"different"VCDs"and"at"


















MedI'CHO& cells&were& seeded& at& 0.2& x& 106& cells&mL'1& in& 50&mL& cultures& and& grown& for& 9& days.& ViCell&
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2.2.2.(Doubling(time(









cell" divisions)" a" culture"underwent" in"one"passage" (Equation"4)."The"number"of"
generations"a"cell" line"progressed"through"during"a"multipleUpassage"experiment"
was" determined" by" addition" of" the" generation" numbers" from" each" separate"





















The" daily" specific" productivity" rate" of" a" culture" (Qp," pg" cellU1" dayU1;" Equation" 6)"
was"used"to"normalise"culture"productivity"levels"for"varying"cell"growth"rates."It"
was" taken" from" previous" work" in" the" DCJ" group" (Pybus" et" al." 2014)." Qp" was"
calculated"using"the"change"in"titre"level"between"timeUpoint"0"(T0)"and"time"point"
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1" (T1)," the"change" in"cell"density"between" the" two" time"points" (Xv0,"Xv1)"and" the"
overall"change"in"time"(Δt)."
Equation!6!–!calculating"the"specific"productivity"of"CHO"cells.!

















different" solutions" and" the" expected" volume" of" dissolved" drug" compound" to" be"
added" to" cell" culture." DMSO" and" ethanol" volumes" were" minimised" so" as" to" be"
below"0.15%"(DMSO)"or"1%"(EtOH)"of"total"cell"culture"volume"when"compounds"
were"used"at"milimolar"concentrations,"so"as"to"avoid"any"effect(s)"of"the"vehicle"
compound"upon"cell" growth"or" function."Prior" to"use," vehicle" solution"was" filter"
sterilised" using" a" syringeUtip" filter" (0.2" μm," Corning)." Due" to" compounds" being"
bought"in"small"(milligram,"mg)"quantities,"vehicle"solution"was"added"directly"to"






°C" and" thawed" at" 37" °C" before" addition" to" cell" culture" at" the" required"working"
solution."Aliquot"volumes"were" limited" to"approximately"200"μL"so"as" to" reduce"












Exo1! Santa"Cruz" 50"mM" DMSO"
"
Exo2! Sigma" 10"mM" DMSO"
"
FLI[06! Santa"Cruz" 1"mM" DMSO" to" 10" mM," further"
diluted"to"1"mM"in"CDUCHO."
"






Compounds"were" tested"within" CHO" cell" culture" at" varying" levels" to" determine"




required" concentrations," incubated" for"72U96"h"before" cell" growth"was"analysed"
using" PB." For" kill" curves" to" determine" precise" compound" concentrations" to" be"
used" in" shaken" culture," or" to" determine" the" stability" of" evolved" cell" lines," cells"
were"seeded"at"0.2"x"106"in"550"μL"total"volume"in"96"deep"well"plates"with"test"
compound(s)" added" at" the" previously" determined" concentrations." A" 100" μL"
sample"was"taken"for"PB"analysis"to"better"define"seeding"density."After"48U72"h"
shaken" growth" (as" section" 2.1.2.2)" a" further" 100" μL" sample"was" taken" so" as" to"
calculate" cell" growth." All" kill" curve" concentrations" were" repeated" at" least" in"
duplicate," in" triplicate" where" plate" space" allowed." All" kill" curves" contained"
untreated"control"cultures"and"were"designed"with"at"least"two"concentrations"at"
which"all"cell"growth"failed"in"an"attempt"to"produce"a"sigmoidal"kill"curve"so"as"to"
confirm" a" compound’s" 100%" lethal" dose" (LD100)" concentration." MediaUonly" and"
media/compound" wells" were" compared" to" ensure" compounds" did" not" impact"
upon"PB"analysis"
2.3.2.1.$Determination$of$lethal$dose$values$
To" determine" LD" values," linear" regression" of" IVCD" fold" change" from" untreated"
control"cells"was"performed"using"Prism"7"for"Mac"OS"X."Extreme"data"points"from"




response" to" changes" in" compound"concentration" is" seen," so" as" to"not" skew"data"
with"flatter"areas"of"the"kill"curve."Regression"analysis"produced"a"linear"formula"
from"which"change"in"growth"rate"from"the"untreated"control"cells"(LD0)"could"be"
used" to" produced" compound" concentrations" that" resulted" in" further" LD" values."
Through"the"formula,"the"compound"concentration"resulting"in"a"0.75Ufold"change"
in"IVCD"(i.e."a"25%"IVCD"reduction"compared"to"untreated"cells,"effectively"killing"









the" model" Mabs" were" used" to" transiently" and" stably" transfect" CHO" cells" so"
productivity"levels"of"cell"lines"could"be"ascertained."Accessory"genes"with"which"
the" CHO" secretory" and" biosynthetic" pathways" were" engineered" were" also"
expressed"from"plasmid"vectors."
2.4.1.(Plasmid(DNA(design(
All" plasmid" DNA" used" during" the" project" was" inserted" into" a" proprietary"








All" model" Mabs" and" accessory" genes" were" expressed" from" the" recombinant"
backbone"vector."Two"recombinant"Mab"molecules,"one"difficult"to"express"(DTE)"




(CMV)" promoter." Model" Mab" genes" were" used" in" the" standard" expression"
backbone" for" both" stable" and" transient" expression" studies." For" some" stableU
expression" experiments," the" same"ETE" and"DTE"Mabs"were" also" expressed" in" a"
backbone" vector" that" contained" a" transcriptional" enhancing" element" (TEE)"
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ensuring" more" replicable" transcription" between" transfectants" (Saunders" et" al."
2015)."
"
LongUterm" transient" studies" (between" 4" U" 10" days" in" length)" were" carried" out"
using"fedUbatch"culture"of"the"MedIUTran"longUterm"transient"cell" line."LongUterm"
transient" expression" was" run" from" a" CMV" promoter" in" a" standard" expression"
plasmid" containing" an" EpsteinUBarr" virusUderived"OriP" gene" that"was" necessary"









ETEUTEE" Backbone" vector" expressing" ETE" Mab," also"
containing" a" transcriptional" enhancing" element"
(TEE)."
Standard"DTE" Backbone"vector"expressing"DTE"Mab""
DTEUTEE" Backbone" vector" expressing" DTE" Mab," also"
containing"a"TEE."
DTEUOriP" Backbone" vector" expressing"DTE"Mab" under" CMV,"

















The&GOI& locations&could& include&Mab&or&effector&genes.&The&GS&expression&cassette& is&shown&under&a&
weaker&SV40&promoter.&[a]&The&standard&backbone&was&used&predominantly&for&transient&expression,&
though& some& stable& transfections& were& carried& out& with& this& plasmid.& [b]& this& plasmid& contains& a&





Circular" plasmid" DNA" was" used" to" transform" DH5α" competent" Escherichia& coli"










at" 121" °C" for" 15" mins." After" cooling" to" <55" °C" media" was" supplemented" with"
requisite" antibiotic" selection" agent" for" growth" of" bacteria" transformed" with"
recombinant"plasmid"DNA,"normally"Ampicillin"(Amp,"100"μg/mL)"or"Kanamycin"
(Kan," 50" μg/mL)"which"was" added" from"a" 1000x" stock" solution" (Sigma)." Liquid"





immediately"prior" to"use."Plasmid"DNA" (1"μg," approximately"1"μL" total" volume)"
from"a"plasmid"stock"solution"was"added"to"a"50"μL"aliquot"of"cells,"gently"mixed"
by" light" flicking" and" incubated" on" ice" for" 10" mins." DNA" was" introduced" to" the"
bacteria" by" a" heatUshock" in" a" water" bath" (42" °C" for" 20" U" 40" seconds)" before" a"





plates" upsideUdown" at" 37" °C." Colonies" were" used" to" inoculate" shaken" culture."












MaxiPrep" kit" (MaxiPrep;" Qiagen," Manchester," UK)" according" to" the" included"







Plasmid"DNA" concentration" and" purity"was"measured" using" a"NanoDrop™"OneC"
(ThermoFisher)" with" the" buffer" containing" the" DNA" used" as" a" blank." For" each"
plasmid"readings"were"taken"in"triplicate"and"an"average"value"determined."Purity"
was" measured" using" A260/A280" and" A230/A260" ratios," with" values" of"
approximately" 1.8" and" 2.0U2.2" respectively" indicating" pure" DNA" with" minimal"




ensure" the" correct" plasmids" were" used." SingleU" or" doubleUenzyme" restriction"
digests" were" carried" out" on" purified" DNA" using" High" Fidelity" (HF)" restriction"
endonucleases" (NEB)." The" enzymes" used" depended" upon" the" plasmid" being"
digested," with" EcoRI," BamHI," AgeI" and" SbfI" the" most" common" enzymes" used."
Restriction" digests" (20" μL" final" volume)" were" prepared" containing" 10" units" of"




loading" dye" (NEB)." Samples" (10" μL)" were" loaded" in" to" wells" of" an" analysis" gel"
(1.0%"Agarose"dissolved"by"microwaving" in"50"mL"1x"Tris," acetate,"EDTA" [TAE;"
Gibco]" buffer" with" 0.5" μL" 10000x" SYBR™safe" DNA" gel" stain" added" (Invitrogen;"
added" once" agarose" had" cooled" but" before" gel" poured)." A" nucleotide" ladder"
(HyperLadder™,"BioLine,"London"UK)"was"also"loaded"on"to"the"gel"to"determine"
the" size" of" DNA" fragments,"with" a" blank" lane" and" unUdigested" plasmid" run" as" a"
negative"control."The"loaded"gel"was"run"in"a"gel"tank,"containing"1x"TAE"buffer,"at"
100V"for"30"mins"to"separate"DNA"bands"based"on"size."Gels"were"visualised"on"a"
Benchtop" UV" Transilluminator" (UVP," AnalytikJena," Jena," Germany)" and" images"









with" linearised"plasmid"DNA."DNA"used"originated" from"the"same"stocks"as" that"
used"for"transient"transfections."
2.4.4.1.$Linearisation$of$Plasmid$DNA$
Plasmid" DNA"was" linearised" by" restriction" digest" using" PvuIUHF" enzyme" (NEB)"
which"cut"each"model"Mab"plasmid"at"one"restriction"site"situated"in"the"bacterial"
resistanceUencoding" gene" to" not" impact" upon" transcription" of" the" recombinant"
genes." Gene" sequences"were" designed" so" as" to" not" contain" the" Pvu1" restriction"
site."Plasmid"DNA"(100"μg)"was"cut"with"500"units"of"restriction"endonuclease"in"a"






To" prepare" linearised" plasmid" DNA" for" transfection" it" underwent" cleanup" to"













Ethanol! Precipitation." Two" volumes" of" 100%" EtOH" (U20" °C;" VWR)" and" 3" M"




washing" and" centrifuged" (13000" rpm," 10" mins," 4" °C)" to" reUpellet." Remaining"
preparation" steps" were" performed" in" a" sterile" environment." Supernatant" was"
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removed"and"the"DNA"pellet"airUdried"for"5U10"minutes."DNA"was"resuspended"in"






and" assay" productivity" levels" of" evolved" and" genetically" manipulated" cell" lines."
Recombinant" plasmid" DNA" encoding" model" Mabs," engineering" target" effector"
genes" or" green" fluorescent" protein" (GFP)," were" introduced" to" MedIUCHOU" and"
MedIUTRAN–derived"cell"lines"by"electroporationUmediated"transfection,"using"the"
Nucleofection"platform"(Lonza,"Basel," Switzerland)."Both"cuvette"and"Amaxa"96U
well" Shuttle™" nucleofection" technologies"were" utilised" though" the" course" of" the"





For" all" transfections" cells"were" taken" on" day" three" of" culture," early" exponential"
phase,"with"a"VCD"of"approximately"1.0"x"106"cells"mLU1"and"a"viability"above"95%."
MSX" and/or" any" other" selection/evolutionary" agents" used" in" cell" culture" were"
removed" from" cell" culture" two" passages" prior" to" transfection" to" prevent" any"
negative" effects" upon" transfection" efficiency." The" following" describes" the"
protocols" used" for" transient" transfection" of"MedIUCHO" (section"2.5.1)" and"MedIU
TRAN" and" stably" expressing" (section" 2.5.2)" cell" lines." Production" of" stablyU
expressing" pools" from" MedIUCHOUderived" cell" lines" is" also" described" (section"
2.5.3)."Plasmid"DNA"used"is"listed"in"table"2U3.""
2.5.1.(Transient(transfection(of(CHO(cells(–(cuvette(system(
Transient" transfection" of" CHO" cells" with" plasmid" DNA" was" performed" by" an"
electroporation" protocol" used" previously" within" the" laboratory" (Johari" et" al."
2015)," based" upon" the" original" manufacturer’s" protocol" for" suspension" cells"




Transfection" was" conducted" using" the" Amaxa™" Cell" Line" Nucleofector™" Kit" V"
system"(Lonza)."The"passage"prior"to"transfection,"cells"were"seeded"as"normal"at"
0.2"x"106" cells"mLU1,"with" transfection"being" carried"out"on"day"3"of" culture."For"
transfection" 4.5" x" 106" cells" per" cuvette"were" centrifuged" at" 130" x" g" for" 5"mins,"






preUgassed" culture" medium" in" a" TPP" Tubespin" cultiflask," at" an" approximate"
seeding" density" of" 0.4" x" 106" cells" mLU1." After" 1U2" h" of" shaken" incubation" ViCell"
samples"were" taken" to" determine" an" accurate" seeding"density" and" cell" viability."
After"4"days’"growth,"cell"viability"and"growth"measurements"were"taken"by"ViCell."
Cells" were" harvested" by" centrifugation" at" 130" x" g" for" 5" min" and" supernatant"




Transfection" efficiency" was" determined" when" new" transfection" protocols" were"
used," or" new" cell" lines" being" transfected," to" ensure" transfection" repeats" were"
comparable."To"determine"transfection"efficiency,"transfection"with"plasmid"DNA"




(Applied" Biosystems," Life" tech," ThermoFisher)." GFP"was" excited"with" a" 488" nm"
laser,"with"emission"detected"at"530"nm" to"determine" the"percentage"of" the" cell"
population" that" was" GFP" positive" (therefore" shown" to" have" been" successfully"
transfected"with"and"expressing"GFP)"to"determine"a"transfection"efficiency."
2.5.1.2.$Determining$transfection$efficiency:$Co9transfection$with$GFP$
To"avoid" excessive" transfection" and" cell" culture,"where"many"different" cell" lines"
were" transiently" transfected," pMAXGFP™" was" coUtransfected" alongside" effector"
gene"DNA."Due"to"the"size"difference"between"MabUencoding"plasmid"DNA"(~9500"
bp)"and"pMAXGFP"(3486"bp),"effector"and"GFP"genes"were"coUtransfected"at"a"1:1"
molar" ratio" which" was" calculated" by" dividing" the" size" of" the" MabUexpressing"
plasmid" (in" bp)" by" that" of" the" pMAXGFP" plasmid." The" two" plasmids" were"
combined" in" the" 1:1" ratio," with" a" total" DNA" mass" of" 4.6" μg." Transfection" was"




nucleofections" in" parallel," using" a" protocol" based" upon" the" manufacturer’s"
suggested" protocol" for" CHOUS" derived" cell" lines" (Lonza" 2009)" and" further"
developed" within" the" laboratory" group" resulting" in" transfection" efficiency"
(determined" by" GFP" expression)" of" above" 95%" (Arnall" et" al.," manuscript" in"
preparation)." This" platform" was" used" to" carry" out" gene" screen" experiments" to"
determine" the" effect" of" varying" levels" of" different" genes," both" singularly" and" in"
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combination," upon" CHO" cell" productivity." Each" gene" dose" permutation" was"
repeated" three" times"within"a"plate" to"give" three"biological" replicates,"with"each"
plate"repeated" twoUthree" times" to"produce" technical" replicates."Transfected"cells"
were" cultured" in" shaken" square" well," VUbottomed" 96Uwell" deep" well" plates"
(Greiner" BioUOne)" as" described" in" section" 2.1.2.2," with" any" changes" to" this"
protocol"specific"to"96Uwell"transfection"listed"here."




Prior" to" transfection," 500" μL" of" growth"media" (unUsupplemented" CDUCHO)" was"
transferred"to"each"well"of"96"deep"well"plate,"covered"with"a"sterilised"‘Sandwich"
Cover’" lid" and" transferred" to" a" shaking" incubator" for" equilibration" at" 37" °C," 5%"
CO2,"320"rpm"for"a"minimum"duration"of"1"h.""
"
DNA" and" cells" were" prepared" and" combined" with" an" excess" volume" of" 25%" to"
allow"for"easier"pipetting"and"to"ensure"the"correct"volume"was"used"throughout."
Plasmid"DNA"was"mixed"with"nucleofector" solution"mix" (a"4.5:1" ratio"mix"of" SG"
Cell" Line" 96Uwell" Nucleofector™" Solution:Supplement" [Lonza]" which" were"
combined"on" the"day"of"use)" in"a" sterile" roundUbottom"96Uwell"plate" (Nunc)."To"
avoid"evaporation"of"small"quantities"of"DNA,"7.5"μL"nucleofector"solution"mix"was"
initially"added"to"separate"wells"of"the"round"bottomed"96Uwell"plate"in"the"same"













μL" was" transferred" to" the" 96Uwell" Nucleocuvette™" plate" (Lonza)." Bubbles" were"
carefully"removed"using"fine"sterile"needles"(Microlance™,"BD"BioSciences,"Oxford,"
UK)" to" reduce" electroporation" error" through" arcing" of" charge." The" plate" was"
electroporated" within" the" Nucleofector™" 96Uwell" Shuttle™" addUon" device," using"
program" FFU158" (CHOUS" optimised)." Immediately" postUtransfection," 80" μL" preU
warmed" culture" medium" was" added" to" each" well." The" viability" of" three" wells,"
selected" at" random," was" assessed" to" determine" an" average" postUtransfection"
viability" and"VCD."All"wells"were"mixed"and"an"average"of" the" three"VCD"values"
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Immediately" after" seeding," 100" μL" of" cell" suspension" from" each" well" was"
transferred" to" flatUbottomed" 96Uwell" plates" (Nunc)" for" PB" analysis" (section"
2.1.4.1)" to" determine" individual" seeding" density" values" for" each" well." The"





cell" lines," especially" to" compare" evolved/filtered" cell" lines"with" the" control" host"
cell"line."Stable"pools"were"created"by"electroporation"(nucleofection)"of"CHO"cell"
lines"with" linearised"plasmid"DNA."The" stable" transfection"protocol" is" similar" to"
that" used" for" transient" nucleofection" (section" 2.5.1)" and" was" provided" by"
MedImmune." Before" transfection" cells"were" grown" from"WCB" for" between"4U10"
passages," the" passage" immediately" prior" to" transfection" lasting" no" more" than"
three" days" with" cell" viability" exceeding" 95%." Plasmid" DNA" encoding" the"
recombinant" protein" of" interest" and" a" MSX" resistance" gene" was" linearised" by"
restriction"digest"with"PvuI"restriction"endonuclease"(section"2.4.4.1)"and"cleaned"
and" resuspended" in" sterile" nuclease" free" water" (section" 2.4.4.2)," with" plasmid"
linearisation" checked" on" 1%" agarose" gel" against" untreated" plasmid" controls."
Electroporation"was" conducted"using" the"Amaxa™"Cell" Line"Nucleofector™"Kit"V"





disrupt" the" cell" pellet." The" dry" cell" pellet"was" resuspended" in" 100" μL" of" a" preU
mixed"Kit"V"nucleofector"solution,"in"a"4.5:1"ratio"of"solution:supplement"(Lonza)."
The" resuspended" cells"were" added" to" 15"μL" (6" μg)" linearised"plasmid"DNA" in" a"
sterile"microfuge"tube"and"mixed"gently"by"pipetting."Any"bubbles"were"carefully"
removed" from" the" cuvette" by" lancing" with" a" pipette" tip" or" sterile" needle"
(Microlance™)."The"cell/DNA"mix"was"added"to"the"nucleofection"cuvette"(Lonza)"
and"electroporated"using"program"U024"(for"neonatal"cells).""
Transfected" cells" were" immediately" removed" from" the" cuvette" to" 41" mL" preU
warmed"(37"°C)"and"preUgassed"media"in"an"e125"flask,"using"the"provided"narrow"
dropping"pipette" (Lonza)."A" small" amount"of"media"was" taken" from" the" flask" to"
further" rinse" the" cuvette" and" ensure" as" much" cell" matter" as" possible" was"
transferred" to" culture." The" resuspended" cells" were" incubated" as" described" in"
section"2.1.2.1"for"up"to"1"h."A"ViCell"sample"(1"mL)"was"taken"to"determine"cell"
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as" cells" adapted" to" shaken" culture." Once" cell" growth" rate" and" viability" had"
stabilised,"cells"were"passaged"as"normal"every"3"U"4"days."Cell"banks"of"each"stable"
pool" were" produced" after" 3" U" 4" passages" (roughly" 10" generations)" in" shaken"
culture,"when"growth"levels"had"returned"close"to"the"host"level"(section"2.1.5)."Of"







An" IgG" MabUspecific" Valita™TITER" fluorescence" polarisation" (FP)" assay"
(Valitacell™," Dublin," Ireland)" was" used" to" measure" concentrations" of" Mab"
produced" by" MabUexpressing" CHO" cells" (Thompson" et" al." 2017)." ValitaTiter"
(functional"range"of"2.5U100"mg/L)"plates"were"used"to"measure"Mab"levels"from"
cells"stably"expressing"recombinant"Mab."ValitaTiter"High"Sensitivity" (HS)"plates"
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"
where" F∥ "=" fluorescence" intensity" parallel" to" the" excitation" plane," and" F⊥!="













(ValitaTITER" 2018a)." For" HS" plates," a" standard" curve" between" 0U6" mg/L" was"
produced."An"initial"dilution"in"growth"media"was"produced"to"a"concentration"of"
6"mg/L"in"1"mL."Serial"dilutions"were"carried"out,"as"described"above,"resulting"in"
a" standard" curve" with" values" at" 6," 3," 1.5," 0.75," 0.375" and" 0.1875" mg/L"
(ValitaTITER"2018b).""
"
For" both" curves" a" media" blank" was" used" as" a" 0" mg/L" concentration" and" to"
normalise"between"plates."Standards"were"repeated"in"at"least"duplicate"(2"wells"
per"standard),"with"triplicate"technical"repeats"(3"wells"per"standard)"used"where"
possible."When"using"multiple"Valita™TITER"plates" across" the" same"experiment,"
plates" and" buffer" from" the" same" batch"were" used," coupled"with" the" same" plate"
reader" settings." This" allowed" only" one" standard" curve" could" be" used" across" the"
entire"experiment"instead"of"a"standard"curve"on"each"plate"used.""
2.6.2.(Sample(preparation(
Samples" were" harvested" from" cell" culture" using" centrifugation" as" described" in"
section"2.1.7."All"comparative"samples"underwent"the"same"amount"of"freezeUthaw"
cycles"so"they"could"be"compared"directly."Prior"to"analysis,"samples"were"diluted"





DTE," and"whether" it"was" being" expressed" transiently" or" stably." Frozen" samples"
were" thawed" shortly" before" analysis" was" performed." All" diluted" samples" were"





volume" in" a" separate" microfuge" tube." The" dilution" was" split" in" to" three" equal"




After" harvesting" samples" were" transferred" from" a" 96Uwell" storage" plate" to" a"
dilution"plate."Samples"were"diluted"by"the"required"amount"in"CDUCHO"to"a"final"
volume" of" 100" μL" (normal" Valita™TITER" assay)" or" 150" μL" (Valita™TITER" HS"




use" (Thompson" et" al." 2017;" ValitaTITER" 2018a;" ValitaTITER" 2018b)." Valita™"
buffer"(60"μL/well;"containing"Acetate,"Bovine"Serum"Albumin"[BSA],"NaCl"and"0.5"
g/L"Sodium"azide)"was"added"to"each"well"of"the"assay"plate."Using"a"multichannel"
pipette" and" clean" tips," 60" μL" of" sample" was" transferred" from" the" sample"
preparation"plate"to"the"assay"plate."Once"all"samples"had"been"added,"all"samples"
were" mixed" by" pipetting" up" and" down" 100" μL" six" times" with" a" multichannel"
pipette." The" plate"was" incubated" at" room" temperature" in" darkness" for" 30"mins"
before" being" read" on" a" PHERAstar®" plateUreader" using" specific" Valita™TITER"
software" to"measure" fluorescence" polarisation." Gain" settings" were" set" from" the"
well"with"the"expected"highest"Mab"levels"(the"80"mg/L"standard"if"used).""
2.6.3.1.$Valita™TITER$HS$analysis$
For" Valita™TITER" HS" analysis" the" analysis" plate" was" prepared" as" described" in"








points" (those" at" the"bottom"of" the" curve"being" the"most" likely" to"be" affected"by"
noise)"were" removed"and" the" line"of" best" fit" used" if" an" r2" value" above"0.95"was"
produced." The" produced" equation" for" the" line" of" best" fit" was" used" to" convert"
known"FP"values"to"IgG"concentrations"(mg/L)."
2.6.4.1.$Calculation$of$titre$values$from$Valita™TITRE$HS$data$
To" calculate" IgG" concentrations" from" ValitaTiter" HS" data," the" values" from" the"
blank"plate"had" to"be" taken" in" to" account" (section"2.6.3.1)"by" subtraction"of" the"
blank"plate"values"from"the"read"plate"values."The"parallel"fluorescence"value"from"
the"blank"plate"was"subtracted"from"the"parallel"fluorescence"value"from"the"read"
plate" to" produce" a" new" parallel" fluorescence" value." The" perpendicular"
fluorescence" value" from" the" blank" plate"was" subtracted" from" the" perpendicular"
fluorescence" value" from" the" read" plate," resulting" in" a" new" perpendicular"
" 88"
fluorescence"value."These"two"new"parallel"and"perpendicular"fluorescence"values"
were"used" in"Equation"7" to" calculate" the" correct" FP"values"which" could" then"be"
used"in"the"standard"curve"equation."
2.7.(Cell(morphology(analysis(
To" quickly" visualise" any" changes" within" the" CHO" secretory" pathway" that" may"
result"in"a"change"in"secretory/productivity"phenotype,"antibodies"raised"against"
targets"present"within"the"mammalian"secretory"pathway"were"used"to"probe"the"
cell." Immunofluorescence" microscopy" (IF)" was" used" to" visualise" changes" in"
organelle"morphology"and"target"and"product"distribution"within"the"cell."Western"
blotting" (WB)" was" used" to" approximately" visualise" abundance" levels" of"
components" within" a" cell" population." Flow" Cytometry" (FC)" was" used" to" better"
quantify" expression" levels" of" secretory" pathway" components" and" recombinant"
proteins"across"an"entire"cell"population."
2.7.1.(Immunofluorescence(microscopy((IF)(






well" cell" culture" plate" (Nunc)" using" EtOHUsterilised" tweezers." Each" slide" was"
flooded" with" a" minimum" of" 500" μL" 0.01%" PolyULUlysine" (PLL)" solution" (w/v,"
diluted"from"0.1%"solution"in"diH2O;"Sigma)"and"incubated"at"37"°C"for">15"mins."
PLL" solution"was" removed"by"aspiration"and"coverslips"washed" in"1"mL"1x"PBS"








centrifuged" at" 200" x" g" to" ensure" adherence" to" the" coverslip" prior" to" the"
fixing/staining"procedure.""
2.7.1.2.$Cell$fixation$
Cell" fixation" was" performed" on" both" coverUslip" mounted" and" nonUmounted"
(pelleted)" cells" to" allow" storage" of" cell" samples" prior" to" analysis," as" well" as" to"
allow" accurate" staining" of" cells." For" mounted" cell" samples," fixing/washing"




removed" by" decanting" and" careful" pipetting" to" remove" as" much" as" possible"
without"disturbing"the"cell"pellet."Depending"upon"the"antibody"to"be"used,"cells"




PFA! fixation.! Growth" media" was" removed" from" the" cell" pellet/mounted" cells"
which"were" then"washed"with" 1x" PBS" (1"mL)." FridgeUcold" fixative" solution"was"
added"with" cells" at" a" concentration" of" 1" x" 107" cells"mLU1" PFA" solution" and" cells"
incubated"at"4"°C"for"15"minutes."Cells"were"not"fixed"for"longer"than"this"so"as"to"
avoid" overUfixation" that" would" impinge" upon" cell" staining." PFA" solution" was"
removed" and," for" slideUmounted" cells" to" be" antibody" stained" for"
immunofluorescence,"500"μL"0.1"M"Glycine"solution"in"1x"PBS"added"to"quench"the"
fixative" before" removal" and" rinsing" and" storage" in" 1"mL" 1x" PBS." If" not" stained"
immediately,"PFAUfixed"cells"were"stored"at"4"°C"for"<6"months"before"use."
"
Methanol! fixation.!MeOH"(100%)!was"preUchilled" in"1"mL"aliquots" in"a"12Uwell"
cell"culture"plate"(Nunc)"at"U20"°C"for">20"mins."Growth"media"was"removed"from"




Cells" were" permeabilised" using" a" saponinUFBS" permeabilisation" and" staining"
solution," with" Fetal" bovine" serum" (FBS)" acting" as" a" blocking" agent" (0.1%" w/v"
saponin" from" Quillaja" bark" [Sigma];" 5%" v/v" FBS;" dissolved" in" 1x" PBS," sterile"
filtered"through"a"0.2"μM"filter"Stericup®"[Millipore,"Sigma]"and"stored"at"4"°C)."All"
staining"protocols"were" carried"out" at" room" temperature" (18U22" °C)."Antibodies"
were"stored"at"U20"°C"and"maintained"at"this"temperature"in"a"cold"pot"during"use."
Primary" antibodies" were" tested" by" both" IF" and" Western" blotting" to" confirm"
efficacy"in"CHO"cells"prior"to"wider"use"within"the"project."Two"primary"antibodies"





cells." SaponinUFBS" solution" was" removed" and" the" primary" antibody/antibodies"
added" at" the" required" concentration" in" 300" μL" saponinUFBS" solution" and"
incubated" at" RT" for" 30" mins" (See" table" 2U4" for" antibody" concentrations)." The"
primary"antibody"solution"was" removed"and"cells"washed"with"300"μL"saponinU
FBS" solution." The" secondary" antibody/antibodies," diluted" at" the" required"
concentration" in" saponinUFBS" solution," was/were" added" and" incubated" for" 30"
" 90"
mins"at"RT."Secondary"antibody"solution"was"removed"and"cells"washed"a"further"
two" times"with" saponinUFBS" solution" to" remove" any" excess" secondary" antibody"
before" the" slip"was" flooded"with" 1x" PBS." A" drop" of" RT" ProLong™"Gold"Antifade"
Mountant"(Invitrogen™)"U"containing"the"nuclear"DNA"stain"DAPI"U"was"placed"on"a"
preUlabeled" glass"microscope" slide" (VWR)." Cover" slips" were" removed" from" PBS"
and"dried" by" blotting" before" being" placed," cellUside" down," on" the"mountant" and"










Antibody! Dilution.! Target.! Raised!in! Manufacturer!
GM130"
monoclonal"










































1/750"(IF)" 590" 617" Red" Invitrogen"































Olympus" upright" epifluorescence" BX61" system" running" a" Hamamatsu" Orca"
monochrome" camera" through" Volocity" imaging" software" (Olympus," Shinjuku,"
Tokyo," Japan)." A" FITC" laser/filter" combination" was" used" to" image" cells" stained"
with" AlexaFluor" 488Uconjugated" secondary" antibodies." A" TXURed" laser/filter"
combination" was" used" to" image" cells" stained" with" AlexaFluor" 594Uconjugated"





2003;" MolecularProbesTM" 2005)" and" previous" use" of" these" dyes" in" CHO" cells"
(Tigges" and" Fussenegger" 2006)," so" as" to" maximise" correct" organelle" staining"
whilst"minimising"offUtarget"background"staining,"particularly" that"of" the"plasma"
membrane."For"microscopy,"staining"was"carried"out"in"a"12Uwell"plate"with"cells"
mounted" on" coverslips." For" cell" pellets," staining" was" carried" out" in" 1.5" mL"
microfuge"tubes,"with"solutions"removed"by"centrifugation"at"200"x"g"for"5"mins."
"
ER! tracker! staining." A" 1.0"mM" ERUTracker™" Green" glibenclamide" BODIPY®" FL"
(Molecular" Probes™," Invitrogen)" stock" solution" was" produced" in" DMSO."
Optimisation"resulted"in"a"protocol"where"a"1"μM"working"solution"was"produced"
in"growth"media"and"preUwarmed"to"37"°C."Cells"(2"x"106)"were"washed"in"1"mL"1x"
PBS." Working" solution" (300" μL)" was" added" to" the" cells," mixed" gently" and"





















was" used" for" analysis" of" organelleUtracker" stained" cells" at" MedImmune,"
Cambridge." Cells" (up" to" 4" x" 106" in" 1" mL" of" culture" media" or" 1x" PBS)" were"
harvested/stained" and" stored" on" ice" prior" to" analysis." For" all" analyses" an"
unstained/nonUtransfected" negative" control" sample"was" used"with"which" to" set"
negative"control"gates."The"cell"population"was" first"gated" to" remove"debris"and"
cell" doublets" according" to" forward" scatter" (FSC)" and" side" scatter" (SSC)" ratio."
Fluorescence" level" and" intensity" were" then" gated" according" to" the" negative"
control,"with"a"positive"value"determined"as"anything"above"99%"of"the"negative"
population." GreenUfluorescing" cells" were" analysed" using" a" 488" nm" laser" with"




CHO" cells" stably" expressing" recombinant"Mabs"were" stained" so" the" intracellular"




were" stained" with" goat" antiUHuman" IgG" FcγUAPC" antibody" (Jackson"
ImmunoResearch,"West"Grove," PA,"USA)" to" stain"heavy" chain," and"LambdaUFITC"
goat" antiUHuman" or" KappaUFITC" goat" antiUHuman" antibodies" (both" Southern"















Whole" Cell" Protein" (WCP)" samples" for" separation" by" SDSUPAGE" and" analysis" by"
western" blotting" were" produced" by" lysing" of" cell" cultures" in" Pierce™"
" 94"
Radioimmunoprecipitation"(RIPA)"cell"lysis"buffer"(ThermoFisher)"supplemented"
with" a" 1/250" dilution" of" Protease" inhibitor" cocktail" set" III," EDTA" free" (EMD"
Millipore"Corp.UCalbiochem,"Billerica,"MA,"USA)."Cells"were"harvested"at"300"RCF"
for" 5" mins" at" a" concentration" of" 2.5" x" 107" cells" per" 1" mL" of" RIPAUprotease"
inhibitors"to"be"used."Supernatant"was"removed"by"aspiration"and"the"cell"pellet"
washed" in" 1" mL" 1x" PBS" at" room" temperature." After" centrifugation" and" PBS"
removal" by" aspiration," cells" were" resuspended" in" the" required" volume" of" preU
chilled" (4" °C)" RIPAUprotease" inhibitor" buffer" and" incubated" on" ice" for" 30"mins."
Cells"were"further"disrupted"by"homogenisation"using"a"QIAshredder"(Qiagen),"the"
sample"being"passed" through" the" shredder"1U3" times" at"13,000"x" g" for"1"min."A"
refrigerated" centrifuge" was" used" at" 4" °C" to" maintain" a" chilled" cell" lysate." After"
homogenisation," lysate" was" incubated" on" ice" for" a" further" 30" mins" before"
centrifuging" at" 10,000"RCF" for"10"mins" at" 4" °C."The" supernatant," containing" the"
whole" cell" lysate," was" transferred" to" a" LoUBind" microfuge" tube" (Eppendorf,"
Stevenage," UK)." Protein" samples" were" stored" at" U20" °C" (short" term;" up" to" 2"





mixing" one" volume" RIPA" sample" with" 2" volumes" diH2O" and" one" volume" 4x"






Protein" separation"gels" (NuPAGE"4U12%"BisUTris," 1.5"mm"x"15"well;" Invitrogen)"
were" rinsed"with" diH2O," the" comb" and" plug" tape" removed" and"wells" rinsed" out"
with"1x"NuPAGE"MOPS"SDS"running"buffer"(from"20x"stock"by"dilution"with"diH2O;"
Invitrogen)." Gels" were" placed" in" to" a" gel" running" tank" and" the" upper" buffer"
chamber" filled" with" 1x" running" buffer" to" ensure" there" were" no" leaks," with" the"
outer" tank" then" partUfilled" with" 1x" running" buffer." Samples" (20" μL" equating" to"
50,000" cells)" or" 4" μL" Chameleon" duo" protein" ladder"were" loaded"per"well." Gels"





















the"membrane" underwent" 3" x" 5"min"washes" in" 15"mL"washing" buffer." Staining"
with"2°"antibodies"was"carried"out" in"10"mL"blocking"buffer" for"1"h"before"3"x"5"
min"blocking"buffer"washes."Membrane"was"dried"on"chromatography"paper"and"
stored" in" the" dark" before" analysis" (blots"were" stable" for" up" to" 6"months)." Blots"
were"scanned"and" imaged"using"an"Odyssey"SA" fluorescent"blot" imager"(LiUCor),"





The" Polymerase" Chain" Reaction" (PCR)" was" used" to" analyse" mRNA" transcripts"
within" the"CHO"cell."Reverse" transcription"PCR"(RTUPCR)"was"used"to"determine"





bleach" (sodium" hypochlorate" 10U15%" active" chlorine;" Acros" Organics,"
ThermoFisher)" and" RNaseZap®" (ThermoFisher)." All" plastic" ware" used" was"














RNA" was" converted" into" complementary" DNA" (cDNA)" by" reverse" transcription"
using" the" QuantiTect®" Reverse" Transcription" kit" (Qiagen)." RNA" (800" ng)" from"
each" sample"was" converted" to" cDNA,"with" a" nonUreverse" transcriptase" negative"
control" also" produced" for" each" sample." RNA" samples" were" thawed" on" ice" and"
genomic" DNA" (gDNA)" eliminated" with" a" wipeout" buffer" at" 42" °C" for" 2" mins."
Reverse" transcription" was" then" performed," with" reverse" transcription" buffer,"






Primers" were" designed" to" amplify" the" Sec7" domain" of" the" GBF1," ArfGef1" and"
ArfGef2" (BIG1/BIG2" synonyms)" genes." These" primers" were" used" for" both"
sequencing" and"RTUPCR." Primers"were" also" designed" to" amplify" sections" of" BiP,"
ATF6," CREB3L2" and" XBP1" genes" for" RTUPCR" analysis." Design" of" forward" and"
reverse" primer" pairs" was" carried" out" using" primer3" through" the" NCBI" PrimerU
BLAST"(basic" local"alignment"search" tool)"software"(Koressaar"and"Remm"2007;"
Untergasser" et" al." 2012;" Ye" et" al." 2012)." Primers" were" designed" against" gene"
sequences"taken"from"the"CHOUK1"genome"2014"update"(Lewis"et"al."2013;"Xu"et"




set" such" that" a"maximum"of" three"G" and" C" residues"were" present" in" the" final" 5"
bases" at" the" 3’" end" of" the" primer." Single" and" diUnucleotide" repeats/runs" were"
limited" to" a" maximum" of" four" in" a" row" to" limit" incorrect" binding." With" the"
upstream" (5’)" forward" primer" binding" the"mRNA" sequence" this" primer"was" the"
same" as" the" DNA" sequence" of" the" annealing" site." The" downstream" (3’)" reverse"










for" cDNA" levels." These" are" historically" used" within" the" laboratory" group" as"
reference" genes" for" qPCRU" and" RTUPCRUbased" techniques" having" been" selected"





determine" transcript" levels" of" specific" genes." For" each" gene" to"be" analysed" each"
RTUPCR" reaction" was" repeated" in" triplicate." Reactions" containing" noUreverse"
transcriptase" cDNA" and" no" template" (cDNA" replaced"with"water)"were" used" as"
negative"controls"for"each"primer"set."Primer"pairs"were"diluted"in"nucleaseUfree"
water" such" that" each" primer" was" present" in" the" RTUPCR" reaction" at" 2" μM"
concentration.""
"
RTUPCR"was" carried" out" using" QuantiFast®" SYBR®" Green" PCR" Kit" (Qiagen)." For"
each"RTUPCR"reaction"2.5"μL"of"primer"pair"was"mixed"with"12.5"μL"SYBR"Green"
and" 1.1" μL" cDNA" sample" (or" negative" control" substitutions)." The" final" reaction"
volume"was"made"up"to"25"μL"with"8"μL"nucleaseUfree"water."All"RTUPCR"reactions"




reaction"mixture"was" transferred" to" a"MicroAmp®" Fast" optical" 96Uwell" reaction"
plate" (Applied"Biosystems),"with" each" technical" replicate"put" in" a" separate"well."
The" plate" was" sealed" with" a" MicroAmp™" optical" adhesive" film" (Applied"
Biosystems)"and"transferred"to"an"Applied"Biosystems"7500"Fast"RealUTime"PCR"
system" for" execution" of" the" RTUPCR" experiment." RTUPCR" was" prepared" and"
























Fwd" AGGAAGCCGCCTCGATTTTC" 20" 2026" 2045" 60.7" 55"
739"
Rev" GATCATAGCTGCCAGGAGGT" 20" 2764" 2745" 58.9" 55"
ArfGef1!
Fwd" TGGCAGCTACAGTACACAGATG" 22" 2241" 2262" 60.1" 50"
770"Rev" GAACATGGCTCACTGCTTCC" 20" 3010" 2991" 59.2" 48"
ArfGef2!
Fwd" GGGACCCAGACAACCATTCA" 20" 1900" 1919" 59.6" 55"
735"
Rev" AGCTTTGGCCGTTTTAGCCA" 20" 2634" 2615" 60.8" 50"
ATF6!
Fwd" TGGCAAAGCAGCAATCATCG" 20" 608" 627" 59.8" 50"
185"Rev" TGGCACCACATTGACCACAT" 20" 792" 773" 60.2" 50"
BiP!(HSPA5a)!
Fwd" GCCACGAATGGAGACACTCA" 20" 885" 904" 60.0" 55"
148"
Rev" CCTTTTCCACCTCACGACGA" 20" 1032" 1013" 60.0" 55"
CREB3L2!
Fwd" GGGGTCTTTGGTCTCCAACAA" 21" 386" 406" 60.1" 52"
199"Rev" GAGACAGGCTGAAGGGATGC" 20" 584" 565" 60.5" 60"
XBP1s!
Fwd" TCTGTCAGTGGGGACCTCAT" 20" 694" 713" 59.9" 55"
154"
Rev" GCTGAGAGGTGCTTCCTCAA" 20" 847" 828" 60.0" 55"
FKBP1a!(housekeeping"control"–"designed"by"Adam"Brown)!
Fwd" CTCTCGGGACAGAAACAAGC 20" 36" 55" 58.6" 55"
95"
Rev" GACCTACACTCATCTGGGCTAC 22" 130" 109" 59.6" 55"
MMADHC!(housekeeping"control"–"designed"by"Adam"Brown)!
Fwd" TGTCACCTCAATGGGACTGC" 20" 344" 363" 61.7" 55"






RTUPCR" data" was" produced" as" a" cycle" time" (Ct)" value," with" higher" numbers"
indicating"that"more"RTUPCR"cycles"were"required"to"reach"a"certain"fluorescence"
threshold," indicating" lower" initial" transcript" levels." Ct" values" are"measured"on" a"
log"scale"and"as"such"are"not"linear"(a"change"of"1"relating"to"a"10Ufold"change"in"
expression" level)." Analysis" threshold" was" reduced" to" 0.02" amplify" low" levels"
expected"with"endogenous"genes."Each"Ct"value"was"converted" to"an"expression"
fold" change" value" by" comparing" the" raw" value" of" the" test" subjects" and" primers"
against" the" control" samples" and" housekeeping" gene" primers" using" the" doubleU





gene" transcript" level" between" the" test" and" control," whilst" normalising" against"
housekeeping"controls"
"
∆!"# = !" − !""
∆!"! = !" − !""
"
!"#$!%%&'(!!"#$!!ℎ!"#$ = !2∆!"#!!∆!"! "
"




Primer" efficiencies" were" tested" to" ensure" primer" pairs" functioned" as" designed."

















Stage! Temperature!(°C)! Duration!(min)! repeats!
1! 50.0" 02:00" 1"
2! 95.0" 15:00" 1"
3! 94.0" 00:15" 40"
60.0" 01:00"
Disassociation!step:!for!primer!efficiency!test!only.!














Stage" Temperature!(°C)" Duration!(min)" repeats"
1:"Denaturation" 98" 00:30" 1"
2:"Amplification" 98" 00:10" 35"
67" 00:30"
72" 00:30"
3:"Final"extension" 72" 02:00" 1"








Forward" and" reverse" primers" were" designed" to" sequence" the" Sec7" domain" of"
endogenous"CHO"GBF1."Primers"were"designed"such" that"at" least"50"bases"were"
present" between" the" primer" site" and" the" start/end" of" the" target" Sec7" sequence"
(within"a"maximum"of"180"base"pairs"of"the"Sec7"sequence"outer"limits)."The"Sec7"
protein"sequence"was"found"using"NCBI"BLAST"with"BLAST"tools"used"to"locate"it"
within" the" whole" GBF1" protein" sequence" (Altschul" et" al." 1990)." From" this" the"
region"of"the"GBF1"gene"encoding"the"Sec7"domain"was"elucidated,"with"sequence"
translation"software"(EMBOSS"transeq)"used"to"confirm"the"correct"region"of"DNA"








in" table" 2U6." Tubes" were" loaded" in" to" a" Veriti" 96" well" thermal" cycler" (Applied"
Biosystems)"and"the"PCR"amplification"reaction"carried"out"as"in"Table"2U7."
"
After" PCR" 5" μL" 6x" purple" loading" buffer" (NEB)" was" added" to" the" 25" μL" PCR"
reaction" and"mixed." Samples" (25" μL)"were" run" on" a" 1%"agarose" gel" (as" section"
2.4.2.6)" at" 100" V" for" 20" mins." PCR" amplified" DNA" was" visualised" using" a" UV"
visualiser"and"excised"from"the"gel"using"an"ethanolUsterilised"blade."PCR"product"
was" purified" using" QIAquick" gel" extraction" kit" (Qiagen)" –" agarose" gel" was"
dissolved"at"50"°C"before"PCR"product"was"bound"to"a"QIAquick"DNA"binding"tube"
and" washed" before" elution" in" nuclease" free" water." TwoUway" sequencing" was"






















Data" was" curated," manipulated" and" analysed" using" Excel®:Mac" 2011" version"














Standard" deviation" (SD)" quantifies" the" spread" of" data" points" about" the" mean,"





points" to" provide"more" power" and" accuracy" to" the" data" and" conclusions" drawn"
from" it." As" such," the"use" of" SEM" instead"of" standard"deviation" is" viable" so" as" to"
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To" compare" data" to" the" control" in" a" small" experiment" (less" than" a" total" of" six"
comparisons"required)"an"unpaired"parametric"(assuming"Gaussian"distribution)"
Student’s" TUtest" was" used," using" Welch’s" correlation" as" equal" SDs" were" not"













be" used" as"with" this" there" is" a" 5%" (1" in" 20)" chance" of" error" and" as" such" is" not"
suitable" in" larger"data" sets," especially" those"with"20"or"more"comparisons" to"be"






The" Design" of" Experiment" (DoE)" approach" was" used" to" plan" and" perform"
experiments"to"determine"cause"and"effect"relationships"with"respect"to"multigene"
engineering" of" CHO" cells." TwoUlevel" factorials"were" used"with" the" effect" of" gene"
dose" levels" compared" at" upper" and" lower" levels," where" upper" levels"were" data"
driven" and" lower" levels" set" to" zero." DesignUExpert®" version" 10" software" (StatU
Ease,"Minneapolis,"MN,"USA)"was"used"to"plan"factorial"experiments"and"analyse"
the"data"collected"so"as"to"determine"factors"impacting"upon"experimental"results"






3) Secretory* pathway* mapping* and*
identification* of* CHO* engineering*
targets*
"
Several" datasets" were" used" during" this" chapter." The" inUlab" CHO" transcriptomic"

















• Plasma'cell& data& sets& produced& by& the& Peden& laboratory& highlighted& genes&
important&in&conferring&enhanced&productivity&and&secretory&specificity&upon&
plasma&cells.&&










An" inUdepth,"well" annotated"map"of" the" CHO" secretory" pathway" is" not" available"
within" the" literature" due" in" part" to" the" current" incomplete" nature" of" the" CHO"
genome" (Lewis" et" al." 2013;" Xu" et" al." 2011)." However," resources" mapping" the"
general"ER"protein"folding"and"secretory"pathways"within"other"mammalian"cells,"
including"from"CHOUrelevant"cell" lines"of"a"rodent"lineage,"are"available"from"the"
Kyoto" Encyclopedia" of" Genes" and" Genomes" (KEGG;" Kanehisa" and" Goto" 2000;"
Kanehisa"et"al."2014)."CHO"‘omic"data"has"been"combined"with"prior"mapping"and"





with" knowledge" of" secretory" bottlenecks" and" previous" CHO" engineering"
strategies,"this"informed"decisions"as"to"specific"regions"of"the"secretory"pathway"
to"target"with"engineering"in"an"attempt"to"increase"cellular"machinery,"alleviating"
biosynthetic" and" secretory" bottlenecks" to" increase" flux" though" the" secretory"
pathway,"aiming"to"ultimately"increase"CHO"cell"productivity"(Becker"et"al."2008;"
Hansen"et"al."2017;"Peng"et"al."2011;"Peng"and"Fussenegger"2009b)."The"rational"






Transcriptomic" and" proteomic" data" sets" produced" from" MedImmune" CHO" cell"
lines" by" the" DCJ" laboratory" group" were" used" to" enhance" secretory" pathway"
mapping"within"the"CHO"cell."CHO"’omic"data"was"used"to"better"inform"selection"
of"targets"for"genetic"engineering"of"the"CHO"biosynthetic"and"secretory"pathways."
The" ‘omic" data" provided" information" on" genotypic" and" proteotypic" changes"
occurring"within"CHO"cells"at"different"times"within"cell"culture"and"in"cells"with"
different"Mab"productivity" level."Using"transcriptomic"and"proteomic"datasets" to"
compare" MabUproducing" and" nonUproducing" cell" lines" highlighted" pathway"
alterations" and" changes" in" genetic" expression" levels" that" occur" upon" turning" a"
parental" CHO" cell" into" a"mammalian" cell" factory." This" allowed" links" to" be"made"
between" genotype," proteotype" and" phenotype." That" many" genes" and" proteins"
shown" to" be" enhanced" in" producing" CHO" cells" have" previously" been" linked" to"
enhanced" productivity" in" both" CHO" and" other" cell" lines" (e.g." UPR" transcription"
factors"and"response"elements)"further"highlighted"the"close"link"between"various"





Transcriptomic" profiling" is" used" to" study" the" transcriptome" of" an" organism,"
providing"information"on"the"sum"of"RNA"transcripts"and"therefore"the"control"of"
gene"expression"levels"(Mantione"et"al."2014)."The"abundance"of"RNA"transcripts"
only" shows" the" level" at" which" genes" are" transcribed" and" whilst" this" does" not"
necessarily"correlate"with"cellular"protein"levels"it"does"intimate"at"protein"levels"
whilst"providing"an"insight"into"regulatory"and"controlUbased"changes"within"the"
cell"at"a" specific"point" in" time."Transcriptomic"profiling" includes"nonUcoding"and"
small"RNAs"in"the"dataset,"whilst"gene"splicing,"active/inactive"forms"of"proteins"
and" PTM" status" are" not" accounted" for." Therefore" the" exact" functional"
stoichiometry"is"not"known."
"
If" knowledge" of" the" transcription" levels" of" a" small" number" of" genes" is" required,"
quantitative" PCR" (qPCR)" can" be" used" to" compare" against" cellular" and"
housekeeping" controls." For" largeUscale" global" transcriptomic" analysis" of" a" cell"
line/organism"the"two"prevalent"techniques"are"microarrays,"which"quantify"a"set"
of"preUdetermined"sequences"(e.g." from"a"certain"organism"or"cell"pathway),"and"
RNA" sequencing" (RNAUseq)," in" which" all" transcripts" are" recorded" by" highU
throughput" sequencing." Whilst" more" costly" than" microarray" analysis," RNAUseq"




InUlab" transcriptomic" data" sets" used" throughout" this" project" showed" gene"
transcript" levels" as" Fragments" per"Kilobase" of" transcript" per"Million" of"mapped"
reads"(FKPM)."This"shows"the"relative"expression"level"of"a"specific"transcript"(i.e."
the" higher" the" FKPM," the" more" transcripts" that" are" present)." This" transcript"
abundance"data"was"converted"to"a"foldUchange"of"transcript"abundance"in"the"test"
subject" (e.g." higher" producing" cells)" compared" to" transcript" abundance" in" the"
control"(e.g."parental"cells),"allowing"the"relative"change"in"expression"levels"to"be"
determined" (i.e." the" larger" the" fold" change," the" bigger" the" change" in" abundance"
level)." Fold" change" data" was" the" most" commonly" used" to" mine" differences"
between"producing"and"nonUproducing" cell" lines."However," attention" still"had" to"
be"paid"to"the"absolute"FKPM"value,"as"a"high"foldUchange"value"could"be"produced"
from" a" combination" of" a" very" low" control" FKPM" value" paired" to" a" modest" test"
FKPM,"resulting" in"an"amplified" fold"change"value"overUestimating"the"effect" this"
gene’s"transcription"level"change"would"have"upon"the"cell"phenotype.""
"
Raw" transcriptomic" data" of" MedIUCHO" cell" lines," produced" by" RNAUseq," was"
provided" by" Darren" Geoghegan" of" the" DCJ" group" (Geoghegan" et" al." 2018)." Data"
compared"host"MedIUCHO"with"a"MedIUCHO"cell" line"stably"expressing"an"easy"to"
express"Mab,"with"both"cell"lines"grown"in"bioreactor"culture."RNA"profiles"of"each"
cell" line" were" taken," in" duplicate," at" days" four" and" eight" of" culture" to" provide"
" 108"
information" on" transcript" profile" during" growth" and" stationary" growth" phases."





four"of" culture" to" compare" changes" that"occur"within"a"producing"CHO"cell" as" it"






Whilst" transcriptomic"data"provides" information" as" to" regulatory" control"within"
the"cell"at"the"sampled"time"point,"proteomic"data"provides"a"quantitative"insight"
to" exact" protein" levels" as" well" as" providing" information" on" present" PTMs." This"







at"days" three" (growth"phase)"and"eight" (stationary"phase)"of"bioreactor" culture,"
with" biological" duplicates" taken" of" each" sample" (Schwanhaeusser" et" al." 2011)."
Proteomic"data"was"produced"by"Dr."Joseph"Longworth"of"the"DCJ"laboratory"and"




An" RNAUseq" data" set" comparing" transcript" levels" between" naïve" B" cells" and"
terminally" differentiated" plasma" cells" was" provided" by" Nabila" F" Rahman" of" the"
Peden" laboratory" group," who" also" carried" out" foldUchange" calculations" and"
analysis."Data"was"presented"as" a" log2" foldUchange" in" abundance" levels"between"
the" two" stages"of" cell" development" (as" in" Shi" et" al." 2015)."The"dataset"provided"
insight" to" the"regulatory"changes"that"result" in" the"highUproducing"and"secreting"
plasma" cell" phenotype." All" plasma" cell" data" sets" were" taken" from" publically"






Due" to" limits" regarding" plasmid" size" and" DNA" loads" possible" in" multigene"
engineering" of" the" CHO" cell," difficulty" in" upregulating" lots" of" separate" genes"
individually"and"the"likely"lack"of"effect"the"engineering"of"a"few"specific"molecules"
will" have" upon" the" cell" due" to" the" imposition" of" stoichiometric" imbalances," it" is"
likely" that" transcription" factors" will" play" an" important" role" in" multigene"
engineering" of" the" CHO" cell" biosynthetic" and" secretory" pathways." As" such"
expression"of"a"single"or"small"selection"of"genes"activating"signaling"cascades"that"
instigate" myriad" changes" within" the" cell" should" allow" fine" and" balanced"
























As" highUproductivity" plasma" cells" mature" from" naïve" B" cells" they" undergo" an"
increase" in" ER" and" Golgi" volumes" alongside" an" increase" in" a" wider" array" of"
secretory" and" biosynthetic" pathway" components" (Shaffer" et" al." 2004;" ShapiroU
Shelef"and"Calame"2005)."It"is"therefore"not"unexpected"that"transcription"levels"of"
many" transcription" factors" involved" in" the" UPR" see" an" increase" in" plasma" cells."
XBP1," IRE1," ATFs" 4," 5" and" 6" and"DDIT3/CHOP" are" all" UPRUlinked" transcription"
factors" that" increase" in" abundance" in" plasma" cells," further" enhancing" their"
reputation"as"targets" for"engineering"of"protein"folding"and"secretion"capacity" in"
CHO"cells"(Nishimiya"et"al."2013;"Pybus"et"al."2014;"Tigges"and"Fussenegger"2006)."
TRIP11" may" play" a" role" in" Golgi" stress" response" as" well" as" Golgi" structure"
" 110"
maintenance," whilst" CREB3" family" members" are" known" to" regulate" secretory"




PSIP1" and" HMGN3" both" function" in" stem" cell" differentiation," but" their" known"
function"in"pancreatic"cells"alongside"upregulation"in"plasma"cells"shows"potential"
stressUresponse" and" general" secretion" roles" respectively." Some" of" the" listed"
transcription"factors"(PRDM1,"ARID3A)"may"be"plasmaUcell"specific"with"functions"
leading" to" terminal" differentiation" and" as" such" they" are" unlikely" to" be" feasible"
targets" within" CHO" manufacturing" processes." With" roles" in" promoting"
homologous"IgG"gene"expression"in"plasma"cells"it"is"feasible"that"IRF4,"TCF4"and"
POU2AF1"could" increase"transcription" levels"of"recombinant"IgG"genes,"although"
this" would" likely" require" the" transgene" to" be" under" control" of" a" promoter"
containing"plasma"cell"specific"TFREs."Whilst"this"is"not"feasible"within"the"scope"
of" this" project" it" could" be" an" area" of" development" in" synthetic" promoter/"





the& initial& RNA'seq& data& set& genes& were& narrowed& down& as& follows:& Genes& listed& as& transcription&
factors&were&retained;&genes&that&were&considered& &artificially&amplified&were&removed;&to&maintain&
focus& on& cell& growth& and& productivity,& genes& involved& in& cell& growth,& proliferation,& cargo& protein&
biosynthesis,&protein&folding,&PTMs,&secretion&or&ER&stress&response&were&retained.&The&transcriptional&















HID1! Q8R1F6" 9.37" Intracellular" protein" transport," Brefeldin" A"
response."
PRDM1! Q60636" 7.49" Transcriptional" repressor," drives" BU
lymphocytes"maturation"to"IgG"secreting"cells."
FOS! P01101" 7.00" Cell" proliferation" and" differentiation."
Activates"Phospholipid"synth"in"growing"cells."
CREB3L2! Q8BH52" 6.13" Promotes" transport" and" secretion" and" ER"
biogenesis."




Q9EQY0" 5.00" Serine/Threonine" kinase." Senses" unfolded"
proteins" leading" to" enzyme" activation" and"
splicing"of"XBP1"DNA"to"active"form."
ATF5! O70191" 4.53" Cell"survival,"proliferation"&"differentiation."
ELL2! Q3UKU1" 4.31" Elongation" Factor." Increases" catalytic" rate" of"
RNApolII" transcription" (suppresses" transient"
pausing)." Role" in" IgG" production," influences"
mRNA" processing:" Poly(A)" site" choice," exon"
skipping"&"Ig"HC"processing""
IRF4! Q64287" 3.03" Binds" MHC" class" I" promoter." IgG" LC"
transcription"enhancer"(alongside"PU.1)."
HMGN3! Q9DCB1" 2.90" Affects"insulin/glucagon"levels"and"modulates"
expression" of" pancreatic" genes" involved" in"
insulin"secretion.""
ARID3A! Q62431" 2.65" Involved" in" B" cell" differentiation." Binds"
promoter"for"induced"HC"transcription"
ATF6! F6VAN0" 2.28" Initiates"UPR"under"ER"stress"
MLLT3! A2AM29" 2.05" SuperUelongation" complex" member" –"
increases"rate"of"RNApolII"transcription""
TCF4! Q60722" 1.77" Binds"Ig"enhancer"muUE5/KE5"motif"
PSIP1! Q99JF8" 1.62" Involved" in" stem" cell" differentiation/"
neurogenesis." Possible" protective" role" during"
stressUinduced"apoptosis."
ATF4! Q06507" 1.45" ER"stress"response:"DDIT3/CHOP"




CREB3! O43889" 1.23" ERUbased"UPR"




The" CHO" cell" RNAUseq" data" set"was" compared" to" that" of" the" plasma" cell." Genes"
within"the"CHO"cell"were"ranked"based"on"the"FKPM"fold"change"seen"between"the"
parental" and" producing" cell" lines" on" day" eight" (stationary" phase)" of" bioreactor"
culture" to" elucidate" genes" that" undergo" the" greatest" increase" in" activity" during"
recombinant" protein" production" in" CHO" cells." After" removal" of" artificially"
amplified"genes"(i.e." those"with"a"top"FKPM"value"≤1,"an"arbitrary"selection),"the"
top" 50" ranked" CHO" genes"were" searched" for"within" the" plasma" cell" data" set" to"






That" only" six" of" the" topU50"highest" overexpressed" genes" in"producing"CHO" cells"
(when"compared"to"parental"cells)"are"present"in"plasma"cells"may"be"due"to"poor"
annotation" of" the" CHO"genome"but"may" also" be" due" to" the" specificity" of" human"
plasma"cells"and"the"difference"between"them"and"CHO"cells"with"regard"to"Mab"
productivity" levels." Of" the" six" genes" present" in" both" lists" only" one,"
ATP8a2/ATP8b2,"involved"in"phospholipid"transport,"appears"to"be"linked"to"the"
secretory"or"biosynthetic"pathways,"with"a"potential"role" in"organelle"biogenesis"
and" expansion." Both" these" points" highlight" that" CHO" cells" are" not" specified" for"
enhanced"productivity,"even"when"expressing"a"recombinant"Mab.""
"
As" such," looking" in" to" CHO" transcriptomic" data" may" not" necessarily" aid" in"
deciphering" potential" engineering" targets" with" which" to" enhance" CHO"
productivity,"with"secretory"specific"cell"lines"likely"to"provide"more"novel"targets."
With" many" of" the" gene" hits" being" involved" in" molecular" and" mechanical"
interactions"with"other"CHOUresident"proteins"in"the"process"of"biosynthesis"and"
secretion," these" targets" may" require" CHO" homologues" to" function" within" CHO"
cells,"whereas"CHOUderived" targets"will"be"known"to" function"correctly."As"such,"
use"of"nonUCHO"derived"targets"is"a"potential"highUrisk"strategy"but"with"potential"
high" rewards" with" the" knowledge" that" they" are" known" to" function" in" highU
producing"cell" lines."The"plasma"cell" transcript"abundance" levels"of"genes"with"a"
direct" role" in" protein" folding" and" secretion" (e.g." SNAREs," protein" folding"
chaperones," vesicle" proteins)" were" also" used" to" better" inform" gene" selection."
However," due" to" the" likelihood" of"more" precise" stoichiometric" balance" between"







































































to"assay" the" ‘omic"status"of" the"CHO"cell"biosynthetic"and"secretory"pathways" in"
comparison" with" widely" available" molecular" maps" of" mammalian" cell" protein"
processing" in" the" ER." Pathways" relevant" to" ER" processing" and" secretion" were"
taken" from" KEGG" and" were" specified" for" Chinese" hamster" (Kanehisa" and" Goto"
2000;" Kanehisa" et" al." 2014)." CHO" and" plasma" cell" ‘omic" data" used" to" augment"
these"gene"pathway/interaction"maps.""
"
Mapping" focus" was" directed" towards" pathways" more" specifically" involved" in"
protein" transport" into" the" ER," protein" folding/misfolding," the" ER" stress"
response/UPR" and" COPII" vesicle" formation" (figure" 3U1)," as" well" as" SNARE"
interactions"at" the"ER," the"cis',"medial" and" transUGolgi" and" the"TGN" (figure"3U2)."
CHO"and"plasma"cell" ‘omic"data" for" the"genes" listed"within"the"maps"were"taken"
from" the" requisite" data" sets" and" plotted" to" show" the" foldUchange" in"
transcript/protein" level" of" these" genes" between" producing" and" nonUproducing"
CHO" cells" (transcriptomic"data);" the" stationary" and" growth"phases" of" producing"
CHO" cells" (transcriptomic" and" proteomic" data);" and" naïve" B" and" plasma" cells"
(transcriptomic" data)." As" well" as" providing" information" on" the" activity" and"
abundance"of"specific"genes"and"proteins,"these"comparisons"also"provided:"
"









The" KEGG" ‘protein" processing" in" the" ER’" and" ‘SNARE" interactions" in" vesicular"
transport’"molecular"pathway"maps"are"shown"in" figure"3U1"and"figure"3U2,"with"
relevant"sections"of" the"map"highlighted."For"some"sections" (e.g." translocon)" the"
entire" pathway" is" not" shown" on" the"map" but" components" of" this" subUpathways"
were" taken" from" the" requisite" KEGGUlinked" pathway" and" are" included" in" the"
overall" mapping" exercise" for" completeness." Data" from" the" transcriptomic" and"




1. CHO" transcriptomic" data" –" comparison" of" expressing" and"nonUexpressing"
CHO" cells:" Comparing" foldUchange" of" FKPM" abundance" levels" in" stablyU
producing"MedIUCHOUETE"to"that"of"nonUproducing"MedIUCHO."Both"during"
stationary"growth"phase."
2. CHO" transcriptomic"data"–" comparison"of" cells" in" the"exponential" growth"
(day" 4)" and" static" growth/production" (day" 8)" stages:" Comparing" foldU
change" in" FKPM" in" stablyUproducing" MedIUCHOUETE" in" stationary"
producing"phase"to"that"of"the"same"cell"line"in"exponential"growth"phase."
3. CHO"proteomic"data"–"comparison"of"cells" in"the"exponential"growth"(day"








were" the" same" for" both" CHO" and" human" processes," suggesting" that" these"maps"
show"general"pathways"that"are"conserved"across"mammalian"cells."Gene/protein"
synonyms"were"taken"from"uniprot.org"and"were"combined"when"feasible."Where"
‘omic"data" for"a" specific"gene"could"not"be" found" in" the"data"sets"used"no"bar" is"
presented" in" the" expression" charts." Whilst" fold" change" values" are" often" the"








and& export& from& the&ER,& [c]&ER& stress& response&and& [d]&ER'associated&degradation&and& response& to&














plotted& as& described& in& section& 3.3.& Fold& changes& show& the& difference& in& expression& levels& between&
producing& and& non'producing& CHO& cells& (transcriptomic);& producing& CHO& cells& during& exponential&
and& stationary& growth& phases& (transcriptomic& and& proteomic);& and& naïve& B& and& plasma& cells&
(transcriptomic).& [a]& Genes& with& a& function& in& protein& transport& into& the& ER,& including& ribosome&
docking,& translocon& and& signal& peptidases& (figure& 3'1& a).& [b]& Genes& involved& in& protein& folding& and&































































































Comparisson of expression levels of genes and 
proteins involved in protein import to the ER.
CHO transcriptomic - producing vs. non-producing
CHO transcriptomic - stationary vs. growth phase
CHO proteomic - producing vs. non-producing
Plasma cell vs. naive B cell














































































Comparisson of expression levels of genes and 
proteins involved in protein folding and export. 


































































Comparisson of expression levels of genes and 
proteins involved in vesicular SNARE 
interactions.
ER








as& described& in& figure& 3'3& legend.& [a]& Genes& with& a& function& in& the& UPR& (Figure& 3'1& c).& [b]& Genes&































































Comparisson of expression levels of genes and 
proteins involved in the ER stress response.
CHO transcriptomic - producing vs. non-
producing
CHO transcriptomic - stationary vs. 
growth phase
CHO proteomic - producing vs. non-
producing
































































Comparisson of expression levels of genes and 
proteins involved in ER-associated degredation.
CHO transcriptomic - producing vs. non-producing
CHO transcriptomic - stationary vs. growth phase
CHO proteomic - producing vs. non-producing



















































Comparisson of expression levels of genes and 
proteins involved in the misfolded protein 
response.
CHO transcriptomic - producing vs. non-producing
CHO transcriptomic - stationary vs. growth phase
CHO proteomic - producing vs. non-producing






Transcriptional" activity" changes" occurring" during" the" terminal" differentiation" of"
naïve" B" cells" to" plasma" cells" can" be" expected" to" include" genes" involved" in" ER"
structure," the"ER" stress" response," protein" folding," the"UPR"and" secretion."Genes"
involved" in" protein" import" from" the" ribosome," such" as" CKAP4" (Climp63)" and"
RRBP1" (p180)" see" a" 2U4" fold" increase" in" transcript" abundance" in" plasma" cells,"
whilst" many" translocon" subunits" (e.g." Sec61)" see" a" smaller" 1.5U3Ufold" increase."
This"shows"the"adaption"of"plasma"cells" to" increased"numbers"of"ribosomes"and"





as" chaperones," increase" in" abundance" in" plasma" cells."Hyou1" (NEF)," BiP,"Hsp40"
and"HSP90B1"(Endoplasmin)"all"see"a"2U4Ufold"increase"in"abundance."Whilst"the"
ERES"forming"proteins"Sec12"(PREB)"and"Sar1"both"see"a"close"to"2Ufold"increase"
in" abundance," COPII" coat" subunit" genes" (Sec" 23/24," 13/31)" see" only" a" slight"
increase,"suggesting"that"ERES"formation"and"not"vesicle"budding"is"a"rateUlimiting"
step"in"cargo"export"from"the"ER"in"plasma"cells"(figure"3U3"b)."SNARE"genes,"when"
present" in" the" plasma" cell" data" set," generally" see" an" increase" in" expression" in"
plasma" cells" across" all" secretory" pathway" organelles" except" the" TGN." Bet1" and"
Sec22"see"a"2Ufold"or"higher"increase"in"expression"levels,"whilst"Stx18,"Stx5"and"
VAMP3"see"smaller" increases."However,"Sec20"and"SNAP29"do"see"a"decrease" in"








one" of" enhanced" productivity" (Moore" and"Hollien" 2012;"Walter" and"Ron" 2011)."
UPR" effector" genes"with" roles" in" apoptosis" activation" (ATF4," CHOP)" see" a" slight"
increase"in"abundance,"highlighting"that"the"UPR"response"may"need"to"direct"cells"
to"apoptosis,"but"that"this"occurrence"is"not"much"more"common"than"in"normal,"
nonUproducing" cells" (figure" 3U4" a," see" section" 1.5.3)." Likewise," many" proteins"
involved" in" the"ER"associated"protein"degradation" (ERAD)"of"misfolded"proteins"
are"not"present"in"plasma"cells"except"for"Derlin"which"has"a"functional"ERAD"role"
and" sees" a" 7.8Ufold" increase" in" gene" activity" (figure" 3U4" b)." Genes" involved" in"





The" transcriptomic" and" proteomic" response" of" CHO" cells" to" recombinant" Mab"
expression"sees"more"subtle"changes"when"compared"to"that"of"maturing"plasma"
cells." Most" of" the" genes" involved" in" protein" import" into" the" ER"were" shown" to"
decrease"in"transcriptomic"level"in"producing"CHO"cells"(figure"3U3"a;"black"bars)."
The" same" pattern" was" observed" for" protein" folding" and" misfolded" protein"
response" genes," with" the" exception" of" ERGL" (an" LMAN1" isoform)," whilst" the"
transcription" levels" of" COPII" vesicle" components" remained" relatively" unchanged"
(figure" 3U3" b," figure" 3U3" c)." Whilst" BiP" and" ER" chaperones" see" a" decrease" in"
expression" levels" (to" approximately" half" the" level" in" parental" cells)," the" UPR"
activators" IRE1," PERK," ATF6" and" CHOP" all" remain" at" a" similar" level." The" only"






stay" at" a" similar" level" or" decrease" slightly" when" compared" to" parental" cells,"







exponential" and" stationary" growth" phases" than" between" nonUproducing" and"
producing"CHO"cells," although"again" these"are" still" fairly"minimal."UPR"activator"
BiP" remains"at"a" similar"proteomic"and" transcriptomic" level" along"with" the"UPR"
signalers" PERK" and" CHOP," whilst" ATF6" and" IRE" see" an" increase" in" transcript"
abundance," suggesting" that" these" capacityUincreasing" pathways" do" see" some"
upregulation" during" the" enhanced" productivity" levels" of" the" stationary" growth"
phase." However," there" is" no" proteomic" data" to" confirm" this" pattern" carries"
through"to"a"molecular"level"(figure"3U4,"a;"dark"grey"bars).""
"
Most" ER" protein" import," ER" chaperones" and" proteinUprocessing" genes/proteins"
see" little" change" or" a" slight" decrease" in" transcript" and" protein" levels," although"
gene"expression"of"Hyou1"does"increase"by"nearly"2Ufold"during"stationary"phase"
(figure"3U3"a,"b;"dark"and"light"grey"bars)."Transcription"levels"of"SNAREs"see"little"
change" between" growth" and" stationary" phases," although" protein" levels" of" some"
Syntaxin" family" members" (StxU18," U16" and" U4)" increase" by" 2U3" fold," suggesting"





Transcriptomic" and" proteomic" data" suggests" that" there" is" little" increase" in" the"
gene" transcription" and" protein" levels" of" genes" linked" to" protein" productivity" in"
CHO"cells"when"comparing"growth"and"stationary"phases."As"the"stationary"phase"
is" the"period" in"which"CHO" cells" prioritise"production"over" growth," this"may"be"
because" the" cells" have" already" adapted" (during" the" growth" phase)" to" the"
productivity"requirements"placed"upon"it"by"the"transgene.""
"
Comparative" ‘omic" data" highlights" the" transcriptomic" difference" between" CHO"
cells"and"plasma"cells,"with" large" levels"of"overexpression"of"protein" folding"and"
UPR"effectors"detected"as"B"cells"mature"to"plasma"cells."Meanwhile"CHO"cells"see"
little" positive" change" (and" in" some" cases" a" decrease)" in" transcriptional" levels" of"
genes"involved"in"the"UPR"and"protein"processing"in"response"to"recombinant"Mab"
expression." Overall," this" suggests" that" there" is" wide" scope" for" engineering" to"
improve" protein" processing" within" the" CHO" cell" ER" as," when" compared" to"
secretoryUspecific" plasma" cells," CHO" cells" do" not" appear" to" respond" to" their"
increased"metabolic"burden"or"alter"much"at"a"molecular"level"during"a"production"
phase"of"growth."However," this"could"be"due"to"use"of"a"ETEUexpressing"cell" line"
for" dataset" production," as" low" recombinant" expression" and" increased" ER" stress"









Fussenegger" 2006)." Many" proteins" involved" in" polypeptide" import" into" the" ER"
(e.g." RRBP1," CKAP" and" SRPs)" are" upregulated," with" SRPs" having" already" been"
shown" to" enhance" CHO" productivity" levels" (Le" Fourn" et" al." 2014)." Meanwhile"
chaperones" and" proteinUfolding" genes" are" also" widely" upregulated" (e.g." HYou1,"
HSP90B1,"Calnexin,"Calreticulin),"with"some"of" these"having"already"been"shown"
to" enhance"mammalian" cell" productivity," along"with" related" chaperone" proteins"
(Borth" et" al." 2005;" Chung" et" al." 2004;" Ishaque" et" al." 2007;" Josse" et" al." 2010)."
Coupled" with" plasmaUcell" transcription" factors" these" provide" a" selection" of"




There" are" many" examples" within" the" literature" where" transcriptomic" and"




elucidated." As" with" section" 3.3," this" allows" a" view" into" the" molecular" changes"
within"the"cell"that"lead"to"increased"productivity,"as"well"as"changes"the"CHO"cell"
undergoes" to" change" from" a" growing" cell" (in" exponential" phase)" to" one" more"
targeted" towards" production" and" secretion" of" recombinant" genes" (during"
stationary"phase)."A"metaUanalysis"of"CHO"transcriptomic"data"has"recently"been"
published," performed" to"map" a" transcriptomic" profile" of" a" highUproducing" CHO"
cell."However" this" found" little" concordance"across" the" available"data" sets" except"
for" genes" involved" in" the" cell" cycle" and" lysosome" pathways" (Tamosaitis" and"
Smales" 2018)." Here" (with" work" performed" before" the" publication" of" the"
previously"referenced"paper)"genes"and"proteins"that"are"upU"and"downUregulated"
within"the"datasets"selected"were"sorted"into"functional"groups"so"as"to"provide"a"
more" directed" view" as" to"what" is" required" by" the" CHO" cell" to" have" a" enhanced"
productivity" phenotype." This" provided" guidance" towards" potential" CHO"
engineering"strategies"and"targets.""
"
Data" from" nine" CHO" ’omic" papers"were" combined" to" find" a" consensus" of" genes"
and/or" proteins" enriched" in" highUproducing"CHO" cells"which" could" therefore" be"
considered"as"functional"in"increasing"CHO"cell"productivity."Many"of"these"papers"
took" a" global" approach," providing" transcriptomic" and" proteomic" data" across" all"
gene" types," correlating" gene/protein" expression" levels" to" high" productivity." To"
better" focus"data" towards" the"secretory"and"biosynthetic"pathways"comparisons"
were"made"between"data"related"to"transcription"factors;"protein"export;"protein"
folding;"ER"stress"and"the"UPR;"organelle"biogenesis;"structure"and"capacity"(e.g."
lipid" metabolism)" and" secretory" pathway" elements." The" papers" used" all" listed"
‘omic" data" for" specific" genes," generally" considered" productivity" biomarkers." A"
précis"of"the"literature"used"for"this"exercise"is"shown"in"table"3U3."Data"from"three"
further"papers" investigating"proteomic"and" transcriptomic"changes" in"producing"
murine" myeloma" NS0" cells" was" also" analysed" to" provide" supplementary"




combine" gene" synonyms." A" threshold" of" an" increased" transcript/protein"
abundance"seen"in"at"least"three"datasets"was"set"to"sort"for"genes"that"were"likely"
conserved" in" having" a" large" impact" upon" CHO" cell" productivity." From" the" nine"
papers"listed"in"table"3U3,"319"genes"and"proteins"with"biological"functions"linked"




upregulated" in" the" Clarke" et" al." 2011" paper" and" as" such" data" from" this" is" not"
" 124"






(HSPA5," GRP78)" is" unsurprisingly" shown" to" be" upregulated" and" correlated" to"
enhanced"CHO"productivity" in" four"different"datasets."This" is"despite"some"of" its"
increased" function" initiating" protein" signaling" cascades" that" can" result" in"
apoptosis"activation."However,"BiP"levels"are"seen"to"reduce"in"CHO"cells"at"33"°C"
compared" to" those" at" 37" °C," a" pattern" also" seen" in" hybridoma" cells" that" do" not"





As" expected" in" cells" producing"Mabs" (which" contain" four" disulphide" bonds" per"
molecule),"there"is"a"consensus"across"the"‘omic"datasets"that"disulphide"forming"
PDIAs" 1," 3" and" 4" are" upregulated" in" producing" CHO" and" NS0" cells." The" folding"
chaperones" HSP90B1" (Endoplasmin)" and" Hyou1" are" also" upregulated," as" is" the"
related" heatUshock" protein" HSPD1," although" this" appears" to" function" more" in"
interactions" with" mitochondrial" proteins" than" general" ER" cargo." The" ER"
housekeeping" proteins" Calreticulin" and" Calnexin," both" with" roles" in" protein"
sorting," folding," oligomer" assembly" and" quality" control" within" the" ER," are" both"
upregulated" in" several" different" analyses" showing" their" importance" in" ER"
maintenance."Upregulation"of"ACAA2"is"explained"by"its"role"in"halting"apoptosis,"
thus" allowing" cells" to" survive" the" higher" ER" stress" levels" associated" with"
recombinant" protein" production." EEF1a1" enhances" elongation" of" nascent"
polypeptide" chains" as" they" exit" the" ribosome," speeding" up" the" process" of"



























(fusion" protein)" compared" to"
nonUproducing"parental"line."




High" producing" (Mab)" CHOU
DG44" in" exponential" phase"













compared" to" parental" CHOU
DUKX"








































IgG" highUproducing" CHO" cells"
at" 33" °C," compared" to" same"











Wide" range" of" CHO" cells"
grown" under" different"
conditions" expressing" variety"






Nine& papers& from& the& literature& which& studied& ‘omic& changes& within& high& and& low& producing& CHO&
cells/CHO&cell&growth&stages,&were&compared&to&see&if&there&was&any&consensus&as&to&genes&involved&in&




























































































BiP! P20029! +!! +2.8! +3.45! +! ! ! ! .1.5! ER!stress!response;!UPR!activation!
Pdia3! P27773! +! ! +2.28! ! ! ! ! ! Protein! disulphide! isomerase;! also!
upregulated!in!2!NS0!cell!analyses.!
Pdia4! P08003! +! ! +2.36! +! ! ! ! ! Protein!disulphide!isomerase.!
HSP90B1!! P08113! +! ! +2.63! +! ! +! ! +1.3! Endoplasmin,! molecular! chaperone;!
upregulated!in!2!NS0!analyses!
Hyou1! Q9JKR6! +! ! +2.25! +! ! ! +! ! Molecular! chaperone;! upregulated! in! 2!
NS0!analyses!
Calr! P14211! +! ! +2.55! ! ! ! ! ! Promotes!folding,!assembly!and!quality!
in!ER.!Upregulated!in!1!NS0!analysis!
CANX! P35564! +! ! +2.07! +! ! ! ! ! Calnexin,!ER!protein!sorting,!molecular!
chaperone!
PDIA1! P09103! +! ! +1.95! ! ! ! ! ! Protein! disulphide! isomerase;!
upregulated!in!2!NS0!analyses!
ACAA2! Q8BWT1! ! ! +2.20! ! +! ! ! +1.5! Abolishes!BNIP3.mediated!apoptosis.!
HSPD1!
(HSP60)!
P63038! ! ! ! ! ! +! +! ! Mitochondrial! protein! import! and!
folding.!Upregulated!in!1!NS0!analysis.!
EEF1a1! P10126! ! ! ! ! ! ! gene! >1.5!
protein!>1.2!






papers! analysed! and! highlighted! in! table! 3(3.! Consensus! of! genes! upregulated! across! several!
different!CHO’omic!data!sets!comparing!high!and! low!producing!cell! lines! is! shown.! If!a!gene!was!
shown!to!be!upregulated!in!high!producing!cells!it!is!shown!with!a!“+”,!with!the!fold(change!increase!




combined! data! that! show! a! consensus! in! upregulation! in! producing/high=












secretory! pathways! of! the! CHO! cell! was! produced.! This! provided! an! easily!
accessible! and! understandable! way! to! capture! scientific! and! data=based!
knowledge! on! a! wide! range! of! potential! gene! engineering! targets.! It! allowed!
comparison!of!different!genes!as!well!as!basic!information!on!the!gene’s!function!
and! information! on! any! previous! use! in! genetic! engineering! to! enhance! CHO!








in=depth! information! on! gene! targets,! including! a! short! literature! review!
covering!its!molecular!role!within!the!cell.!This!especially!focused!upon!potential!
roles! in! protein! production! and! secretion,! as! well! as! any! previous! use! within!














HSP70;! Tor1a;! HSP90B1;! FKBP11;!
PDIAs! (various);! Calnexin;! Calreticulin;!











Sar1;! Sec12;! Sec16;!TMED2;!GBF1;! SRP!
family! (including! translocon);! Clec3b;!





Sly1;! Munc18c;! Stx5;! VTI1a;! SNAP29;!
YKT6;! Rab1;! Rab11a;! Rab8;! Rab26;!
RabD;! Sec3;! SCAMP2;! SytI;! SytII;! Bet1;!














Ero1Lα;! MZB1;! PERK;! ATF6;! IRE1;!
eIF2α;! ATF4;! BiP;! CHOP;! TRIB3;!




















Accessory/effector! genes! with! which! to! engineer! the! CHO! secretory! pathway!
were! selected! using! information! on! their! function! and! pathway! gleaned! from!
literature,!pathway!mapping!and! transcriptomic!and!proteomic!data! from!both!
CHO! and! plasma! cells.! These! techniques! were! also! used! to! select! genes! with!
which! to! more! directly! engineer! non=secretory! regions! of! protein! processing!






1. Early! secretory! pathway:! Selection! and! loading! of! cargo! into! COPII!
vesicles!at! the!ERES;!vesicular! transport! through!the!ERGIC;!vesicle!
fusion!at!the!Golgi.!
2. Late!secretory!pathway:!Transport!of!cargo! through! the!Golgi! stack!




4. Lipid! Biosynthesis:! Engineering! of! the! CHO! lipid! biosynthesis! and!
transport! systems!with! a! view! to! increasing! organelle! volume! and!
transport!requirements.!
!
Genes!were!selected!(for! the!most!part)!upon! two!premises.!Firstly,!due! to! the!
expectation!they!would!directly!impact!upon!CHO!productivity!when!expressed!




resulted! in! a! stacking! effect! of! improvements,! further! elevating! CHO!
productivity.!A!number!of!genes!previously!shown!to!enhance!productivity!were!
also!selected!both! to!act!as!a!positive!control!but!also! to! further! test! them!in!a!
multigene! system,! test! sequences! taken! from! a! different! origin! and! to! see!
whether!results!from!literature!could!be!replicated.!Some!‘wildcard’!genes!were!










these!could!have!an! impact!upon!accessory!gene! function!within!the!cell.! If! the!
function! of! the! accessory! gene’s! product! involves! direct! interaction! with! the!
recombinant! biologic! it! stands! to! reason! that! a! human=derived! gene! sequence!
was!used!to!better!facilitate!this!interaction!and!its!function.!!
!
As! such,! genes! encoding! ER! chaperones! and! catalysing! disulphide! bond!
formation,! as!well! as! those! that! interact!with! these!effectors,!were!encoded!by!
human=derived! gene! sequences.! Many! of! these! proteins! will! of! course! also!
interact! with! other! CHO! ER! machinery! but! human! sequences! were! selected!
based!upon!their!primary!interaction!with!the!recombinant!product.!Engineering!
targets!known! to! function!as! transcription! factors!or!within! the!CHO!secretory!
pathway!interact!directly!with!CHO!molecular!machinery!and!so!were!expressed!
from! CHO=derived! sequences.! Some! of! the! target! genes! (especially! those!
involved!in!protein!processing!and!the!early!stages!of!vesicle!formation)!interact!
with! both! CHO! machinery! and! the! humanised! recombinant! product.! In! these!
cases!a!decision!as!to!what!sequence!to!use!was!made!based!upon!the!perceived!
importance! of! each! interaction,! though! with! the! back=up! that! conservation! of!
components!between!mammalian!cells!would!allow!some!level!of!functionality!to!




A! total! of! 16! gene! targets! were! selected! with! which! to! engineer! the! CHO!
secretory! pathway.! The! selection! process! utilised! the! gene! target! database!
produced! in! chapter! 3! and! shown! in! Appendix! 1.! The! gene! database! list! was!
narrowed!to!a!testable!number!of!gene!targets!by!further!literature!research!on!
the!gene’s! function.!However,!not!all!gene! targets!are! listed!on! the!database!as!
this! was! mainly! used! to! gather! known! information! from! literature! and! ‘omic!
data.!As!such,!some!genes!known!to!play!a!key!role!in!the!secretory!pathway!but!
not!yet!shown!to!have!a!potential!link!to!productivity!have!been!selected!as!part!











the! ERGIC,! is! reviewed! in! depth! in! section! 1.4.1.! Some! of! the! reasons! for! the!
selection!of!specific!genes!are!discussed!and!listed!in!table!3=6!
!
Cargo& loading& at& ER.& Correct! sorting! of! cargo! into!COPII! vesicles! initiates! the!
secretory!pathway.! Increasing! the! amount!of!ERES!and! therefore!COPII! vesicle!
budding!events!would!increase!transport!from!the!ER,!alleviating!the!burden!of!
increased! protein! levels! within! the! ER.! The! GEF!PREB! (the! homologue! of! the!
yeast! Sec12! gene)! activates! the! Sar1! protein! which! acts! as! a! focal! point! for!
ERES/COPII! vesicle! formation,! with! Sec12! required! for! ER=Golgi! protein!
transport! in!yeast! (Jensen!and!Schekman!2011;!Nakano!et! al.! 1988).! Increased!
PREB!concentration!at!ERES!also!allows!secretion!of!proteins!(such!as!collagen)!
normally! too! large! for!COPII! vesicles! (Saito! et! al.! 2014).! It! has,! alongside!Sar1,!
been!associated!with!increased!CHO!production!capacity!and!is!up=regulated!in!
plasma! cells! (Harreither! et! al.! 2015).! As! such! increasing! PREB! levels! should!
increase!Sar1!activation!levels!and!therefore!the!number!of!ERES!and!therefore!
try!and!enhance!ER=Golgi!vesicle!numbers.!It!may!also!aid!the!formation!of!larger!




occurs! via! the! ERGIC! (sections! 1.4.1.2,! 1.4.1.3).! The! transmembrane! lectin!
LMAN1& (ERGIC53)! has! been! linked! to! increased! productivity! in! CHO! cells!
(Harreither! et! al.! 2015).! It! is! present! in! a! 1:1! stoichiometry! with!MCFD2,! a!
luminal! interaction! partner.! Together! they! form! a! cargo! receptor! complex!
(Nyfeler! et! al.! 2006).! The! two! proteins! are! linked! to! the! transport! of! blood!
factors,! glycoproteins! and! lysosome=resident! enzymes,! with! both! genes!
upregulated! in! plasma! cells! (Appenzeller! et! al.! 1999;! Nyfeler! et! al.! 2008;!
Vollenweider!et!al.!1998;!Zhang!et!al.!2005).!!
!
Vesicle& tethering&and& fusion&at& the&ERGIC/Golgi.&Tethering!of!vesicles!at!the!
cis=Golgi!brings!target!and!vesicle!SNARE!proteins!into!close!proximity,!allowing!
vesicle! fusion.!GEF=activation!of!Rab1! by!Bet3! allows! it! to! interact!with!ERES,!
recruiting! P115! (USO1)! tethers! to! COPII! vesicles! (Allan! et! al.! 2000a).! P115!
promotes! tethering! at! the! ERGIC! and! cis=Golgi! via! interaction! with! target!
GRASP/GM130! tethers.! P115! knockdown! inhibits! cargo! trafficking! and! it! also!
has! an! activating! role! in! the! vesicle! docking! and! fusion! process! (Sztul! and!
Lupashin!2006).!Rab1!sees!an!increase!in!plasma!cells!and!has!roles!in!mediating!
other! SNARE! and! tether! interactions! (Sztul! and! Lupashin! 2009).! The! Bet1&
protein! is! a! SNARE! known! to! function! in! correct! protein! sorting! in! yeast!
(Morsomme!et!al.!2003).!It!interacts!with!P115!and!alongside!Syntaxin!5!(Stx5)!










Transport! through! the! Golgi! and! on! to! the! plasma! membrane! is! not! as! well!
defined!as!ER=Golgi!transport.!The!Rab11a!protein!can!not!be!found!in!the!CHO!
or!plasma!cell!datasets!used! in! this!project,!although!some! interacting!proteins!
are.! It! is! associated! with! both! constitutive! and! regulated! secretion! and! is!
upregulated!in!tissues!with!high!secretion!levels!(Urbe!et!al.!1993).!It!is!involved!
in!post=Golgi!exocytosis!and!endocytosis,! interacting!with! the!exocyst! tethering!
complex! and!motor! proteins.! However,! it! also! plays! a! role! in! trafficking! from!




Plasma! cell! transcription! data! was! mined! for! novel! targets! to! enhance! the!
secretory! pathway,! with! transcription! factors! particularly! of! interest! (section!
3.2.1).! CRELD2! is! ER=! and! Golgi=located! and! highly! expressed! in! endocrine!
tissues!as!well!as!plasma!cells.!It!is!ER=stress!inducible,!with!suggested!functions!




factor! is! also! upregulated! in! plasma! cells.! It! binds! the! enhancers! of! secretory!
pathway!genes!and,!along!with!related!family!members,!has!been!shown!to!up=
regulate! secretion! in! non=secretory! insect! and! HEK! cells! (Barbosa! et! al.! 2013;!
Fox!et!al.!2010;!Panagopoulos!et!al.!2007).!The!TFE3! transcription!factor!has!a!
role!in!the!Golgi!stress!response.!Activated!(by!dephosphorylation)!by!the!onset!
















Expansion! of! organelle! volume! should! result! in! an! increased! capacity! for! both!
protein!folding!and!modification!as!well!as!providing!a!larger!surface!area!from!
which!vesicle!budding!can!occur.!Expression!of!an!activated!form!of!the!ceramide!
transfer! protein! (CERT)! helped! increase! CHO! productivity! through! enhancing!
lipid! transport! to! the! Golgi! (Florin! et! al.! 2009;! Rahimpour! et! al.! 2013).!







Fourteen! genes! were! selected! with! which! to! directly! engineer! the! CHO!
biosynthetic! pathway.! Some!of! these! genes! had!been!previously! tested! in! CHO!
cells! and! as! such! were! selected! to! both! confirm! previous! results! within! our!
platform,! but! also!with! a! view! to! their! use! as! part! of!multigene! combinations.!




Increasing! the! level! of! chaperones! that! aid! and! increase! the! rate! of! protein!
folding!should!increase!the!rate!at!which!complicated!recombinant!proteins!can!
be! produced! within! the! CHO! cell.! HSP90B1! (also! known! as!
GRP94/Endoplasmin)! aids! in! the! processing! of! secretory! proteins.! It! is!
upregulated!in!plasma!cells!and!has!been!linked!to!increased!production!capacity!
in! CHO! cells! in! three! separate! studies! (Harreither! et! al.! 2015;! Meleady! et! al.!
2011;!Yee!et!al.!2009).!HYou1!has!a!cyto=protective!role! in!response!to!oxygen!
deprivation! as! well! as! a! potential! role! in! protein! folding.! It! is! upregulated! in!
plasma! cells! and! high=producing! CHO! cells! (Nissom! et! al.! 2006).! Torsin! A!





increased! in! plasma! cells! and! linked! to! increased! productivity! in! CHO! cells!
(Harreither!et!al.!2015).!Their!co=expression!in!CHO!cells!resulted!in!an!increase!
in! total!product! levels!within!the!cell,!although!secreted! levels!did!not! increase!
(Chung!et!al.!2004).!FKBP11&accelerates!protein!folding!during!protein!synthesis!
and! is! upregulated! in! plasma! cells! (Shaffer! et! al.! 2004).! CypB! is! a! molecular!
chaperone!with!some!roles!in!fatty!acid!metabolism.!Co=expression!with!BiP!and!









Post=translational! modifications! such! as! disulphide! bond! formation! and!
glycosylation!are!essential!for!the!production!of!a!functional!product.!Enhancing!
the! cellular! machinery! that! performs! these! modifications! should! increase! the!
cell’s!ability!to!produce!high=quality!product.!Protein!disulphide!isomerases!such!
as! PDIA4! catalyse! the! formation! of! the! disulphide! bonds! essential! for! Mab!
structure! and! function.! All! PDIs! are! upregulated! in! plasma! cells! and! PDI!
overexpression!has!been!shown!to!increase!CHO!productivity!(Borth!et!al.!2005;!
Johari!et!al.!2015;!Pybus!et!al.!2014).!PDIA4!is!linked!to!increased!productivity!in!







is! believed! to! alter! the! epigenetic! profile! of! cells! and! its! overexpression! in!
various! CHO! and! human! cell! lines! has! increased! productivity! by! up! to! six=fold!
(Tastanova! et! al.! 2016).! The! transcription! factor! Largen! does! not! specifically!
target!the!ER!or!protein!processing.!It!is!thought!to!be!involved!in!regulation!of!
cell! size! and!mitochondrial! respiration! and! overexpression! in!mouse! cell! lines!
has!resulted! in! increases! in!cell! size!(Yamamoto!et!al.!2014).!Were! it! to!have!a!
similar!effect!in!CHO!cells!it!could!increase!cell!capacity!and!thus!productivity.!It!




Members!of! the! signal! recognition!complex! family!aid! ribosome!docking!at! the!
ER!and! transport!of!nascent!polypeptide!chains! from!the!ribosome! into! the!ER!
lumen! via! the! translocon.! SRP14! has! been! linked! to! increased! productivity! in!
CHO! cells! and! is! upregulated! in! plasma! cells.! SRP14! overexpression! increases!
CHO! productivity! seven=fold,! with! co=expression! alongside! other! SRPs! further!
enhancing! productivity! (Harreither! et! al.! 2015;! Le! Fourn! et! al.! 2014).!
Perioredoxin! peroxidases! catalyse! the! hydrolysis! of! hydrogen! peroxide,!











































































































































































































































































































Analysis! of! plasma! cell! transcriptomic! data! has! shown! that! many! molecular!
components!involved!in!secretion!see!an!upregulation!at!the!transcript!level!as!B!
cells! mature! into! plasma! cells.! The! data! further! backs! up! existing! literature!
suggesting! the! UPR! plays! a! role! in! enhancing! the! biosynthetic! and! secretory!
pathways! of! secretory=specific! cells,! with! genes! involved! in! its! initiation! (BiP)!
and!signaling!cascades!(XBP1,! IRE1,!ATF! family!members!and!CHOP)!all!seeing!





figure! 3=3,! 3=4;! white! bars).! That! some! of! these! factors! have! previously! been!
shown! to! enhance! transcription! of! secretory! pathway! components! provides! a!
solid!foundation!upon!which!to!base!an!engineering!strategy!to!enhance!CHO!cell!
productivity! (Barbosa! et! al.! 2013;! Fox! et! al.! 2010).! It! can! therefore! be!
hypothesised!that!utilisation!of!a!small!number!of!transcription!factors!will!allow!
upregulation! of! a! large! number! of! secretory! pathway! genes,! with! each! one!





Comparison! of! non=producing! and! stably=producing! CHO! cells! suggests! that!
there! is! generally! little! difference! in! gene! expression! between! the! two! when!
comparing! the! biosynthetic! and! secretory! pathways.! This! was! not! entirely!
unexpected! as! it! is! known! CHO! cells! are! not! specialised! for! excessive! protein!
production! and! secretion! and! as! such! at!most! a!moderate! increase! in! protein!
processing! and! vesicle! transport! factors! was! hypothesised.! However,! with!
regards! to! the! UPR! and! ER! stress! response! this!was! somewhat! unexpected.! It!
was!hypothesised!that!expression!of!a!recombinant!Mab!would!overload!the!ER,!
resulting! in! a! tangible! ER! stress! response.! It! was! also! surprising! that! the! ER!
stress! sensor! BiP! and! ER! chaperones!were! downregulated! (figure! 3=4! a).! This!







that,! during! the! clonal! selection! process! by!which! the! producing! cell! line!was!










growth! shows! more! ‘omic! changes! than! are! seen! between! parental! and!
producing!CHO!cells.!The!increased!expression!of!some!UPR!response!genes!(e.g.!
ATF6,! IRE1)! show! that! during! the! stationary! phase! there! is! an! increase! in! the!
burden!placed!upon!the!ER.!This!increase!in!expression!correlates!with!the!most!
productive! part! of! the! cell’s! growth! cycle,! although! it! is! interesting! that! some!
other!UPR!activators!(XBP1,!CHOP,!PERK)!do!not!see!a!similar!increase.!Likewise!








or! due! to! growth! stage)! suggest! that! there! is! little! value! in! choosing! genetic!
engineering!targets!due!to!their!preponderance!in!producing!CHO!cells.!However!
this!data!could!be!used!to!rectify!‘omic!deficiencies!seen!in!CHO!cells!that!are!not!




increase! in! CHO! cells! the! levels! of! genes! known! to! function! within! the! UPR,!
protein! processing! and! vesicle! transport,! as! they! do! not! already! see! large!
increases!in!expression!levels!upon!production!of!a!recombinant!Mab.!As!such!it!
could! be! considered! that! there! is! no! one! specific! bottleneck! within! the! CHO!
biosynthetic!and!secretory!pathways!inhibiting!productivity.!Instead!all!levels!of!






chaperones!and! folding!machinery! levels,! resulting! in! increased!productivity! in!
plasma! cells,! highlights! the! role! that! global! transcription! factors! can! have! in!
enhancing!cellular!productivity.!Utilisation!of!these!factors!is!a!strong!candidate!
for!improving!cell!productivity.!However,!there!are!likely!to!be!only!a!handful!of!




upon! the! CHO! cell! to! increase! its! productivity.! As! such,! engineering! of! specific!
parts! of! the! biosynthetic! and! secretory! pathways,! informed! by! knowledge! of!
molecular!interaction!that!occur!within!them,!is!still!a!valid!strategy!to!increase!
capacity! and! productivity,! as! has! been! shown! with! SRPs,! SNAREs,! SNARE!
effectors!and!lipid!transport!engineering!(Florin!et!al.!2009;!Le!Fourn!et!al.!2014;!
Peng! et! al.! 2011;! Peng! and! Fussenegger! 2009b;! Rahimpour! et! al.! 2013).!
However,!due! to! limitations! in! the!number!of!direct! effector! genes! that! can!be!





This! chapter! produced! information! on! the! CHO! cell’s! ‘omic! response! to!
recombinant! Mab! production,! comparing! this! to! that! of! the! secretory! specific!
plasma! cell.! Combinatorial! analysis! of! other! CHO! ‘omic! analyses! within! the!
literature! further! enhanced! this! insight.! The! information! presented! in! this!
chapter! and! Appendix! 1! will! be! used! in! proceeding! chapters! to! help! the!











carried! out! alongside! JC! and! CA.! Some! gene! selection! and! design! work!
(specifically! those! targeting! the!non=secretory! functions!of! the!ER)!was!carried!
out! by! CA! independently! of! the! gene! target! list! produced! in! chapter! 3! by! NB.!
Genes! were! designed! so! as! to! work! in! the! single! gene! and! MGEV! expression!
vector!platforms!designed!by!Yash!Patel!(YP)!and!CA.!
!
Genes! were! selected! with! which! to! engineer! the! CHO! biosynthetic! and! secretory!
pathways.!An!initial!transient!single(gene!screen!of!32!genes!specifically!targeting!
the! biosynthetic! and! secretory! pathways!was! carried! out! to! determine! the! effect!
each!gene!and!their!dose!level!had!upon!CHO!production!of!a!DTE!Mab!being!both!
transiently(! and! stably(expressed.! This! also! allowed! comparisons! to! be! made!
between! the! response! of! the! two! expression! systems! to! genetic! engineering,!
especially!of!the!unfolded!protein!response.!Accessory!genes!were!then!co(expressed!
in!two/three(gene!combinations!that!were!selected!based!on!both!the!single!gene!
screen! data! as! well! as! scientific! knowledge! of! the! secretory! and! biosynthetic!
pathways.!!
!
The! two! single(gene! screens! showed! that! the! effect! of! accessory! genes! in! cells!
transiently!expressing!a!model!DTE!Mab!is!not!repeated!in!cells!stably!expressing!
the! same! Mab.! However! some! genes! did! enhance! production! levels! of! DTE(Mab!
being! expressed! transiently! and! stably.! Multigene! engineering! of! the! CHO!
biosynthetic!and!secretory!pathway!in!a!cell!line!transiently!expressing!a!DTE(Mab!
showed!that!some!gene!combinations!can!concurrently!increase!CHO!productivity,!








CHO! cell.! Engineering! to! enhance! transcription! and! translation! increases! the!
amount! of! proteins! required! to! be! processed! by! the! cell’s! biosynthetic! and!
secretory! pathways,! further! increasing! the! metabolic! burden! upon! the! cell’s!
processing! and! secretory! pathways.! That! the! relationship! between! mRNA!
transcript!level!(for!both!Fc!fusion!and!EPO!model!proteins)!and!Qp!of!CHO!cells!
is!non=linear!highlights! the!presence!of!a!post=transcriptional!bottleneck! in! the!
production!and!secretion!of!recombinant!proteins!(Hansen!et!al.!2017;!Johari!et!
al.!2015;!Ku!et!al.!2008).!As!such,!enhancing!cellular! levels!of!transcription!and!







Engineering! and! improvement! of! host! CHO! cells,! to! a! certain! extent,! has! likely!
resulted! in! all! super=high! producers,! with! directed! evolution! strategies! and!
genetic!enhancements!used!to!improve!cell!viability,!growth!levels,!the!ability!to!
carry! transgenes!and!utilisation!of! selection!strategies! (Fischer!et!al.!2015).!To!
cope!with! an! increased! flux! of! proteins! to!process! and! secrete,! several! genetic!
engineering! strategies! have! been! undertaken!with!which! to! augment! the! CHO!
biosynthetic! and! secretory!pathways! and! increase!productivity.!That! the!Qp!of!
professional! secretory! plasma! cells! can! be! up! to! four=fold! higher! than! that! of!




within! these! pathways! or! more! novel! genes! taken! from! other! organisms,! has!
been! shown! to! change! organelle! morphology! and! enhance! processing! and!
transport! processes,! resulting! in! an! overall! enhanced! productivity! phenotype.!
Genetic!engineering!of!the!UPR!has!seen!an!increase!in!cellular!productivity,!but!
if! incorrectly! facilitated! can! lead! to! apoptosis.! Ectopic! overexpression! of!
transcription! factors! can! allow! the! fine! alteration! of!many! requisite!molecular!


















increasing! the! number! of! high=producing! clones! by! 75%! (Orellana! et! al.! 2017;!
Orellana!et!al.!2015).!The!use!of!chemical!chaperones!and!regulators!can!also!be!





been! shown! to! increase! CHO! productivity.! Overexpression! of! SRPs! and!
translocon!elements!improved!the!transfer!of!nascent!polypeptides!into!the!ER,!
increasing! DTE! productivity! by! up! to! seven=fold! (Le! Fourn! et! al.! 2014).!
Increasing! levels! of! ER=resident! chaperones,! foldases! and! disulphide! bond!
forming! enzymes! has! generally! resulted! in! productivity! increases.! Torsin! 1A!
overexpression! increased! levels! of! secreted! luciferase! (2.5=fold)! and!Mab! (1.3=
fold),!highlighting!the!differing!effect!one!effector!gene!can!have!on!two!different!
types!of!protein!product!(Josse!et!al.!2010).!Stable!co=expression!of!Calnexin!and!
Calreticulin!(via!an! inducible!system!resulting! in!a!2.9=!and!2.8=fold! increase!of!




Overexpression!of!disulphide!bond! forming!PDIs! resulted! in!a!37%! increase! in!
Mab! production! rate,! supporting! previous! experiments! performed! in! bacteria,!
yeast! and! insect! cells,! showing! that! the! use! of! other! cell! lines! as! models! is! a!
viable! practice! (Borth! et! al.! 2005;!Davis! et! al.! 2000;!Nishimiya! et! al.! 2013).! In!















oncogenic! mutant! of! the! tyrosine! receptor! kinase! KIT! (onco=KIT),! shown! to!
function! in! cell! differentiation! and! cancer! cell! survival,! increased! CHO!
productivity!of! a! stably=expressed!GFP=Fc! fusion!protein!by!up! to!2=fold.!Onco=
KIT! also! increased! cell! proliferation! and! growth,! promoting! mitochondrial!
activity! and! cellular! resistance! to! hypoxia! through! enhancing! the! UPR!
(Mahameed!and!Tirosh!2017).!Likewise,!expression!of!the!chromatin!remodeller!










specific! secretion! levels!whilst! its! repression! has! increased! secretion! levels! by!
up=to!3=fold.!This!suggests!BiP!has!an! important!role! in!ER!stress!management!
but! not! necessarily! protein! secretion! (Borth! et! al.! 2005;! Dorner! and! Kaufman!
1994;!Dorner!et!al.!1988;!Morris!et!al.!1997).!!
!
It! is! possible! that! these! inconsistencies! may! arise! courtesy! of! experimental!
differences.! Utilisation! of! different! transfection! methods! of! the! effector! or!
production! genes! (stable! or! transient);! different! recombinant! products! having!
distinct! responses! to! specific! effectors! dependent! upon! their! molecular!
requirements;!or!contrasts!in!process!and!testing!between!different!experiments!
could! all! result! in! results! that! are! difficult! to! compare.!Whilst! these! examples!
show!that!any!positive!data!taken!from!genetic!engineering!experiments!may!not!





and! therefore! its! impact! upon! CHO! cell! productivity! (Hansen! et! al.! 2017).!
Exceeding! the! optimal! levels! of! an! ER=resident! enzyme! such! as! a! PDI! –!which!
catalyses!disulphide!bond!formation!=!can!overwhelm!other!parts!of!the!protein!
folding!machinery! (Davis! et! al.! 2000).! Overexpression! of! CHOP! at! a! high! level!
saw!a!decrease!in!Mab!expression,!whilst!a!low=level!overexpression!saw!a!slight!
















range!of! effector!genes! to!enhance!CHO!productivity!of! a!DTE!model!Mab.!The!
effect!of!target!genes!upon!transient!and!stable!DTE=Mab!production!was!tested!
to!a)!determine!the!effect!of!genes!upon!Mab!production;!b)!allow!comparison!of!
how!CHO! cells! react!when!using! the! two! separate! expression! systems.!A!DTE=
Mab!was!used!as!an!expression!model!as! it! is!more! industrially! relevant! to! try!
and! enhance! the! production! levels! of! products! that! are! DTE,! as! ETE=Mab!
production! levels! are! generally! perceived! to! be! satisfactory.! Furthermore,!
expression! of! a! DTE=Mab! would! place! the! CHO! biosynthetic! and! secretory!



















Effector! gene! sequences! derived! from! CHO! genes! were! taken! from!
CHOgenome.org,!utilising!the!CHO=K1!2014!genome!sequence,!release!101!of!the!
original!2011!genome!sequence!(Hammond!et!al.!2012;!Lewis!et!al.!2013;!Xu!et!




uniprot.org! with! the! relevant! gene! sequence! sourced! from! NCBI! gene.!
Comparison!of! the!selected!protein!and!nucleotide!sequences!against!other! the!
genomes! and!proteomes! of! other!mammalian! species!were!made!using!BLAST!








To! reduce! phosphorylation! with! the! aim! of! increasing! CERT’s! lipid! transfer!
ability,! the! serine! 132! residue! was! replaced! with! an! alanine! residue! (S132A),!
with! the! specific! codon! encoding! residue! 132! deciphered! and! swapped! for! an!
alanine=encoding! codon! (Florin! et! al.! 2009).! Likewise! with! the! TFE3!
transcription!factor,!phosphorylation!of!the!serine!108!residue!anchors!TFE3!in!
the! cytoplasm,! rendering! it! unable! to! enter! the! nucleus! and! activate!
transcription.!Again!the!serine!was!replaced!with!an!alanine!residue!(S108A)!so!
as! to! produce! a! constitutively! active! mutant! which! could! enter! the! nucleus!
without!any!upstream!activation!required!(Taniguchi!et!al.!2015).!!
!
The!CREB3L2! transcription! factor! is!made!up!of! lumenal,! trans=membrane!and!
N=terminal! cytosolic! domains.! Under! normal! conditions! the! entire! protein! is!
present!across!and!on!both! sides!of! the!ER!membrane.!Upon! transportation! to!
the! Golgi! membrane! the! protein! is! cleaved! by! an! S2P! integral! membrane!
protease!proximal!to!the!cytosolic!face!of!the!lipid!bilayer!(Barbosa!et!al.!2013;!
Rawson! 2013).! This! releases! the! transcriptionally! active! cytosolic! domain,!
allowing!it!to!enter!the!nucleus!and!induce!transcription!of!secretory!genes!(Fox!
et!al.!2010).!For!this!reason!only!the!active!cytosolic!domain!was!used!for!CHO!
cell! engineering.! A! hydrophobicity! plot! (ExPASy! ProtScale)! highlighted! the!
transmembrane! domain! as! starting! around! residues! 310/320! (Gasteiger! et! al.!
2005;!Kyte!and!Doolittle!1982).!This!region!was!searched!for!the!target!sequence!
of! the! S2P! cleavage! domain! (TCLMV)! that! resides! just! within! the! Golgi! lipid!
bilayer!(Barbosa!et!al.!2013).!This!was!found!to!start!at!amino!acid!residue!316!
and! as! such! the! DNA! sequence! downstream! of! this! point! (encoding! the!












a! Kozak! sequence.! The! 3’! 8! base! pair! downstream! sequence! was! placed!
immediately! after! the! TGA! stop! codon! and! contained! a! restriction! enzyme! cut!
site.! All! recombinant! genes! were! under! the! control! of! a! CMV! promoter.! All!





Effector! genes! were! transiently! transfected! alongside! a! transiently! expressed!














was! designed! to! compare! dose! levels! of! the! same! gene! to! determine! the!most!
effective!gene!dose!levels!for!each!gene!separately.!As!such!the!variance!in!gene!
dose! level!across! the!different!effector!genes!was!not!seen!as!problematic!with!
comparisons! being!made! to! the!Mab=only! control! and!within! cells! transfected!
with! the! same! plasmid.! Post=transfection! cells! were! seeded! in! a! 96! deep=well!
plate!and!grown!for!120!h,!with!a! feed!at!72!hours.!Cell!viability!samples!were!
















specific! productivity.! Data! was! normalised! against! the! average! of! all! control!
across!all!plates!such!that!it!could!be!displayed!as!a!fold!change!of!the!control.!A!
one=way!ANOVA,!utilising!a!Dunnett’s!multiple!comparisons!test!(a!many=to=one!
comparison)! was! used! to! compare! the! combined! data! from! each! transfection!
condition!to!that!of!the!controls!and!calculate!statistical!significance.!The!overall!











Total!DNA!load! 100! (! 800!
Mab! 66.6! 100! 533&
Effector!10%! 10& 15! 80!
Effector!5%! 5& 7.5! 40!
Effector!2.5%! 2.5& 3.75! 20!
Effector!1.25%! 1.25& 1.88! 10!
Gene&screen&with&stable&Mab&expression&




Effector!30%! 20& 30! 160!
Effector!17.5%! 11.7& 17.5! 93.6!
Effector!5%! 3.3& 5! 26.7!






















CREB3L2)! produce! a! slight! increase! in! IVCD! when! compared! to! the! control,!










Titre! was! measure! using! the! Valita™TITER! high=sensitivity! assay.! Across! the!
gene! screen! there! are! varying! levels! of! effect! upon! overall! DTE! Mab! titre!
compared!to!the!level!in!control!Mab=only!transfected!cells.!which!averaged!4.12!
mg/L! across! the! twelve! plates.! A! small! selection! of! genes! appear! to! improve!
overall! titre! whilst! many! appear! to! have! little! effect,! or! actually! instigate! a!
decrease!titre! levels!(figure!4=1!b).!Expression!of!both!XBP1s!genes!(27=XBP1s=










the! same! gene! dose! levels!with! the! CHO! isoform.! As! both! genes! are! of! similar!
sizes!(CHO!–!1113!bp;!Human!–!1131!bp;!Appendix!2)!it!can!be!considered!that!




data! not! shown).! With! XBP1s! interacting! with! promoter! regions! and! TFREs!




isoform! would! provide! enhanced! interaction! with! promoter! elements! and!
therefore!increased!transcriptional!activation!of!biosynthetic!and!transcriptional!
enhancing! genes,! increasing! productivity.! This! would! suggest! that! enhancing!
effector! gene! activity! is! not! necessarily! achieved! by! the! origin! of! the! gene!




CRELD2,! which! saw! a! 1.5=! and! 1.4=fold! increase! in! titre! respectively! at! the!
highest! 10%! gene! dose.! One! other! gene! –! 15=CREB3L2! at! 10%! =! produces! an!
equal!to!or!greater!than!1.4=fold!increase!in!titre,!though!this!is!not!statistically!
significant.! That! XBP1,! CRELD2! and! CREB3L2! expression! all! result! in! titre!
increase!shows!that!transcription!factor!engineering!can!play!an!important!role!
in! enhancing! transient! Mab! production.! That! PRDX4! expression! significantly!




produce! a! slight! increase! in! productivity! (1.2=fold,! though! neither! statistically!
significant)!shows!that!enhancement!of!ER!processing!may!enhance!productivity,!
though! 20=Tor1a! and! 24=Calreticulin! both! instigate! a! slight! insignificant!









any! increase! in! titre! levels! is!as!a!direct!result!of!an! increase! in!Qp,!due! to!cell!
growth! being! generally! unaffected! by! effector! gene! expression! (figure! 4=1! a).!!
Effectively!there!is!little!difference!between!the!graphs!showing!!Qp!and!titre.!
!
The! single! gene! screen! in! a! transiently=expressing! cell! line! show! that! there! is!
scope! for! enhancing! CHO! transient! DTE=Mab! productivity! levels.! This! is!
particularly!prevalent! in! the! case!of! transcription! factors,! especially!XBP1s!but!
also! the! plasma=cell! highlighted! CREB3L2! and! CRELD2.! However! some!
transcription! factors! (TFE3,! YY1,! Largen)! had! little! or! no! positive! effect! upon!
productivity!and!titre!levels.!Single=gene!expression!of!molecular!components!of!
the! biosynthetic! and! secretory! pathways! had! a! less!marked! effect! than! that! of!












Figure& 4(1.& Gene& screen& of& transiently(expressed& single(effector& genes& in& a& CHO& cell&
transiently&expressing&a&DTE(Mab.&
.MedI(TRAN!cells!were!transiently!transfected!with!a!DTE(Mab!and!a!range!of!effector!genes,!each!
at!4!different!dose! levels.!After!120!h! incubation! [a]!growth,! [b]! titre!and! [c]! specific!productivity!




















































































































































































































































































































































































TitreAccessory gene amount, as 


































































































































































































QpAccessory gene amount, as 






















Genetic! engineering! of! CHO! cells! transiently! expressing! a! product! provides!
useful! information! as! to! the! function! of! each! gene! within! the! cell! as! well! as!




will! provide! more! tangible! information! as! to! a! genes’! potential! in! enhancing!
productivity!in!a!more!industrially!relevant!scenario.!!
!
The! increased! levels!of!Mab!being!produced! in!a!stably=expressing!cell! is!much!
greater!than!when!expressed!transiently!(section!5.4.2;!Daramola!et!al.!2014).!As!
such! the!CHO! cell’s! secretory! and!biosynthetic! pathway! is! likely! to! be!under! a!
greater! burden! when! stably! expressing! that! under! transient! gene! expression.!
Whilst! the! stable! selection!process! results! in! a!pool! in!which!all! cells! can!both!
produce!product!and!grow!well,!use!of!a!pool! instead!of!a!clonally=derived!cell!
line!allows!for!some!heterogeneity!across!the!entire!cell!pool!population.!As!such!
some! bottlenecks! will! be! present! across! the! population! and! not! all! cells! will!
already!be!maximally!producing!recombinant!product,!as!would!more! likely!be!
the!case!in!a!clonally!derived!population.!As!the!pools!have!not!been!pre=selected!
as!high!producers! ! there! is! also!more!head=space! into!which! they!can! increase!
performance.!As! such!any! impact!of! expressed!effector!genes!will! be!amplified!
and!thus!easier!to!spot.!
!
Using! the! same! high! throughput! transfection! and! growth! platform! for! the!
transient!production!effector! gene! screen,! another! gene! screen!was!performed!
using!a!pool!of!cells!stably!expressing! the!same!DTE=Mab!used! in! the! transient!
screen! (see!section!5.2.4.4! for!pool!production;! sections!4.2.3,!2.5.2!and!2.1.2.2!
for! gene! screen! platform).! Growth! and! productivity! profiles! for! this! DTE=




were! tested! at! three! levels! to! better! streamline! the! gene! screening! process,!











The! majority! of! the! genes! used! were! the! same! as! those! in! section! 4.3.2.! The!
exceptions!were!Tor1a,!XBP1=human,!Dad1!and!Largen.!Tor1a!and!Largen!were!








Due! to! industrial! constraints! the! screen!was! set! to! try! and! improve! titre! as! a!
function!of!enhanced!Qp.!This!is!because!a!as!a!large!increase!in!cell!growth!can!
cause! problems! in! both! upstream! (increased! chance! of! shear! forces! in!
bioreactors,!increasing!cell!breakage!and!possibly!increasing!HCP!levels)!as!well!




Human! isoforms! of! the! transcription! factor! ATF6αc! and! protein! disulphide!
isomerase! PDI! were! added! to! the! gene! screen,! both! having! previously! been!
shown!to!improve!CHO!productivity!(Borth!et!al.!2005;!Johari!et!al.!2015;!Pybus!
et!al.!2014).!A!human!ATF6c! isoform!was!used,!despite! it!being!a! transcription!











as!parental!cells!but! that!defined! lag,!exponential,! stationary!and!death!phases!were!present.!Cell!
































































In! the! transient! screen! all! cells! were! transfected! with! DNA! encoding!
recombinant!genes!(both!effector!and!Mab).!Despite!the!levels!of!gene=encoding!
(and!therefore!transcriptionally!active)!vectors!varying!slightly!due!to!differing!
dose! levels! this!was!minimal! due! to! the!Mab=encoding! plasmid!making! up! the!
majority! of! the! vector! load.! However! in! the! gene! screen! of! stably=expressing!
cells,!despite!control!cells!being!transfected!with!empty!vector!to!control!for!the!
electroporation! process! and! DNA! cytotoxicity,! with! empty! vector! DNA! not!
containing!a!gene!it!is!much!less!transcriptionally!active!than!encoding!vectors.!!
!
As! such! the! transcriptomic,! translational! and! protein! processing! burden! put!
upon!cells!transfected!with!effector!gene!will!be!greater!than!that!put!upon!the!
control!cells.!To!control!for!this!increased!transcriptional!and!metabolic!burden!
in! stably! expressing! cells! transiently! expressing! effector! genes,! and! to! better!
make! a! comparison! to! non=effector! control! cells,! titre! and! growth! data!






This! normalisation! has! the! effect! of! bringing! all! data! points,! either! above! or!
below! that! of! the! control,! slightly! closer! to! the! control.! As! such! it! can! not! be!
considered!to!artificially!amplify!any!productivity!or!growth!data!but!instead!has!
more!of!a!dampening!effect!upon!the!results.!Data!points!for!the!controls!did!not!
undergo! any!normalisation! as! they!were!not! transfected!with! transcriptionally!





shown! in! Figure! 4=3.! Data!was! processed! as! in! the! transient! gene! screen!with!
regards! to! biological! and! technical! replicates,! with! the! exception! of! data!














gene! levels! tested! this! would! be! more! difficult! to! fully! elucidate! than! in! the!
transient!four=level!screen.!
4.2.3.2.2.&Titre&
A! small! selection! of! genes! increased! titre! levels! by! a! statistically! significant!
amount!(figure!4=3!b).!The!average!titre!across!all!control!wells!was!80.4!mg/L,!a!
20=fold! increase! compared! to! the! transiently=expressed! DTE! screen! (section!
4.2.2).!At!the!lowest!gene!dose!level!both!Ero1=Lα!and!PDI!increase!productivity!
by!1.2=! and!1.3=fold! respectively,!with! the! results!being! statistically! significant.!
Both!genes!show!a!dose!response!with! lower!gene!doses!having!a! larger!effect!
upon!the!overall!titre!than!higher!doses.!At!the!highest!level!of!gene!dose!PRDX4!
displays!a!1.2=fold! titer! increase,! though!PDIA4!does!not!have!an! impact.!All!of!
these!genes!are!involved!in!disulphide!bond!formation.!That!expression!of!three!






which! reinforced! previous! literature! studying! the! effect! of! XBP1s! on! a!
transiently=expressing! reporter! gene.! Other! transcription! factors! in! the! screen!
(CREB3L2,!CRELD2,!YY1!and!TFE3)!had!no!effect!upon!cell!productivity! levels,!
however! a! high! dose! of! ATF6c! did! reduce! overall! titre.! Of! the! genes! directly!
involved! in! the! secretory! pathway,! expression! of! Bet3! (vesicle! tethering)! and!
PREB! (ERES! formation)! at! high! levels! both! resulted! in! 1.2=fold! increases! in!
productivity! although! neither! were! statistically! significant.! Whilst! the! former!
does!not!show!a!dose!response!the!later!does,!with!titre!increasing!as!gene!dose!






(HSPA1a,! FKBP11,! Canx,! Calr,! Hyou1,! HSP90B1,! CypB)! appear! to! have! no!
significant!impact!upon!titre!levels,!with!only!FKBP11!showing!a!different!trend!
to! that! seen! in! transiently=expressing! cells.! The! two! ERGIC! genes! (ERGIC53,!
MCFD2)!have!differing!effects!upon!titre!levels.!The!former!reduces!productivity!
whilst! the! later! has! no! effect.! Whilst! many! genes! showed! little! impact! upon!








improve! cellular! productivity! (figure! 4=3! c).! However,! variation! in! the! data!
suggest! it! is! less!clear! than! the!direct! titre!and!growth!measurement!data!sets.!
Average!Qp!across!all!control!wells!was!2.2!pg!cell=1!day=1.!In!general!expression!
of!transcription!factors!derived!from!plasma!cells!appear!to!have!no!significant!




The! effect! of! genes! involved! in! vesicle! transport! varies! somewhat.! Bet3! sees! a!
1.4=fold!Qp!increase!at!a!high!dose!level,!Rab11a!a!1.3=fold!increase!at!a!low!level!
and!PREB!a!1.3=fold! increase!at! a!medium! level! (though! these! changes!are!not!
significant),! whilst! other! vesicle! transport! effectors! have! little! impact! on! Qp!
levels.!Expression!of!chaperones!has!varying!effects!on!Qp.!Calr!and!Canx!have!no!
effect,!FKBP11,!HSPA1a!and!Hyou1!all!see!an! insignificant!1.3=fold!Qp!increase,!
whilst!HSP90B1! sees! a! significant! 1.4=fold! increase.! All! these! changes! occur! at!
differing!dose! levels.!Genes! linked! to!disulphide!bond! formation! (ERO1Lα,!PDI,!
PRDX4)! nearly! all! see! at! least! a! 1.3=fold! increase! in!Qp! (with! the! exception! of!
PDIA4)!with!lower!levels!of!gene!generally!seeing!the!largest!increase.!PRKD1!is!
the!only!other!gene!(other!than!HSP90B1)!to!statistically!increase!Qp!levels!with!
a! close=to! 1.5=fold! Qp! increase! seen! at! the!medium! dose! level.! However! again!
there!is!no!dose=response!seen.!
!
The! difference! in! data! between! the! transiently=! and! stably=expressing! gene!
screens! shows! that! in! general! the! former! can! not! inform! the! later.! This! is!
particularly! prevalent!when! looking! at! the! gene! families.! Transcription! factors!
that!increase!transient!productivity!(XBP1s=CHO,!CREB3L2,!CRELD2)!have!little!










Figure&4(3.&Gene&screen&of& transiently&expressed&effector&genes& in&a&CHO&cell&pool& stably&
expressing&a&DTE(Mab.&
.MedI(CHO(DTE! cells! (stably! expressing! DTE(Mab)were! transiently! transfected! with! a! range! of!
effector!genes,! each!at!3!different!dose! levels.!After!120!h! incubation! [a]!growth,! [b]! titre!and! [c]!
specific!productivity!were!assayed!and!displayed!as!a! fold! change!of! level! of!Mab(only! expressing!







































































































































Accessory gene amount as 






































































































































Accessory gene amount as 












































































































































Due! to! the! large! number! and! small! volume! of! culture! produced! in! the! gene!
screen! it! was! not! possible! to! perform! in=depth! screens! on! the! activity! of!




gene! screen! platform! with! GFP! showed! that! recombinant! expression! of!
transfected! DNA! was! replicable! across! wells! in! the! same! plate,! and! across!
different! plates! (data! not! shown;! Arnall! et! al.! Manuscript! in! preparation).!
Furthermore,!as!all!wells!were!treated!the!same,!and!with!very!similar!levels!of!
plasmid!DNA,!it!can!be!assumed!that!all!recombinant!genes!were!equally!active.!
Tightness! of! data! across! in=plate! replicates! and! across! replicate! plates! further!
adds!to!this.!
4.3.$Multigene$engineering$of$CHO$secretory$functions$
Single! gene! engineering! of! specific! sections! of! the! biosynthetic! and! secretory!
pathways! can! lead! to! stoichiometric! imbalances.! As! such! when! increasing!
cellular!levels!of!these!genes!there!are!three!possible!outcomes:!!
!
1) An! increase! in!productivity!occurs!as! the!gene!expressed!was!a! limiting!
factor!and!rate=limiting!step!in!protein!processing/secretion.!!
2) There! is! no! change! in! cell! productivity.! The! expressed! gene! has! no!
negative!effects!upon!growth/productivity,!but! its! function! is!dependent!
upon! specific! interactions!with! other!molecules! that! have! not! been! up=
regulated.!As!such!the!engineered!gene!does!not!have!the!desired!effect!as!
the!excess!levels!can!not!function.!!
3) Productivity! decreases.! A! specific! stoichiometric! ratio! of! molecules! is!
required! to! allow! correct! pathway! functionality! and! increased! levels! of!
one! molecule! alters! this! balance! to! such! an! extent! that! the! targeted!
pathway! is!blocked.!This!could!be!due!to!aggregation!or!oligomerisation!






entire! pathway! (He! et! al.! 2010).! However,! engineering! of! a! single! molecule!











CHO! productivity.! This! is! shown! by! engineering! of! the! translocon! and! SRP!
complex,! with! expression! of! one! component! increasing! productivity,! but!
expression!of!multiple!SRP!subunits!further!increasing!this!effect!(Le!Fourn!et!al.!
2014).!It!is!also!shown!with!engineering!of!SM!family!SNARE!regulators,!with!Sly!
1! and! Munc18c! both! individually! increasing! CHO! secretion! levels,! with! levels!
increasing! further! upon! their! co=expression! (Peng! and! Fussenegger! 2009b).!
However,! this! is!not!always! the!case,!with!co=expression!of! interacting!SNAREs!
resulting! in! no! further! productivity! enhancement! than! that! seen!with! singular!
SNARE!expression!(Peng!et!al.!2011).!!
!
This!would!suggest! that! in!some!molecular! interactions!only!one!component! is!








Both! data=driven! (from! the! single! gene! screen)! and! knowledge=driven! (from!
secretory! pathway!mapping! and! previous! literature)! approaches!were! used! to!
produce!up=to! three=gene! combinations!with!which! to! transiently! engineer! the!
CHO!biosynthetic!and!secretory!pathways!to!increase!CHO!productivity!of!a!DTE!
Mab.! Despite! separate! vectors! being! used! for! each! gene! a! maximum! of! three!
genes!were!selected!for!each!combination!to!better!mimic!the!three=gene!MGEV!
platform! with! which! the! gene! library! will! eventually! be! used.! This! limit! also!
avoided!excessive!transcriptional!burden!upon!the!cell!and!the!dilution!of!gene!
expression!levels!due!to!the!presence!of! increasing!numbers!of!genes.!For!both!
data=! and! knowledge=driven! combinations! the! gene! levels! used! were! selected!
from! the! initial! single=gene! screen,! with! the! level! that! had! the! most! positive!
effect!upon!titre!and/or!Qp!being!chosen.!In!future!studies!gene!expression!levels!




work! in! combination! targeting! a! specific! pathway.! As! such! they! were! not!
necessarily! expected! to! work! independently! of! each! other! in! the! single! gene!





functional! effect! both! individually! and! in! dual! and! triple! combinations.! A!
summary!of!each!combination!is!shown!in!table!4=2.!
4.3.1.1.&Lipid&transport&pathway&multigene&engineering.&
PRKD1,& SGMS1& and& CERT! will! be! co=expressed! to! try! and! enhance! lipid!
transport! to! the! Golgi! and! TGN! and! better! catalyse! the! conversion! of! CERT! to!
DAG! (by! SGMS1).! The! hypothesised! outcome! of! this! is! an! improvement! and!
increase! in! vesicle! fission! at! the! TGN! (initiated! by! PRKD1)! with! a! view! to!
increasing!TGN!capacity!and!budding!events!though!the!increase!of!PRKD1!and!
DAG!levels!at!the!TGN!(Baron!and!Malhotra!2002;!Fugmann!et!al.!2007;!Hausser!
et! al.! 2005;! Huitema! et! al.! 2004;! Liljedahl! et! al.! 2001).! Overexpression! of! an!
active!mutant!of!CERT!has!been!shown!to!improve!CHO!productivity,!though!this!
was! not! seen! in! our! single=gene! screen! with! expression! of! CERT,! SGMS1! and!
PRKD1!all!resulting!in!small!titre!and!Qp!reductions!(Fig.!4=1;!Florin!et!al.!2009;!
Rahimpour!et!al.!2013).!This!gene!combination!is!intended!to!better!balance!the!







ERGIC53& and& MCFD2& form! a! cargo! receptor! complex! involved! in! ER=Golgi!
transport! (section! 1.5.1.2;! Appenzeller=Herzog! and! Hauri! 2006).! The! two& are!
present! in! a! 1:1! stoichiometry! with! mutations! and! miss=targeting! of! the!
components! shown! to! inhibit! the! secretion! of! blood! factors! (Appenzeller! et! al.!
1999;! Baines! and! Zhang! 2007;! Nyfeler! et! al.! 2006;! Vollenweider! et! al.! 1998;!
Zhang!et!al.!2005).!Expression!of!both!in!the!transient!gene!screen!showed!little!
impact!upon!productivity!(figure!4=1)!–!expected!due!to!their!close!synchronous!




Bet3& is! a! vesicle=localised! subunit! of! the! TRAPPI! tether! complex.! As! well! as!
targeting! the! TRAPPI! complex! to! COPII=vesicles,! thus! aiding! COPII! vesicle!
docking!at!the!Golgi,!Bet3!acts!as!a!GEF!for!vesicle=localised!Rab1!which!in!turn!
recruits!the!coiled=coil!tether!P115!(Cai!et!al.!2007b;!Sztul!and!Lupashin!2009).!
Over=expression! of! these! three! proteins! together! is! expected! to! enhance!








of! these! SNAREs! prior! to! vesicle! docking,! initiating! the! preliminary! steps! of!
vesicle!fusion!(Hong!and!Lev!2014;!Sztul!and!Lupashin!2006;!Sztul!and!Lupashin!
2009).! As! with! previous! studies! co=expression! of! Stx5! and! Bet1! is! hoped! to!





screen! in! transient! cells.! Expression!of! the! three! transcription! factors! together!
will! be! carried!out! to! ascertain!whether! the! trio!have! a! compound!effect!upon!
cell!productivity.!The!expression!levels!of!all!three!are!increased!in!plasma!cells!
(section! 3.2;! table! 3=1),! with! XBP1! and! CREB3L2! both! linked! to! directly!
enhancing!secretion! in!many!cell! types! through!the! initiation!of!secretory!gene!
transcription! (Fox! et! al.! 2010;! Shaffer! et! al.! 2004).! XBP1! has! been! expressed!
many!times!in!CHO!cells!including!alongside!other!effectors,!in!these!cases!seeing!




have!been! linked!to! increased!productivity!capacity! in!CHO!cells! (Harreither!et!
al.!2015).!All!the!genes!selected!also!see!an!increase!in!transcript!abundance!in!
plasma! cells.! Gene! combinations! are! summarised! in! table! 4=2.! The! gene! levels!



















Enhance! transport! of! ceramide! from! ER! to!
Golgi/TGN;! Increased! conversion!of! ceramide!












Increasing! levels! of! vesicle=localised! tethers!




















if! there! is! a! compounding! of! the! effect! of! all!
three!transcription!factors.!
!








from! the! selected! gene! combinations.! Each! accessory! gene! was! encoded! by! a!
separate!vector,!with!gene!dose!levels!shown!in!table!4=3.!The!transfection!and!
growth!was! carried! out! as! with! the! single! gene! screen,! with! growth! and! titre!
samples!taken!after!120!h!shaken!culture!(sections!2.5.2,!2.1.2.2!and!4.3.2).!!
!
Five! DoE! two=level! factorials! were! prepared! to! test! all! possible! gene!
combinations!within!the!five!gene!groups!and!to!determine!the!effect!each!gene!
had!upon!cell!growth,!overall!titre!and!specific!productivity!(section!2.9.5).!This!
allowed! the! effect! of! each! gene! upon! cell! growth,! overall! titre! and! Qp! to! be!
analysed,!both!singularly!and!in!combination.!For!each!three=gene!selection!this!
resulted!in!three!single=gene!combinations!(a,!b,!c),!three!two=gene!combinations!










to! contamination).! Any! contaminated!wells! or!wells!which! did! not! grow!were!
removed!prior!to!data!analysis.!This!resulted!in!a!maximum!of!six!data!points!for!
each!gene!combination!and!twelve!data!points!for!controls.!A!Dunnett’s!multiple!
comparison! test! was! performed! on! all! results! data! so! as! to! compare! them!
directly!to!the!controls!and!determine!any!statistically!significant!results.!Design=





gene! screen! (figure!4=1)! each!of! the! single! genes! (PRKD1!at!10%!of! total!DNA!
load,! SGMS1!at!5%!and!CERT!at!10%)!have! little! impact!upon! cell! growth!and!
productivity,!with! a! slight! reduction! in! titre! and/or! productivity! seen! from! all!
three,! though! none! of! these! are! statistically! significant.! All! gene! combinations!
have!no!obvious!effect!upon!CHO!growth!levels!with!only!small!decreases!seen!in!




does! appear! to! reduce! titre! and! Qp! compared! to! the! control! (figure! 4=4! b,!
combination! 2.3).! However,! the! single=gene! data! shows! that! MCFD2! at! 10%!





















PRKD1& 10%! 80! Least!negative!effect!on!titre!and!growth.!




10%! 80! Least! effect! on! titre,! no! effect! on! IVCD,!
small!decrease!in!Qp.!
ERGIC53& 10%! 80! Works! 1:1! with! MCFD2.! Minimal! effect!
upon! titre/growth! between! different!
levels!
MCFD2& 10%! 80! No!large!effect!on!titre!or!IVCD,!therefore!
none! on! Qp,! but! best! of! all! gene! dose!
levels.!
Bet3& 5%! 40! Slight! titre! increase,! similar! impact! on!
growth! across! all! levels;! largest! Qp!
increase.!
Rab1a& 10%! 80! No! impact! on! titre,! IVCD! or! Qp! at! all!
levels.! Used! highest! dose! for! maximum!
effect.!
P115& 2.5%! 20! Increase! in! titre,!growth!decrease!similar!
across!all!levels;!best!Qp!increase!
Stx5a& 10%! 80! Least! negative! impact! upon! titre;! impact!
upon!growth!similar!across!all!levels.!
Bet1& 5%! 40! Slight! titre! increase;! no! difference! in!
growth!across!all!levels.!
CRELD2& 5%! 40! Increase! in! titre,! no! effect! on! IVCD.! Qp!
increase.!














As! with! other! gene! combinations,! engineering! of! CHO! cells! with! the! vesicle!
binding!genes!Bet3!(at!5%!of!total!DNA!dose),!Rab1a!(10%),!P115!(2.5%),!Stx5a!
(10%)! and! Bet1! (5%)! has! no! impact! upon! cell! growth,! either! singularly! or! in!
combination! (figure! 4=5! a,! b).! Expression! of! these! genes! singularly! appears! to!













Results! for! engineering! of! CHO! cells! with! the! transcription! factors! CRELD2,!
CREB3L2! and! XBP1s=CHO! are! shown! in! figure! 4=5! c.! Single! gene! engineering!








seen! when! XBP1s! is! co=expressed! alongside! the! other! transcription! factors.!
Combining! CREB3L2! and! CRELD2! results! in! a! slight! decrease! on! cell! growth,!
productivity!and!titre!(5.3).!Co=expression!of!CRELD2!and!XBP1!(5.5),!CREB3L2!
and!XBP1!(5.6)!and!all!three!genes!together!(5.7)!all!result!in!a!slight!decrease!in!





an! effect! upon! CHO! cell! growth! and! productivity,! analysis! of! the! multigene!
experiment! was! carried! out! using! Design=Expert®! software.! Analysis! was!
performed!on!all!gene!screen!combinations!but,!as! the!only!significant!positive!












productivity.!After! five!days’! growth! in!96!deep!well! plate! culture!growth!and! titre! samples!were!
analysed.!Experimental!data!is!shown!as!a!fold(change!compared!to!the!control!results.!A!Dunnett’s!
































































































































CHO! cells! were! transiently! transfected! with! DTE(Mab! alongside! gene! combinations! designed! to!
engineer![a,!b]!vesicle!binding!and!tethering!in!the!early!secretory!pathway,!and![c]!biosynthetic!and!
























































































































































































































For! CHO! cell! growth!DoE! analysis! shows! that! XBP1! on! its! own! and! XBP1! and!
CRELD2! in! combination! have! a! negative! effect! upon! cell! growth.! Probability!
scores! show! that!CRELD2!and!XBP1!are!both!significant!model! terms! (i.e.! they!
have! an! effect! upon! the! outcome! being!measured),!with! an! adequate! signal! to!
noise! ratio! of! 9.471! achieved! (greater! than! 4! being! perceived! as! adequate).!







With! regards! to! overall! titre,! engineering! with! XBP1! individually! and! a!
XBP1/CREB3L2! combination! both! have! an! effect! (figure! 4=6! b).! An! F=value! of!




































Model! 0.210649955! 2! 0.105325! 16.27179! 7.856!E=06!
A=
CRELD2!
0.077623323! 1! 0.077623! 11.99213! 0.001338!
C=XBP1! 0.133026631! 1! 0.133027! 20.55145! 5.636!E=05!
Residual! 0.245968585! 38! 0.006473! ! !
Cor!Total! 0.742640079! 51! ! ! !
Titre.&







Model! 2.300018008! 3! 0.766673! 9.178685! 0.000113!
B=
CREB3L2!
0.004126053! 1! 0.004126! 0.049398! 0.825337!
C=XBP1! 1.847235317! 1! 1.847235! 22.11529! 3.521!E=05!
BC! 0.451842465! 1! 0.451842! 5.409505! 0.0256!
Residual! 3.090517899! 37! 0.083528! ! !
Cor!Total! 8.345503751! 51! ! ! !
Qp.&










Model! 0! 0! ! ! !
Residual! 7.978766! 40! 0.99469! ! !































Overall! this! shows! that! whilst! CRELD2! and! XBP1s! may! have! a! slightly!
detrimental! effect! upon! CHO! cell! growth,! XBP1s! and! CREB3L2! have! a!




A! gene! screen! of! effector! genes! was! performed! in! cells! both! transiently! and!
stably! expressing! the! same!DTE!Mab.! This! allowed! the! effectiveness! of! all! the!
genes!screened!to!be!assayed!in!two!model!expression!systems.!Furthermore!it!





The!overall!outcome!of! the! transient!gene!screen!was! that!many!genes!did!not!
increase! transient! Mab! expression.! The! exception! to! this! was! XBP1s! which!
increased!productivity!up! to!2.5=fold! in!both! its!human!and!CHO! isoforms.! In!a!
transient! system! this! replicates! the!XBP1s=mediated!productivity!enhancement!
seen! in! previous! literature.! Exact! productivity! increases! can! not! be! compared!







DTE=Mab! did! not! result! in! the! increase! in! productivity! that! has! been! seen!
previously!and!in!the!transient=expression!system!(Fig.!4=3;!Becker!et!al.!2008).!
This!lack!of!change!suggests!that,!during!the!process!of!developing!a!stable!pool!





chronic! ER! stress.! It! has! previously! been! shown! that! this! can! result! in!
suppression!of!the!UPR!response!(Gomez!and!Rutkowski!2016).!It!has!also!been!
shown!that!under!stress!conditions!ectopic!expression!of!XBP1s!(in!CHO=S!cells)!
can! repress! endogenous! XBP1! splicing! without! also! repressing! the! PERK!
pathway,! suggesting! the! presence! of! a! feedback! mechanism! in! CHO=S! cells! to!
attenuate!IRE1!activity!in!the!presence!of!XBP1!(Chalmers!et!al.!2017).!Of!course!





high! level! within! the! cell! and! as! such! further! overexpression! would! not! have!




The! transcription! factor! and! chromatin! regulator! YY1! has! previously! been!
shown!to!increase!stable!Mab!titre!by!close!to!4=fold!in!CHO!cells,!increasing!both!
intra=! and! extra=cellular! Mab! levels.! It! was! also! shown! to! increase! transient!
production!by!close!to!3=fold.!In!both!systems!increasing!YY1!DNA!levels!by!too!
much! resulted! in! a! reduction! in! productivity! enhancement! (Tastanova! et! al.!
2016).!This!suggests!that!excessive!overexpression!of!a!transcription!factor!can!
have! less! of! an! effect! upon! transient! productivity! and!highlighting! the! need! to!






shown! to! increase! productivity! in! CHO! cell! lines! both! transiently! and! stably!
expressing!Mabs.!In!this!screen,!expression!of!Ero1=Lα!transiently!had!no!effect!
upon!transient!CHO!productivity!(figure!4=1),!contradicting!what!has!been!seen!
previously! (Cain! et! al.! 2013).! However,! in! this! paper! Ero1=Lα! was! stably!
expressed!alongside!XBP1s!and!whilst!productivity!did!increase!compared!to!an!









Both! previous! studies! showing! an! increase! in! CHO! productivity! upon! CERT!
overexpression!were!carried!out!in!cell!lines!stably!expressing!both!the!product!
(Mab! or! tPa)! and! CERT! (Florin! et! al.! 2009;! Rahimpour! et! al.! 2013).! As! such!




transiently,! as! it!may!prove! that!CERT!must!be!expressed!at!a! level!above! that!
possible!in!a!transient!system!to!have!an!effect!upon!ceramide!transfer!and!Golgi!
lipid! synthesis.! However,! that! high! levels! of! CERT!were! out=performed! by! low!




Interestingly! reduced! ceramide! synthesis,! brought! about! by! knockdown! of! the!
ceramide! synthetase! (CerS2),! has!been! shown! to! alter! the! ceramide! content!of!
membranes! and! increased! CHO! cell! IgG! productivity! (Pieper! et! al.! 2017a),!
suggesting!reduced,!not! increased,!ceramide! levels!are! linked!to! increased!CHO!
cell!productivity.!
!
Whilst! it! is! not! possible! to! directly! compare! the! vesicle! tethering! and! fusion!
genes!expressed!in!the!gene!screen!to!previous!literature,!previous!expression!of!
SNAREs! (specifically! SNAP23! and! VAMP8)! and! SNARE! effectors! has! been!
performed!with!both!products!and!effectors!transiently!expressed.!In!both!these!








Stable! expression! of! SRP14! protein! has! been! shown! to! increase! stable! Mab!
production!(Le!Fourn!et!al.!2014).!This!is!contrary!to!what!is!seen!in!our!screens!
where! SRP! expression! resulted! in! decreased! transient! production! and! only! a!
small!increase!in!stable!production.!Increasing!ATF6!activity!has!been!shown!to!
increase!CHO!transient!productivity!(Johari!et!al.!2015;!Pieper!et!al.!2017b),!but!
was! not! shown! to! increase! the! productivity! of! a! stable! product! though! again!
productivity! was! linked! to! the! specific! product! used! (Pybus! et! al.! 2014).! This!
matches!data! from!this!screen!where!expression! in!a!stably=producing!cell! line!
resulted!in!a!slight!increase!in!Qp!but!a!decrease!in!overall!titre.!Increasing!Rab1!
activity!in!CHO!cells,!achieved!through!knockdown!of!Tbc1D20,!has!been!shown!
to! increase! CHO! productivity,! albeit! in! combination! with! CerS2! knockdown!
(Pieper!et!al.!2017a).!Here!Rab1!had!no!impact!upon!productivity!in!transient!or!
stably! producing! cells,! though! a! slight! increase! in! stable! Qp! is! seen! once!
normalised!for!DNA!load.!
!
That! the! two! main! plasma=cell! derived! transcription! factors! CREB3L2! and!
CRELD2! both! increase! transient! DTE=Mab! titer! by! 1.4=fold! somewhat! upholds!
the!hypothesis!that!transcription!factors!with!a!role!in!plasma!cell!differentiation!
can! increase! productivity! of! a! transiently=expressed! Mab.! However,! these!
transcription! factors! had! no! effect! upon! stable! Mab! production,! wheras! more!
specific!targets!did!appear!to!have!a!slight!impact!upon!stable!Mab!productivity.!
This! mirrors! the! lack! of! effect! on! stable! production! of! XBP1,! with! the! overall!







This! would! suggest! that! in! a! stably=producing! system,! especially! when! a! DTE!
Mab!is!being!produced,!the!cell!population!manages!to!overcome!the!UPR!and!as!
such!it!can!not!be!further!enhanced.!This!could!be!somewhat!false!and!be!due!to!
either! the! selection! process! involved! in! stable! pool! production,! or! the! natural!
selection!of!a!cell! line!with!enhanced!ER!capacity! that!does!not!require! further!
UPR! activation! and! therefore! has! an! advantage! over! the! rest! of! the! cell!
population! and! thus! becomes! predominant.! It! is! also! possible! that! stable!
expression! of! a! DTE=Mab! induces! chronic! ER! stress! upon! the! cell,! which! can!
suppress! the! UPR! through! dampening! expression! of! BiP! mRNA! (Gomez! and!
Rutkowski!2016).!!
!
Of! the! genes! that! have!not! previously! been! ectopically! expressed! in!CHO! cells,!
many!produced!a!slight!increase!in!titre!and!productivity!as!discussed!in!section!
4.3.3.2.!Expression!of!a!single!SNARE!or!tether!protein!may!slightly!enhance!cell!




Whilst! chaperones! can! work! independently! of! each! other,! it! is! possible! that!
overexpression! of! one! chaperone! could! only! shift! the! protein! processing!
bottleneck! elsewhere! within! the! ER,! therefore! not! enhancing! overall! CHO!
productivity.! Expression!of!HSPA1a!has!been! shown! to! improve!both! titre! and!
Qp!of!BHK=expressed!factor!VIII!by!approximately!a!third!(Ishaque!et!al.!2007).!
Here!it!can!be!seen!that!in!CHO!cells!HSPA1a!expression!resulted!in!no!change!in!




increase! in! transient! CHO! productivity! in! the! four! knowledge=driven! gene!
combinations!(lipid! transporting,!ERGIC!and!two!vesicle!docking!combinations;!
Fig.! 4=4! and! Fig.! 4=5! a,! b).! The! data=! and! knowledge=driven! combination!
(transcription!factors;!Fig.!4=5!c)!did!result!in!an!increase!in!both!Qp!and!overall!




as! definitive! as! the! DoE! framework! allows.! Comparing! the! single=gene!
transfections!from!the!DoE!to!those!of!the!initial!single=gene!screen!(figure!4=1)!
exposes!quite!marked!differences!between!the!same!genes!between!different!the!






case!of!sole!expression!of!XBP1s=CHO.!A!2.5=fold! increase! in!titre! is!seen! in!the!




intra=plate! =!variability!during! the!multigene!screen.!Whilst! this!was!present! in!
the!single=gene!screen!it!was!not!to!the!same!level!as!that!seen!in!the!multigene!
experiment.!In!the!multigene!experiment!variability!in!titre!and!productivity!was!
seen! even! between! control! replicates! on! the! same! plate,! as! well! as! between!
technical! replicates! of! both! test! and! control! subjects! on! repeat! plates.! This!
variance!is!shown!in!the!large!error!bars!seen!in!the!multigene!experiment,!with!
very! few! results! shown! to! be! statistically! significant! when! compared! to! the!
control.!It!is!also!possible!that!the!increased!transcriptional!burden!of!expressing!
up!to!four!genes!from!separate!plasmids!produced!too!much!of!a!transcriptional!






to! increase! capacity.! Increasing! the! presence! of! only! three! genes! may! open! a!
pathway! up! a! bit! more,! but! again! it! could! shift! the! functional! bottleneck! to!
elsewhere! within! the! pathway.! For! example! with! the! lipid! transport! gene!
selection! (PRKD1,!SGMS1!and!CERT),!phosphatidylinositol!kinases!also!play!an!








whilst! it! has! been! suggested! that! not! only! DAG! but! protein! kinase! C! may! be!
required!for!PRKD1!activation!(Wang!2006).!!
!
Whilst! expression! of! a! small! selection! of! SNARE! proteins! has! been! shown! to!
increase! CHO! productivity! levels,! even! co=expressing! proteins! known! to! work!
together!has!previously!resulted!in!no!increase!in!productivity,!highlighting!that!








UPR! and! secretory! pathways! respectively),! allows! the! cell! to! make! myriad!
changes! at! a! transcriptomic! level,! enhancing! the! protein! processing! and!
secretion!machinery!to!achieve!an!increased!productivity!phenotype.!!
!
With!all! genes! treated! the! same! it! can!be!assumed! that! all!data! in!both! single=!
and!multi=gene! screens! is! comparable.!However,! it! is!possible! that! some!genes!
are!more! easily! transcribed! than! others,! or! their! products!more! active! due! to!
post=translational! modifications! or! more! favourable! stoichiometric! ratios.!
Because!of!the!large=scale!high=throughput!process!used!to!test!the!genes,!it!was!
not!possible!to!check!the!mRNA!or!proteomic!levels!of!each!gene,!even!at!a!low!
level! (e.g.! by! RT=PCR! or! Western! blotting/fluorescence! measurement!
respectively),! as! has! been! performed! in! previous! low=throughput! gene!
expression!studies! to!confirm! increased! levels!of! the!accessory!gene!and/or! its!
protein! (Borth! et! al.! 2005;! Cain! et! al.! 2013).! This! technique! was! also! used! to!





of! the! UPR,! protein! folding! and! secretion,! it! can! be! considered! that! any! effect!





pathway!with!which! to! increase! product! yields.!However,! the! Largen! gene! did!
not! have! any! effect! upon! CHO! cell! productivity! (figure! 4=1).! Furthermore,!
increasing!the!biomass!of!a!culture!past!a!certain!point,!through!increasing!either!
cell! density! or! size,! can! increase! sheer! stress! within! bioreactors! or! increase!
burden!upon!the!downstream!processing!of!product,!both!of!which!can!impinge!
upon!ultimate!final!process!yield.!As!such!engineering!within!the!cell!to!increase!





to! be! stably! expressed! alongside! a! stably=expressed! recombinant! product.! As!
seen!in!the!single=gene!screen,!the!effect!of!multiple!genes!is!likely!to!differ!in!a!
cell!line!stably!expressing!a!product!compared!to!a!transient!expression!system!
(section! 4.3.3).! Furthermore,! for! industry=relevant! practices! expression! of!
recombinant!product!and!accessory!genes!from!up!to!four!separate!plasmids!is!





simplified! engineering! solution,! especially! with! regard! to! stable! expression! of!
multiple! product! and! accessory! genes! from! one! transcriptionally! active! site! in!
the! genome.! Use! of! synthetic! promoters! in! this! system! can! also! ensure! better!
transcriptional! control! of! both! the! recombinant! product! but! also! the! effector!






appear! to!not!be! the!best!way! in!which! to!screen!genes! that!will!be!used! in!an!
attempt! to! enhance! stable!production.!Multi=gene!engineering!of!CHO!cells! can!
enhance!the!effect!of!single=gene!engineering!when!gene!combinations!are!data!
driven.!Whilst!it!may!be!enticing!to!use!knowledge=driven!approaches!to!multi=
gene! CHO! engineering! data! here! shows! that! this! results! in! no! increase! in!
productivity.! This! is! likely! due! to! there! being! a! finite! (and! generally! small)!
number! of! genes! that! can! be! expressed,! taking! little! consideration! in! to! the!












productivity! phenotype! by! evolving! against! a! secretory! blocking! agent.! Previous!
directed! evolution! strategies! were! reviewed! and! a! review! of! secretory! blocking!
agents! was! carried! out! to! inform! selection! of! suitable! secretory(blocking! agents!
against!which!to!evolve!the!cell! line.!A!parental!CHO!cell! line!was!evolved!against!
the! selected! secretory! blockers.! To! quantify! the! effect! the! directed! evolution!
strategy!had!upon!CHO!cell!productivity!levels,!transient!and!stable!transfections!of!
the! evolved! cell! lines! were! performed! with! easy(! and! difficult(to(express! model!







to! help! produce! cell! lines! with! phenotypes! desirable! for! manufacturing! and!
research! purposes.! Screening! paired! with! single=cell! sorting! allows! for! the!
selection!of!a!single!cell!with!desirable!growth!and!productivity!characteristics.!
Over! time! this! population! would! eventually! diverge,! becoming! genetically,!
epigenetically!and!phenotypically!diverse,!as!has!been!shown!by!growth!of!CHO!
clones! over! time! resulting! in! a! population’s! growth! rate! gradually! increasing,!
even! after! the! cells! have! been! allowed! to! adapt! to! their! growth! conditions!
(Fernandez=Martell!et!al.!2017).!As!the!cell!culturing!process!progresses,!faster=
proliferating! cells! become! more! prevalent! within! the! population,! resulting! in!
evolution! of! the! population’s! growth! rate.! If! basic! long=term! culturing! of! CHO!
cells! can! result! in! the! enhancement! of! a! desirable! phenotype! within! the!
population,!a!more!designed!and!specific!long=term!growth!strategy,!utilising!an!




phenotypes! are! produced.! The! first! and!most! common! of! these! is! based! on! a!
mutate=and=screen!process!whereby!a!mutant!library!is!produced!then!screened!
for!a!desired!phenotype,!cells!with!this!phenotype!being!selected.!Mutations!can!





(epPCR)!can!be!used! to! target! specific!genes/genomic!areas,!producing!a!more!
defined!set!of!mutations!(Yang!et!al.!2017).!Libraries!are!then!screened!to!select!
those!with!desirable!phenotypes.!Due!to!the!slow!growth!characteristics!of!CHO,!
this! screening! process! does! not! really! improve! upon! current! technologies! and!
techniques! used! within! cell! line! development! (Wurm! 2004).! Furthermore,!
mutations!produced!will!alter!a!specific! target!and,! in!the!process!of!screening,!
more! nuanced! changes! around! this! target! may! well! be! lost.! However,! the!




and! allowing! it! to! naturally! overcome! this! over! time.! These! conditions! can! be!
either! global! or! specific! to! a! certain! problem/pathway! within! the! cell.! This!
method! of! directed! evolution! has! been! used! to! produce!mammalian! cell! lines!
that! are! highly! resilient! to! bioreactor! stresses! (e.g.! increased! ammonia/lactate!
concentrations,!shear!forces,!nutrient!deprivation)!to!improve!cell!growth!within!
bioreactors! (Matsumura!et!al.!1991;!Prentice!et!al.!2007),!as!well!as!producing!
cold=adapted! CHO! cells,! resulting! in! normal! growth! metrics! despite! a! larger!
volume!and!increased!productivity!compared!to!the!parental!line!(Syddall!et!al.,!
manuscript! in! preparation).! Continued! exposure! of! CHO! cells! to! the! apoptosis!
inhibitor! staurosporine! resulted! in! progressively! lower! apoptosis! induction!
thresholds,! showing! repeat! exposure! to! a! stress! can! bring! about! enhanced!
performance!(Majors!et!al.!2012).!!
!
This! method! of! exposure! to! a! harsh! environment! is! able! to! utilise! any! small!
variances!within!a!cell!population!that!is!initially!clonally!derived!and!therefore!






artificial! blockage! brought! upon! by! a! specific! agent.! This! may! result! in! an!
increase! in! molecular! components! of! that! pathway,! or! potentially! enhancing!
neighbouring!pathways! (active!or! redundant)! to!overcome! the! imposition.! It! is!
likely! that!multiple! fine! changes! at! the!molecular! and! genetic! level!will! occur,!










could! result! in! the! development! of! a! cellular! phenotype! with! increased!
productivity,! in! this! case! due! to! cells! overcoming! a! blockage! of! the! cellular!
secretory!pathway!resulting!in!an!enhanced!secretory!phenotype.!!
!
Mutation! and! selection! has! been! used! to! good! effect! in! both! microbial! and!
mammalian! cells! to! evolve! new! desired! phenotypes.! However,! due! to! the!
relatively! long! generation! time! of! mammalian! cells,! applying! mutation!






By!blocking! the!secretory!system!of!CHO!cells,! it!was! intended!that!phenotypic!
variations!across!the!cell!population!that!were!already!present!would!be!allowed!
to! proliferate! under! the! selective! pressure.! This!was! expected! to! result! in! the!
proliferation! of! cells! that! have! overcome! the! secretory! blockage! due! to! an!
increased!secretory!phenotype.!Stepped!increases!in!the!concentration!blocking!
agent!would!allow!greater!evolution!of!the!cell!population!and!therefore!greater!
enhancement! of! the! CHO! secretory! pathway.! When! returned! to! normal!
conditions! it! was! hoped! that! the! evolved! cell! line! would! have! an! enhanced!
secretory!pathway! capacity,! increasing! secretion! levels! of! recombinant!protein!
products!and!therefore!increasing!production!levels!when!compared!to!the!wild!










75%! (knocking! growth! down! to! 25(50%! that! of! untreated! cells),! with! compound! added! at! each!
passage.!After!gradual!recovery!of!cell!growth!and!viability!towards!normal!levels,!concentration!of!
inhibitory!blocker!would!be!increased,!with!the!process!being!repeated!upon!cell!growth!recovery.!
The! resulting! cell! line!may! have! a! slightly! reduced! level! of! growth,! but! when! removed! from! the!
selective!pressure!this!would!be!expected!to!return!to!normal!levels.!
! !










































5.2.$ Selection$ of$ secretory$ blocking$ molecules$ for$ directed$
evolution$
Many! secretory=blocking! chemicals! have! been! used! to! dissect! and! therefore!
elucidate! the! mammalian! cell! secretory! pathway.! The! majority! of! secretory=
blocking!compounds!have!been!used! to!dissect! the!secretory!pathway!of!many!
mammalian!cell!lines,!but!not!specifically!that!of!CHO!cells.!As!such,!compounds!

















Many! secretory! pathway! proteins! have! family! members! present! within! other!
transport!pathways!(e.g.!endocytosis).!Due!to!the!similarity!of!these!proteins!and!















due! to! an! increase! in! molecular! components! of! the! COPI! pathway! as! well! as!
potentially! enhancing! surrounding! secretory! pathways! and! components.!





and! other! effector!molecules! to! the! cis=Golgi!membrane,! creating! a!membrane!
region!from!which!vesicle!formation!and!budding!can!occur!(Beck!et!al.!2009).!!
!
Arf1! activity! is! regulated! by! Arf=GEFs! (generally! activating)! and! Arf=GAPs!
(generally! deactivating).! The! Golgi=specific! Brefeldin! A=resistance! factor! GEF! 1!
(GBF1)!is!a!peripheral!Arf=GEF!associated!with!formation!of!COPI!vesicles!at!the!
Golgi! (Beck! et! al.! 2009;! Niu! et! al.! 2005).! The! nucleotide! exchange! activity! of!
Golgi=related! Arf=GEFs! is! catalysed! by! a! well! conserved! central! Sec7! domain!
(Chardin!et!al.!1996;!Jackson!and!Casanova!2000).!Many!drugs!target!this!region!
which,!when!blocked!by!molecular!binding,! stops! the!GEF! interacting!with!and!
activating!its!requisite!Arf!(Mansour!et!al.!1999;!Saenz!et!al.!2009).!!
!









more! targeted! effect! to! that! of! BFA.! These! could! be! used! to! treat! CHO! cells! to!
modify! the! CHO! secretory! pathway! with! a! view! to! enhancing! CHO! secretory!
capacity.!A!summary!of!these!compounds!can!be!found!in!table!5.1.!
5.2.1.1.&Brefeldin&A&(BFA)&




at! the! Golgi,! COPII=component! recycling! to! the! ER! and! intra=Golgi! transport!
(Claude!et!al.!1999;!Guillemain!and!Exton!1997;!Mansour!et!al.!1999;!Orci!et!al.!




BFA=resistant! CHO! cell! lines! have! previously! been! developed! and! shown! to!
generally!be!genetically!stable!with!their!resistance!not!due!to!BFA!degradation!







cell! species! type,!with! BFA! functional! in! reducing! CHO! cell! growth! (Orci! et! al.!
1991;!Torii!et!al.!1995),!but!ineffective!within!some!mammalian!cell!lines!such!as!
MCDK!canine!cells.!This!is!likely!due!to!differences!in!GBF1’s!Arf=binding!site!in!
these! cells! (Boal! et! al.! 2010;! Hunziker! et! al.! 1991;! Prydz! et! al.! 1992).! Sec7=
localised!mutations! have! also! been! shown! to! alter! the! BFA! resistance! of! yeast!
cells!(Peyroche!et!al.!1999).!Were!this!type!of!point!mutation!to!be!an!outcome!of!
the! evolutionary! process! it! would! most! likely! result! in! a! BFA=resistance!
phenotype! but! without! the! desired! enhanced! secretory! or! productivity!
phenotype.!
!
In! human! cells! BFA! is! pleiotropic,! targeting! and! inhibiting! at! least! 3! Arf=GEFs!
(GBF1,!BIG1!and!BIG2)!that!activate!Arf1!proteins!involved!in!vesicle!formation!
and!as!such!BFA!treatment! impacts!upon!endocytosis!at! the!plasma!membrane!
(Torii! et! al.! 1995).! That! some! BFA=resistant! cell! lines! can! maintain! Golgi!
structure! but! are! unable! to! grow! in! the! presence! of! BFA! further! suggests! that!
BFA! has! multiple! organelle=specific! targets! (Yan! et! al.! 1994),! whilst!
overexpression! of! GBF1! has! been! shown! to! facilitate! CHO! cell! growth! in! the!
presence!of!BFA! (Claude! et! al.! 1999).!Treatment! of!mammalian! cells!with!BFA!







However! it! is! likely! to! function! through! blocking! Arf! interactions! with! coat!
complexes,!possibly!acting!as!an!Arf=GAP!(Feng!et!al.!2003).! Instead!of!directly!
inhibiting!an!Arf=GEF,!it!is!believed!to!stimulate!an!Arf=GAP!(Pauloin!et!al.!2016),!
deactivating! Arf! and! therefore! inducing! the! disassociation! of! Arf1! from! Golgi!
membranes.! Exo1! treatment! inhibits! traffic! from! the! ER! and! induces! a! rapid!
collapse!of!the!Golgi!to!the!ER,!but!with!a!reduced!effect!upon!TGN!organisation!
compared!to!BFA.!Unlike!BFA,!Exo1!does!not!directly!interfere!with!Arf=GEFs!or!
fatty! acid! exchange! activity! of! other! BFA=target! genes! (such! as! BIG1/2)! so!
therefore! would! have! fewer! pleiotropic! effects.! Exo1! treatment! of! many! cell!
types! (including! CHO)! saw! the! blocking! of! VSVG=GFP! exit! from! the! ER,! with!
treatment! at!20!μM!killing!50%!of! the! cell! population.!Treatment!with!Exo1! is!












little! effect! on! endocytosis.! Like!Exo1! and!BFA! it! blocks! anterograde! transport!
from!the!ER!to!the!Golgi!(Mishev!et!al.!2013)!and!completely!disrupts!the!Golgi.!
Unlike! BFA! it! has! minimal! effect! on! the! TGN,! retrograde! transport! and! the!
endocytic!pathway!(Boal!et!al.!2010;!Guetzoyan!et!al.!2010),!although!retrograde!
transport!of!toxin!proteins!in!Exo2=treated!cells!varies!depending!upon!the!toxin!




due! to! steric! hindrance! being! antagonistic! against! GBF1! but! not! BIG1/2.! It!
induces! Golgi! disassembly! in! cells! unaffected! by! BFA! (e.g.!MDCK! canine! cells),!
whilst!treatment!of!HeLa!cells!resulted!in!a!decrease!in!Arf!activation!leading!to!a!
loss!of!COPI!components!from!Golgi!membranes,!Golgi!collapse!and!blockage!of!




Golgicide& A& (GCA)! is! a! Sec7! inhibitor,! with! GCA! treatment! of! human! cells!
inhibiting!GBF1!function!leading!to!disassociation!of!COPI!coat!proteins!from!the!
Golgi! membrane! and! Golgi/TGN! disassembly,! halting! protein! secretion! and!
causing!protein!aggregation!at!the!ERGIC,!with!GBF1!relocating!from!cytoplasmic!
vesicles! to! the! fragmented! Golgi! (Kraemer! et! al.! 2013;! Saenz! et! al.! 2009).!
However,!GCA!treatment!of!BHK!and!canine!cells!did!not!match!the!response!of!
human! cells,! suggesting! that! GBF1! in! some! cell! lines! is! not! affected! by! some!
drugs! that! target! it,! including! in!hamster=derived!cell! lines.!As!such,!changes! in!




AG1478! inhibits! GBF! and! has! a! lower! cytotoxicity! than! BFA,! selectively! and!
reversibly! targeting! the!cis=Golgi! in!human!cells!whilst!not!affecting!endosomal!
compartments,! the! cytoskeleton,!Golgi! structure,! internal! cell! pH!or!ATP! levels!
and!not!impacting!upon!cell!survival!(Pan!et!al.!2008).!LM11!impairs!targets!the!
interaction! between! Arf1! and! ARNO=GEF,! producing! a! nonfunctional! Arf1=
GDP/ARNO!complex,!impairing!Arf=dependent!trafficking!structures!at!the!Golgi,!
including!endosomal!trafficking!(Mishev!et!al.!2013;!Viaud!et!al.!2007).!AMF(26!














FLI=06! is! a! dihydropyridine! that! affects! the! secretory! transport! of! both!
transmembrane!and!secretory!proteins!in!HeLa!cells,!inhibiting!general!secretion!
at! an! unknown! step! prior! to! cargo! exiting! the! ER.! In! FLI=06=treated! cells,!
recruitment!of!cargo! to!ERES! is!greatly!reduced,!but! the!continued!presence!of!
ERES!markers!suggests!FLI=06!functions!prior!to!the!ERES!and!does!not!impact!
upon! COPII! vesicle! budding,! instead! acting! upon! cargo! recruitment.! It! also!
inhibits! export! from! the!TGN! (Yonemura! et! al.! 2016).! FLI=06!does!not! interact!
with!GBF1!but!is!shown!to!completely!disrupt!both!the!cis=!and!trans=Golgi!whilst!
not! affecting! endocytosis! or! tubulating! endosomes.! Treatment! changes! ER!
morphology!from!a!tubule!to!a!sheet!but!does!not!result!in!ER=Golgi!fusion!or!a!




The! antibiotics& Monensin! and! Nigericin! incorporate! in! to! the! trans=Golgi!
membrane,!mediating!H+/Na+! or! K+/H+! exchange! respectively,! neutralising! the!
Golgi!lumen!leading!to!Golgi!stress!and!cisternael!osmotic!swelling!This!inhibited!
protein! transport! from! the! Golgi! (with! proteins! accumulating! in! vesicles! and!
storage!bodies),!the!cell=surface!expression!of!surface!proteins!and!the!reduction!
of! effective!protein!glycosylation! (Dinter! and!Berger!1998;!Misumi!et! al.! 1986;!
Miyata!et!al.!2013;!Oku!et!al.!2011;!Tartakoff!1983).!!
!
Secramine& B! inhibits! activation! and! membrane=binding! of! the! Rho! GTPase!
Cdc42,! which! is! essential! for! vesicle! transport,! halting! Golgi=to=PM! vesicle!
trafficking!and!perturbing!Golgi=PM!protein!transport!without!an!obvious!impact!




Dispergo! induces! reversible! ER! structure! changes! in! HeLa! and! CHO! cells,!
resulting! in! Golgi! cisternae& loss& and! tubulation,! preventing! ER=Golgi! transport!
and!cargo!loading!at!the!ER.!(Ivanov!2014;!Lu!et!al.!2013).!Okadaic&acid!inhibits!
serine/threonine!phosphatases,!reducing!amylase!secretion!by!up!to!90%!in!rat!









There! are! many! drugs! that! target! Arf=GEFs! in! modes! similar! to! that! of! BFA.!
Whilst! BFA! is! non=specific,! targeting! three!Arf=GEFs! (GBF1,! BIG1/2),! there! are!
plenty!of!molecules!that!target!only!GBF1.!However!BFA!may!still!prove!a!useful!
evolutionary!agent!as! its!mode!of! action! is! relatively!well! characterised!and!as!
such!it!could!be!used!as!a!control!compound.!Like!BFA,!LM11!also!impacts!upon!
endocytosis! so! is! not! suitable.! AMF=26! directly! induces! apoptosis! and! inhibits!
cell!growth!GCA!and!AG1478!have!been!shown!not!to!work!in!rodent!cell!lines!so!
are!not!suitable!for!work!with!CHO.!As!a!specifically!designed!compound,!LG186!
is! not! available! commercially.! Therefore,! to! replicate!BFA’s! actions!whilst! only!





range! of! secretory! and! ER! stress! pathway! regions! targeted.! Monensin! and!
Nigericin!both!induce!Golgi!stress!through!altering!its!H+!profile!and!not!through!
a! specific! section! of! the! secretory! pathway,! so! are! not! entirely! suitable! for!
specific! secretory! pathway! targeting.! Okadaic! acid! impinges! upon! protein!
secretion,! but! also! protein! synthesis! and! therefore! is! unsuitable.! Dispergo! and!
Secramine! B! are! both! potential! evolutionary! agents,! targeting! ER=Golgi! and!




unknown,! it!has!been!shown! to!work! in!many!different! cell! lines!and! targets!a!
similar!part!of!the!secretory!pathway!as!BFA/Exo1!and!2,!but!at!a!different!point!
–!COPII!vesicle!cargo!loading!rather!than!COPI!component!recycling!–!and!will!be!





































Golgi! transporting! of! H+!
and!Na+/K+!!













Arf1!disassociation! from!Golgi.! Collapse!of! the!































Inhibits! GBF1,! inhibiting! Arf1! function! and!
therefore! COPI! vesicle! formation.! Transported!





















Exerts! numerous! effects! on! protein! secretion!
and!Golgi!morphology;!




















Impacts! cargo! loading! at! ERES! without!
impacting! COPII! release.! Changes! ER!
morphology! from!a! tubule! to!a!sheet.!Disrupts!
cis/trans! Golgi! without! impacting! upon!


















Targets! cis8Golgi! whilst! not! affecting!
endosomal! compartments,! the! cytoskeleton,!
internal! cell! pH! or! ATP! levels.! AG1478!
reversibly!disrupts!the!Golgi;!
Does!not!work!in!rodent!cells.!










Inhibits! Golgi! to! PM! trafficking.! Stops! Cdc42’s!









Loss! of! ER! cisternae! and! extensive! ER!













Induces! Golgi! disruption! by! targeting! the!














some! regions! of! the! endocytic! pathway,! its! inhibition! of! ERBGolgi! transport! via!





















Literature! suggested! that! Exo2! impacts! upon! cell! function! and! Golgi! structure,!
through! Arf! inhibition,! at! a! concentration! of! 50! μM.! At! this! concentration! Exo2!
was! shown! to! instigate! Golgi! collapse! into! the! ER! with! little! effect! upon! the!
endocytic!pathway!in!monkey!BSC1!cells!(Feng!et!al.!2004).!In!HeLa!cells,!the!same!
concentration! resulted! in! statistically! significant! Arf! inhibition,! which! was! not!
seen!at!10!μM!(Boal!et!al.!2010;!Spooner!et!al.!2008),!whilst! in!Arabidopsis!plant!
cells! a! higher! concentration! (200! μM)! of! both! Exo2! and! its! derivatives! did! not!
result! in!ER!or!Golgi!morphological!changes!(Sorieul!et!al.!2011).!An!initial!Exo2!




impact! upon! CHO! cell! growth! at! 100! μM! Exo2! (data! not! shown).! Exo2!






staining!with! antibodies! against! the!Golgi!markers! Stx5! and!GM130! (staining! of!
AP1!was! also! performed! but! did! not!work! as!well),! using! the! staining! protocol!
described! in! section! 2.7.1/Table! 2.3.!MedIBCHO! cells!were! treated!with! 200! μM!
Exo2,! DMSO! at! the! same! volume! (negative! control)! and! 10! μM! BFA! (positive!
control)!at!room!temperature! for!30!mins!before!being! fixed,!permeabilised!and!
stained!with! antiBStx5! and! –GM130! primary! antibodies! and! relevant! secondary!
antibodies!before!imaging!by!microscope!(figure.!5.2!b).!Each!drug!treatment!was!











is! still! visible! and! there! is! no! dispersal! as! is! seen! in! the! BFABtreated! positive!
control.!!
!











agent!with!which!to! treat!CHO!cells.!This!may!be!due!to!a!difference! in! the!Sec7!
binding!pocket! (that!BFA!binds)!within!CHO!cells! compared! to!human/monkeyB
derived! cell! lines.! High! concentrations! of! Exo2!were! shown! to! not! impact! upon!
plant!cell!morphology!and!this!may!be!for!a!similar!reason!(Sorieul!et!al.!2011).!It!
was! decided,! having! used! Exo2! concentrations! 6Bfold! higher! than! that! seen! to!
have! a! definitive! effect! upon! CHO! cell! growth! and! morphology,! that! higher!






There! was! less! literature! upon! which! to! base! Exo1! experimentation! when!
compared! to! that! for!Exo2.!Literature!suggested! that!Exo1! inhibited!mammalian!
cell!function!through!inhibition!of!exocytosis!with!an!IC50!of!approximately!20!μM,!
with! 100! μM! Exo1! completely! halting! ERBGolgi! transport! of! VSVGBGFP! in! BSC1!
monkey!cells!(Feng!et!al.!2003).!As!such,!an!initial!kill!curve!between!20!B!100!μM!












Due! to! the! lack! of! effect! Exo1! treatment! has! upon! CHO! cell! growth! at!
concentrations!previously!shown!to!have!an!effect!upon!mammalian!cell!growth!
and!morphology,!combined!with!the!knowledge!that!Exo1!targets!the!same!region!
of! the!secretory!pathway!as!Exo2!which!also!did!not! impact!upon!cell!growth,! it!





MedI-CHO1 was1 treated1 with1 the1 secretory1 blocking1 agent1 Exo21 at1 varying1 concentrations1 to1



















As! with! Exo1,! there! is! much! less! literature! information! regarding! FLIB06!
compared!to!Exo2!or!BFA.!FLIB06!was!shown!to!function!at!10!μM!in!HeLa!cells,!
informing!an!initial!kill!curve!between!0!B!20!μM!(Kraemer!et!al.!2013;!Yonemura!
et! al.! 2016).! Even! at! the! lowest! concentration! of! 2.5! μM,! cell! growth! was!
completely!halted!(data!not!shown)!so!proceeding!kill!curves!were!performed!in!





even! a! small! increase! has! a!measureable! effect,!with! cell! growth! being! severely!






change! compared! to! the! growth! of! the! untreated! control! and! linear! regression!











To! determine! the! effect! FLIB06! had! upon! CHO! cell!morphology,!MedIBCHO! cells!
were!treated!with!0.1!μM!FLIB06!for!30!min!before!being!fixed,!permeabilised!and!
stained! with! antibodies! against! GM130! and! Calreticulin! (ER! marker)! before!
imaging.! Images! show! that! FLIB06! treatment! had! little! impact! upon! Golgi!
morphology! but! that! ER! morphology! does! appear! to! change! upon! FLIB06!
treatment!when! compared! to! untreated! control! cells.! Even! at! the! relatively! low!




The! combination! of! kill! curves! and!microscopy! show! that! FLIB06! has! an! impact!
upon!CHO!cell! growth!as!well! as! the!morphology!of! the! secretory!pathway.!FLIB
06’s! functionality! in! CHO! cells,! corroborated! by! information! from! the! literature!
! 199!












Growth! rate! (not! shown),! change! in! IVCD! over! the! course! of! cell! growth! and!
viability! measurements! show! that! BFA! has! a! large! impact! on! CHO! cell! growth!
between!1!and!1.5!μM!(figure!5B5!a).!Fold!change!in!IVCD!values!compared!to!the!





5B5! b).! Linear! regression! produced! an! r2! value! of! 0.95,! showing! the! linear!
relationship!between!BFA!concentration!(between!0!and!1.5!μM)!and!cell!growth,!




fixed,! permeabilised! and! stained! with! antibodies! against! GM130! and! the! BFA!
target! molecule! GBF1.! Imaging! shows! that! when! treated! with! BFA! the! Golgi!
structure!within!CHO!cells,! is!dispersed,!with!both!GM130!and!GBF1!being!more!
scattered!throughout!the!cell!when!compared!to!the!tight!Golgi!structure!seen!in!
the!untreated! control! cells! (figure!5B5! c).!That!GBF1! is!no! longer!Golgi! localised!
suggests!that!COPI!vesicle!formation!at!the!membranes!of!Golgi!cisternae!can!not!









Linear1 regression1 analysis1 of1 IVCD1 change1 kill1 curve1 fold1 change1was1 used1 to1 determine1 FLI-061LD1






These! growth! and!morphology! data,! alongside! prior! knowledge! from! literature,!
suggest! that!using!BFA! to!direct!evolution!of! the!CHO!secretory!pathway!should!
result! in!changes!within! the! intracellular! transport!pathway! in!CHO!cells.!Whilst!
BFA!targets!are!not! limited!to!being!involved!in!anterograde!secretory!transport!
(specifically! the! BIG1/2! ArfBGEFs! involved! in! endocytosis),! offBtarget! effects!
should! not! impact! too! heavily! upon! cell! growth! and! other! regions! of! the!
biosynthetic!pathway.!As!BFA!is!the!most!well!researched!of!the!previously!listed!
secretory!blocking!agents! (table!5B1),! it!will!also!provide!a!positive!control!with!









0.75! 25! 0.132! 0.478!
0.50! 50! 0.194! 0.850!
0.25! 75! 0.256! 1.222!
0.00! 100! 0.318! 1.594!
!
The1lethal1dose1(LD)1in1MedI-CHO1cells1for1FLI-061and1BFA1is1shown.1LD1values1were1determined1as1the1
drug1 concentration1 at1 which1 25,1 501 and1 75%1 of1 the1 cell1 population1 is1 killed.1 IVCD1 was1 used1 as1 a1
measure1 of1 this1 effect1 upon1 CHO1 growth.1 IVCD1 levels1 of1 the1 kill1 curve1 were1 compared1 to1 that1 of1
untreated1control1cells.1If1a1concentration1had1a125%1effect1on1growth1(LD25),1it1resulted1in1an1IVCD1
that1 was1 75%1 that1 of1 the1 control.1 Similarly1 an1 LD751 corresponded1 to1 a1 75%1 reduction1 in1 IVCD1






and1 morphology.1 [a]1 Kill1 curve1 measuring1 BFA1 effect1 on1 cell1 growth1 and1 viability1 at1 increasing1
concentrations1 [b]1 Linear1 regression1 analysis1 of1 IVCD1 change1 fold1 change1 from1 untreated1 cells1 to1
determine1 BFA1 LD1 levels.1 [c]1 Golgi1 staining1 of1 BFA1 treated1MedI-CHO1 cells1 with1 GM1301 and1 GBF11
antibodies1 shows1BFA1 treatment1 results1 in1Golgi1dispersal.1Each1data1point1 shows1mean1average1of1




5.4.$ Directed$ evolution$ of$ CHO$ secretory$ pathway$ against$
secretory$blocking$compounds$
Parental!MedIBCHO!cells!(4!passages!out!of!vial)!were!grown!in!the!presence!of!the!
selected! secretory! blocking! compounds.! Cells! were! grown! in! 10! mL! culture!
volumes! in! Cultiflasks! (section! 2.1.2.1).! Concentration! of! compounds! was!
determined! from! the! initial! kill! curve! data! shown! above.! Cells! were! initially!
treated!with!a!low!concentration!of!the!compound!until!growth!rate!and!viability!
levels! recovered! to! parental! levels.! After! stabilisation! at! this! concentration,!
compound! concentration! was! increased! with! this! process! repeated! until! cell!
growth!had!recovered!in!the!presence!of!1.0!μM!of!the!evolutionary!compound!(as!
described!in!figure!5B1).!On!occasions!where!cell!growth!was!greatly!impeded!by!
compound! presence,! passage! length!was! extended! to! 5B7! days! and! cell! seeding!
density! increased! to! 0.4! x! 106! cells! mLB1! where! necessary.! PostBevolution! cell!
banks! were! produced! which! were! then! transfected! (transient! and! stable)! with!
model!Mabs! to!ascertain! the!productivity!capacity!of! the!evolved!cell! lines.!Cells!
staining!and!Western!blotting!was!carried!out!to!better!define!any!morphological!





of! an! stably! producing! cell! line!would! not! allow! this! flexibility.! Furthermore,! as!











pressure! for! 3B4! passages.! MedIBCHO! cells! was! used! as! a! control! cell! line.! The!
effect! of!BFA!evolution!upon! the!productivity,! growth!and!morphology!of!MedIB






BA! in! the! presence! of! 1! μM! BFA! after! passage! 1.! Transient! transfection!
(nucleofection)!of!both!cell!lines!with!GFP!(pMAX,!Lonza)!was!performed!and!cells!
grown! for! 4! days! under! standard! cultiflask! conditions! (i.e.! no! BFA! present! in!
MedIBBA! cells).! Cell! samples! (1!mL)!were! taken! for! analysis! by! flow! cytometry,!
with! nonBtransfected! cells! used! as! a! negative! gating! control.! Analysis! showed!




To! determine! productivity! levels! of! MedIBBA! compared! to! MedIBCHO,! both! cell!
lines!were!transiently!transfected!(via!nucleofection)!with!plasmid!DNA!encoding!
ETE! and! DTE! model! Mabs! (section! 2.5.1)! before! growth! in! 10! mL! standard!
cultiflask! culture! for! four! days.! Growth! data! was! collected! and! supernatant!
samples!taken!for!titre!analysis,!performed!with!the!Valita™TITER!HS!assay!plate!
(section! 2.6).! Each! cell! line! was! separately! transfected! three! times! to! provide!
three! biological! replicates,! with! three! supernatant! samples! from! each! cell! line!
analysed!in!triplicate.!Titre!and!Qp!values!show!that,!for!both!ETE!and!DTE!Mabs,!




Mab,!where!MedIBCHO! is!1.61B! (overall! titre)!and!2.0Bfold! (Qp)!more!productive!
than!MedIBBA.!!
!
When! expressing! both! ETE! and! DTE! Mabs,! the! growth! rate! of! MedIBBA! was!
significantly!higher!than!that!of!MedIBCHO!by!1.18Bfold,!with!no!difference!in!cell!
viability.! It! is! likely! that! this! is! due! to! the! removal! of! BFA! from! the! MedIBBA!
culture! conditions,!which!was! seen! to! result! in! a! slight! increase! in! growth! rate!




Transient!expression!of!a!recombinant!Mab! is!a!good! indicator!as! to!a!cell! line’s!
production! characteristics! when! stably! expressing! the! same! recombinant! gene!
(Daramola! et! al.! 2014).! However,! analysing! productivity! within! a! stable! pool!
allows!more! robust! conclusions! to! be!made! regarding! a! cell! line’s! performance!
capabilities.!The!selection!and!amplification!process!required!in!the!production!of!
stable! pools! ensures! all! cells! within! the! population! are! expressing! the!






After1 41 days’1 growth1 supernatant1 and1 cell1 growth1 samples1 were1 taken1 and1 titre1 determined1 by1
Valita™TITER1HS1assay.1[a,1b;1d,1e]1Productivity1of1the1parental1cell1line1was1greater1than1that1of1the1
evolved1cell1 line1when1comparing1both1titre1and1Qp1of1both1DTE1and1ETE1Mabs.1[c,1 f]1This1is1despite1
MedI-BA1 growing1 quicker1 than1MedI-CHO1 post-transfection.1 Titre1 and1 Qp1 data1 shows1 the1mean1 of1
three1technical1replicates1(repeats1of1Valita™TITER1analysis)1of1each1of1the1three1biological1replicates1




















































































normally! distributed! with! regards! to! Mab! production.! The! higher! level! of!!




a! clonallyBderived!population,!allows! for!much!quicker!production!of! the! stablyB
producing!cell!line,!as!well!as!allowing!data!on!an!entire!population!of!cells!to!be!
collected,!not!just!data!from!a!stablyBexpressing!cell!line!derived!from!the!highestB
producing! singleBcell! clone! of! each! pool.! ! This! would! therefore! allow! a! better!
measure!of!the!directed!evolutionary!process’s!true!effect.!
5.4.2.3.&Production&of&stable&pools&from&standard&expression&vector&
StablyBexpressing! pools! were! created! from! MedIBCHO! and! MedIBBA! cell! lines,!
expressing! ETE! and! DTE! Mabs! from! linearised! standard! plasmid! DNA! (that! is,!
DNA!encoding!just!the!Mab!and!a!GS!selection!marker;!section!2.4).!Cell!lines!were!
revived! and! passaged! alongside! each! other! for! comparison! purposes.! Plasmid!
DNA!was!linearised!by!restriction!digest!with!PVUI!endonuclease!and!purified!by!
phenolBchloroform!extraction!and!ethanol!precipitation!(section!2.4.4).!Linearised!
DNA! was! introduced! in! to! cells! by! cuvette! nucleofection! (section! 2.5.3).!
Transfected! cells!were! resuspended! in! 40!mL!warmed! CDBCHO!which!was! split!
across!8!x!5!mL!cultures,!each!in!a!separate!T25!flask!which!was!incubated!at!37!








and,! for!evolved!cell! lines,!1!μM!BFA!from!the!start!of!passage!2.!Cell! lines!were!
passaged!as!normal,!with!samples!taken!for!cell!growth!calculations!to!ensure!cell!
lines!were!growing!as!expected!and!similarly!to!each!other,!such!that!they!could!




passage)! so! once! growth! data! was! accounted! for! productivity! values! could! be!
compared! directly.! Once! cells! had! reached! 30! generations! of! growth! out! of! the!
vial,! cultures!were! left! for!10!days!so!an!overgrow!study!(cells!cultured!until!all!
nutrients! have! been! taken! up! and! all! cells! have! died)! could! be! performed,!with!
growth!and!productivity!samples! taken!on!day!10!of!culture!so!productivities!of!
pools’! entire! growth! cycles! could! be! compared.! Supernatant! samples! were!
analysed! by! Valita™TITER! Mab! assay! plate! (section! 2.6).! Each! sample! was!
! 207!
repeated! three! times! on! the! same! Valita™TITER! plate! so! as! to! provide! three!
technical!replicates!of!each!biological!replicate.!Growth!and!specific!productivity!
values!were!calculated!using! the! titre!values!and!growth!data!collected!(for!G30!
samples! only,! as! these! cultures! have! only! been! in! a! growth! phase! whereas!
overgrow!cultures!have!passed!through!exponential,!stationary!and!death!phases!







This! shows! there! was! no! initial! growth! difference! between! the! two! cell! lines!
(figure!5B7!a,!b).!However,!after!the!selective!pressure!of!BFA!was!returned!to!the!
MedIBBA! pool! (passage! 5),! both! the! growth! rate! and! viability! of!MedIBBA!were!
reduced!when!compared!to!that!of!MedIBCHO,!with!both!growth!rate!and!viability!





The!mean! average! titre! from!MedIBCHO!G30!ETE! stable! pools! (from! cultures! in!
exponential!phase)!was!in!the!range!of!25!mg/L.!In!MedIBBA!cells,!this!dropped!to!
around!10!mg/L,!a!0.4Bfold!change!in!titre!when!compared!to!the!parental!cell!line!
(figure! 5B7! c).! This! result! is! replicated! in! the! Qp! data,! with! the! parental! line!
producing!an!average!of!1.5!pg!cellB1!dayB1!compared!to!0.5!pg!cellB1!dayB1!from!the!
evolved! cell! line,! a! 0.31Bfold! change! (figure! 5B7! d).! Finally,! over! a! 10Bday!




As! in! the! ETEBexpressing! stable! pools,! the! growth! of! pools! derived! from! both!
MedIBCHO!and!MedIBBA!recover!at!a!similar!rate!to!each!other!over!the!initial!10!
generations! of! shaken! culture! (figure! 5B8! a,! b),! with! growth! rate! and! viability!
levels! of!MedIBBA! again! reducing! slightly! upon! reBintroduction! of! BFA! selective!
pressure! at! passage! 5.! This! disparity! disappears! within! approximately! 7!
generations,! whereas! in! ETEBexpressing! pools! closer! to! 15! generations! were!







BFA-evolved1 and1 non-evolved1 CHO1 cells1 were1 stably1 transfected1 with1 an1 ETE1 model1 Mab1 and1 cell1
growth1 recovered1 in1 shaken1 culture1 for1 301 generations.1 [a,1 b]1 Stable1 pool1 growth1 was1 tracked1 to1
compare1cell1recovery1between1different1pools.1 [c,1d]1Titre1samples1taken1at1G301showed1that1MedI-
CHO1 cell1 line1 productivity1 out-performed1 that1 of1 MedI-BA.1 [e]1 At1 G301 10-day1 batch-overgrow1 was1




































































































































































































Due! to!MedIBBA!slightly!outBgrowing!MedIBCHO,!as! cells! reached!30!generations!






As! expected! there! appears! to! be! little! difference! in! cell! growth! between! stablyB
expressing! pools! derived! from! either! parental! or! evolved! lines,! as! evolved! cells!
have! recovered! their! growth! ability! in! the! presence! of! BFA! selective! pressure.!
However,! due! to! the! evolved! cells! having! been! exposed! to,! and! developing!
resistance!to,!an!ER!stress!inducing!compound!(aside!from!its!secretory!blocking!




proteins,! its! cell! growth! when! faced! with! the! extra! metabolic! burden! of! Mab!
production!is!unlikely!to!be!greatly!impacted.!
!
In! both! ETE! and! DTEBexpressing! pools,! productivity! data! shows! a! statistically!
significant!decrease!in!Mab!production!levels!–!both!titre!and!specific!productivity!
–! in!MedIBBA!when! compared! to! the!MedIBCHO.! However,! this! data! does! come!
with!some!caveats.!The!production!of!stable!pools!using!standard!plasmids!allows!
for! random!plasmid! insertion! into! the!CHO!cell! genome.!This! insertion! could!be!
into! a! region! with! reduced! genetic! activity! (e.g.! a! region! of! heterochromatin)!
where! regions! of! the! transgene! can! be! modified! (e.g.! methylation! of! CMV!
promoter),!reducing!productivity!(Yang!et!al.!2010).!!
!















BFA-evolved1 and1 non-evolved1 CHO1 cells1 were1 stably1 transfected1 with1 a1 DTE1 model1 Mab1 and1 cell1
growth1 recovered1 in1 shaken1 culture.1 [a,1 b]1 Stable1 pool1 growth1 was1 tracked1 to1 compare1 recovery1
across1different1pools.1[c,1d]1Titre1samples1taken1at1G301showed1that1MedI-CHO1out-performed1MedI-
BA1in1terms1of1both1titre1and1Qp.1[e]1At1G301a110-day1batch-overgrow1showed1that1over1the1course1of1a1















































































































































































































assay! the! transcriptional!activity!of! the!recombinant!gene!across!all!pools,!using!
this! information!would!only!normalise! the!data! for! transcriptional! activity,!with!
no!consideration!made!for!other!factors!(e.g.!translational,!postBtranslational)!that!
would! impact! the! Mab! productivity! levels! of! a! population! pool.! However,! by!
producing!stable!pools!in!which!the!transcription!level!can!be!assumed!to!be!very!
similar!(if!not!the!same)!across!all!replicates!and!cell!lines,!all!results!are!naturally!
controlled! for! in! terms! of! transcriptional! activity,! allowing! data! to! be! analysed!
with!much! less!doubt! than!retrospective!normalising! to! results! from!an!entirely!
separate!experiment!such!as!qPCR.!
!
There! are! two! main! ways! of! ensuring! recombinant! genes! are! inserted! into! a!
region!of!the!genome!with!the!same/similar!levels!of!transcription!activity.!Use!of!
a! site! specific! targeted! integration! (TI)! system!allows! a! recombinant! gene! to!be!
inserted,! using! a! ‘landing! pad’,! into! a! known! and! highly! active! region! of! the!
genome.!Use!of!a!TI!also!ensures!only!one!copy!of!the!gene!is!present!within!each!
cell,! resulting! in! a! more! homogenous! population! (Lee! et! al.! 2015).! With! a! TI!
system! not! available! for! use,! stable! pools! were! produced! using! a! plasmid!
containing! a! transcription! enhancing! element! (TEE).! A! TEE! ensures! the! stable!
transcriptional! activity! of! the! transgene! upon! its! insertion! into! the! genome,!
reducing! transgene! silencing! and! allowing! for! stable,! consistent! and! highBlevel!
gene!expression!(Saunders!et!al.!2015).!Plasmid!DNA!is!still!randomly!integrated,!
with! copy! numbers! varying! between! cells,! but! the! transcription! levels! of! each!
insert! are! the! same! across! a! population! in! which! the! transcript! levels! of! the!
recombinant! product! can! be! assumed! to! be! somewhat! heterogeneous,! but!
normally!distributed.!!
!
MedIBCHO! and! MedIBBA! cell! lines! were! both! transfected! with! two! separate!
linearised!plasmids,!one!encoding!an!ETE!model!Mab,!the!other!a!DTE!model!Mab,!
with!both!plasmids!contained!the!aforementioned!TEE!alongside!the!Mab!and!GS!
genes.! The! model! Mabs! used! were! the! same! as! those! used! to! create! previous!
stable! pools.! Stable! pool! production! was! carried! out! as! described! previously!
(sections! 2.4.4;! 2.5;! 5.4.2.3).! For! each! cell! line/vector! combination! tested,! three!
separate! transfections! were! carried! out! to! provide! three! biological! replicates.!
Transfections! with! normal! plasmids! were! also! performed! out! to! control! for!
differences! in!productivity! and!growth! levels!produced!by! the!different! types!of!
plasmid!vector.!Initial!productivity!data!was!taken!at!the!end!of!passage!one!so!as!
to! screen!all!pools! to!decide!which!were! to!be! taken! forward.!This!data!showed!
that!at!this!early!stage,!TEEBcontaining!stable!pools!had!higher!production!levels!
! 212!
than! those! produced!with! normal! vectors! (figure! 5B7,! 5B8),!with! TEE!ETE! titres!
exceeding! 200! mg/L! compared! to! approximately! 30! mg/L! in! normal! plasmid!
pools!(figure!5B9).!!
!
Use! of! a! TEE! also! provides!more! reproducible! data! across! biological! replicates,!
with!minimal!difference! seen!across!TEE!pools! compared! to!as!much!as!a!5B10B
fold! difference! between! top! and! bottom! producing! nonBTEE! pools! (data! not!
shown).! Whilst! this! is! due! in! part! to! more! of! the! TEE! pools! recovering! fully,!
resulting!in!more!data!points!being!available!with!which!to!calculate!spread!about!
the! mean,! the! titre! and! Qp! values! of! biological! replicates! were! much! more!
reproducible!in!TEE!pools!compared!to!nonBTEE!pools,!the!latter!often!having!one!
pool!which!far!outBperformed!its!replicates,! likely!an!artifact!of!random!genomic!
integration.! Taking! approximately! two! weeks,! recovery! of! TEE! pools! to! static!
culture!confluency!was!quicker!and!more!standardised!across!replicates!than!that!
of!nonBTEE!pools,!a!trait!again!due!to!the!open!genetic!conformation!of!the!TEEB















comparison! of! growth! and! productivity! of! MedIBBA! and! MedIBCHOs! could! be!
made.! For! the! productivity! curves! BFA! selective! pressure! was! removed! from!
MedIBBA! cell! lines,! whilst! MSX! selective! pressure! was! maintained! across! all!
cultures.! Cell! growth! and! productivity! samples! were! taken! every! 2! B! 3! days!






without1 a1 TEE1 to1 better1 control1 transgene1 transcription1 levels.1 Data1 is1 taken1 from1 pool1 screening1
samples1taken1at1the1end1of1passage111of1shaken1culture.1[a,1c]1Stable1expression1of1both1ETE1and1DTE1
from1a1TEE-containing1plasmid1resulted1 in1consistently1higher1 titres1 than1 from1non-TEE1containing1























































































































































































IVCD!of! both!MedIBBA! and!MedIBCHO! cell! lines! are! comparative.!However,! once!
beyond!this!point!the!growth!of!the!two!cell!lines!diverge,!with!MedIBBA!reaching!
a! higher! cumulative! IVCD! than!MedIBCHO! at! the! end! of! culture! (figure! 5.10! d).!
Likewise,!MedIBBA!maintains!healthy!viability!levels!(above!95%)!to!day!8!before!
the! culture! enters! its! death! phase,!whilst! a! small! drop! in!MedIBCHO! viability! is!






Despite! this! enhanced! level! of! growth,! the! overall! ETE! titre! level! of!MedIBBA! is!
much! less! than! that!of!MedIBCHO.!MedIBBA!reaches!a!peak! titre!of!650!mg/L!on!
day! 7,! compared! to! MedIBCHO’s! 1085! mg/L! at! the! same! timeBpoint,! which!
increases!to!a!maximum!of!1167!mg/L!on!day!10!(figure!5B8!d).!The!difference!in!
both! growth! and! productivity! results! in! MedIBBA! cells! having! a! large! deficit! in!





grew! MedIBCHO,! with! cell! again! viability! staying! higher! for! slightly! longer! and!
little!difference!in!cell!diameter!after!9!generations!of!shaken!culture!(figure!5B11!
a,! b,! c).! Comparing! cumulative! IVCD!of!both!ETEB! and!DTEBexpressing! cell! lines,!







in!MedIBBA!compared! to!MedIBCHO,!with!DTE!expression! levels!appearing! to!be!






MedI-CHO1and1MedI-BA1 pools1 stably1 expressing1 an1ETE1Mab1 alongside1 a1 TEE1 underwent1 a1 12-day1
growth1and1productivity1curve.1[a,1b,1c]1Pools1were1recovered1from1static1culture1for1301generations1in1
shaken1 culture1 until1 the1 growth1 characteristics1were1 comparative.1 [d,1 e,1 f]1 12-day1 batch1 overgrow1
cultures1were1 set1 up1 so1 that1 the1 cumulative1 cell1 growth1and1productivity1 of1 each1 cell1 line1 could1 be1
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A1 model1 DTE1 Mab1 was1 stably1 expressed1 in1 MedI-CHO1 and1 MedI-BA.1 [a,1 b,1 c]1 Stable1 pools1 were1
recovered1from1static1culture1for1301generations1in1shaken1culture1until1their1growth1characteristics1
were1 comparative.1 [d,1 e,1 f]1 12-day1 batch1 overgrow1 cultures1 were1 performed1 to1 compare1 the1
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molecule! (Pybus! et! al.! 2014).! To! ensure! that! any! differences! in! stable! pool!
productivity!levels!were!not!artifacts!of!Mab!HC!or!LC!levels,!either!due!to!lack!of!
expression!of!the!HC!and/or!LC!genes!or!the!obvious!overexpression!of!one!of!the!
HC/LC! genes! compared! to! the! other,! stablyBexpressing! pools!were! stained!with!
antiBHC! and! antiBLC! antibodies! before! analysis! by! flow! cytometry! to! elucidate!
intracellular! HC! and! LC! levels! across! the! pool.! Staining! also! allowed! the!
distribution!of!HC/LC!expression!across! the!entire!population! to!be!determined,!
highlighting!whether!Mab! production! across! a! pool! was! relatively! homogenous!
(normally!distributed),! or!whether! the!pool!was!not!normally!distributed,!being!











ratio.!Data!on! cell! fluorescence!was! collected! from!20,000! cells!within! this! gate.!
For!both!HC!and!LC!staining!negative!controls!were!used!to!set!up!a!gate!for!cells!
not!containing!any!antibody,!with!99%!of!the!cells!within!this!gate!presumed!to!be!
not! expressing! recombinant!Mab.! All! other! cells! with! fluorescence! levels! above!
this!gating!threshold!were!assumed!to!be!positive!and!containing!intracellular!HC!
and!LC!(figure!5B12,!5B13).!The!presence!of!HC!was!measured!using!(using!a!Red!






Negative!controls! showed! the!background! level!of! staining! for!nonBstained!cells.!
That! nonBtransfected!CHO! cells! stained!with! the! antiBHC! and! anti–LC! antibodies!
showed!a!similar!low!level!of!fluorescence!shows!that!these!tagged!antibodies!do!
not! have! any! offBtarget! effects! and! therefore! any! fluorescence! seen! is! due! to!












All! three! MedIBCHO! ETEBexpressing! pools! (figure! 5B12,! b)! show! a! normal!





peak! shown! to! be!within! the! negative! control! range.! LC! distribution! suggests! a!
small!amount!of! the!pool!8!population!are!not!LC!positive,!although!the!data! for!





regards! to! intracellular! HC! and! LC! content! (figure! 5B13! b,! c).! However,! all!
distributions! are! positive! for! both! Mab! chains,! showing! that! all! cells! are!
expressing!Mab! HC! and! LC,! albeit! that! expression! levels! are! not! fully! normally!
distributed.! There! is! a! small! doubleBpeak! in! the! LC! profile! of! pool! 12! which! is!
matched!slightly!by!the!concurrent!HC!fluorescence!profile.!
!
The! slightly! nonBnormal! HC! and! LC! distributions,! alongside! the! slightly! lower!
fluorescence!levels!seen!in!the!MedIBBA!ETE!stable!pools!when!compared!to!MedIB
CHO!cells!may!partly!explain!the!difference!in!production!levels!between!the!two!
cell! lines,! suggesting! that,! there! is! a! slightly! reduced! level! of! Mab! HC! and! LC!
present! within! the! MedIBBA! cells.! In! DTEBexpressing! stable! pools! there! is! nonB
normal! distribution! of! both!HC! and!LC! abundance!present! in! both! parental! and!
evolved! cell! lines,! with! the! exception! of! pool! 5.! That! there! is! little! difference!
between! ETE! HC/LC! levels! in! different! cell! lines! on! day! 4! of! culture! is!
unsurprising,!given!that!at!this!stage!the!titre!of!both!cell!lines!is!comparable,!with!
the!main!difference! in!production! levels!between!the! two!cell! lines!coming!after!
this!point!in!growth!(figure!5B10!f).!However,!in!DTEBexpressing!cells!at!day!four!





parental! and! evolved! cell! lines! expressing! ETE! Mab! –! both! Mabs! showing! a!
difference!in!productivity!levels!between!the!two!cell!lines!despite!similar!HC/LC!
abundance! profiles! B! suggests! that! the! difference! in! Mab! productivity! levels!
between!the!parental!and!evolved!cell!lines!is!not!due!to!differing!levels!of!Mab!HC!







anti1 human1 lambda1 LC1 antibodies.1 [a]1 Flow1 cytometry1 analysis1 was1 carried1 out1 to1 elucidate1




A! decrease! in! productivity! in! BFABevolved! cells! compared! to! parental! cells!
disproves!the!hypothesis!that!evolution!of!CHO!cells!against!BFA!would!allow!the!
cell!population!to!overcome!the!secretory!blockage!imparted!by!BFA,!resulting!in!
an! population! with! an! enhanced! secretory! and! productivity! phenotype.! This! is!
especially!surprising!given! that!MedIBBA!stable!pools!outBgrew!MedIBCHO!stable!
pools,! although! as! discussed! this! growth! difference! may! be! due! to! a! positive!
reaction! to! the! removal! of! BFA! selective! pressure! from!MedIBBA! cells.! That! the!
productivity! decrease! was! seen! in! both! ETEB! and! DTEB! expressing! stable! pools!
confirms!data!seen!in!transient!pools!(figures!5B5,!5B6),!but!is!the!opposite!of!what!
was!seen!in!the!initial!early!screening!of!stable!pools!at!the!end!of!one!passage!in!
shaken! culture! (figure! 5B7).! This! suggests! that! it! takes! time! for! stable! pools! to!
stabilise!with! regards! to!Mab! production,! but! also! raises! the! question! as! to! the!
efficiency! of! screening! cells/cell! populations! for! phenotypic! differences! early! in!
their!life!cycle.!!
5.4.2.6.&Organelle&morphology&of&BFA?evolved&CHO&cells.&
Previous! antibody! staining! of! BFABtreated! MedIBCHO! cells! showed! that! BFA!
treatment!results!in!the!dispersal!of!the!Golgi!in!CHO!cells!(figure!5B5).!ETEB!and!
DTEB! expressing! TEE! pools! (both! parental! and! evolved)! were! sampled! in! the!
exponential! growth! phase! of! shaken! culture! at! G30.! Cells! were! PFA! fixed! and!
stained! with! antiBGM130,! antiBGBF1! and! antiBCalreticulin! antibodies! (section!
2.7.1)!to!determine!whether!stable!Mab!expression!has!any! impact!upon!ER!and!
Golgi!morphology!or!the!cellular!localisation!of!the!BFA!target!protein!GBF1.!Pools!





only! negative! controls! (images! not! shown),! confirming! that! fluorescence! is! not!
due! to! background! binding.! That! staining! with! all! antibodies! results! in! similar!
signal!intensity!to!that!seen!in!the!nonBexpressing!negative!control!confirms!that!
none!of! the!antibodies!used! crossBreacted!with! the! recombinant!Mab.!Were! this!
the! case! signals! would! be! very! intense! (based! on! previous! staining! of! a! Mab!
stablyBexpressing!cell! line!stained!with!antiBhuman!antibody!showing!high,!often!










DTEBexpressing,! MedIBCHO! or! MedIBBA! derived,! suggesting! that! none! of! these!
different! factors! has! an! obvious! impact! upon! the! UPR! status! of! the! cell..! Golgi!







Across! all! cell! lines! ER! morphology,! shown! by! Calreticulin! staining,! does! not!
appear! to! differ.! However,! when! taking! in! to! account! the! difference! in! image!
exposure!required!to!ensure! image!saturation!did!not!occur,! it!can!be!suggested!
that!Calreticulin!staining!in!DTEBexpressing!cell!lines!is!brighter!than!that!seen!in!
nonB!and!ETEBexpressing!cell! lines,! suggesting!a!possible! increase! in!Calreticulin!
levels,! and! therefore! possibly! ER! volume,! within! DTEBexpressing! cells.! GBF1!
staining! in! expressing! cells! is! slightly! more! intense! than! that! seen! in! the! nonB
expressing! control.! For! expression!of! both!model!Mabs,! once!differing! exposure!
times!have!been!taken!in!to!account!(specifically!the!lower!exposure!required!for!




Overall! the!microscopy!data!shows! that! there! is! little!difference! in!ER!and!Golgi!
morphology!between!ETEB,!DTEB!and!nonBexpressing!cells,!nor!between! the! two!
different! cell! lines.! There!may! be! some! difference! in! image! intensity! across! the!
differing! cell! and! Mab! lines,! suggesting! possible! differences! in! BiP! and! GBF1!
expression! levels.! However,! IF! provides! only! a! qualitative! measurement! of!




samples!during!preparation/imaging).! For!more! accurate!data!on!BiP! and!GBF1!











the1different1exposure1 times1are1 shown1so1better1 comparison1between1 images1 can1be1made1 (longer1
exposure1time1will1lead1to1greater1colour1intensity.1Gain1and1offset1settings1remained1the1same1across1






in! the! transcriptomic! and/or! proteomic! nature! of! the! CHO! cell,! the! levels! of!
genes/proteins! that! are! either! targeted! by! BFA! or! involved! in! the! UPR! were!
measured.!Western! blotting!was! used! to! determine! protein! levels,!with! RTBPCR!
used!to!determine!transcript!levels.!With!mutation!of!BFA’s!target!likely!to!result!
in! BFA! resistance! without! increasing! cell! productivity,! further! to! the!
transcriptomic! analysis! sequencing! of! the! secretory! blocking! agent’s! specific!
target!was!performed!do!see!whether!a!point!mutation(s)!had!indeed!occurred.!!
5.4.3.1.&Determining&UPR&status&of&evolved&CHO&cells.&
MedIBCHO! and! MedIBBA! cell! lines! were! grown! in! biological! triplicate! for! ten!
passages!before!sampling!during!exponential!growth.!Whole!cell!protein!samples!
were! produced! by! RIPA! extraction! (section! 2.7.3.1),! with! all! RIPA! samples!
normalised! for! cell! number.! Protein! samples! were! separated! by! SDSBPAGE!
(section! 2.7.3.2)! before! transfer! to! a! membrane! for! blotting! with! primary!
antibodies!raised!against!GBF1!(a! target!of!BFA)!or! the!UPR!marker!BiP.!βBactin!
was! used! as! a! housekeeping! protein! (sections! 2.7.3.3,! 2.7.3.4;! table! 2B4).! After!
secondary! antibody! incubation! membranes! were! imaged! by! LiBCor! and!
quantitatively! analysed.!Whilst! initial! samples!were!normalised! for! cell! number,!
quantitative! data! from! the! test! antibodies! (GBF1/BiP)! were! normalised! to! the!
level! of! the! housekeeping! control! to! further! ensure! samples! could! be! better!
compared.!Samples!were!taken!from!three!biological!replicates!of!both!cell! lines,!
with!Western! blotting! repeated! twice! to! provide! two! technical! replicates.! NonB




the!GBF1! antibody,! suggesting! there!may!be! an! increase! in!GBF1! levels! in!BFAB
evolved! cells,! however! further! experiments! showed! this! was! not! replicable.!















technical1 replicates.1 [b]1 The1 intensity1 of1 bands1 from1 the1Western1 blot1 image1were1 quantified1 using1
Image1Studio1software.1Intensity1of1the1BiP1bands1were1first1normalised1against1the1housekeeping1β-
actin1before1fold-change1compared1to1the1parental1control1was1calculated.1Columns1show1the1mean1of1






The!effect!of! the!BFABevolution!process!upon! the! transcriptional! activity!of!BFA!
targets! and! UPRBrelated! genes! was! investigated.! Total! RNA! of! three! biological!
replicates! of! MedIBCHO! and! MedIBBA! was! extracted! and! converted! to! cDNA! by!
reverse! transcription! (sections!2.8.1! ,! 2.8.2).! Forward!and! reverse!primers!were!
designed!to!determine!the!transcript! levels!of!three!known!BFA!targets!and!four!
UPRBrelated!genes,!with!two!housekeeping!genes!used!as!controls.!To!analyse!the!
effect! BFA! evolution! had! on! specific! BFA! targets,! primers! were! designed! to!
analyse! transcript! levels! of!GBF1,!ArfGef1! and!ArfGef2.!Whilst!BIG1/2!had!been!
determined!as!GBF1!targets! their!gene!sequences!were!not!available! in! the!CHO!
genome.!Alignment!of!BIG/ArfGef!protein!sequences! from!other!species!resulted!
in! 100%! alignment! (including! coverage! of! the! Sec7! domain)! and! so! ArfGef1/2!
gene! sequences!were! substituted! for! BIG1/2! gene! sequences.! To! determine! the!
effect! BFA! evolution! had! upon! the! UPR,! primers! were! designed! to! amplify!
segments! of! BiP,! CREB3L2,! ATF6! and! XBP1! genes.! The! MMADHC! and! FKBP1a!





cDNA! levels! required.! Primer! efficiencies! between! 95B105%! were! deemed!
acceptable!for!RTBPCR!(table!5B3;!section!2.8.4.1).!Analysis!of!transcript!levels!was!
performed! by! RTBPCR.! Each! biological! replicate! underwent! two! analyses! with!
each! primer! set! to! provide! technical! duplicates.! Negative! controls! comprised! of!
RTBPCR!samples!with!DNA!originating!from!no!reverse!transcriptase!and!no!cDNA!
samples! for! each! primer! pair! (section! 2.8.4).! RTBPCR! Ct! values!were! converted!
into!a!transcript!abundance!foldBchange!value!using!the!doubleBdelta!calculation,!
comparing!test!transcript! levels! in!the!parental!and!test!cell! lines!to!those!of!the!
two!housekeeping!genes!(section!2.8.4,!equation!8).!
!
Transcript! analysis! of!MedIBBA! cells! shows! that! there! is! a! 2.68Bfold! increase! in!
GBF1!transcript! levels! in!MedIBBA!cells!compared!to! the!parental!cells,!with! this!
difference! being! statistically! significant.! A! 1.52Bfold! increase! in!ArfGef2! levels! is!
seen! in!MedIBBA,!alongside!slight! increases! in!ATF6,!BiP,!XBP1,!although!a!slight!





calculation,! this! variance! from! the! expected! value! (of! 1)! suggests! that! lowBlevel!




















The1 transcript1 levels1 of1 UPR-related1 genes1 and1 BFA1 targets1 were1 analysed1 by1 RT-PCR.1 RNA1 was1
extracted1from1MedI-CHO1and1MedI-BA1cells1and1reverse1transcribed1to1cDNA.1Primers1were1designed1
to1analyse1transcript1levels1of1GBF1,1ArfGef1,1ArfGef2,1ATF6,1BiP1and1XBP11genes,1with1MMADHC1and1
FKBP1a1used1as1 housekeeping1genes1 and1positive1 controls.1Non-cDNA1negative1 controls1 showed1no1
transcript1 levels1 (data1 not1 shown).1 RT-PCR1 Ct1 values1were1 converted1 to1 an1 expression1 fold1 change1




































by! BFA! inhibiting! ArfBGEF! function! (Claude! et! al.! 1999;! Mansour! et! al.! 1999;!
Peyroche!et!al.!1999).!It!was!planned!to!sequence!the!Sec7!domain!of!endogenous!
GBF1!so!as!to!determine!whether!BFA!resistance!in!MedIBBA!cells!had!come!about!




produce! cDNA.!From! this! the! Sec7!domain!of!GBF1!was! amplified!by!PCR!using!
forward!and!reverse!primers!also!used!for!RTBPCR!(sections!2.8.3,!2.8.5;!tables!2B
4,! 2B7,! 2B8).! However! between! the! PCR! and! PCR! product! purification! processes!











the! start! of! culture! being! shown! to! stop! cell! growth! whilst! possibly! having! an!









MedIBCHO! cells! were! treated! with! FLIB06! upon! seeding.! Untreated! cells! were!
maintained!as!a!control!for!general!genetic!drift,!with!DMSO!only!treated!cells!(at!
the!same!volume!as!FLIB06!solution!added!to!the!evolution!cells)!maintained!as!a!
vehicle! control.! Each! permutation! (test,! untreated! control! and! vehicle! control)!
was! repeated! in! triplicate! to! provide! biological! replicates.! Evolved! cells! were!
initially! treated! with! 0.1! μM! FLIB06.! Upon! recovery! and! stabilisation! of! cell!
growth,!FLIB06!concentration!was!increased!to!0.15!μM!(at!37!generations)!then!
0.2!μM!(at!50!generations).!Intermediate!kill!curves!were!performed!to!determine!
the!evolved!cell! line’s! resistance! to!FLIB06! to! inform! the! concentration! to!which!
! 229!
FLIB06!should!be!raised!with!which!to!have!an!effect!upon!CHO!cells.!Kill!curves!at!
G103! showed! that! evolved! cells! could! grow! as! normal! in! 0.2! μM! FLIB06! and! as!
such!FLIB06!levels!were!increased!further!and!quicker!than!previously!to!0.6!μM!
(data! not! shown),! then! 1.0! μM! at! 175! generations.! Cells! were! cultured! in! the!
presence!of!1.0!μM!FLIB06!until!270!generations!at!which!point! cell!banks!were!
produced.! Henceforth,! FLIB06Bevolved! cells! will! be! referred! to! as! MedIBFLI! and!
DMSO!vehicle!controls!as!MedIBDMSO.!
!
Growth! metrics! of! MedIBCHO,! MedIBDMSO! and! MedIBFLI! over! the! course! of!
evolution!are!shown!in!figure!5B17.!Across!the!three!different!evolution!conditions!
viability!and!growth!rate!are!generally!comparable,!with!growth!of!MedIBFLI!being!
slightly! below! that! of! the! two! control! conditions.! Wide! error! bars! and! sudden!
drops! in! viability! (and,! to! some! extent,! growth! rate)! can! often! be! explained! by!
contamination!resulting! in!a!passage!having! to!be! taken! from!a!previous!culture!
closer! to! stationary! than! exponential! phase.! Across! all! cultures,! growth! rate! is!
seen! to! gradually! increase! across! the! course! of! 270! generations! (figure! 5B17! a;!
from! an! initial! 0.6! towards! 0.8! μ! dayB1)! whilst! cell! volume! (figure! 5B17! c;! as! a!
function!of! cell!diameter,! from!an! initial!15!μm! to!14.5!μm)! is! seen! to!decrease,!
both! being! trends! that! have! been! previously! seen! in! long! culture! of! CHO! cells!
(FernandezBMartell! et! al.! 2017).! The! long! gaps! between! increases! in! secretory!
blocker! concentration,! due! to! other! time! pressures,! were! not! ideal! as! the!
evolution!process!took!longer!than!ideal!(nearly!nine!months!in!duration).!
!
Whilst! the! selective! pressure! of! the! evolutionary! agent! remained,! the! lack! of!
regular! stimulus! change!within! the!growth!environment!may!have!allowed! subB
populations! to! develop! within! the! cell! population! as! a! whole.! Cells! may! have!

















rate,1 [b]1 cell1 viability1 and1 [c]1 cell1 diameter1metrics1were1measured1 to1 allow1 the1 comparison1 of1 the1























































































Evolved! and! control! cell! lines!were! transiently! transfected! (by!nucleofection,! as!
section! 2.5.1)! with! plasmid! DNA! expressing! an! ETE! or! DTE! model! Mab.!
Transfected!cells!were!seeded!in!10!mL!cultiflask!culture!and!grown!for!four!days,!
at!which!point!cell!growth!and!supernatant!samples!were!taken.!Mab!titre!levels!
were! assayed! by! Valita™TITER! HS! Mab! assay! (section! 2.6).! No! evolutionary!






control.!This! is!despite! the!reduced!growthBrate!of! transiently! transfected!MedIB
FLI!cells,!which!is!20%!of!that!seen!in!the!MedIBCHO.!Once!this!reduced!growthB
rate!is!taken!in!to!account,!the!Qp!of!MedIBFLI!ETE!productivity!shows!a!3.7Bfold!
increase! when! compared! to! MedIBCHO,! with! little! difference! between! the! Qp!
values!between!the!MedIBCHO!and!MedIBDMSO!control!cells.!The!increase!in!both!





large! impact! upon! cell! growth,!MedIBFLI’s! growth! rate! being! only! 4%!of! that! of!
MedIBCHO,!with!little!cell!growth!occurring.!When!expressing!a!DTE!Mab,!there!is!
a! slight! difference! between! expression! levels! in! the!MedIBCHO! and!MedIBDMSO!
vehicle!control!cells.!This!may!be!due!to!the!lower!DTE!productivity!levels!being!in!
a!noisier!region!of!the!Valita™TITER!HS!assay!standard!curve,!resulting!in!a!slight!
reduction! in! titre! measurement! accuracy.! The! titre! levels! of! MedIBFLI! are!
approximately! half! that! of! parental! cell! lines! and! two! thirds! that! of! the! vehicle!
control.!However,!once!the!greatly!reduced!growth!rate!of!MedIBFLI!is!taken!in!to!
account! it! sees! a! statistically! significant! 2.15Bfold! increase! in! DTE! Qp! when!
compared! to! MedIBCHO,! although! the! smaller! increase! compared! to! the! MedIB
DMSO! control! is! not! statistically! significant.! This! suggests! that! the! longBterm!








































































































































mainly! to! the! decrease! in! cell! growth! of! transiently! transfected! MedIBFLI!
compared!to!MedIBCHO,!with!growth!rate!over!4!days!being!only!20%!(ETE)!and!
4%!(DTE)!of! that!seen! in! the!parental!cell! lines!(figure!5B18).!That!both!evolved!
cell!lines!saw!a!decrease!in!growth!rate,!with!cell!viability!also!decreasing!and!cell!
diameter! reducing! slightly! (data! not! shown)! suggests! that! the! process! of!
transfection!may!have!an!impact!upon!growth!of!MedIBFLI!cells!that!is!not!seen!in!
MedIBCHO.! Therefore! the! FLIB06! evolutionary! process!may!have! altered! the! cell!
population! such! that! it! is! less! conducive! to! transfection! than! the! parental!
population.! It! is!possible! that! the!age!of! the! cells! (close! to!270!generations/100!
passages! over! the! course! of! the! evolution! procedure)! has! had! an! impact! upon!
their!susceptibility!to!transfection,!but!this!is!controlled!by!the!MedIBCHO!control!




Comparative! MedIBCHO,! MedIBDMSO! and! MedIBFLI! cells! were! transiently!
transfected!with!pMAXGFP!as!per!the!protocol!used!for!Mab!expression!(sections!
5.4.3.2! and! 2.5.1).! A! nonBtransfected!MedIBCHO! cell! line!was! used! as! a! negative!
control! for! both! growth! and! transfection! efficiency.! Four! days! postBtransfection!










MedI-FLI1 and1 control1 cell1 lines1 were1 transiently1 transfected1 with1 GFP1 to1 assay1 the1 effect1 the1
evolutionary1process1has1had1upon1CHO1cell1transfectability.1A1non-transfected1cell1line1was1used1as1a1
growth1 control.1 [a]1 Flow1 cytometry1 of1 GFP-transfected1 cells1 was1 used1 to1 determine1 transfection1
efficiency.1 [b,1 c,1 d]1 Cell1 growth1 data1 was1 collected1 to1 compare1 how1 different1 cell1 lines1 reacted1 to1
transfection.1 All1 bars1 show1 fold1 change1 from1 the1mean1 of1 parental1 cell1 line1 data.1 For1 growth1data,1
each1 bar1 shows1 one1 data1 point1 from1 three1 biological1 replicates1 (n1 =1 3).1 For1 transfection1 efficiency,1
bars1 show1the1mean1of1 two1 technical1 replicates1of1 three1biological1 replicates1 (n1=16).1All1 error1bars1
show1SEM.11 !
























































































There! is! no! statistically! significant! difference! in! transfection! efficiency! between!
MedIBFLI!and!MedIBCHO,!with!mean!transfection!efficiencies!of!85.0%!and!83.2%!
respectively.!However,!the!MedIBDMSO!vehicle!control!cell!lines,!with!an!average!
transfection! efficiency! of! 89.8%,! are! significantly! higher! (with! 95%! confidence)!
than!both!MedIBCHO!and!MedIBFLI! (figure!5B19,! a).!There! is! a! slight!decrease! in!
MedIBFLI’s!growth!rate!(90%!of!that!of!MedBCHO;!figure!5B19!b),!although!this!is!
not! statistically! significant! and! is! also! a! much! smaller! decrease! than! that! seen!
previously! upon! transfection! with! ETE! and! DTE! Mabs! (figure! 5B18,! section!
5.4.3.2).! There! is! no! statistical! difference! in! viability! or! cell! diameter! between!
MedIBCHO!and!MedIBFLI! (figure!5B19),! again!different! to!what!was!seen! in!MabB
transfected! cells! (figure! 5B18).! As! expected,! due! to! undergoing! electroporation!







CHO,! this! decrease! (to! 90%)! was! not! statistically! significant! and! was! a! much!
smaller!decrease!than!that!seen!when!both!cell!lines!were!transfected!with!MabB
encoding! DNA! (figure! 5B18),! where! a! drop! to! 20%! (ETE)! and! 4%! (DTE)! of! the!
MedIBCHO!growth!rate!was!seen!in!MedIBFLI,!with!viability!and!cell!diameter!data!




That! the! growth! rate! decrease!was!much! larger! in!DTEBexpressing! cells! further!
enhances! this!hypothesis! (figure!5B18!a! vs.! b),!with! the! cell! unable! to! grow!and!
produce!DTE!Mab!at!a!high!level!at!the!same!time.!However,!it!is!also!possible!that!
the! difference! in! size! between! the! two! plasmids! (ETE! and! DTE! Mabs! being!
approximately! three! times! larger! than! that! of! pMAXBGFP)! with! larger! DNA!
constructs! know! to! have! a! slightly! toxic! effect! upon! CHO! cells,! though! all! cells!
were! transfected! with! the! same! mass! of! plasmid! DNA.! This! experiment! was!
performed!to!control! for!the!effect!Mab!production!has!upon!different!CHO!lines!
as! well! as! the! physical! process! of! electroporation! opening! pores! in! the! cell!
membrane,!not!necessarily!against!any!toxic!effects!of!DNA.!Were!the!experiment!
to!be!repeated,!a!control!transfection!with!a!nonBcoding!vector!of!a!similar!size!to!




rate!and,!whilst! an! increase! in!Qp! is!a!positive!outcome,!a! large!decrease! in! cell!
growth! (such! that! the! overall! titre! sees! a! decrease)! is! not.! As! such,! FLIB06!
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evolution! appears! to! improve! the! overall! performance! of! both! culture! and!








a! short! timeBframe! in!which! to! produce!Mab.! Stable! pools! expressing! DTE!Mab!
were! produced! such! that! transfected! cells! could! be! allowed! to! recover! over! a!







revived! and!passaged! concurrently! for! 6! passages.! Batch! overgrow! cultures! (12!
day! duration)! for! each! cell! line! (providing! three! biological! replicates)! were!






MedIBFLI! grows! slightly! better! than! the! parental! and! vehicle! control! cell! lines,!
with! cumulative! IVCD! reaching! a! higher! level! between! days! 10B12! and! cell!
viability!staying!higher!for!slightly!longer!after!day!8!of!culture!when!compared!to!
the! control! cell! lines! (figure! 5B20! a).! This! follows! the! pattern! of! growth!
characteristics!seen!in!MedIBBA!stablyBexpressing!pools!(section!5.2.4.4,!figure!5B







cell! productivity! the! homogeneity! of! the! cell! pools!with! regards! to! intracellular!
abundance! of! HC! and! LC! was! tested! (section! 2.7.2.1).! It! was! hypothesised! that!
heterogeneity! of! heavy! and! light! chain! production! levels! within! the! cell! pools!
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Stable1 pools1 expressing1DTE1Mab1were1 produced1 using1MedI-FLI1 (and1 control1 cells)1 so1 as1 to1 assay1
their1level1of1Mab1productivity.1[a]1Growth1and1titre1data1over1the1course1of1a112-day1batch1overgrow1









cells! match! both! negative! controls! for! both! HC! and! LC! levels,! indicating! that!
neither!Mab!gene!is!being!expressed!within!these!pools.!In!many!pools!(C1,!C2,!C3,!
D2,! F2)! the! cell! population! is! split! in! to! two! distinct! peaks! showing! that! the!
population!is!heterogeneous!with!regards!to!HC/LC!expression!levels.!In!all!these!
pools,! for! both! HC! and! LC! abundance,! one! of! the! peaks! is! mostly! within! the!
negative!control!fluorescence!gate,!with!the!other!peak!showing!that!Mab!HC!and!
LC! are! both! present! in! a! section! of! the! population.! Only! one! pool! (F1)! shows! a!





Comparison! of! individual! productivity! data! of! each! cell! line! (data! not! shown)!
further! supports! the! importance! HC/LC! level! population! homogeneity.! The! F1!
pool! was! the! highest! producer! of! all! pools,! with! D1,! D3! and! F3! producing! the!
lowest! titres.! The! remaining! pools! all! produce! titre! levels! between! these! two!
distinct!groups,! the!exact! level!correlating! to! the!amount!of!cells!positive! for!HC!
and!LC!abundance.!
!
That! positive! HC! and! LC! signal! intensities! are! similar! within! the! same! pool!
suggests!that!the!cause!for!low!Mab!productivity!levels!is!not!necessarily!due!to!a!
stoichiometric!imbalance!between!HC!and!LC!levels,!showing!instead!that!there!is!
a! potential! problem!with! the! expression! of! genes! encoded! by! the!Mab! plasmid.!
That!nonBexpressing!populations!of!all!pools!show!similar!profiles!to!the!negative!
controls!would!suggest! that!a!nonBexpressing!subBpopulation!has!developed!and!
thrived!within!culture.! It! is! likely! that! these!populations!have!derived! from!cells!
with! high! endogenous! GS! levels! that! can! survive! the! MSX! growth! media! was!
supplemented! with,! as! all! cells! expressing! recombinant! GS! should! also! express!
Mab!due!to! the!difference! in!strength!of! the!promoters! the!transcription!of!both!
expression!cassettes!are!transcribed!from.!!
!
The! variance! of! Mab! titre! and! HC! and! LC! expression! levels! seen!with! nonBTEE!
vectors,!compared!to!the!similarity!of!production!levels!and!HC/LC!abundance!of!
pools! produced! with! TEE! vectors! (sections! 5.2.4.4! and! 5.2.4.5),! shows! the!
importance! of! knowing! and! controlling! the! transcription! level! of! a! recombinant!
gene!within! a! cell.! The! continuously! openBconfirmation! of! a! stable! recombinant!
gene! conferred! by! a! TEE! effectively! controls! across! cell! lines! for! transgene!
transcription! levels,! whereas! in! nonBTEE! plasmids! this! is! not! the! case,! with!
transcription! levels! depending! entirely! upon! the! transcriptional! activity! of! the!




Directed! evolution!was! used! as! a! strategy! by!which! to! effect! largeBscale! genetic!
changes!upon!the!CHO!cell.!It!was!hypothesised!that!evolving!CHO!cells!against!a!
compound! that! inhibits! the! secretory! pathway! would! result! in! myriad! fine!
transcriptomic!and!proteomic!changes!within!the!cell!B!many!more!than!could!be!
instigated! by! direct! ectopic! expression/repression! of! genes! –! such! that! the! cell!
population!could!overcome!the!inhibitory!effect,!with!the!aim!of!producing!a!CHO!
cell! with! an! enhanced! secretory! pathway! and! thus! an! enhanced! productivity!
phenotype.!!
!
A! parental! CHO! cell! line!was! separately! evolved! against! two! secretory! blocking!
agent!that!were!selected!based!on!previous!literature!and!efficiency!testing!in!CHO!
cells! (section! 5.3).! The! resultant! evolved! cell! lines!were! transfected!with!model!
recombinant! proteins! to! determine!whether! the! directed! evolution! process! had!
changed! cell! productivity! capacity.! Cells! were! stained! to! determine! any!
morphological! changes! that!might! have! resulted! in! any! phenotypic! change.! RTB
PCR!and!Western!blotting!was!performed! to!probe!any!potential! changes! in! the!
targeted!areas!of!the!cell!lines’!transcriptomic!and!proteomic!profile.!
!
Evolution! of! CHO! cells! against! BFA! resulted! in! a! cell! line! that,!when! transiently!
expressing! ETE! and! DTE! model! Mabs,! saw! an! overall! decrease! in! productivity!
compared!to!MedIBCHO.!MedIBBA!saw!a!small!but!statistically!significant!increase!
in! growth! rate! of! 18%! with! both! Mabs.! However,! overall! titre! and! specific!
productivity! levels!both!decreased,!with! total!MedIBBA! titres! reaching!only!80%!
(ETE)!and!62%!(DTE)!that!of!MedIBCHO,!with!specific!productivity!of!each!evolved!




to! better! analyse! cell! line! productivity.! Use! of! a! normal! expression! plasmid!
resulted! in!a!wide!range!of!results!across!biological!replicates!and!as!such!could!
not!be!used!to!support!a!definitive!conclusion!as!to!the!productivity!capacity!of!an!
evolved! cell! line! (figure! 5B7,! 5B8).! Production! of! a! stable! pool! with! a! plasmid!
containing! a! TEE! allowed! better! control! of! transgene! transcription! levels,!
resulting!in!better!data!upon!which!to!base!conclusions!(figure!5B9).!Productivity!
and! growth! curves! of! MedIBCHO! and! MedIBBA! stably! expressing! ETE! and! DTE!
Mabs!showed!that!MedIBCHO!outBproduced!MedIBBA!by!2.2Bfold!(ETE)!and!11Bfold!
(DTE)! in! terms!of!maximum! titre! at! day!10! of! growth,! despite!MedIBBA! slightly!
outBgrowing! MedIBCHO! between! days! 5B7! of! culture! (figure! 5B10,! 5B11).! The!
evolutionary!process!also!appeared!to!have!little!effect!upon!CHO!cell!morphology,!
as! shown!by! there!being! little!difference! in! secretory!organelle! imaging!and!BiP!
protein!levels!between!the!two!cell!lines!(figures!5B14,!5B15).!
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A!decrease! in!Mab!productivity! in!BFABevolved! cells! compared! to! parental! cells!
disproves! the! hypothesis! that! evolution! of! CHO! cells! against! BFA! would! affect!
myriad! small! genetic! and! phenotypic! changes! within! the! cell,! resulting! in! an!
enhanced! secretory! pathway! which! in! turn! would! produced! an! enhanced!
productivity!phenotype.!A!possible! reason! for! this! is! that!BFA!blocking!of!COPIB
mediated!ERBGolgi!and! intraBGolgi! transport!results! in! the! induction!of! the!Golgi!
stress!response!(Yoshida!2009).!!
!
It!was! initially! hypothesised! that! cells! overcoming! induced! stresses!would! have!
increased!capacity!for!protein!folding,!processing!and!vesicle!transport!so!as!to!be!
better! able! to! survive! these! stresses,! resulting! in! a! cell! line! with! an! enhanced!
productivity!phenotype.!This!response!to!increased!UPR!activation!has!been!seen!
in!plasma!cells!(Shaffer!et!al.!2004;!ShapiroBShelef!and!Calame!2005).!However,!in!
evolved! CHO! cells! there! was! no! significant! increase! in! either! the! transcript! or!
protein!levels!of!the!ER!stress!marker!BiP,!suggesting!that!any!major!enhancement!
in! stress! response! brought! about! by! the! addition! of! an! evolutionary! agent! is!
muted! over! the! course! of! an! evolutionary! process! (figure! 5B16).! This! further!
suggests!that!if!exposed!to!an!inhibitory!pressure!over!an!extended!duration,!a!cell!




longBterm! exposure! to! stress! (and! thus! repeated! UPR! activation)! results! in!
feedbackBmediated!suppression!of!mRNAs!involved!in!the!UPR!(including!BiP!and!
some!ER!chaperones).!This! leads!to!a! ‘new!normal’!status!for!the!cell! in!which!it!
becomes! more! resistant! to! normal! UPR! responses! as! it! has! experienced! them!
many! times! before! (Gomez! and!Rutkowski! 2016).! That! this! does! not! happen! in!
plasma!cells!is!likely!due!to!their!terminally!differentiated!nature.!!
!
Another!possibility! is! that,! as!BFA! concentrations!were! gradually! increased! in! a!
stepBwise!manner,!the!cells!are!only!ever!put!under!a!mild!ER!stress,!under!which!




agent! those! cells! with! inherently! weaker! protein! processing! and! secretory!
capacities!would!be!quickly!directed!towards!apoptosis,!leaving!only!cells!with!the!
enhanced! productivity! phenotype! to! survive.! Sequencing! of! the! BFABsusceptible!
Sec7! domain! of! GBF1! was! attempted! but! was! unsuccessful.! Were! this! to! be!
successful! it! would! provide! important! information! as! to! whether! the! BFA!





in! a! cell! line! that,!when! transiently! transfected!with!model!Mabs,! saw!a! general!
increase!in!productivity!compared!to!MedIBCHO.!Despite!an!80%!(ETE)!and!96%!
(DTE)! decrease! in! growth! rate,!MedIBFLI! saw! a! 1.7Bfold! increase! in! overall! ETE!
titre,! representing!a!3.7Bfold! increase! in!Qp.!When!expressing!a!DTE!Mab,!MedIB






DTE! Mabs! suggests! that! the! hypothesis! of! directed! evolution! of! the! secretory!
pathway! has! not! been! completely! disproven! but! that! the! outcome! varies!
depending!upon!the!inhibitory!compound!used.!This!could!be!due!to!the!mode!of!
action!of! the!specific!compound,!but!also!the!specific! target! it! interacts!with!and!
the! role! of! this! within! the! targeted! pathway,! as! highlighted! by! FLIB06! more!
directly!targeting!ER!machinery!and!function!more!specifically!than!BFA.!!
!
However,! the! FLIB06! data! does! come!with! some! caveats.! Due! to! the! inability! of!
stable!pools!to!produce!consistent!results,!conclusions!can!only!be!drawn!from!the!
transient! data! and! thus! a! comparison! of! growth! and! productivity! over! an!
extended! period! of! time! can! not! be! made.! However,! that! transient! and! stable!
transfection! of! BFA! cell! lines! produced! similar! results! does! somewhat!mitigate!
this.! A! further! issue! is! that,! whilst! ETEBexpressing!MedIBFLI! produced! a! higher!
titre!than!MedIBCHO,!the!overall!titre!of!DTE!was!lower,!despite!a!higher!Qp.!This!






process! (Majors! et! al.! 2009;! Nicolaides! et! al.! 2005).! Furthermore,! treatment! of!
CHO! cells! with! chemical! compounds! can! result! in! chromosomal! abnormalities!
(Radha!and!Natarajan!1998).!Neither!of!these!outcomes!would!be!welcome!within!
an! industrial! cell! line! and! so! do! raise! some! questions! as! to! the! practicability! of!
using!chemical!compounds!in!cell!line!development.!
!
To! allow! a! firm! conclusion! to! be! made! as! to! the! suitability! of! FLIB06! as! a!
compound!with!which!to!mediate!directed!evolution!with!the!aim!of!producing!an!
enhanced! productivity! phenotype! in! CHO! cells,! stable! pools! would! have! to! be!
created!so!as!to!definitively!assay!MedIBFLI’s!productivity!capacity.!Using!a!TEE!or!
TI!system!to!produce!these!stable!pools!would!ensure!the!transcriptional!activity!
of! the! transgene! is! comparable! across! all! test! subjects! and! replicates,! allowing!
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much!more!accurate!data!upon!which!to!base!this!conclusion,!as!was!seen!in!TEEB
containing! MedIBBA! stable! pools.! Furthermore,! RTBPCR! of! the! UPRBrelated!
proteins! could!be! carried!out!on!MedIBFLI! cells! to! see!whether! the!evolutionary!
process! has! had! an! impact! upon! the! CHO! cell’s! UPR! status.! Whilst! the! exact!
molecular!target!of!FLIB06!is!unknown!the!relative!transcript!and!protein!levels!of!
genes!and!proteins!involved!in!ERES!formation!and!cargo!loading!(e.g.!PREB,!Sar1!
and! COPII! coat! subunits)! could! be! determined! by! RTBPCR/Western! blotting! to!







Despite! these! results,! the! idea! of! using! directed! evolution! against! a! chemical!
compound! to! speed! up! the! normal! evolution! of! longBterm! CHO! cultures! is! not!
entirely!redundant.!Directed!evolution!against!temperature!reduction!has!resulted!
in!CHO!cells!with!an! increased!productivity!phenotype,! longBterm!passaging!can!
improve! cell! growth! levels! and! evolution! against! certain! growth! inhibitors!
produced! in!bioreactor!culture!have!resulted! in!cell! lines!with!enhanced!growth!
and! productivity! characteristics! (Syddall! et! al.,! manuscript! in! preparation;!
FernandezBMartell!et!al.!2017;!Majors!et!al.!2009).!OverBexposure!to!ER!stress!(in!
this!case!mediated!by!an!inhibitory!compound)!can!result!in!many!repeated!cycles!
of! UPR! activation,! dulling! the! cell’s! response! to! the! UPR,! resulting! in! a! ‘reset’!
(Gomez! and!Rutkowski! 2016).! Also,! gentle! increasing! of! selective! pressure!may!
not! have! allowed! cells! with! a! highlyBsecreting! phenotype! to! outBcompete! those!
with!a!normal!secretory!capacity!(Rutkowski!et!al.!2006).!!
!
This! data! has! lead! to! the! conclusion! that! treating! CHO! cells! with! gradually!
increasing! concentration! of! an! inhibitory! agent! may! bring! about! resistance! by!
mutation,! or! cells! reverting! to! their! normal! phenotype.! As! such! a! long!
evolutionary!process!may!not!be!suitable!for!production!of!a!highBproducing!cell!
line,! especially! for! an! industrial! environment.! As! such! it! is! hypothesised! that!
exposure!to!an!inhibitory!agent!at!a!high!concentration!for!a!short!period!of!time!
(e.g.!only!until!cell!growth!has!returned!towards!normal!levels!and!no!longer)!may!
result! in! poorBsecreting! cells! being! filtered! out! of! the! overall! population,! with!













time-frame1 would1 not1 allow1 resistance1 to1 the1 chemicals1 used1 to1 develop,1 instead1
resulting1 in1 the1 death1 of1 cells1 unable1 to1 survive1 the1 blocking1 of1 the1 secretory1
pathway.1 After1 undergoing1 short-term1 chemical1 selection1 cell1 productivity1 was1
assayed1by1transient1transfection1with1a1model1DTE1Mab,1with1Western1blotting1and1




The! directed! evolution! approach! to! enhancing! CHO! cell! productivity! used! in!
chapter! 5! did! not,! in! the! case! of! Brefeldin! A,! produce! a! cell! line!with! enhanced!
secretory! capacity.!Transient!and! stable!production!of!both!ETEB!and!DTEBMabs!
was! reduced! in! the! MedIBBA! cell! line! compared! to! nonBevolved! control! cells.!
Evolution! against! FLIB06! resulted! in! a! slight! productivity! increase! in! MedIBFLI!
evolved!cells!transiently!expressing!DTEBMab,!though!this!could!not!be!replicated!
in!stable!pool!production.!This!finding,!especially!that!of!the!BFABevolved!cell!line,!
was! contrary! to! the! initial! hypothesis! that! blocking! of! a! certain! region! of! the!
constitutive! secretory! pathway! would! result! in! the! CHO! cell! population!




due! to! the! overexposure! of! the! CHO! cell! to! the! selective! pressure.! LongBterm!
exposure! to! an! inhibitory! agent! may! have! resulted! in! the! development! of!
mutations!within!that!compound’s!target!pathway.!These!mutations!would!convey!
resistance!to!the!inhibitory!compound,!giving!them!a!selective!advantage!over!the!
rest! of! the! cell! population! and! allowing! the! mutation! to! take! hold! and! prevail!
within! the! cell! population.! Any!mutation(s)! would! therefore! allow! cell! survival!
and!perseverance!within!the!population!without!any!change!in!phenotype.!!
!
It! has! also! been! shown! that! growing! cells! under! the! same! conditions! for! an!
extended!period!of!time!allows!genetic!drift!resulting!in!changes!in!cell!phenotype!
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(Davies! et! al.! 2013;! FernandezBMartell! et! al.! 2017).! Whilst! this! effect! was!
controlled! against! during! the! evolutionary! processes! used! in! chapter! 5! it! is!
feasible! that! this! could! have! an! effect! upon! cell! growth! and! productivity! that! is!
unrelated!to!the!addition!of!the!secretory!inhibitor.!!
!
Finally,! longBterm! exposure! to! BFA! and! FLIB06! could! instigate! some! level! of!
chronic!ER! stress!upon! the! cell!population,! resulting! in! feedback! suppression!of!
the!unfolded!protein!response!(Gomez!and!Rutkowski!2016).!This!response!could!
also! be! replicated! within! the! Golgi! stress! response.!Were! this! the! case! the! cell!
would!eventually!overcome!the!imposed!stress!without!affecting!any!phenotypic!
change.!Finally,!focusing!upon!a!very!specific!molecular!target!may!only!result!in!a!
small! change! within! the! cell’s! proteotype,! having! little! impact! upon! overall!




To! specifically! enhance!CHO!cell! productivity! through! targeting!of! the! secretory!
pathway,!it!was!hypothesised!that!a!more!condensed!evolutionary!process!might!
better! enhance! the! overall! productivity! of! a! CHO! cell! population! than! a! process!
that!was! drawnBout.! ShortBterm! treatment! of! a! cell! population!with! a! secretory!
blocking!agent!would!have!an!effect!of!filtering!the!cell!population,!removing!cells!





enough! exposure! to! allow!mutations! to! take! hold!within! the! population,! or! the!
effect!of!chronic!ER!stress!dampening!the!ER!stress!response.!Whilst!application!
of!a!chemical!inhibitor!as!a!selective!pressure!(as!in!directed!evolution)!may!allow!
a! genotypic! change! to! occur! (e.g.! point!mutation),! resulting! in! resistance! to! the!
compound!without!a!change!in!phenotype!occurring.!This!genotypic!change!could!
feasibly!result!in!an!increase!of!the!compound’s!specific!target!and!not!pathways!
around! it,! resulting! only! in! the! enhancement! of! a! specific! section! of! the!
biosynthetic! pathway,! merely! shifting! the! bottleneck! to! elsewhere! within! the!
biosynthetic!pathway!and!not!enhancing!overall!secretion.!
!
Furthermore,! a! shorter! timeBframe! required! compared! to! a! full! evolutionary!
strategy!would!potentially!allow!highBproducing!cell!lines!to!be!selected!earlier!in!
the!cell! line!development!process,!shortening!timeBlines! in! the!development!of!a!
highBproducing!CHO!cell!chassis!with!a!highBsecreting!phenotype!(as!discussed!in!
Fan! et! al.! 2013).! Other! strategies! discussed! included! evolution! against! an! ERB
stress! inducer! to! instigate! more! global! changes! around! the! biosynthetic! and!
secretory! pathways,! and! secondary! evolution,! where! cell! surface! hostBcell!
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proteins!essential!for!cell!function!and!survival!were!blocked.!These!(e.g.!essential!
amino! acid! transporters)! are! transported! to! the! cell! surface! via! the! constitutive!
secretory! pathway! and! so! blocking! their! presence! would! result! in! increased!







A! single! compound! chemical! selection!with! just! BFA!was! initially! performed.! A!
second!dual!chemical!selection!was!also!performed!using!both!BFA!and!FLIB06!in!
concert!to!target!two!specific!regions!of!the!secretory!pathway!at!the!same!time;!
GolgiBoriginating! transport! vesicle! formation! and! ER! cargo! loading! respectively.!
Cells!were!treated!with!BFA!or!a!cocktail!of!BFA!and!FLIB06!(henceforth!referred!







reduced! secretory! capacity! from! the! overall! population.! The! main! difference!
between! this! process! and! that! of! the! full! evolution! processes! used! in! chapter! 5!
are:!
!
1. Cells!are!only! treated!with!one!concentration!of!drug.! In! the!evolutionary!
process! cells! were! initially! treated! with! a! low! concentration! of! the!
inhibitory! compound! which! was! gradually! increased! as! the! process!
proceeded.!
2. Once! cell! growth! has! recovered! cell! culture! is! stopped.! During! the!
evolutionary! process! once! cells! had! adapted! to! the! inhibitory! compound!
they! were! maintained! in! its! presence! for! varying! lengths! of! time.! This!
extended!period!would! likely! induce! chronic! effects!upon! the! cell! and! its!
organelles.!
!
The! shortBterm!chemical! selection! strategy! is!designed!not! to!drastically! change!
the! overall! phenotype! of! a! cell! population! through! wider! changes! in! the!
transcriptomic! and/or! proteomic! profile! of! a! cell,! as! with! a! straight! evolution!
strategy!where!full!inhibition!of!a!target!was!performed!to!overexpress!the!target!
(Claude! et! al.! 1999;! van! der! Linden! et! al.! 2010).! It! is! designed! to! allow! for! the!






(Davies! et! al.! 2013).!The! spread!of! these!phenotypes!depends!upon!various! cell!
functions! and! parameters! (e.g.! those! that! are! tangible! such! as! growth! rate,! cell!
volume;! those! that! are! less! tangible,! such! as! secretory! capacity).! It! is! a!
combination!of!these!parameters!that!result! in!the!cell’s!productivity!phenotype,!
and!these!parameters!are!expected!to!be!normally!distributed.!As!such,!there!will!
be! some! cells! in! the! heterogeneous! population! –! those! towards! the! right! of! the!
normal!distribution!–!that!will!have!a!desired!phenotype!for!a!combination!of!the!
required!functions!(figure!6B1).!Cells!with!desirable!phenotypes!(e.g.!high!Qp)!are!










Host! MedIBCHO! cells! were! split! from! the! same! initial! population! into! 10! mL!
cultiflask!cultures.!Cultures!were!treated!with!the!required!concentration!of!BFA!
or! BFA/FLI,! at! LD25,! LD50! or! LD75! (table! 5B2).! Passaging! continued! in! the!





passages!duration,! to! that!of! the!nonBtreated!parental!control!cells.!At! this!point!



























number! of! passages! (10! passages! for! LD75! and! LD50! cultures,! compared! to! 11!














All! BFABfiltered! cells! were! revived! from! cell! banks! for! productivity! analysis! by!













[c]1 cell1diameter1 throughout1 the1chemical1 selection1process.1Each1point1 shows1data1collected1at1 the1
end1of1a1single1passage,1showing1the1mean1of1three1biological1replicates.1Error1bars1show1the1SEM1of1
the1growth1metric1measured1(y-axis)1and1the1generation1number1(x-axis).1 !








































































PostBtransfection! all! three! selected! cell! lines! saw! a! reduction! in! growthBrate!



















with! a! model! Mab! resulted! in! a! significant! decrease! in! the! growth! of! the!





cytometry,!with! a!nonBtransfected! cell! line!used! as! a! negative! control! for! gating!
analysis!of!cell!fluorescence!(section!2.7.2).!One!of!the!LD0!cell!lines!did!not!grow!
as! expected! due! to! contamination! and! as! such! the! data! for! this! cell! line! was!







growth1 cultures1 were1 sampled1 for1 growth1 and1 productivity1 data.1 Data1 is1 shown1 as1 a1 fold1 change1
compared1 to1 the1 control1 (LD0)1 cells1 for1 [a]1 cell1 growth1 rate,1 [b]1 viability,1 [c]1 overall1 titre1 and1 [d]1






















































































significant! difference! in! transfection! efficiency!between! the! treated! (in! this! case!





all! cultures.! As! with! the! MabBonly! transfected! cells,! growth! rate! in! the! BFAB
selected!cells!reduced!to!68%!(61%!in!MabBonly!transfected!cells)!of!that!seen!in!
the!control!cells!with!only!a!small!change!in!viability,!which!remained!at!97%!of!
that! of! the! control! in! both! experiments! (figures! 6B4! b,! c;! 6B3! a,! b).! Both!
experiments! saw! a! significant! increase! in! overall! titre,! though! this! was! more!
pronounced!(1.9Bfold! increase)! in! the!coBtransfection!experiment! than!the!single!
transfection!(1.3Bfold;!Figures!6B4!d;!6B4!c).!This!may!be!due!to!the!use!of!an!ELISA!
to! measure! productivity! level! in! the! coBtransfection! experiment! (due! to! stock!
issues)!whilst!Valita™TITER!HS!was!used! to!measure!productivity! in! the! singleB
transfection! experiment.! However,! whilst! exact! titre! measurements! may! vary!







plasmid1 DNA.1 After1 four1 days’1 growth1 cells1 were1 sampled1 for1 [a]1 transfection1 efficiency,1 [b,1 c]1 cell1
growth1and1viability1and1[d]1productivity.1Bars1for1growth1data1and1transfection1efficiency1show1the1
mean1 average1 of1 two1 (LD0)1 or1 three1 (LD75)1 biological1 replicates.1 Bars1 for1 titre1 show1 the1mean1 of1

























































































the!selection!chemical!and! the!cellBbanking!process!had!not! resulted! in! the!cells!
losing! their! BFA! resistance.! A! killBcurve! was! performed! on! all! cell! lines! to!
determine! BFABresistance! levels! and! judge! how! the! different! cell! lines! reacted!
after!ten!passages!without!the!presence!of!BFA.!Kill!curves!were!carried!out!in!96!




cell! lines! cultured! without! the! presence! of! BFA.! The! kill! curve! shows! that! the!
unselected! control! cells,! alongside! the! LD25! cells,! have! no! resistance! to! BFA.!
Whilst! at! 1.0! μM! BFA! the! LD75! cell! line! sees! a! slight! reduction! in! growth! rate!
compared!to!that!of!the!same!cell!line!grown!without!BFA!(94%!of!LD75!cells!with!
no!BFA!present)!this!decrease!is!not!at!the!same!level!as!that!seen!from!the!LD50!
cell! line! at! the! same!BFA! concentration! (which!had!72%! the! growth! rate! of! the!
same!cell!line!grown!without!BFA).!The!kill!curve!highlights!the!difference!in!BFA!
resistance! between! the! three! differently! selected! cell! lines,! showing! that! even!
after! removal! of! BFA! the! BFABresistance! phenotype! of! the! LD75! cell! line!






After1 ten1passages1of1growth1without1 the1presence1of1BFA,1 the1BFA1resistance1of1CHO1cells1 selected1
with1BFA1at1control,1LD25,1LD501and1LD751levels1were1tested1in1a1kill1curve.1All1the1different1cell1lines1
were1grown1with1BFA1in1a1shaken1961deep1well1plate1at10,10.51and11.01μM1BFA.1Cells1were1grown1for1






























































two! different! points! within! the! secretory! pathway! at! the! same! time! –! at! ERES!
formation!(FLIB06Bmediated)!and!GolgiBER!and!interBGolgi!transport!(BFA).!!
!
As! with! the! BFABonly! single! selection,! CHO! cells! were! treated! with! both!
compounds! at! LD25,! LD50! and! LD75! concentrations.! Treatment! with! both!
compounds!was!performed!concurrently! in!an!attempt! to! increase! the!power!of!
the! selection! process! by! imposing! harsher! conditions! upon! the! cell! population.!
The!LD!values!for!each!of!the!two!compounds!used!in!the!chemical!selection!were!
the! same! as! those! calculated! from! the! initial! kill! curves! (sections! 5.3.2.3! and!













As! with! the! BFABonly! chemical! selection,! the! presence! of! two! compounds!
inhibitory!to!CHO!cell!growth!slowed!cell!growth!compared!to!that!of!the!control!
cells,! reducing! the! number! of! generations! the! filtered! cells! progressed! through!
despite!undergoing!a!similar!number!of!passages.!Cell!cultures!were!passaged!as!












Parental1 MedI-CHO1 cells1 were1 treated1 with1 BFA1 and1 FLI-061 in1 combination1 at1 concentrations1
equivalent1 to1 LD25,1 LD501and1LD75.1 Cell1 growth1data1was1 collected1at1 the1 end1 of1 each1passage1 to1












































































As! with! the! BFABonly! shortBterm! selection! process,! the! growth! metrics! of! the!
LD25Btreated! cells!were! comparable! to! those! of! the! control! cells! (figure! 6B6! a).!
The!LD50!and!LD75!cell!lines,!as!in!the!BFA!single!selection!process,!took!between!
six! to! ten!passages!(20B30!generations)! for!growth! to!recover! to! the! level!of! the!
control!cells.!In!general!the!LD50!cells!recovered!quicker!than!LD75!cells!in!terms!
of! both! growth! rate! and! viability! (figure! 6B6! a,! b).!Whilst! the! cell! size! of! some!
selected! cells! varied! early! in! the! selection! process,! this! also! stabilised! within!
roughly!five!passages!(figure!6B6!c).!
6.4.2.$Productivity$analysis$of$short2term$dual2selected$CHO$cells.$
All! dualBselected! cells! (biological! duplicates! from! control! and! DMSO! controls;!
biological!triplicates!from!LD25,!LD50!and!LD75!test!subjects)!were!revived!from!
cell! banks! and! grown! for! at! least! four! passages! without! the! presence! of! any!
selective! pressure.! After! three! days! of! postBpassage! growth,! cells! from! each!
culture! was! transiently! transfected! by! nucleofection,! using! the! Lonza! Amaxa™!
cuvette! system! (section! 2.5.1).! Cells! from! each! culture! were! transfected! with!
plasmid!DNA!made!up!of!a!1:1!molar!ratio!of!DTEBMab!and!pMAXGFP!such! that!
both! cell! productivity! and! transfection!efficiency! could!be! assayed! concurrently.!
PostBtransfection! cells! were! grown! for! four! days! before! sampling! for! growth,!
transfection! efficiency! (by! flow! cytometry)! and! titre! (by! Valita™TITER).! Growth!
and!productivity!data!are!shown!in!figure!6B7,!with!data!shown!as!a!fold!change!of!
the! average! value! of! the! control! cells.! Control! data! from! both! untreated! and!
DMSOBcontrolled! cells! has! been! combined! due! to! the! lack! of! differentiation!
between! these! two! separate! controls! in! terms! of! both! cell! growth! during! the!
filtration!process!and!behaviour!postBtransfection.!
!
Transfection! efficiency! of! the! control! cells! is! slightly! lower! than! previously!
observed! (54%),! although! as! in! section! 6.2.2! this! may! be! due! to! the! fourBday!
expression! process.! However,! as! all! cell! lines! were! treated! the! same! they! are!
directly!comparable.!The!transfection!efficiency!of!the!LD25!cells!does!not!differ!to!
that! of! the! control.! However,! the! transfection! efficiency! of! the! LD50! and! LD75!
dualBselected!cell!lines!see!a!significant!increase,!with!a!17%!and!21%!increase!in!
GFPBpositive!cells!respectively!(figure!6B7!a).!In!contradiction!to!growth!rates!seen!
in! the! BFA! selected! and! FLIB06Bevolved! cells,! in! the! dual! selection! the! postB
transfection!growth!rate!of! the!LD50!cells!sees!a!significant!15%!increase.!LD75!
cells! also! see!a!12%! increase! though!as! this! is!not! significant! it! could!be!due! to!
noise!(figure!6B7!b).!There!is!no!change!in!viability!between!the!cultures,!though!






and1 GFP.1 After1 four1 days’1 growth1 cultures1were1 sampled1 for1 growth,1 productivity1 and1 transfection1
efficiency1 data.1 Data1 is1 shown1 as1 a1 fold1 change1 of1 the1 control1 (LD0)1 data1 for1 [a]1 transfection1
efficiency,1[b]1growth1rate,1[c]1overall1titre1and1[d]1specific1productivity.1For1growth/viability,1columns1





































































































this! data! alongside! that! of! cell! growth,! the! LD75! cells! see! no! increase! in! Qp!
compared! to! the! control.! This! is! in! contradiction! to! the! LD25! cells!which! see! a!
statistically! significant! Qp! increase! of! 18%,! whilst! LD50! cells! see! a! significant!
decrease!in!Qp!to!86%!of!the!level!seen!in!the!control!cells!(figure!6B7!d).!!
!




growth! rate! response.!That! transfection! efficiency! is! higher! in! the!more!harshly!
filtered!cells!than!the!control/LD25!cells!further!highlights!that!treating!cells!with!
secretory! inhibitors! does! not! negatively! impact! upon! transfection! efficiency.!
However! it! is! not! known!why! this! process!may! result! in! increased! transfection!
efficiency! after! four! days’! growth,! especially! with! the! growth! rate! of! betterB





As! in! section!6.2.3,! the! stability! of! the! selected! cells!was! tested! to! determine! to!
what! level! resistance! to! the! BFA/FLIB06! cocktail! persevered! after! cell! banking,!
revival! and! six!passages!without! the!presence!of! selective!pressure.!A!kill! curve!
was!carried!out!to!test!all!biological!replicates!in!duplicate!at!untreated,!LD50!and!






Treatment! with! a! LD50! level! of! the! inhibitor! cocktail! resulted! in! a! severe!
reduction! of! growth! rate! and! IVCD! change! in! the! LD25! and! LD0! cell! lines.!
Treatment!of!the!LD75!cells!results!in!a!reduction!in!IVCD!change!over!three!days!
to!73%!of! that!of!untreated!LD75!cells.!When! treated!with!an!LD75! level!of! the!
inhibitor!mixture!the!IVCD!of!LD75!cells!reduces!to!64%!of!the!untreated!cells.!A!
similar!pattern! is! seen! in! the!LD50! cells,!with! a! larger!decrease! in! IVCD! change!
seen!when! these! cells! are! treated!with! the! LD75Blevel! of! the! inhibitor!mixture,!









[b]1 growth1 rate1 could1 be1 determined1 across1 all1 cell1 lines1 and1BFA1 concentrations.1 Each1 data1 point1
shows1 the1 average1 of1 a1maximum1of1 two1 technical1 replicates1 of1 three1 biological1 replicates1 (n1 =1 6).1
Error1bars1show1SEM1 1











































This!data! suggests! that! the! cells!have!not!maintained! full! resistance! to! the!drug!
mixture!at!the!levels!used!(figure!6B8!a).!GrowthBrate!levels!of!the!LD50!and!LD75!
cell! lines! also! show! that! resistance! to! the! BFA/FLI! combination! has! decreased!
somewhat.!At!the!LD50!concentration!the!growth!of!the!LD50!cell! line!is!90%!of!
the! same! cell! line! with! no! drug! treatment,! decreasing! to! 53%! when! in! the!
presence! of! LD75! of! the! inhibitor! cocktail.! Growth! rate! of! the! LD75! cell! line! is!








As! with! fully! evolved! cell! lines! (section! 5.2.5.2),! shortBterm! selected! cells!
underwent! basic! proteomic! and! transcriptomic! analysis! to! better! decipher! the!















However,! in! the!dualBselection!cells,!whilst! the!BiP!band! intensity!appears! to!be!
greater! than! that!of! the!other! cell! lines! (figure!6B9! a),! once! the! intensity!data! is!
normalised! for!βBactin!housekeeping! levels! there! is!a! significant!decrease! in!BiP!
protein!level!to!64%!of!that!seen!in!the!control!(figure!6B9!b).!This!suggests!that!
cells!treated!with!both!secretionBinhibiting!compounds!the!ER!stress!response!and!
UPR! has! been! knocked! down.! βBactin!was! used! as! a! housekeeping! gene! as! it! is!
historically!used!as!such!and!antibodies!against!it!are!readily!available.!However!
more! recent! studies! have! suggested! that! it! may! actually! display! divergent!
expression! levels! that!make! it!unsuitable! for! this! role.!As! such! this!data!may!be!





The1 UPR1 status1 of1 MedI-CHO1 and1 BFA-1 and1 FLI-06-filtered1 CHO1 cell1 lines1 were1 analysed1 by1
quantitative1 western1 blotting1 of1 the1 UPR1 marker1 BiP,1 with1 β-actin1 was1 used1 as1 a1 housekeeping1
control.1[a]1Protein1bands1at1the1requisite1sizes1were1seen1for1BiP1(72.41kDa)1and1β-actin1(41.71kDa).1









The1 transcript1 levels1 of1 UPR-related1 genes1 (ATF6,1 BiP1 and1 XBP1)1 and1 BFA1 targets1 (GBF1,1 ArfGef1,1




























































fold! greater! than! in! the! control.! Whilst! ArfGef1! and! ATF6! levels! stay! stable!




Cells! that! have! undergone! the! dual! BFA/FLIB06! selection! see! a! nonBsignificant!
1.46Bfold!increase!in!GBF1!levels.!However,!all!other!test!genes!see!a!decrease!in!
transcript!abundance!level,!with!levels!of!ArfGef1!(43%!of!control)!and!BiP!(53%!
of! control)! both! being! statistically! significant.! This! transcriptomic! data,! taken!
alongside!the!productivity!data,!suggests!that!both!a!slight!upregulation!or!downB
regulation!of!the!CHO!UPR!stress!response!can!result! in!a!slight! increase! in!CHO!
productivity!(figures!6B4,!6B7!and!6B10).!
!
Although! the! shortened! chemical! exposure! time!of! the! selection! strategy! should!
limit! the! opportunity! for! resistance! through!mutation! to! occur,! this! outcome! is!
still!a!possibility.!As!in!section!5.2.5.3,!an!attempt!was!made!to!sequence!the!Sec7!
domain!of!the!GBF1!gene!to!determine!whether!a!mutation!may!have!resulted!in!
the! BFA! resistance! of! the! filtered! cell! lines.! However,! the! PCR! and! product!




Data! from! both! single! (BFA! only)! and! dual! (BFA/FLI)! shortBterm! selection!
experiments! suggests! that! secretory! blocking! agents! can! be! used! to! filter! a!
population! of! CHO! cells,! resulting! in! a! population! selected! for! an! increased!
productivity! phenotype,! resulting! in! a! small! increase! in! titre! and! Qp.! However,!
that! there! is! no! stepwise! increase! in! overall! titre! or! Qp! across! both! selection!
experiments! (i.e.!productivity! increases!as! the!LD!value! increases)! suggests! that!
the!selection!effect!is!not!necessarily!as!directly!linked!to!the!concentration!of!the!
secretory! inhibitor! used! in! the! selection! process.! This! may! be! due! to! some!
flexibility! being! allowed! in! the! selection! process! to! ensure! cells! could! recover!
growth!after!chemical!treatment.!!
!
Whilst! the! overall! outcome! is! somewhat! satisfactory! it! does! appear! to! be! a!
somewhat! trialBandBerror!process.!Whilst! the!shortBterm!selection!process!has!a!







with! BFA! does! not! reduce! transfection! efficiency! (figure! 6B4! a).! However,! these!
cells!do!still!see!a!reduction!in!cell!growth!to!approximately!60B70%!the!level!of!
untreated!control!cells!after!transfection,!despite!there!being!no!difference!during!




That! the! reduction! in! cell! growth! in!DTEBMab! and!GFP! coBtransfected! cells!was!
less! than! that! seen! in!DTEBMabBonly! transfected! cells! (figures!6B3! a,! 6B4!b)! also!
points! towards! this! as! DTEBMabBonly! transfected! cells! were! transfected! with! a!
higher!total!level!of!MabBencoding!plasmid!than!the!coBtransfected!cells.!As!such!it!
can!be!suggested!that!the!MabBonly!cells!were!producing!more!Mab!than!the!coB
transfected! cells.! As! such! these! cells! had!more!Mab! to! process! and! so! directed!
more! cellular! resources! to! this! (and! away! from! cell! growth)! than! the! coB


















there! is! some! opportunity! for! the! two! compounds! to! interact! with! each! other,!
which! could! limit! their! function! or! impact! upon! CHO! cell! function! by! an!
unexpected! interaction.! However,! that! the! dual! and! single! BFA! shortBterm!




This! again! highlights! that! the! shortBterm! selection! process! is! somewhat!
unpredictable.!A!scientific!decision!can!be!made!as!to!a!pathway!to!target!(and!the!
compound! used! to! target! it),! but! with! the! shortBterm! selection! process! being!
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The! extended! exposure! of! evolved! cells! to! BFA! when! compared! to! the! short!
exposure! time! of! the! chemical! selection! suggests! that! a! BFABresistant!mutation!
may! have! persevered! within! the! population! and,! whilst! an! increase! in! GBF1!





ShortBterm! selection! of! CHO! cells!with! both!BFA! and!FLIB06! resulted! in! a!much!
more!marked!difference! in! transcriptomic!profile! compared! to!BFABonly! treated!
cells!(figure!6B10).!This!could!be!explained!by!the!targeting!of!two!sections!of!the!
secretory!pathway,!although!this! is!not!entirely!clear.!A!FLIB06!only!selected!cell!
line! would! need! to! be! produced! for! this,! whilst! comparison! of! UPR! marker!
transcript!abundance!of!this,!FLIB06Bevolved!cells!and!the!dual!selection!would!be!
required!to!allow!a!firm!conclusion!to!be!made.!However!it!is!again!worth!noting!
that,!despite! the!differences! in! (an!albeit! limited)! transcriptomic!profile,!FLIB06B
selected! cells! saw! the! same! increase! in! DTE! transient! production! as! the! BFAB
selected!cells.!
!
Overall,! this!data!suggests! that! shortBterm!chemical!selection!could!be!used!as!a!
method!to!enhance!productivity!in!transient!culture,!which!can!be!used!in!biologic!
production! (Daramola! et! al.! 2014).! If! the! secretory! pathway! has! indeed! been!
enhanced!then!the!improvement!in!titre!level!should!be!seen!across!the!range!of!
model!products! as! the! secretory!pathway! sections! targeted!are! constitutive,!not!
specific.! Testing! the! effect! the! shortBterm! selection! process! has! upon! stable!





line! stably! expressing! a!model! recombinant! protein!would! allow!an! insight! into!
whether! the! selection! process! can! have! the! same! effect! when! a! cell! is! already!










some! productivity! benefits! (as!well! as! those! of! time)! to! a! short,! sharp! filtering!
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biosynthetic! and! secretory! pathway! of! the! CHO! cell! when! comparing!
producing! and!non!producing! cells,! or! cells!with!highBor! lowB!production!
levels.!
• This! differs! to! the! plasma! cell,! where! there! are! many! large! changes! in!





• Ectopic! expression! of! single! genes! targeting! specific! areas! of! the! CHO!
secretory! pathway! had! little! effect! upon! CHO! cell! productivity! of! a!
transiently!expressed!DTEBMab.!
• Expression! of! transcription! factors! that! cut! across! several! regions! of! the!
CHO!secretory!and!biosynthetic!pathways!can!increase!the!productivity!of!
CHO!cells!transiently!expressing!a!DTEBMab.!!
• Combination! of! up! to! three! genes! targeting! a! specific! region! of! the! CHO!
secretory!pathway!is!not!sufficient!to!enhance!CHO!cell!productivity.!
• Combination! of! globallyBeffective! transcription! factors! can! have! a!
concomitant!effect!upon!CHO!cell!transient!productivity.!
• Ectopic!expression!of! transcription! factors! in!a!stablyBproducing!CHO!cell!
pool!does!not!have! the!same!effect!as!seen! in! transientlyBexpressing!CHO!






• HamsterBderived! cell! lines! react! differently! to! secretory! blocking! agents!
that!function!in!other!mammalian!cell!lineages.!




• ShortBterm! treatment! of! CHO! cells! with! chemical! secretory! pathway!





the!CHO! cell,! removing! secretory!bottlenecks! and! leading! to! an! enhancement!of!
productivity!levels.!CHO!cells!are!widely!used!in!the!manufacture!of!biologics!due!




By!enhancing! the!CHO!secretory!pathway! it!was!hypothesised! that! the! titre!and!
specific! productivity! of! model! recombinant! biologics! would! be! enhanced.!
Furthermore,!the!engineering!strategies!used!might!enhance!the!capacity!of!CHO!
cells! to! produce! the! increasing! array! of!more! difficult! to! express! biologics! (e.g.!




used! to! enhance! CHO! cell! productivity.! There! are! many! examples! within! the!
literature! of! direct! genetic! engineering! approaches! increasing!CHO!productivity.!
Whilst!there!have!been!examples!secretory!pathway!engineering!these!have!only!
targeted! a! single! section! of! the! secretory! pathway.!Here,! using! highBthroughput!
techniques,!a!large!number!of!genes!targeting!many!different!sections!of!the!CHO!
biosynthetic! and! secretory! pathways! could! be! screened.! Novel! targets! were!
discovered! though! utilisation! of! plasma! cell! transcriptomic! data,! with! some!
increasing! CHO! productivity! levels.! Enhancement! of! the! secretory! pathway!
through!directed!evolutionary!and!selection!processes!was!performed,!a!method!
that! has! yet! to! be! fully! investigated! in! the! literature.! This! has! lead! to! the! novel!
strategy! of! a! shortBterm! chemical! selection,! utilising! secretory! blocking!





In! chapters! 1! and! 3! prior! knowledge! from! the! literature! was! combined! with!
transcriptomic!and!proteomic!data!from!CHO!cells!to!better!understand!the!CHO!
biosynthetic!and!secretory!systems.!Comparison!of!‘omic!data!from!highB!and!lowB
producing! CHO! cells! (productivity! difference! being! due! to! either! cell! line!
development! and! selection,! different! growth! phases! or! different! expression!
processes)! showed! there! was! little! ‘omic! difference! between! highB! and! lowB
producing!CHO!populations!when!looking!at!genes/proteins!involved!in!secretion.!!
!
However,! transcriptomic! data! comparing! naïve! B! cells! to! their! terminally!
differentiated!state,!the!Mab!producing!and!highBsecreting!plasma!cell,!highlighted!
myriad!changes!in!gene!expression!that!are!required!to!turn!a!low!producing!cell!
in! to! one! specialising! in! high! production! and! secretion! levels.! From! ‘omic! data,!
general!secretory!pathway!knowledge!and!previous!CHO!engineering!strategies,!a!




in! chapter!4.!The!effect!of! each!of! the! single!genes!at!different!dose! levels!upon!
CHO! productivity! of! a! transiently! expressed! DTEBMab!was! tested.! This! showed!
that!a!few!of!the!genes!selected!had!a!positive!impact!upon!CHO!productivity!of!a!
DTEBMab.! In! general! more! global! engineering! targets,! such! as! transcription!
factors,! enhanced!CHO!cell! productivity.!Whilst! ectopic! expression!of!XBP1s!has!





CHO! productivity! levels.! Single! gene! data! was! used! to! inform! multigene!
engineering!strategies!to!further!boost!CHO!productivity!levels.!Alongside!a!dataB
driven! combination! of! transcription! factors,! knowledgeBdriven! two/three! gene!
combinations! were! also! designed! to! target! specific! sections! of! the! secretory!
pathway.!!
!
Expression! of! many! genes! selected! to! directly! engineer! specific! sections! of! the!
biosynthetic! and! secretory! pathways! had! little! impact! upon! the! level! of! CHO!
production! of! a! transiently! expressed! DTEBMab.! However,! effector! genes!which!
had! a!more! global! effect! in! enhancing! transcription! levels! of!many! genes,! had! a!
concerted!positive! impact!upon!CHO!cell!productivity.!With! some!effector!genes!





effects! of! some! targets! in! a! transientlyBexpressing! cell! line! were! not! seen! in! a!
stably!expressing!pool.!Whilst!XBP1,!CREB3L2!and!CRELD2!all!enhanced!transient!
DTEBMab! expression! levels,! they! had! little! effect! upon! production! levels! of! a!
stablyBexpressed!DTEBMab.!!
!
We!hypothesise! that! continuous!expression!of! a! recombinant!protein,! especially!
one!considered!difficult! to!express,!generates!a!chronic!ER!stress!response.!This!
can! perpetuate! feedback! suppression! of! proteins! involved! in! unfolded! protein!
response! activation.! This!may! explain! the! lack! of! response! of! stably! expressing!




multiBgene! engineering! of! complicated! molecular! pathways! is! generally! not!
suitable! for! enhancing! CHO! productivity.! There! are! many! molecular! targets!
involved! in! different! areas! of! the! biosynthetic! secretory! pathway,!whilst! only! a!
small!number!can!feasibly!be!used!to!engineer!the!cell.!As!such!the!overexpression!









Interestingly! sole! expression!of! some! targets!previously! shown! to! enhance!CHO!
productivity!(e.g.!CERT,!YY1)!did!not!have!the!same!effect!within!this!gene!screen.!
This! highlights! that! the! differences! between! different! CHO! cell! lines,! model!
recombinant!proteins!and!expression!systems!can!have!all! impact!upon!a!gene’s!
effect! upon! cell! productivity.! This! again! highlights! that! a! directed! genetic!
engineering! solution! for! one!problem!may!not!necessarily! solve! another! similar!
problem,! as! well! as! highlighting! the! importance! of! reproducibility! between!




In! chapters!5!and!6! two!different!directed!evolution!strategies!were!used! to! try!
and! enhance! CHO! productivity! levels.! It! was! hypothesised! that! blocking! of! a!
section! of! the! secretory! pathway! would! perpetuate! myriad! transcriptomic! and!
proteomic! changes! within! the! cell! so! as! to! overcome! the! blockage,! with! these!
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cell! growth! and! secretory! pathway!morphology.! Two! compounds!were! selected!
and!shown!to!have!an!effect!upon!CHO!cells:!Brefeldin!A!inhibits!vesicle!formation!




determined!by!assaying! the!productivity!of! resultant!cell! lines! through!transient!
and!stable!transfection!with!a!difficultB!and!easyBtoBexpress!model!Mabs.!!
!
In! chapter! 5! it! was! hypothesised! that! blocking! of! the! secretory! pathway! at! a!
specific! point! for! an! extended! period! of! time! would! result! in! either! the!
upregulation! of! molecular! machinery! within! the! region! targeted,! and/or!
enhancement!of!other!pathways!to!overcome!the!blockage.!Both!outcomes!would!
result! in!an! increase! in!cellular!secretory!capacity!upon!removal!of! the!selection!






From! the! Brefeldin! A! evolution! results! it! was! hypothesised! that! a! longBterm!
exposure! to! increasing! levels! of! this! selective! agent! brought! about! mutations!
within!the!compound’s!target!pathway.!These!produced!resistance!to!Brefeldin!A,!
perpetuating! a! Brefeldin! A! resistance! phenotype! without! the! hypothesised!
concomitant!secretory!enhancements.!As!such! it!was!suggested! that!a! longBterm!




The! inability!of! the!BFA!evolutionary!process!to! instigate!an! increased!secretory!
and!productivity!phenotype! led!to!the!hypothesis! that!a!shortBterm!treatment!of!
CHO! cells! with! a! high! concentration! of! a! secretory! inhibitor! could! act! as! a!
“chemical!selection”.!This!would!have!the!effect!of!attenuating!the!growth!of!cells!
with!a!low!secretory!phenotype,!allowing!cells!with!a!high!secretory!phenotype!to!
pervade!within! the!population.!Rather! than! trying! to!change! the! ‘omic!profile!of!
CHO! cells! as! attempted! by! directed! evolution,! the! shortBterm! selection! process!





single! concentration! of! inhibitor! until! cell! growth! recovered.! Two! shortBterm!
chemical!selections!were!tested!–!a!BFABonly!selection!and!a!dual!selection!where!
BFA! and! FLIB06! were! used! in! tandem.! The! effectiveness! of! the! two! shortBterm!
selection!processes!was!tested!by!transient!expression!of!a!DTE!Mab.!This!showed!
that!an!overall! increase! in!Qp!was!seen! in!CHO!cells! treated!with!a!high!dose!of!








shortBterm! chemically! selected! cell! lines,! would! need! to! be! assayed.! This! was!
attempted! in! the! thesis! but! cell! productivity! levels! varied! too! much! for! a!
conclusion!to!be!made.!Use!of!TEE!technology!would!normalise!Mab!transcription!
levels!across!test!and!control!cell!lines,!providing!clearer!data!on!the!productivity!
of! the! FLIB06! evolved! and! shortBterm! selected! cell! lines.! Whilst! transient!
expression! studies! have! suggested! that! chemically! selected! cell! lines! have! an!





single! vector! could! simplify! gene! engineering! process.! Controlling! component!
levels! by! placing! them!under! the! transcriptional! control! of! synthetic! promoters!
would!also!allow!tunable!expression!of!genes.!This!would!allow!tighter!control!of!
product! and! effector! levels,! providing! a! process! by! which! processing! load! and!





changes! that! have! produced! the! phenotypes! of! the! evolved! and! shortBterm!




blotting! –! would! provide! quantifiable! information! on! the! protein! levels! of! BFA!
targets,! as! well! as! UPR! effectors,! allowing! a! deeper! insight! into! the! effects!
evolutionary!and!filtering!processes!have!had!upon!the!cell.!This!was!performed!
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but! analysis! of! GBF1! levels! was! unsuccessful.! The! application! and! effect! of!
evolutionary!and!filtering!processes!still!need!to!be!defined!to!ensure!they!are!not!
a! trialBandBerror! approach! to! cell! line! development.! Evolution! of! a! stablyB
expressing! cell! line! could! be! tested! to! better! determine! the! step! of! cell! line!
development!at!which!these!processes!could!be!best!deployed.!
!
Further! to! the! scope! of! this! project! there! are! other!methods! by!which! the! CHO!
secretory!pathway! could!be! engineered.!Better!CHOBrelevant! secretory!pathway!
maps!could!be!produced!by!utilising!gene!knockBdown!and!screening!technologies!
such! as! siRNA.! This! could! better! inform! the! selection! of! gene! and! pathway!
engineering! targets.! Further! to! this,! the! knockBdown! of! host! cell! proteins! that!
undergo!constitutive!secretion,!but!are!not!required!for!the!specific!function!of!the!
CHO!cell,!could!free!up!space!within!the!CHO!secretory!pathway!for!recombinant!
proteins.! The! reduction! in! secretory! cargo! could! reduce! the! pressure! upon!
secretory!bottlenecks,!as!well!as!easing!the!process!of!product!purification.!!
!
Furthermore,! the! use! of! genome! editing! tools! such! as! CRISPR! could! be! used! to!
engineer!endogenous!genes.!For!example!the!XBP1!(ensuring!it!is!always!within!a!
spliced! conformation),! CREB3L2! (ensuring! only! its! transcriptionally! active!
cytosolic!domain! is!present)!or!CERT!(engineering! the!phosphorylation!site! that!
determines!its!functionality!such!that!it!can!always!transfer!ceramide)!genes!used!
in! the! project! were! designed! to! be! transcriptionally! active.! Modification! of! the!
endogenous! gene! by! CRISPR! would! allow! genes! to! be! in! a! more! active!










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































L! 50%! increase! in! specific! productivity! in! single!

























4Lfold! increase! in! RNA! transcript! abundance! in!

































CHO! cells! grown! at! 33! °C! when! compared! to!
lowerLproducers! at! 37! °C.! Increased! proteomic!
abundance! in! CHO! cells! with! sustained!
productivity! compared! to! those! with! nonL










































































































TXNDC5! protein! levels! increased! 1.97Lfold! in! a!
MabLexpressing!CHO!line!overexpressing!the!antiL























































L! Inhibition! of! glycosylation! and! decrease! in!
Amyloid! Precursor! Protein! processing! and!




















L! L! L! Secretory!
pathway!
mapping!











L! L! L! TranscripL
tomic!
6.1Lfold! increase! in! plasma! cell! RNA! abundance.!







Plasma! L! L! TranscripL
tomic!
2Lfold! increase! in! plasma! cell! RNA! abundance.!
Small! increase! in! RNA! abundance! in! producing!















5.2Lfold! increase! in! plasma! cell! RNA! abundance!
and! associated! with! increased! CHO! production!
capacity.! Increase! in! production! of! SEAP,! SAMY!
and!VEGF!of!between!2L6Lfold.!CoLexpression!with!
Munc18! and! Sly1! further! enhanced! the! effect! of!
these! genes.! 15L85%! increase! in!Mab! production!





















Plasma! L! L! TranscripL
tomic!
7.5Lfold!increase!in!plasma!cell!abundance.!Master!
regulator! in! B! lymphocyte! maturation! and!













































L! L! L! Secretory!
pathway!
mapping!
1.7Lfold! increase! in! plasma! cell! RNA! abundance.!









HeLa,!! ! ! Secretory!
pathway!
mapping!
1.9Lfold! increase! in! plasma! cell! RNA! abundance.!






































































Inhibition! in! yeast! blocked! secretion! of! some!
cargo!loads!but!not!others;.!
Inhibition! in! mammalian! cells! inhibited! VSVLG!
transport.!
























L! Engineering! of! CHO! cells! with! SRP/SR! proteins!
increases! of! DTE!Qp! by! 20L80%! depending! upon!
combinations!used.!
SRPR! has! positive! correlation! with! stable! CHO!
productivity.!
SRP19! (1.3Lfold),! SRP54a! (5.2Lfold)! RNA!
transcripts! both! increased! in! plasma! cells.!
























CHOLK1! L! L! TranscripL
tomic!





















Plasma! L! L! TranscripL
tomics!
3Lfold!increase!in!plasma!cell!RNA!abundance.!


















L! Gene! deletion! of! both! (independently! of! each!
other)! increased! secretion! of! cargo,! whilst!













Sec23:! 1.5Lfold! increase! in! plasma! cell! RNA!
abundance.!
Sec24:! 2.6L5Lfold! increase! in! plasma! cell! RNA!
abundance,!depending!on!isoform.!
Together!they!form!COPII!coat!then!interacts!with!











Zebrafish! L! L! TranscripL
tomic!
2.8Lfold!increase!in!plasma!cell!RNA!abundance.!











L! L! Involed! in! sorting! and! regulation! of! secretion! of!
































L! Overexpression! results! in! 2L3Lfold! increase! in!
SEAP,!SAMY!and!VEGF!production.!
CoLexpression!of!Sly1!and!Munc18c!saw!a!further!















Associated! with! increased! CHO! production!
capacity.!Golgi!SNARE!mediating!vesicle!docking!at!

















Inhibition! of! protein! halts! VSVG! transport! to! cell!













Proteomic! Found! in! rat! liver! secretory! pathway,! but!
downregulated! (L1.2Lfold)! in! plasma! cells.! KnockL
down! by! siRNA! showed! essential! role! in!




























Present! in! rat! liver! secretory! pathway.!
Knockdown! showed! essential! role! in!mammalian!















RAB11a% P62492! L! L! L! Secretory!
pathway!
mapping!





















surface.! Rab26! depletion/mutation! reduces!













L! RabD! overexpression! resulted! in! an! increase! of!


























Exocyst! component! at! the! plasma! membrane!
(PM),! marking! polarised! exocytosis! sites.!
Associated!with! increased! production! capacity! in!
CHO!cells.!
Overexpression! in!budding!yeast!does!not!change!














Small! increase! in! Plasma! cells! RNA! abundance!
(1.14Lfold).! Role! in! GolgiLPM! transport! in! plant!
cells! with! roles! in! membrane! fusion! and! vesicle!












PM,! binding! syntaxins! in! a! Ca2+Lindependent!
manner.! SytI/SytII! mutations! in! mouse! cells!










2.5Lfold! increase! in! plasma! cell! RNA! abundance.!
Associated!with! increased! production! capacity! in!
CHO!cells.!Present!in!rat!liver!secretory!pathway.!
Facilitates!fusion!of!COPII!vesicles!to!each!other!to!
form! transport! intermediates,! and! binding! at! cisL
Golgi.! Interacts! with! P115.! Inhibition! (antibodyL































Inactivation! leads! to! 70%!decrease! in! YFPLVSVLG!
transport! cargo,! with! accumulation! at! the! Golgi.!







SCFD2% Q8BTY8! L! L! L! L! Sec1/Munc18! family! member! –! role! in! vesicle!














2.6Lfold! increase! in! plasma! cell! RNA! abundance.!
Protein! present! in! rat! liver! secretory! pathway.!

















1.4Lfold! increase! in! plasma! cell! RNA! abundance.!
1.6Lfold! increase! in! CREBLexpressing! cells.! In!








Golph3% Q9CRA5! Rat!liver! L! L! L! 1.36Lfold! increase! in!plasma! cell!RNA!abundance.!
Protein! present! in! rat! liver! secretory! pathway.!
PI4Lkinase! effector,! which! regulate! mediated!



















VAMP4% O70480! CHO! L! L! TranscripL
tomic!
Associated!with! increased! production! capacity! in!









4.9Lfold! increase! in! plasma! cell! RNA! abundance.!
High! levels! of! CRELD2! expression! in! endocrine!
tissues.! ER_stress! related,! being! downstream! of!
























3.0Lfold! increase! in! plasma! cell! RNA! abundance.!











1.4Lfold! increase! in! plasma! cell! RNA! abundance.!











































1.5Lfold! increase! in! plasma! cell! RNA! abundance.!
Inhibition! with! antibodies! reduced! secretion! of!
amylase! in! rat! cells.! Interacts! with! SM! proteins!














LMAN1:! 4.3Lfold! increase! in! plasma! cell! RNA!
abundance;! associated!with! increased! production!
capacity!in!CHO!cells.!
















3.0Lfold! increase! in! plasma! cell! RNA! abundance.!
Transcription! factor! required! for! terminal!

















8.8Lfold! increase! in! plasma! cell! RNA! abundance.!

















BPRKD1% Q62101! HeLa! L! Inhibition! Lipid!
synthesis!
mapping!
PRKD1! activity! inhibition! in! HeLa! leads! to! Golgi!














29L45%! increase! in! tPA! Qp,! 26%! increase! in! IgG!
Qp.!CERT!traffics!ceramide!(DAG!preLcursor)!from!























located! oxidoreductase! with! role! in! lipid!





PItp% P55065! CHO! IgG! L! TranscripL
tomic!
1.6Lfold!increase!in!higherLproducing!CHO!cells!at!






PLD3% O35405! MAK! ! ! TranscripL
tomic!



























CoLexpression! with! XBP1! resulted! in! a! 5L6Lfold!
increase! in! Mab! productivity! (greater! than! just!
XBP1! expression),! increase! in! ER! volume! and!















3.4Lfold! increase! in! plasma! cell! RNA! abundance.!
Overexpression! in! MZ! B! cells! resulted! in! 5Lfold!
increase! in! antibody! secreting! cells.! Deletion! in!
plasma! cells! reduces! antibody! secretion.! Possibly!















L! PERK! mutation! in! mouse! embryonic! stem! cells!
leads!to!increased!protein!synthesis!levels!but!also!










2.3Lfold! increase! in! plasma! cell! RNA! abundance.!
Activation! of! ATF6!with! small!molecules! reduces!
secretion! of! missLfolded/destabilised! proteins.!
OverLexpression! in! HeLa! cells! saw! increased!
transcription! from!ERSE.! Expression! in! CHO! cells!



























Associated!with! increased! production! capacity! in!








1.8Lfold! increase! in! plasma! cell! RNA! abundance.!
eIF!family!members.!Activation,!helps!protect!cells!















1.45Lfold! increase! in!plasma! cell!RNA!abundance.!
Transient! overexpression! in! CHO! resulted! in! a!
decrease!in!Mab!production.!
Stable! overexpression! in! CHO! resulted! in! 2Lfold!
increase! in! human! antithrombin! III! productivity.!













P20029! CHO2F5! Mab! Stable!over!
expression!
















L! Recombinant! protein! expression! decreased! upon!














































Transient! overexpression! in! COSL1! saw! a! 2Lfold!
increase! in! IgG! production.! Overexpression!
alongside! BiP,! ERdj3/5! resulted! in! a! 3Lfold!
increase!in!IgG.!Overexpression!alongside!PDI!and!
ERO1LLβ!saw!a!2Lfold!increase.!






CTMEM214% Q8BM55! ! L! KD/OverL
expression!








NRF1/NRF2% Q9WU00! mouse! L! KnockL
down!
L! eIF2αLactivating! transcription! factor.! Deficiency!













L! Antioxidant! role! in! glutathione! (GSH)! synthesis.!
GSH!increase!linked!to!increased!CHO!productivity!
levels.! Stable! expression! of! GCLM! in! CHO!
transiently! expressing! IgG1! saw! Qp! increase!
between! 1.37L1.95Lfold! depending! on! growth!
phase,! with! a! 1.71L2.0Lfold! increase! in! titre! over!


























Expression! L! Expression! of! mutated! KIT! resulted! in! increased!









L! L! L! 5Lfold! increase! in! plasma! cell! RNA! abundance.!





















Genes!selected! for!engineering!of! the!CHO!cell!biosynthetic!and!secretory!pathways!were!designed!with!5’!and!3’! flanking!regions!of!
DNA!enabling!them!to!be!inserted!into!a!MedImmuneLspecific!single!gene!expression!vector!or!multi!gene!expression!vector!(MGEV).!
This!appendix!shows!the!cDNA!sequence!for!each!accessory!gene!used!in!the!project,! from!the!ATG!start!codon!to!the!TAA/TGA!stop!
codon.!Flanking!regions!are!not!included.!
Gene%name;%%
Human/CHO;%
NCBI%ref;%Gene%size%
cDNA%Sequence%
PRKD1%
CHO!
XM_016974047.1!
2522!bp!
atggcttgctccatcgtggaccagaagttccctgaatgtggtttctatggactgtatgataagatcctgcttttccgtcatgatcctacctctgaaaacatccttcagctggtgaaaatggcaagtgatatccagg
aaggagatcttattgaagtggtcctgtcagcttcagccacctttgaagactttcaaatccggccccatgctctcttcgttcattcctacagagcccccgctttctgtgaccactgtggagaaatgctctggggact
ggtgcgccaaggccttaaatgtgaaggatgtggtctgaattaccataagagatgtgcatttaaaatccctaacaattgcagtggtgtgagaaggagaaggctctcaaacgtttccctcactgggcttagcact
gtccgcacttcatctgctgagttctccaccagtgcccctgatgagcctctactgtctcctgtaagccctggctttgagcaaaagtcaccatcagagtcatttattggccgtgagaagaggtcaaattcgcaatcg
tatattggacggccaattcaacttgacaagattttgatgtcaaaggtgaaggtgccgcatacttttgtcatccactcctacactcgacccacagtatgccagttctgcaaaaagctcctcaagggcctcttccgg
cagggcttgcagtgcaaagattgcagattcaactgtcacaaacgctgtgcaccaaaagtaccaaacaactgcttgggtgaagtgaccatcaatggagatttgcttagccctggagcagaatctgatattgtta
tggaagaaggaagtgatgacaatgacagtgagcggaacagcggactcatggatgacatggatgaggccatggtccagaatgctgagatggctatggctgagggccagggtgatggtgcggaaatgcagg
atccagatgcagaccaggaggactctaacaggaccatcagcccttcgacaagcaacaacatccccctcatgcgggtggtgcagtctgtcaagcacacaaagcggaggagcagcactgtgatgaaggaag
gatggatggtccattacaccagcaaagacacactgcggaaaagacattactggagattggacagcaagtgcatcacactcttccaaaatgacacaggaagccggtactacaaggaaattcctttatcagaa
attttatgtctggaacctgcgaaaccttcagcattaattcccattggagctaacccccactgttttgaaatcactacagcaaatgtagtgtattacgttggagaaaatgtggtcaatccttcaagtcccccaccaa
acaacagtgttttcaccagcggcattggtgcagatgtggccagaatgtgggaggtggccattcagcatgctctcatgcctgtcatccccaagggctcctctgtggggtcaggaaccaatttacataatgtttct
gtgagcatttcagtttcaaattgccagatccaggaaaatgtggacatcagcaccatctatcagatttttcctgatgaagttttgggttctggacagtttggaattgtttatggaggtaaacatcgtaaaacagga
agagatgtagctattaagattattgacaaattaagatttccaacaaaacaagaaagtcagcttcgtaatgaggttgcaattttacagaaccttcatcaccctggtgttgtaaatttggagtgtatgtttgagacg
cctgaaagagtgtttgttgttatggaaaaactccatggagacatgctggagatgatcttgtcaagtgaaaagggcaggttgccagaacacataacgaagtttttaattactcagatactagtggctttgcggca
tcttcatttcaaaaacatcgttcactgtgacctcaagccagaaaatgtgttgctggcatctgccgatcctttccctcaggtgaaactttgtgattttggttttgcccggatcattggagagaagtctttccggaggt
cagtggtgggtaccccagcctacctggcacctgaggttctgaggaacaagggctataatcgctctctagacatgtggtctgttggggtcatcatctatgtgagcctcagtggcaccttcccttttaatgaagatg
aagacatccatgatcagatccagaatgcagccttcatgtatccgcccaatccgtggaaggagatttctcatgaagccattgatcttatcaataacttgctgcaagtgaaaatgagaaagcgctacagtgtgga
caaaaccttgagtcacccgtggctacaggactatcagacctggttagatttacgagagctggaatgcaagattggagaacgctatattacccacgaaagtgatgactcgaggtgggaacagtatgccggtg
accaggggctgcagtatcccgcacacctgatcagcctgagcgctagccacagcgacagtcctgaggctgaagagagagagatgaaagccctcagtgagcgtgtcagcatcctctga!
! 318!
Gene%name;%%
Human/CHO;%
NCBI%ref;%Gene%size%
cDNA%Sequence%
SGMS1!
CHO!
XM_007648117.2!
1244!bp!
atgaaggaagtggtttattggtcacccaagaaggtggcagactggctgctggagaatgctatgcctgaatactgtgagcctctagaacatttcacaggccgggacttgatcaatctaacccaagaggatttca
caaaacccccactgtgccgagtctcatctgacaacgggcagcggctcttagacatgatcgagaccctgaagatggagcaccatatggaagcgcacaagaacggccacgccaatgggcacctcagcgttgg
cgtcgacattcccaaccctgatggcggcagcttcagcatcaagatgaaacccaatggaatgccaaatgggtataggaaagagatgatcaagatccccatgccagaaccagagcgctctcagtaccccatgg
agtggggcaagactcttctggcctttctttatgcactttcctgttttgttctcactacagtgatgatctcggtcgtccatgaacgagtacctcctaaggaggtgcagcctccactaccggacacgttttttgaccatt
ttaaccgggtgcagtgggccttttctatttgcgaaattaacggcatgatccttgtaggactctggttaattcagtggctggtcttaaaatacaagtctattattagcagaagatttttctgcatagttggcacgctg
tacctgtatcggtgtattacaatgtatgtaactacactcccagtacctggcatgcatttcaactgttctccgaagctctttggagactgggaagctcaagtgcggagaataatgaagctcattgctggaggtggc
ttgtccatcacaggctctcacaacatgtgtggggactatctatacagtggccacacggtcatgctaacgctcacctatttatttatcaaagagtattccccgaggcgactctggtggtaccactggatttgctgg
ctccttagcgtcgttggaatcttctgtattctcttagcgcatgaccactacactgtggacgtggtggtggcctactacatcaccacaaggctcttctggtggtatcacacaatggccaatcagcaagtgctgaag
gaagcttcccagatgaacctcctggccagggtgtggtggtacaggccatttcagtactttgaaaagaatgtccaaggaattgtacctcgatcttaccattggcccttcccctggccagtagtccaccttggtag
gcaagttaaatatagccggttggtaaacgacacataa!
CERT%
S132A% mutation%
(TCA%:>%GCT)%
CHO!
XM_007648610.1!
1796!bp!
atgtcggataaccagagctggaactcgtcgggctcggaggaggatccggagacggagtccgggccgcctgtggagcgctgcggggtcctcagcaagtggacaaactatattcatgggtggcaggatcgtt
gggtagttttgaaaaataatactttgagttactacaaatctgaagatgagacagagtacggttgcaggggatccatctgtcttagcaaggctgtgatcacacctcatgattttgatgaatgtcggtttgatatca
gtgttaatgatagtgtttggtatcttcgtgctcaggacccagatcacagacagcagtggatagatgccattgaacagcacaagactgaatcaggatatggatctgagtccagcttacgtagacatggcGCTa
tggtgtcactggtgtctggagcaagtgggtactctgctacatccacatcttcattcaagaaaggacacagtttacgtgagaaattggctgaaatggaaacttttagagacatcttatgtagacaagttgacact
ctccaaaagtactttgatgtctgtgctgatgctgtctccaaggatgaacttcaaagggataaagtggtagaagatgatgaagatgacttccctacaactcgttctgatggagactttttgcacaataccaatggt
aataaggaaaaattatttccacatgtaacccccaaaggaattaatggtatagactttaaaggggaagcaataacttttaaagcaactactgctggaatccttgctacactttctcattgtattgaattaatggta
aaacgggaagagagctggcaaaaaagacatgataaggaaatggagaagagaagacgattagaggaagcatacaagaatgcaatggcagagcttaagaagaaaccccgttttggagggcctgattatga
agaaggtccgaacagtctgattaatgaggaggagttctttgatgctgttgaagctgctcttgacagacaagataaaatagaggaacagtcacagagcgagaaggtcaggttacactggcctacacctttgcc
atctggagatgccttttcttctgttgggacccatagatttgtacaaaaggttgaagagatggtacagaaccacatgacttactcattacaggatgtaggtggtgatgcgaattggcaactagttgtagaagaag
gagaaatgaaggtatacagaagagaagtcgaagaaaatggaattgttctggatcctttgaaagctacccatgcagttaaaggtgttacaggacacgaagtctgcaattacttttggagtgttgatgttcgcaa
tgactgggaaactactatagaaaacttccatgtagtggaaacattagctgataatgcaatcatcatttatcaaacgcacaagagagtgtggcctgcttctcagagagatgtactgtatctttctgctattcgaaa
gatcccagccttgactgagaacgaccctgagacttggatagtttgtaatttttctgtggatcatgacagcgctcctctgaacaatcgatgtgtccgtgccaaaatcaatgttgctatgatttgtcaaaccttagta
agcccaccagagggaaaccaggaaataagcagagacaacattctgtgcaagattacatatgtagctaatgtgaacccaggaggatgggcaccagcctcggtgttaagagcagtggcaaaacgagaatat
cctaaatttctaaaacgttttacttcttacgtccaagaaaaaactgcaggaaaaccaattttgttttag!
! 319!
Gene%name;%%
Human/CHO;%
NCBI%ref;%Gene%size%
cDNA%Sequence%
Bet1%
CHO!
XM_003496956.3!
357!bp!
atgaggcgtgcaggcctgggtgaaggaggacctcctggcaactatgggaactatggctatgctggtagtggctataatgcctgtgaagaagaaaacgacagactcactgaaagtctgagaagcaaagtga
ctgccatcaaatctctttccattgaaataggccatgaagttaaaaatcaaaacaaactactagctgaaatggattcacagtttgattctacaactggatttctaggtaaaaccatgggaagactgaagattttgt
ccagaggaagccaaacaaaattgctatgctatatgatgttgttttcattgtttgtcttttttgtcatttactggattattaaactgaggtga!
Rab1a%
CHO!
XM_003498103.2!
619!bp%
atgtccagcatgaatcccgaatatgattatttattcaagttacttctgattggcgattctggggttggaaagtcttgcctcctcctcaggtttgcagatgacacgtacacggaaagctacatcagcacgattggtg
tggatttcaagatccgaactatagagttagacgggaagacaatcaagcttcagatatgggacacagcaggccaggaaagatttcgaacaatcacctccagttactacagaggagcccatggcatcatagtt
gtgtatgatgtgacagatcaggagtccttcaataatgttaaacagtggctgcaagagatagatcgctatgccagtgaaaatgtcaacaagttgttggtagggaacaaatgtgacctgaccacaaagaaagta
gtagattacacaacagcgaaggaatttgcagattcccttggaattccatttttggaaaccagtgctaagaatgcaacgaatgtagaacagtctttcatgacgatggcagccgagattaaaaagcgaatgggc
cctggagcaacagctggtggtgcagagaagtccaatgttaaaatccagagcactccagtcaagcagtcaggtggaggttgctgctaa!
Rab11a%
CHO!
XM_003508776.2!
651!bp!
atgggcacccgtgacgacgagtacgactacctctttaaagttgtccttattggagattctggtgttggaaagagtaacctcctgtctcgatttactcggaatgagttcaatctggaaagcaagagtaccattgga
gtagagtttgcaacaagaagcatccaggttgatgggaaaacaataaaggcgcagatatgggacacagcagggcaggagcggtacagggctataacatctgcatactatcgtggagcagtaggcgccttac
tggtttatgacattgctaagcatctcacatatgaaaatgtagagcgatggctgaaagaactgagagaccatgctgatagcaacattgttatcatgcttgtgggtaataagagtgatttacgccatctcagggca
gttcctacagatgaagcaagagcttttgcagagaagaatggtttgtcgttcattgagacatctgctctagattctacaaatgttgaagctgcttttcagacaattctaacagagatataccgcattgtttctcaga
agcaaatgtcagacagacgtgaaaatgacatgtctccaagcaacaatgtggttcctattcacgttccacctaccactgaaaacaagccaaaggtgcagtgctgtcagaacatctaa!
CRELD2%
CHO!
NM_001244136.1!
1048!bp%
atgcacctgccgcccgctgccgcagtcgggctgctactgctgctgctgccgcctcccgcgcgcgtggcctcccggaagccgacaatgtgccagaggtgccgggcgctggtggacaagttcaaccaggggat
ggccaacacggccaggaagaatttcggcggcggcaacacggcgtgggaggagaagagtctgtccaagtacgaattcagtgagattcggctcctggagattatggagggcctgtgtgacagcaacgacttt
gaatgcaaccaactcttggaacagcatgaggagcagctagaggcctggtggcagacactgaagaaggagtgccctaacctatttgagtggttctgtgtacacacactgaaagcatgctgtcttccaggcacc
tatgggccagactgtcaggaatgccagggtgggtctcagaggccttgtagcgggaatggccactgcgacggagatggcagcagacagggcgacgggtcctgccagtgtcacgtaggatacaaggggccg
ctgtgtatcgactgcatggatggctacttcagcttgctgaggaacgagacccacagcttctgcacagcctgtgatgagtcctgcaagacatgctcaggtccaaccaacaaaggctgtgtggagtgcgaagtg
ggctggacacgtgtggaggatgcctgtgtggatgttgacgagtgtgcagcagagaccccaccctgcagcaatgtacagtactgtgaaaatgtcaacggctcctacacatgtgaagagtgtgattctacctgtg
tgggctgcacaggaaaaggcccagccaattgtaaagagtgtatctctggctacagcaagcagaaaggagagtgtgcagatatagatgaatgctcattagaaacaaaggtgtgtaagaaggaaaatgaga
actgctacaatactccagggagctttgtctgcgtgtgtccggaaggtttcgaggaagacagaagatgcttgtgtacagacagcagaaggcgaagtggcagaggaaagtcccacacagccaccctcccatga!
! 320!
Gene%name;%%
Human/CHO;%
NCBI%ref;%Gene%size%
cDNA%Sequence%
CREB3L2%
(cytosolic%
domain)%
CHO!
XM_003500972.3!
948!bp%
atggaggtggagccatctccaacatcaccagcgcctctcatccaggctgaacacagctactccctgagcgaggagccccgggctcagtcaccattcacccatgtggctaccagcgatggcttcaatgacgag
gaagtcgagagtgagaagtggtacctgtctccagactttccttcggccaccgtcaagacagagcccatcacagaggagcagcccccagggcttgttccctctgtcactctgaccatcacagccatttctactcc
ttttgaaaaagaagagtcccctctggatatgaatgctggggtctttggtctccaacaaagcatttatcctaggatctcttgttattcttctgggatggatggaatgcatatgttctcttcatcctcagcctccgtgga
tcagctgcacttaccaccaacaccacctagtagccacagcagtgactccgaggggagcctgagccctaacccccgcctgcatcccttcagcctgtctcaggcccacagccctgccagagccatgccccgggg
cccctctgcgttgtccacatctcctctcctcacagctccacataagctacagggatctggtccactggtcctgacggaggaagagaagaggaccttgattgctgagggctatcctattcctaccaaactgcccct
gacaaaatctgaggagaaggccctgaagaaaatccggagaaaaatcaagaataagatttctgcccaagaaagcaggagaaagaagaaagaatatatggacagcctggagaaaaaagtggagtcatgtt
caactgagaacttggaacttcggaagaaggtggaggtgctagagaacaccaataggactctgcttcagcaacttcagaagcttcaggctctggtgatgggcaaggtgtcccgatcctgcaagttagctggca
cccagactggcacctaa!
PREB%
CHO!
XM_003497042.2!
1254!bp%
atgggcaggcgccggggtgtggagctgtaccgggccccgttcccgttgtacgcgctccaggtggaccccaagaacgggctgctcattgctgcgggcggaggaggagccgccaagaccggcatcaagaatg
gtgtgcactttctgcagctagagcaaatcaatggctgcctgagcgcctccttgctacactctcatgacacagagacacgggccactatgaacttggcactggctggtgacatccttgctgccggacaggatgc
ccgatgtcagcttctacgttttcatgtccatcaacagaagcgcaataaaacagagaagtcaggttccaaggagcagggacctcgacaaaggaagggggcagctccagcagagaagaaatctggagcaga
agtacaccctgaaggggtagaactcaaagtaaaaaatttggaggcagtacagacagactttagcactgaaccactgcagaaagttgtgtgcttcaaccacgataataccctgcttgctactggagggactga
tggccatgttcgtgtctggaaggtacctagcctggagaaagttctggatttcaaagcacatgaaggagagattggagatttggctttgggtcctgatggcaagttggtgactgtaggctgggacttaaaggcct
ctgtgtggcagaaggagcaactagtgacacagctacagtggcaagagaatggacccgcctcttctgacacaccataccgctaccaggcctgcaggtttgggaaggttccagatcaacctggggggctgcga
ctcttcacagtgcagatcccccacaagcgcctgcgtcagcccccaccctgctacctcacagcctgggacagttccacattcttgcctcttcggaccaggccctgtggccatgaagtcatctcctgcctcagtgtc
agtgaatccggtaccttcctaggcttaggcacggtcactggctctgtcgccatctatatagctttctctctccagcgcctctattatgtgaaggaggcccatggcattgtggtgacagatgtaacctttctacctg
agaagggttgtggcccagagcttcttggaccccatgaaactgctcttttctctgtggctgtggatagtcgttgccagttgcacctgctgccctcacggcggagtgttccagtatggctactgctgctgatgtgtgt
cggccttattattgtgaccatcctgctgctccagagtgcctttccaggttttctttag!
! 321!
Gene%name;%%
Human/CHO;%
NCBI%ref;%Gene%size%
cDNA%Sequence%
HSP70/%
HSPA1a%
CHO!
XM_003508473.3%
1926!bp!
atggccaagagcacggcgatcggcatcgacctgggcaccacctactcgtgcgtgggcgtgttccagcacggcaaggtggagatcatcgccaacgaccagggcaaccgcacgacccccagctacgtggcct
tcaccgacaccgagcggctgatcggagacgccgccaagaaccaggtggcgctgaacccgcagaacaccgtgttcgacgcgaagcggctgatcggccgcaagttcggcgacgcggtggtgcaggcggac
atgaagcactggcccttccaggtggtgaacgacggcgacaagcccaaggtgcaggtgagctacaagggcgagacgcgggccttctaccccgaggagatctcgtccatggtgctgacgaagatgaaggag
gtcgccgaggcgtacctgggccacccggtgaccaacgcggtgatcacggtgcccgcctacttcaacgactcgcagcggcaggccaccaaggacgcgggcgtgatcgcgggtctgaacgtgctgcggatca
tcaacgagcccacggcggccgccatcgcctacgggctggaccgctcgggcaagggcgagcgcaacgtgctcatcttcgacctggggggcggcacgttcgacgtgtccatcctgacgatcgacgacggcat
cttcgaggtgaaggccacggcgggggacacccacctgggcggcgaggacttcgacaaccggctggtgagccacttcgtggaggagttcaagaggaagcacaagaaggacatcagccagaacaagcgcg
cggtgcggcggctgcgcacggcctgcgagcgcgccaagaggaccctgtcgtccagcacccaggccagcctggagatcgactccctgttcgagggcatcgacttctacacgtccatcacgcgggcgcggttc
gaggagctgtgctcggacctgttccgcggcacgctggagcccgtggagaaggcgctgcgcgacgccaagctggacaaggcgcagatccacgacctggtgctggtgggcggctccacgcgcatccccaag
gtgcagaagctgctgcaggacttcttcaacgggcgcgacctcaacaagagcatcaacccggacgaggcggtggcctacggggcggcggtgcaggcggccatcctgatgggggacaagtctgagaacgtg
caggacctgctgctgctggacgtggcgccgctgtcgctgggtctggagacggcgggcggcgtgatgacggcgctcatcaagcgcaactccaccatccccaccaagcagacgcagaccttcaccacctactc
ggacaaccagcccggcgtgctgatccaggtgtacgcgggcgagcgggccatgacgcgcgacaacaacctgctgggccgcttcgagctcagcggcatcccgccggcgcccaggggcgtgccccagatcga
ggtgaccttcgacatcgatgccaacggcatcctgaacgtcacggccaccgacaagagcaccggcaaggccaacaagatcaccatcaccaacgacaagggccggctgaggaaggaggagatcgagcgca
tggtgcaggaggccgagaggtacaaggccgaggacgaggtgcagcgcgagagggtggcggccaagaacgcgctcgagtcctacgccttcaacatgaagagcgccgtggaggacgagggcctcaaggg
caagatcagcgaggccgacaggaagaaggtgctggacgggtgtcaggaggtcatctcctggctggacgccaacacgctggccgacaaggaggagttcgtgcacaagcggcaggagctggagagggtgt
gcggccccatcgtcagcgggctctaccagggtgcgggtgctcccggggcgggcggcttcggggcccaggcgcccaagggaggctccgggtcggggcccaccatcgaggaggtggattag!
Stx5a%
CHO!
XM_003514181.3!
435!bp!
atgatcccgcggaaacgctacggatctaagaacacagatcagggtgtctacctgggtctctcaaagacacaggttctgtcccctgcaactgctgtcagtagcagcagcgacatcactcctttgcccaccccgg
tggccctggtcccttcccctcccgacaccatgtcctgccgggatcggacccaggagttcctgtctgcctgtaagtcgctgcagagccgtcagaatggaatccaaacaaataaaccagctctacgggctgccag
acaacgcagtgaatttacccttatggccaagcgcattggaaaagatctcagcaatacatttgccaagctggagaagctaacaatcttggcaaagcgcaagtccctctttgatgataaagcagtagaaattga
ggagctaacatacatcatcaaacaggtgagctgctag!
! 322!
Gene%name;%%
Human/CHO;%
NCBI%ref;%Gene%size%
cDNA%Sequence%
P115%
CHO!
XM_007652162.1!
2901!bp%
atgaatttcctccgcggggtgatggggggccagagtgccggaccccagcacacagaagccgagacgattcagaagctctgtgaccgagtagcttcatcaactttactggatgaccgaagaaatgctgtgcg
tgctcttaaatcattatctaagaaataccgcttggaagtaggaatccaagctatggaacatcttatccatgttttacaaacagatcgttcggattctgaaataatagcttatgctttggatacactctataatataa
tatctaatgatgaagaggaagaaatagaagaaaattctgcaagacagactgaggatttgggaagccagttcacagaaattttcatcaagcagccagaaaatgtcactctcctgttgtctctgttggaggaatt
tgatttccatgtccgttggcctggcgtgagactcctgacttctcttttaaaacaattagggcctccagtgcagcagattatcttagtcagtcccatgggtgtttcaagactgatggacttactggcagattccaga
gaaattatacgtaatgatggtgtcctactgctgcaggccttaacaaggagcaatggagcaatccagaaaattgtggcttttgaaaatgcttttgagaggctgctggacatcattacagatgaggggaacagtg
atggaggtatagtagtagaagattgtttgatcttacttcaaaacttgttaaagaacaacaattccaatcaaaacttttttaaggaaggctcatatattcaacgtatgaaaccttggtttgaagttgcagatgaaa
attctggttggtcagcacagaaagtgaccaatctacatttgatgctacagcttgtccgagtactagtgtctcccaccaaccctcctggtgcgaccagcagctgccagaaggccatgtttcagtgcgggttactg
cagcaactttgtaccatcctgatggctacaggaattcctgctgatatcctgaccgagaccataaatactgtatctgaagttattcgaggctgccaagtcaaccaggactactttgcttctgtgaatgcaccttca
aatcccccaagaccagcaattgttgtacttctcatgtccatggtgaacgaaaggcagccatttgtgttacgctgtgctgtcctctactgtttccagtgctttttatataaaaaccagaaaggacagggagaaatt
gtggcaacacttctaccgtccactattgatgcaacaggtaactcagtctcagctggtcagctgctctgtggaggcctcttttctacagattctctttcaaactggtgtgctgctgtggcccttgcccatgcactgca
agggaatgctacccagaaggagcagctgctcagggttcagctggccacgagcattggtaaccccccagtgtccctgctgcagcaatgcaccaacatcctctcccagggtgataagatcgacagacgggga
agcaaaatacagacaagagttgggttgttaatgttgctttgtacctggctaagcagctgtcccattgcagtaacacattttcttcacaattcagccaatgttccatttcttacaggacaaattgcagaaaatctcg
gagaagaagagcagttagtccaaggcctatgtgcccttcttttgggcatttcaatttatttcaatgataattcactagaaaactacatgaaagagaaactaaagcaactaatagagaagagaattggcaagg
agaatttcatagagaaactaggattcattagcaaacatgagttatactccagagcctcacagaaaccccagccaaacttcccgagtccagaatacatgatatttgatcatgagtttacaaaactggtgaaaga
acttgaaggtgttattactaaggctatttataaatccagtgaagaagataagaaagaggaagaggtaaagaagacactagaacagcatgacaacattgtgactcactataagaatatgattcgtgagcaag
acctacagctggaagaactgaaacagcaagtttctacactgaaatgtcaaaatgaacagctgcaaacagcagtcacacaacaggtgtctcagattcaacagcacaaggatcagtataatctccttaaagtc
cagcttggaaaagacagtcaccatcaaggctcccacagtgaaggggcccaggtgaacggcattcagctagaagaggtcagtcggctgagggaagaggtagaagagctgaaaagtcaccaggggctctta
caaagccagctagccgaaaaggactctttgatagaaaatttgaaatcttcacaagcgtctgccctgaatgaacaggcttcagtaacagcttcacccagagattcagagcaagttgttgaattaaaacaggag
ctgacagcattaaagtcccagttgaactcacaggccctggagatcaccagactcaaggcagaaaatcatgagctgctccagagagcagaagccttggcaaagtcagtccctgtacaaggagagagtgaga
atgtgacaactgctaaaactactgatgtagaaggaaggctgtctgccttgcttcaggaaacgaaggaactaaagaatgaaattaaagcgttatctgaggaaaaaactgccattaaaaaacaattggataca
tctaacagcaccattgccattctacaaacggagaaagacaagttagatttggaagtgacagattctaagaaagagcaagatgatctcttggtactgttggccgatcaggatcagaaaatcctgtcactgaag
agtaaactcaagaacctcggtcatccagttgaagaagaagacgaatctggagaccaagaagatgatgatgatgaaatggatgatggtgacaaggaccaggatatctag!
Bet3%
CHO!
XM_003500861.3!
543!bp%
atgtcgaggcaggcgaaccgtggcaccgagagcaagaaaatgagttctgagctatttacgctgacgtatggagcgcttgtcacccagctgtgcaaggactatgaaaacgatgaagacgtgaataagcagc
tggacagaatgggctataacattggagtccgactaattgaagattttttggcacgttcaaatgttggaagatgtcatgattttcgggaaactgcggatgtcattgctaaggtggcattcaagatgtacttaggca
tcactccaagcatcacgaattggagcccagctggcgatgaattctccctcatcttggaaaataacccgttggtggactttgtggagcttcccgatagccactcatcccttatttactccaacctcctgtgtggggt
gctgcggggagccttggagatggtccagatggctgtggaagccaagtttgtccaggacactctgaagggagatggtgtgacagagatcaggatgaggttcctcaggcggattgaagacaatcttccagctg
gagaagaataa!
! 323!
Gene%name;%%
Human/CHO;%
NCBI%ref;%Gene%size%
cDNA%Sequence%
TFE3%
S108A% mutation%
(TCA% :>% GCT)%
CHO!
XM_007645617.2!
1743!bp!
atgtctcatgcagccgagccagctcgggacggcgtagaggccagcgtggagggccctcgagccgtgttcgtgctgttggaagagcgcaggccggccgactcggcccagctgctcagcctgaattctttgctt
ccggaatccgggattgttgctgacatcgaattagaaaacatccttgatcctgacagcttctacgagctcaaaagccaacctctacccctccgctccagcctcccaatatctctgcaggccacaccaaccacccc
agctacactctctgcatcgtcttctgcagggggctccaggacccctgccatgtcaGCTtcatcttcatcgcgggtcttgctgcgtcagcagctgatgcgggcccaggcacaggagcaggagaggcgtgagc
gacgggaacaggcagcagctgctcccttccccaatcctgcacctgcctcaccagccatctctgtgattggcgtctctgctggtggccacacactgggtcgtccaccccctgctcaggtgcccagggaggtgct
caaggttcagacacacctggagaaccccacacgctaccacctgcagcaagctcgccggcagcaggtgaaacagtacttgtctaccacacttgggcccaagctggcttcccaggccctcacccccccaccgg
ggcctgccagtgcccagccacttcctgcccctgaaactgcccatgccactggccctacaggcagtgctcctaacagccccatggcgctgctcaccattggatccagctcagagaaggagtatttactttttccc
cagattgatgatgtcattgatgagatcatcagcctagagtccagttacaacgatgagatgctcagctatcttcctggaggcactgcagggctgcagctccccagcacgctgcctgtgtctggcaacctgcttga
tgtgtacagcaaccaaggagtggccacaccagccatcactgtcagcaattcctgtcctgctgagctgcctaacatcaaacgggagatttctgaaaccgaggcaaaggcccttttgaaggagcgacagaaga
aagacaatcacaacctaattgaacgacgcaggcgattcaacattaacgataggatcaaagagctgggcaccctcatccccaagtccaatgatccggagatgcgctggaacaagggcaccatcctgaaggc
atctgtggattacatccgcaaattacaaaaggaacagcaacgctccaaagacctggagagccggcagcgatccctggagcaagccaaccgaagtctgcagctccgaattcaggagctagaactgcaggcc
cagatccatggtctgccagtacctcctaccccaggactgctctccctagccactagttccgtctctgacagcctcaagccagagcagctggacattgaggaggagggcaggccaagcacgacatcatttcatg
tatcagggggacctatccagaatgcacctcagcagcagcctccagcaccaccctcggatgcccttctggacctgcactttcccagcgaccacttgggggacctgggggaccccttccacctggggctagagg
acattctgatggaggaggagggggtggtgggaggactgtcagggggtaccctgtcccctctgcgggctgcctctgacccccttctttcttcagtatccccggctgtgtccaaggccagcagccgtcgcagcag
cttcagcatggaggaggagtcctga!
ATF6αc!!
Human!
1134!bp!
atgggagaacctgctggcgtggccggcaccatggaaagcccttttagccctggcctgttccaccggctggacgaggattgggactctgccctgtttgccgagctgggctacttcaccgacaccgacgaactcc
agctggaagccgccaacgagacatacgagaacaacttcgacaacctggacttcgacctggacctgatgccctgggagtccgacatctgggacatcaacaaccagatctgcaccgtgaaggacatcaaggc
cgagccccagcctctgtcccctgcctccagctcttactccgtgtcctcccccagatccgtggactcctactcctccacccagcacgtgcccgaggaactggacctgtcctccagcagccagatgtcccccctgtc
tctgtacggcgagaactccaactccctgtccagcgccgagcctctgaaagaggacaagcctgtgaccggccctcggaacaagaccgagaatggcctgacccccaagaaaaagatccaagtgaactccaag
ccctccatccagcccaagcccctgctgctgcctgctgctcctaagacccagaccaactcctccgtgcccgccaagaccatcatcatccagaccgtgcccaccctgatgcccctggctaagcagcagcccatca
tctccctccagcctgcccctaccaagggccagacagtgctgctgtctcagcccaccgtggtgcagctccaggctcctggcgtgctgccatctgctcagcctgtgctggctgtggctggcggagtgacccagctg
cctaatcacgtcgtgaacgtggtgcctgccccctccgccaactctcctgtgaacggcaagctgtccgtgaccaagccagtgctccagtccaccatgcggaacgtgggctccgatatcgccgtgctgagaagg
cagcagagaatgatcaagaacagagagtccgcctgccagtcccggaaaaagaaaaaagagtacatgctgggcctggaagcccggctgaaggccgccctgtctgagaacgagcagctgaagaaagaga
acggcaccctgaagcggcagctggatgaggtggtgtccgagaaccagagactgaaggtgcccagccccaagcggagatga%
! 324!
Gene%name;%%
Human/CHO;%
NCBI%ref;%Gene%size%
cDNA%Sequence%
BiP%(Grp78)%
Human!
1965!bp!
atgaagctgtctctggtggccgccatgctcctgctgctgtctgccgctagagccgaggaagaggacaagaaagaggacgtgggcaccgtcgtgggcatcgacctgggcaccacctactcttgcgtgggcgt
gttcaagaacggccgggtggaaatcattgccaacgaccagggcaaccggatcaccccctcttacgtggcctttacccccgagggcgagagactgatcggcgacgccgctaagaaccagctgacctccaac
cccgagaacaccgtgttcgacgccaagcggctgatcggcagaacctggaacgacccctccgtgcagcaggatatcaagttcctgcccttcaaggtggtggaaaaaaagaccaagccctacatccaggtgg
acatcggcggaggccagaccaagaccttcgcccccgaagagatctccgccatggtgctgaccaagatgaaggaaaccgccgaggcctacctgggcaagaaagtgacccacgccgtcgtgaccgtgcccg
cctacttcaacgacgctcagagacaggccaccaaggacgccggcacaatcgccggcctgaacgtgatgcggatcatcaacgagcccaccgccgctgctatcgcctacggcctggataagcgggaaggcga
gaagaacatcctggtgttcgatctgggcggaggcaccttcgacgtgtccctgctgaccatcgacaacggcgtgttcgaggtggtggctaccaacggcgatacccacctgggcggcgaggacttcgaccaga
gagtgatggaacacttcatcaagctgtacaagaagaaaaccggcaaggacgtgcggaaggacaaccgggccgtgcagaaactgcggagagaggtggaaaaggccaagcgggccctgtcctctcagcac
caggccagaatcgagatcgagtccttctatgagggcgaggatttctccgagacactgacccgggccaagttcgaggaactgaacatggacctgttccggtccacaatgaagcctgtgcagaaggtgctgga
agattccgacctgaagaagtccgacatcgacgagatcgtgctcgtgggcggctccaccagaatccccaagatccagcagctcgtgaaagagttcttcaacggcaaagagccctcccggggcatcaaccctg
atgaggctgtggcttacggcgctgctgtgcaggctggcgtgctgtctggcgatcaggataccggcgatctggtgctgctggacgtgtgtcctctgaccctgggaatcgagacagtgggcggcgtgatgacca
agctgatccccagaaacaccgtggtgcctacaaagaagtcccagatcttctccaccgcctccgacaaccagcctaccgtgaccatcaaggtgtacgagggcgaacggcccctgaccaaggataaccatctg
ctgggcacctttgacctgaccggcatccctcctgctcctagaggcgtgccacagatcgaagtgacctttgagatcgacgtgaacggcatcctgagagtgaccgctgaggacaagggcaccggcaacaagaa
caagatcaccatcaccaacgatcagaacaggctgacacctgaagagatcgagcggatggtcaacgatgccgagaagttcgccgaagaagataagaagctgaaagagcggatcgacacccggaacgagc
tggaatcctacgcctactccctgaagaaccagatcggagacaaagagaagctgggcggcaagctgtccagcgaggacaaagaaaccatggaaaaagccgtggaagagaagatcgagtggctggaatct
caccaggacgctgacatcgaggactttaaggctaagaagaaagaactggaagaaatcgtgcagcccatcatctctaagctgtacggctctgccggccctccacctaccggcgaggaagataccgccgaga
aggacgagctgtga!
Calr!
Human!
1254!bp!
atgctgctgtctgttcctctgctgctgggactgcttggactggctgttgctgagcccgccgtgtacttcaaagagcagtttttggacggcgacggctggacctccagatggatcgagtctaagcacaagtccga
cttcggcaagttcgtgctgtcctctggcaagttctacggcgacgaggaaaaggacaagggcctccagacctctcaggacgccagattctacgccctgtctgcctctttcgagcccttcagcaacaagggccag
acactggtggtgcagttcaccgtgaagcacgagcagaacatcgactgtggcggcggatacgtgaagctgttccctaactctctggaccagaccgacatgcacggcgactccgagtacaacatcatgttcggc
cctgacatctgcggccctggcaccaagaaagtgcacgtgatcttcaactacaagggcaagaacgtgctgatcaacaaggacatccggtgcaaggacgacgagttcacccacctgtataccctgatcgtgcg
gcccgacaacacctacgaagtgaagatcgacaactcccaggtggaatccggcagcctggaagatgactgggacttcctgcctcctaagaagatcaaggaccccgacgcctctaagcctgaggattgggat
gagagagccaagatcgacgaccccaccgactccaaaccagaggactgggacaagcccgagcacatccctgatcctgatgccaaaaagcccgaagattgggacgaagagatggatggcgagtgggagcc
tcctgtgatccagaatcctgagtacaaaggcgaatggaagccccggcagatcgataaccccgactacaaaggcacctggattcaccccgagattgacaaccccgagtactctcccgatccttccatctacgc
ctacgacaactttggcgtgctgggcctcgatctgtggcaagtgaagtccggaaccatcttcgataactttctgatcaccaacgacgaggcctacgccgaagagttcggcaatgagacatggggcgtgaccaa
ggccgctgagaagcagatgaaggacaagcaggatgaggaacagcggctgaaagaggaagaagaggacaagaagcgcaaagaagaggaagaggccgaggacaaagaggacgacgaagataagga
cgaggatgaagaagatgaagaggacaaagaagaggacgaggaagaggacgtcccaggccaggctaaggatgagctgtaa!
! 325!
Gene%name;%%
Human/CHO;%
NCBI%ref;%Gene%size%
cDNA%Sequence%
CANX!
Human!
1779!bp!
atggaaggcaagtggctgctgtgtatgctgctggtgctgggcacagctatcgtggaagctcacgacggccacgacgacgacgtgatcgacatcgaggacgacctggatgatgtgatcgaggaagtggaag
atagcaagcccgacaccaccgctcctccatctagccccaaagtgacctacaaggctcctgtgcctaccggcgaggtgtacttcgccgattctttcgacagaggcaccctgtccggctggattctgtctaaggcc
aagaaggacgacacagacgacgagatcgctaagtacgacggcaagtgggaagtcgaggaaatgaaggaatccaagctgcccggcgacaaaggcctggtgctgatgtctagagccaagcaccacgccat
ctccgccaagctgaacaagcccttcctgttcgacaccaagcctctgatcgtgcagtacgaagtgaacttccagaacggcatcgagtgtggcggcgcttacgtgaagctgctgtctaagacccctgagctgaac
ctggaccagttccacgacaagaccccttacaccatcatgttcggccctgacaagtgcggcgaggactacaagctgcacttcatcttccggcacaagaaccccaagaccggcatctacgaggaaaagcacgc
caagaggcctgacgccgacctgaaaacctacttcaccgacaagaaaacccacctgtacaccctgatcctgaatcctgacaactccttcgagatcctggtggaccagtccgtggtcaactctggcaacctgct
gaacgatatgacccctcctgtgaacccctccagagagatcgaggaccctgaggacagaaagcctgaggactgggacgagcggcctaagattcctgatccagaggccgtgaagcccgacgactgggatga
agatgctcccgctaagatccccgacgaggaagctacaaagcctgaaggctggctggacgacgagcctgagtatgtgccagatcctgatgccgagaagccagaagattgggacgaagatatggatggcga
gtgggaagcccctcagatcgccaatcctagatgcgagtctgctcctggatgtggcgtgtggcagaggcctgtgatcgataaccccaactacaaaggcaaatggaagcctcctatgatcgacaacccttccta
ccaaggcatctggaagccccggaagatccctaatcctgacttcttcgaggacctggaacctttccggatgacccctttttccgccatcggcctggaactgtggtctatgacctccgacatcttcttcgacaacttc
atcatctgcgccgaccggcggatcgtggatgattgggctaatgatggctggggcctgaagaaagctgctgatggtgcagctgaaccaggcgtcgtgggacagatgattgaggccgccgaagaaagacctt
ggctgtgggtcgtgtacatcctgacagtggccctgcctgtgttcctggtcatcctgttctgctgctccggcaagaaacagacctccggcatggagtacaaaaagaccgacgctccccagcctgacgtgaaaga
ggaagaagaggaaaaagaagaagagaaggacaagggcgacgaagaggaagagggcgaagagaagctggaagaaaagcagaagtccgacgccgaagaggatggcggcacagtgtcccaagaaga
agaagatcggaagcccaaggccgaggaagatgagatcctgaacagatcccctcggaaccggaagcctcggagagaatga!
CypB%
Human!
651!bp!
atgctgcggctgtctgagcggaacatgaaggtgctgctggccgctgctctgatcgccggctctgtgttcttcctgctgctgcctggcccttctgccgccgacgagaagaaaaagggccccaaagtgaccgtga
aggtgtacttcgacctgcggatcggcgacgaggacgtgggcagagtgatcttcggcctgttcggcaagaccgtgcctaagaccgtggacaacttcgtggccctggccaccggcgagaagggcttcggctac
aagaactccaagttccatcgagtgatcaaggacttcatgatccagggcggcgacttcaccagaggcgacggaacaggcggcaagtccatctacggcgagcggttccctgacgagaacttcaagctgaagc
actacggccctggctgggtgtccatggccaatgccggcaaggacaccaacggctcccagttcttcatcaccaccgtgaaaaccgcctggctggacggcaagcacgtggtgtttggcaaggtgctggaaggc
atggaagtcgtgcggaaggtggaatccaccaagaccgactcccgggacaagcccctgaaggacgtgatcattgccgactgcggcaagatcgaggtggaaaagcccttcgctatcgccaaagagtga!
! 326!
Gene%name;%%
Human/CHO;%
NCBI%ref;%Gene%size%
cDNA%Sequence%
Largen%
Human!
915!bp!
atgtccgccaagtccaagggcaacccctccagctcttgtcctgccgagggacctcctgccgcctccaagaccaaagtgaaagagcagatcaagatcatcgtggaagatctggaactggtgctgggcgacct
gaaggacgtggccaaagaactgaaagaagtggtggaccagatcgacaccctgacctccgacctccagctggaagatgagatgaccgactccagcaagaccgataccctgaactcctcctcctctggcacc
accgccagctccctggaaaagatcaaggtgcaggccaacgcccccctgatcaagcctcctgctcacccttctgccatcctgaccgtgctgcggaagcccaaccctcctccaccacctcctcgactgacccccg
tgaaatgcgaggaccctaagcgggtggtgcccaccgccaaccctgtgaaaacaaacggcaccctgctgagaaacggcggcctgcctggcggccctaacaagatccctaacggcgacatctgctgcatccc
caactccaacctggacaaggcccccgtgcagctgctgatgcaccggcctgagaaggacagatgtccccaggctggccctcgggaaagagtgcggttcaacgagaaggtgcagtaccacggctactgcccc
gactgcgacacccggtacaacatcaagaaccgggaagtgcatctgcactccgagcccgtgcatccccctggcaagatcccacatcagggccctccactgccccccacacctcatctgcctcccttccctctgg
aaaatggcggcatgggcatctcccacagcaacagcttcccccctatccggcctgctaccgtgcctccacctaccgctcccaagccccagaaaaccatcctgcggaagtctaccaccaccacagtgtga!
ERGIC53%
(LMAN1)%
CHO!
1554!bp!
atggctggctctagaagaaagggaacacaggctggcgctcggccttttatctgtgccctgctgctgtccttcagcagattcgtgggctctgatggcatgggcggagatgctgctgctcctggtgctgcttctact
cctgctgagctgccccacagaagattcgagtacaagtactccttcaagggccctcacctggtgcagtctgatggaaccgtgcctttttgggcccacgccggcaatgctatcccttccagcgatcagatcagaat
cgcccctagcctgaagtctcagaggggctctgtgtggaccaagaccaaggccgccttcgagaactgggaagtcgaagtgaccttcagagtgaccggcagaggcagaatcggagctgatggcctggctatct
ggtacaccgagaatcagggactcgatggccctgtgttcggctctgctgatatgtggaacggcgtgggaatcttcttcgactccttcgacaacgacggcaagaagaacaaccccgccatcgtgatcatcggca
acaacggccagatcaactacgaccaccagaacgatggcacaacccaggctctggcctcttgccagagggacttccggaacaaaccttatcctgtgcgggccaagatcacctactaccagaaaaccctgacc
gtgatgatcaacaatggcttcacccctgacaagaacgactacgagttctgcgccaaggtcgagaacatgatcatccctactcagggccacttcggcatctctgctgctactggcggactggctgacgaccacg
atgtgctgtcttttctgaccttccagctgaccgagcctggcaaagagcctcctacactggaaaaggacatctccgagaaagagaaagaaaagtaccaagaagagttcgagcacttccagcaagagctggac
aagaagaaagaagaatttcagaagggacaccccgacctccagggccagcctgctgatgatgttttcgagtccgtgggcgaccgagagctgagacaggtgttcgagggccagaacagaatccacctggaa
atcaagcagctgaaccggcagctggacatgatcctggacgagcagagaagatacgtgtcctctctgaccgaggaaatctctcggagaggcgctggaactcctggacagcctggacaagtgtcccagcaag
aactcgacaccgtggtcaagacccagcacgagatcctgcggcaagtgaacgagatgaagaactccatgtccgagacagtgcggctggtgtctggtatccagcatcctggatctgctggcgtgtacgagaca
acccagcacttcatggacatcaaagaacacctccacgtcgtgaagcgggacatcgacaatctggcccagcggaacatgccctccaacgagaagcctaagtgtcccgagctgcctccatttcctagctgcctg
tctaccatccacttcgtgatcttcgtggtggtgcagaccgtgctgttcatcggctacatcatgtaccggacacagcaagaggctgccgccaagaagttcttctag!
! 327!
Gene%name;%%
Human/CHO;%
NCBI%ref;%Gene%size%
cDNA%Sequence%
ERo1Lα%!
Human!
1407!bp!
atgggaagaggctggggcttcctgtttggcctgctgggagctgtgtggctgctgtcctctggccatggcgaggaacagcctccagagacagccgcccagagatgcttctgtcaggtgtccggctacctggac
gactgcacctgtgacgtggaaaccatcgacaggttcaacaactaccggctgttcccccggctccagaagctgctggaatccgactacttccggtactacaaagtgaacctgaagcggccctgccccttctgga
acgacatctcccagtgcggcagacgggactgcgccgtgaagccttgccagtctgatgaggtgcccgacggaatcaagtccgcctcctacaagtactccgaggaagccaacaacctgatcgaggaatgcga
gcaggccgagagactgggcgccgtggatgagtccctgtccgaagagacacagaaagccgtgctccagtggaccaagcacgacgactcctccgacaacttctgcgaggccgacgacatccagagccccga
ggccgagtatgtggacctgctgctgaaccccgagcggtacaccggctacaagggccctgatgcctggaagatctggaacgtgatctacgaggaaaactgcttcaagccccagaccatcaagcggcccctga
accctctggcttctggccagggcaccagcgaagagaacaccttctacagctggctggaaggcctgtgtgtggaaaagcgggccttttaccggctgatctccggcctgcacgcctccatcaacgtgcacctgtc
cgccagatacctgctccaggaaacatggctggaaaagaagtggggccacaacatcaccgagttccagcagagattcgacggcatcctgaccgagggcgagggccctagaaggctgaagaacctgtacttc
ctgtatctgatcgagctgcgggccctgtccaaggtgctgccattcttcgagcggcccgacttccagctgttcaccggcaacaagatccaggacgaagaaaacaagatgctgctgctggaaatcctgcacgag
atcaagtccttccccctgcacttcgacgagaacagcttctttgccggcgacaagaaagaggcccacaagctgaaagaggacttccggctgcacttccggaacatctcccggatcatggactgcgtgggctgtt
tcaagtgccggctgtggggcaagctccagacccagggactgggcaccgctctgaagatcctgttctccgagaagctgatcgccaacatgcccgagtccggcccctcctacgagttccacctgacccggcagg
aaatcgtgtccctgttcaacgccttcggccggatctccacctccgtgaaagagctggaaaactttcggaacctgctccagaacatccactga!
FKBP11!
Human!
606!bp!
atgacactcagacctagcctgctgcctctgcacctgttgctgctgttgctcctctctgccgctgtgtgtagagctgaggctggcctggaaacagagtctcctgtgcgaaccctccaggtggaaactctggtggaa
cctcctgagccttgtgccgaacctgctgcttttggcgataccctgcacatccactataccggcagcctggtggacggccggattatcgataccagcctgaccagagatcccctggtcatcgagctgggccaga
aacaagtgatccccggcctggaacagtccctgctggatatgtgtgtgggcgagaagcggagagctatcatcccttctcacctggcctacggcaagagaggctttcctccttctgtgcctgctgacgccgtggt
gcagtacgatgtggaactgatcgccctgatccgggccaactattggctgaagctggtcaagggaatcctgcctctcgtcggcatggctatggtgcctgctctgctgggcctgatcggctaccacctgtacaga
aaggccaaccggcctaaggtgtccaagaagaagctgaaagaggaaaagcgcaacaagtctaagaagaagtga!
! 328!
Gene%name;%%
Human/CHO;%
NCBI%ref;%Gene%size%
cDNA%Sequence%
GRP94/!
HSP90B1%
(Endoplasmin)%
Human!
2412!bp!
atgagagctttgtgggtgctgggcctgtgttgcgtgctgctgacctttggctctgtgcgggccgatgacgaagtggatgtggatggcacagtggaagaggacctgggcaagtccagagagggctctagaaca
gacgacgaggtggtgcagagagaggaagaggctattcagctggacggcctgaacgcctctcagatcagagagctgagagagaagtccgagaagttcgccttccaagccgaagtgaaccggatgatgaag
ctgatcatcaactccctgtacaagaacaaagagatcttcctgcgcgagctgatctccaacgcctctgacgccctggacaagatccggctgatctctctgaccgacgagaacgccctgtctggcaatgaggaa
ctgaccgtgaagatcaagtgcgacaaagagaagaacctgctgcacgtgaccgataccggcgtgggcatgacaagagaggaactggtcaagaacctgggcacaatcgccaagtccggcacctccgagttt
ctgaacaagatgaccgaggctcaagaggacggccagtccacatctgagctgatcggacagtttggcgtgggcttctactctgccttcctggtggctgacaaagtgatcgtgacctccaagcacaacaacgac
acccagcacatctgggagtccgactccaacgagttctccgtgatcgccgatcctagaggcaataccctcggcagaggcaccacaatcaccctggtgctgaaagaagaggcctccgactacctggaactgga
caccatcaagaatctcgtgaagaagtactcccagttcatcaacttccccatctacgtgtggtcctccaagaccgagactgtggaagaacccatggaagaagaggaagccgccaaagaggaaaaagaagag
tccgacgacgaagccgccgtcgaggaagaggaagaagagaagaagcctaagaccaagaaggtggaaaagaccgtctgggactgggagctgatgaacgacatcaagcctatctggcagcggccctcca
aagaggtcgaagaggacgagtacaaggccttctacaagtccttcagcaaagaaagcgacgaccccatggcctacatccatttcacagctgagggcgaagtgaccttcaagtccatcctgttcgtgcctacct
ctgctcccagaggcctgttcgatgagtacggctccaagaagtctgactacatcaagctgtacgtgcggcgggtgttcatcaccgacgacttccacgacatgatgcccaagtacctgaacttcgtgaaaggcgt
ggtggactccgacgacctgcctctgaatgtgtctagagagacactccagcagcacaagctgctgaaagtgatccggaagaagctcgtcagaaagaccctcgacatgatcaagaagatcgccgacgacaag
tacaacgataccttctggaaagagttcggcaccaatatcaagctgggcgtgatcgaggaccactccaacagaaccagactggctaagctgctgcggttccagtcctctcaccatcctaccgacatcaccagc
ctggaccagtacgtggaacggatgaaggaaaagcaggataagatctacttcatggccggctccagccggaaagaggccgagagttctccattcgtggaaagactgctgaagaagggctacgaagtcatct
acctgaccgagccagtggatgagtactgtatccaggctctgcccgagttcgacggcaagagattccagaacgtggccaaagaaggcgtgaagttcgacgagtccgaaaagaccaaagagagcagagagg
ccgttgagaaagagtttgagcccctgctgaattggatgaaggacaaggccctgaaggacaaaatcgagaaggccgtggtgtcccagagactgaccgaatctccttgtgctctggtggcctctcagtacggat
ggtccggcaacatggaaagaatcatgaaggcccaggcctaccagaccggcaaggacatctctaccaactactacgccagccagaagaaaaccttcgagatcaaccctagacaccctctgatccgggacat
gctgcggcggatcaaagaggatgaggacgacaagaccgtgctggacctggctgtggtgctgtttgagacagctaccctgagaagcggctacctgctgcctgataccaaggcctacggcgacagaatcgag
cggatgctgagactgtccctgaacatcgaccctgacgccaaggttgaagaggaacccgaggaagaaccagaggaaaccgctgaggataccaccgaggataccgagcaggacgaggacgaagaaatgg
acgtgggcaccgacgaagaagaagaaacagctaaagagtccaccgccgagaaggatgagctgtga!
MCFD2%
CHO!
438!bp!
atggcttctctgtggctgctgagagtgcctttcctgtgtgctctgctgtggacctcttgcacccctggaacaagagcacatgagcctggcgctggctctcatcattcctctgtcggcctggacaagtccaccgtgc
acgaccaagagcatatcatggaacacctggaaggcgtgatcgacaagcccgagacagagatgtcccctcaagaactccagctgcactacttcaagatgcacgactacgacggcaacgacctgctggatgg
cctggaactgtctaccgctatcacccacgtgcacaaagaggaaggctctgatcaggcccctgtgatgtctgaggacgagctgatcaacatcatcgacggcgtgctgcgggacgacgacaagaacaacgac
ggctacatcgactacgccgagttcgccaagagcctccagtaa!
! 329!
Gene%name;%%
Human/CHO;%
NCBI%ref;%Gene%size%
cDNA%Sequence%
Hyou1%
Human!
3000!bp!
atggctgacaaagttcggagacagaggcctcggagaagagtgtgttgggctcttgtggctgtgctgctggctgatctgctggccttgtctgataccctggccgtgatgtctgtggacctgggctctgaatccat
gaaggtggccattgtgaagcccggcgtgcccatggaaatcgtgctgaacaaagagtctcggcgcaagacccctgtgatcgtgaccctgaaagagaacgagcggttcttcggcgactctgccgcctctatgg
ccatcaagaatcctaaggctaccctgcggtacttccagcatctgctgggcaagcaggccgataatcctcacgtggccctgtaccaggccagatttcctgagcacgagctgacctttgatccccagcggcagac
cgtgcacttccagatctctagccagctccagttcagccctgaagaggtgctcggcatggtgctgaactactctagatccctggccgaggatttcgccgagcagcctatcaaggatgccgtgatcaccgtgcctg
tgttcttcaatcaagccgagagaagggccgtgctccaggctgctagaatggctggactgaaggtgctccagctgatcaacgataacaccgccaccgctctgtcttacggcgtgttcagacggaaggacatca
acaccaccgctcagaacatcatgttttacgacatgggctccggctccaccgtgtgcaccatcgtgacataccagatggtcaagaccaaagaggccggcatgcagccccagttgcagatcagaggcgtgggc
tttgatagaaccctcggcggcctggaaatggaactgagactgagagaaagactggccggcctgttcaacgagcagagaaaaggccagagagccaaggacgtccgcgagaatcctagagctatggccaag
ctgctgagagaggccaacagactgaaaaccgtgctgtctgccaacgccgaccacatggctcagatcgagggactgatggacgacgtggacttcaaggccaaagtgaccagagtggaatttgaggaactgt
gcgccgacctgttcgagagagttcctggacctgttcagcaggccctccagtctgctgagatgtccctggatgagatcgagcaagtgatcctcgtcggcggagctaccagagtgcctagagtgcaagaagtgc
tgctgaaggccgtgggcaaagaggaactgggcaagaacatcaacgccgatgaggctgctgctatgggcgctgtttatcaggccgctgctctgtccaaggccttcaaagtgaagcctttcgtcgtgcgggacg
ccgtggtgtatcctatcctggtcgagttcaccagagaggtggaagaggaacctggcatccacagcctgaagcacaacaagcgggtgctgttctcccggatgggcccttatcctcagcggaaagtgatcacct
tcaaccgctactcccacgacttcaacttccacatcaactacggcgatctgggctttctgggccctgaggatctgagagtgttcggctctcagaacctgaccaccgtgaagctgaaaggcgtgggagactccttc
aagaagtaccccgactacgagtccaagggcatcaaggcccacttcaacctggacgagtctggcgtgctgagcctggatagagtggaaagcgtgttcgagacactggtggaagattccgccgaggaagaga
gcaccctgaccaagctgggcaacaccatcagttctctgttcggcggaggcaccacacctgacgctaaagagaatggcaccgacaccgtgcaagaggaagaagagtctcctgccgagggctctaaggatga
gcctggcgaacaggtggaactgaaagaagaggctgaggcccctgtggaagatggctctcaacctcctccacctgaacctaagggcgacgctacacctgagggcgagaaggccacagagaaagaaaacg
gcgacaagagcgaggcccagaagccatctgaaaaggccgaagctggaccagaaggtgtcgctcctgctccagaaggcgagaagaagcagaagcctgccagaaagcggcggatggtcgaagagattgg
agtggaactggtggtgctggacctgcctgatctgccagaagataagctggcccagtccgtgcagaagctccaggacctgactctgcgcgacctggaaaagcaagagagagagaaggccgccaacagcct
ggaagccttcatcttcgagactcaggacaagctgtaccagcctgagtaccaagaggtgtccaccgaggaacagagagaggaaatctctggcaagctgtccgctgccagcacctggcttgaggatgaaggc
gttggcgctacaacagtgatgctgaaagaaaagctggctgagctgagaaagctgtgtcagggcctgttcttcagagtcgaggaacggaagaagtggcccgagagactgtctgccctggacaacctgctgaa
tcactcctccatgtttctgaagggcgctagactgatccccgagatggaccagatcttcaccgaggtggaaatgaccacactcgagaaagtcatcaacgagacatgggcctggaagaacgctacactggccg
aacaggctaagctgcctgctacagaaaagcccgtgctgctgtctaaggacatcgaggccaagatgatggccctggaccgggaagtgcagtacctgctcaacaaggccaagttcaccaagcctcggcctag
acctaaggacaagaacggaaccagagccgagcctcctctgaacgcctctgcttctgatcagggcgaaaaagtgatccctcctgccggccagacagaggatgctgaacctatctctgagcccgagaaggtg
gaaaccggctctgaacctggcgataccgaacctttggaactcggaggacctggcgctgagccagagcagaaagaacagtctaccggacagaagcggcccctgaagaacgacgagctgtaa!
! 330!
Gene%name;%%
Human/CHO;%
NCBI%ref;%Gene%size%
cDNA%Sequence%
Dad1%
CHO!
342!bp%
atgtctgcatccgtggtgtccgtgatctcccggttcctggaagagtacctgagcagcacccctcagagactgaagctgctggatgcctacctgctgtacattctgctgaccggcgctctccagttcggctattgt
ctgctcgtgggcacctttcctttcaattccttcctgtccggctttatctcctgcgtgggctctttcatcctggccgtgtgcctgagaatccagatcaaccctcagaacaaggccgacttccagggcatctctcctga
gagagccttcgccgatttcctgttcgcctctaccatcctgcacctggtggtcatgaacttcgtgggctga!
PDI%
Human!
1527!bp%
atgctgagaagggccctgctgtgtctggccgtggctgctctcgtgcgagccgatgctcctgaggaagaggaccacgtgctggtgctgcggaagtccaactttgccgaggctctggccgcccacaagtacctg
ctggtggagttctacgccccttggtgcggccactgtaaagccctggcccctgagtacgctaaggccgctggaaagctgaaggccgagggctctgagatccggctggctaaggtggacgccaccgaggaatc
tgacctggcccagcagtatggcgtgcggggctaccccaccatcaagttcttccggaacggcgacaccgcctcccccaaagagtataccgccggcagagaagccgacgacatcgtgaactggctgaagaag
agaaccggccctgccgccaccacactgcctgatggtgctgctgctgagtccctggtggaatcctctgaggtggccgtgatcggcttcttcaaggacgtggaatccgactccgccaagcagtttctccaggccg
ccgaggctatcgacgatatccccttcggcatcacctccaactccgacgtgttctccaagtatcagctggacaaggacggcgtggtgctgttcaagaagttcgacgagggccggaacaacttcgagggcgaag
tgaccaaagagaacctgctggacttcatcaagcacaaccagctgcccctcgtgatcgagttcaccgagcagaccgcccccaagatcttcggcggcgagatcaagacccacatcctgctgtttctgcccaagt
ccgtgtccgactacgacggcaagctgtccaacttcaagaccgccgctgagtccttcaagggcaagatcctgttcatcttcatcgactccgaccacaccgacaaccagcgcatcctggaatttttcggcctgaa
gaaagaggaatgccctgccgtgcggctgatcaccctggaagaggaaatgaccaagtacaagcccgagtctgaggaactgaccgccgagcggatcaccgagttctgccacagatttctggaaggcaagatc
aagcctcacctgatgtcccaggaactgcccgaggactgggacaagcagcccgtgaaagtgctcgtgggcaagaactttgaggacgtggccttcgacgagaagaaaaacgtgttcgtggagttttatgctcct
tggtgtgggcattgcaagcagctggcccccatctgggataagctgggcgagacatacaaggaccacgagaacatcgtgatcgccaagatggactccaccgccaacgaggtggaagccgtgaaggtgcac
agcttccccaccctgaagtttttccccgcctctgccgaccggaccgtgatcgattacaacggcgagagaaccctggacggctttaagaagttcctggaatctggcggccaggacggcgctggcgacgatgac
gatctggaggacctggaagaagctgaggaacccgacatggaagaagatgacgaccagaaagctgtgaaggacgagctgtga!
! 331!
Gene%name;%%
Human/CHO;%
NCBI%ref;%Gene%size%
cDNA%Sequence%
P115%
CHO!
2901!bp!
atgaactttctgagaggcgtgatgggcggccagtctgctggacctcaacataccgaggccgagacaatccagaaactgtgcgacagagtggccagctctaccctgctggacgatagaagaaatgccgtgcg
ggccctgaagtccctgtccaagaagtatagactggaagtcggcatccaggccatggaacacctgatccatgtgctccagaccgacagatccgactccgagatcattgcctacgctctggacaccctgtacaa
catcatctccaacgacgaggaagaggaaatcgaggaaaactctgcccggcagaccgaggatctgggctctcagttcaccgagatcttcatcaagcagcccgagaacgtgaccctgctgctgtctctgctgg
aagagttcgatttccatgtgcggtggcctggcgtcagactgctgacatctctgctgaaacagctgggccctcctgtgcagcagatcatcctggtgtctccaatgggcgtgtcccggctgatggatctgctggcc
gattctagagagatcatccggaacgacggcgtgctgctgttgcaggccttgaccagatctaacggcgccatccagaaaatcgtggccttcgagaacgccttcgagcggctgctggatatcatcaccgacgag
ggcaattctgacggcggcatcgtggtggaagattgcctgatcctgctccagaacctgctgaagaacaacaactccaaccagaacttcttcaaagagggctcctacatccagcggatgaagccttggtttgag
gtggccgacgagaactctggatggtccgcacagaaagtgaccaacctgcacctgatgctccagctcgtcagagtgctggtgtcccctacaaatcctcctggcgccaccagctcttgccagaaagctatgtttc
agtgcggactgctccagcagctgtgcaccattctgatggctaccggcattcctgccgacatcctgaccgagactatcaacaccgtgtccgaagtgatccggggctgccaagtgaaccaggactacttcgcctc
tgtgaacgcccctagcaaccctcctagacctgctatcgtggtgctgctgatgtccatggtcaacgagagacagcccttcgtgctgagatgcgccgtgctgtactgcttccagtgcttcctgtacaagaaccaga
aaggccagggcgagatcgtggccacactgctgccttctacaatcgacgccaccggcaactctgtttctgctggtcaactgctgtgtggcggcctgttctctaccgacagcctgtctaattggtgcgccgctgttg
ctctggctcacgctctccagggcaatgctacccagaaagaacagctgctcagagtgcagctggctacctctatcggcaacccacctgtgtctctgttgcagcagtgcacaaacatcctgtctcagggcgacaa
gatcgacagacggggctccaagatccagaccagagttggactgctgatgctgctgtgtacctggctgtctagctgccctatcgctgtgacccacttcctgcacaactctgccaacgtgccattcctgaccggcc
agatcgctgagaatctgggcgaagaggaacagctggtgcagggactgtgtgctctgctgctgggcatctccatctacttcaacgacaactccctcgagaactacatgaaggaaaagctgaagcagctgatc
gagaagcggatcggcaaagagaacttcattgagaagctgggcttcatcagcaagcacgagctgtactccagagccagccagaagcctcagcctaacttcccatctcctgagtacatgatcttcgatcacgag
ttcaccaagctggtcaaagaactggaaggcgtgatcaccaaggccatctacaagtcctccgaagaggacaagaaagaggaagaagtcaagaaaaccctcgagcagcacgacaacatcgtcacccactac
aagaacatgatcagagagcaggacctccagttggaggaactcaagcagcaagtgtctaccctgaagtgccagaacgagcagctccagacagccgtgacacaacaggtgtcccagattcagcagcataag
gaccagtacaatctgctgaaggtgcagctcggcaaggatagccaccaccagggatctcattctgagggcgcccaagtgaatggcatccagctcgaggaagtgtctcggctgagagaagaggtggaagaac
tgaagtctcaccagggcctgttgcagtctcagctggccgagaaggactccctgattgaaaacctgaagtctagccaggcctccgctctgaatgagcaggcttctgtgaccgcctctcctcgggattctgaaca
ggtggtggaactgaagcaagaactgacagccctgaaatcccagctgaactcccaggctctggaaatcaccagactgaaggccgagaaccacgaactgttgcagagagccgaagctctggccaagtctgtg
ccagtgcagggcgagtctgagaatgtgaccaccgctaagaccaccgacgtggaaggcagattgagcgccctgctgcaagagacaaaagagctgaaaaacgagatcaaggccctgtccgaggaaaagac
cgccatcaaaaagcagctggacacctccaactccacaatcgccatcctccagactgagaaggacaagctggacctggaagtgaccgactccaaaaaagaacaggacgacctgctggtgctcctggccgac
caggatcagaagattctgtctctgaagtccaagctcaagaacctgggccatccagtggaagaagaggacgagtctggcgaccaagaggatgacgacgacgagatggacgacggcgacaaggaccagga
catctag!
! 332!
Gene%name;%%
Human/CHO;%
NCBI%ref;%Gene%size%
cDNA%Sequence%
PDIA4%
Human!
1938!bp!
atgaggcctagaaaggcttttctgctgctgctcctgctgggacttgtgcagttgttggctgttgctggcgctgagggccctgacgaggattcctctaacagagagaacgccatcgaggacgaggaagaagaa
gaggaagaggacgacgacgaagaagaggacgacctggaagtgaaagaagagaacggcgtcctggtgctgaacgacgccaacttcgataacttcgtggccgacaaggacaccgtgctgctcgagttttat
gctccttggtgcggccactgcaagcagtttgcccctgagtacgagaagatcgccaacatcctgaaggacaaggaccctcctattcctgtggccaagatcgacgctacctctgcctctgtgctggcctccagatt
cgatgtgtctggctaccccaccatcaagatcctgaagaaaggccaggccgtggactacgagggcagcagaacacaagaagagatcgtcgccaaagtgcgcgaggtgtcccaacctgattggacccctcca
cctgaagtgaccctggtcctgaccaaagagaacttcgacgaggtcgtgaacgatgccgacatcatcctggtcgagttctacgccccttggtgtggacattgcaagaagctggctcccgagtacgaaaaggcc
gccaaagagctgtccaagcggtcccctccaattccactggctaaggtggacgccaccgctgagacagatctggccaagagatttgacgtgtccggctatcctacactcaagatcttcagaaagggcagaccc
tacgactacaacggccctcgcgagaagtacggcatcgtggattacatgatcgagcagagcggccctcctagcaaagagatcctgacactgaaacaggtgcaagagtttctgaaggacggcgacgacgtga
tcatcatcggagtgttcaagggcgagagcgaccctgcttaccagcagtaccaggatgccgccaacaatctgagagaggactacaagttccaccacaccttctctaccgagatcgctaagttcctgaaagtgt
cccagggccagctggtggtcatgcagcctgagaagttccagtctaagtacgagcctcggagccacatgatggacgtgcagggctctacccaggactccgccatcaaggacttcgtgctgaagtatgccctgc
ctctcgtgggccacagaaaggtgtccaacgatgccaagaggtacacccgcagacctctggtggtggtgtactactccgtggacttcagcttcgactacagagccgccacacagttctggcggtctaaggtgct
ggaagtggccaaggactttcctgagtacaccttcgctatcgccgacgaagaggattacgccggcgaagtgaaggatctgggactgtctgagtctggcgaggatgtgaatgccgccattctggacgagtccg
gcaagaaattcgccatggaacccgaagagttcgacagcgacaccctgagagaatttgtgaccgccttcaagaagggcaagctgaagcccgtgatcaagagccagcctgtgcctaagaacaacaagggcc
ctgtgaaggtggtcgtgggcaagaccttcgactccatcgtgatggaccccaagaaagacgtgctgattgagttttacgcaccttggtgtgggcactgtaaacagctggaacccgtgtacaactccctcgccaa
gaagtacaagggccagaaaggcctcgtgatcgccaagatggatgccaccgccaacgatgtgccctccgacagatacaaggtggaaggcttccctaccatctacttcgccccttccggcgacaagaaaaac
cccgtgaagttcgaaggcggcgacagagatctggaacacctgtccaagttcatcgaggaacacgccaccaagctgtcccggacaaaagaggaactgtag!
PRDX4%
Human!
816!bp!
atggaagctctgcctctgttggccgctaccacacctgatcacggcagacatagaaggctgctgctgctccctctgctgctgtttttgttgcctgctggcgctgtgcaaggctgggagacagaggaaagacccc
ggaccagagaagaggaatgccacttttatgctggcggccaggtttaccctggcgaggcttctagagtgtctgtggccgatcactccctgcacctgtccaaggccaagatctccaagcctgctccttattggga
gggcaccgctgtgatcgacggcgagtttaaagagctgaagctgaccgactaccggggcaagtacctggtgttcttcttctaccctctggacttcaccttcgtgtgccccaccgagatcattgccttcggcgaca
gactggaagagttccggtctatcaataccgaggtggtggcctgctccgtggactctcagtttacccacctggcctggatcaacacccctagaaggcaaggcggactgggccctattagaatcccactgctgtc
cgatctgacccaccagatctctaaggactacggcgtgtacctggaagatagcggccatacactgcggggcctgttcatcatcgacgacaagggcatcctgcggcagatcaccctgaatgatctgcctgtggg
cagatccgtggacgagacactgagactggtgcaggccttccagtacaccgataagcacggcgaagtctgtcctgctggctggaagcctggctccgagacaatcattcctgatcctgccggcaagctcaagta
cttcgacaagctgaactga!
! 333!
Gene%name;%%
Human/CHO;%
NCBI%ref;%Gene%size%
cDNA%Sequence%
SRP14%
CHO!
333!bp!
atggttctgctggaatccgagcagtttctgaccgagctgacccggctgttccagaagtgcagatcctccggctctgtgtacatcaccctgaagaagtacgacggccggaccaagcctacacctagaaagtctg
ccgtggaatccgtggaacccgccgagaacaaatgtctgctgagagccaccgacggcaagcggaagatttctaccgtggtgtcctccaaagaagtgaacaagttccagatggcctactccaacctgctgagg
gccaacatggatggactgaagaagcgggacaagaagaacaagtccaaaaagaccaagccagctcagtga!
Tor1a%
Human!
999!bp!
atgaagctgggtagagctgttctgggactgctgctgctggctccttctgtggttcaggccgtggaacctatctctctcggactggctctggctggcgtgctgaccggctatatctaccctagactgtactgcctgt
tcgccgagtgctgcggccagaagagatccctgtctagagaggccctccagaaggacctggacgataacctgtttggccagcacctggccaagaagatcatcctgaacgccgtgttcggcttcatcaacaacc
ccaagcctaagaagcccctgacactgtctctgcatggatggaccggcaccggcaagaacttcgtgtccaagatcattgccgagaacatctacgaaggcggcctgaatagcgactacgtgcacctgtttgtgg
ctaccctgcacttccctcacgcctccaacatcaccctgtacaaggatcagctccagctgtggatcagaggcaacgtgtccgcctgcgccagatccatcttcatcttcgacgagatggacaagatgcacgccgg
cctgatcgacgccatcaagccctttctggactactacgacctggtggacggcgtgtcctaccagaaagccatgttcatctttctgtccaacgctggcgccgagagaatcaccgatgtggccctggatttttggc
ggagcggcaagcagagagaggacatcaagctgaaggacatcgagcacgccctgtccgtgtccgtgttcaacaacaagaactccggcttctggcactcctctctgatcgaccggaacctgatcgattacttcg
tgcccttcctgcctctcgagtacaagcacctgaagatgtgcatcagagtggaaatgcagtcccggggctacgagatcgacgaggacattgtgtccagagtggccgaggaaatgacattcttcccaaaagag
gaacgggttttctccgacaagggctgcaagaccgtgttcaccaagctggactattactacgacgactga!
XBP1s%
CHO!
1113!bp!
atggttgtggtggctgcttctccttctgctgccactgctgctcctaaggtgctgctgttgtctggccaacctgctgctgatggtagagccctgcctctgatggtgcctggatctagagctgccggatctgaggcta
atggcgcccctcaggctagaaagagacagcggctgacccacctgtctccagaggaaaaggccctgcggcggaagctgaagaatagagtggctgcccagaccgccagagacagaaagaaagcccggatg
tccgagctggaacagcaggtcgtggacctggaagaggaaaaccagaagctgctgctggaaaatcagctgctgagagaaaagacccacggcctggtcatcgagaatcaagagctgagaacccggctcggc
atggacgtgctgacaacagaggaagcccctgagacagagtccaaaggcaatggcgttagacctgtggccggctctgctgaaagtgctgctggtgctggacctgtggtcacctctcctgagcatctgcctatg
gactccgacaccgtggactcctctgactccgagtctgatatcctgctgggcatcctggacaagctggaccccgtgatgttcttcaagtgcccatctcctgagtccgccaatctggaagaactgcccgaagtgta
ccccggaccttcttctctgcctgcctcactgtctctgtccgtgggcacatcttctgccaagctggaagccatcaacgagctgatcagattcgaccacgtgtacaccaagcctctggtgctcgagatcccttccga
gactgagtctcagaccaacgtggtggtcaagatcgaagaggcccctctgtcctccagcgaggaagatcaccctgagttcatcgtgtccgtgaagaaagagcccctcgaagaggacttcatccccgagcctg
gcatctctaacctgctgtcctctagccactgcctgaagcctagctcttgcctgctggacgcctactctgattgtggctacgagggcagcccttctcctttctccgatatgtcctctcctctgggaatcgaccactcc
tgggaagataccttcgccaatgagctgttccctcagctgatctcagtgtga!
! 334!
Gene%name;%%
Human/CHO;%
NCBI%ref;%Gene%size%
cDNA%Sequence%
XBP1s%%
Human!
1131!bp!
atggtggtggtggccgctgctcctaatcctgccgatggcacccctaaggtgctgctgctgtctggccagcctgcttctgctgctggtgctcctgctggacaggccctgcctctgatggtgcctgctcagagaggc
gcttctcctgaggctgcttctggcggactgccccaggccagaaagagacagagactgacccacctgtcccccgaggaaaaggccctgcggcggaagctgaagaacagagtggctgcccagaccgccagg
gaccggaagaaagccagaatgtccgagctggaacagcaggtggtggacctggaagaggaaaaccagaagctgctgctggaaaaccagctgctgagagaaaagacccacggcctggtggtggaaaatc
aggaactgcggcagcggctgggcatggatgctctggtggctgaggaagaggccgaggccaagggcaatgaagtgcgacctgtggccggctctgccgaaagtgctgctggcgctggacctgtcgtgacccc
tcctgagcatctgcctatggactccggcggcatcgactcctccgactccgagtctgatatcctgctgggcatcctggacaacctggaccccgtgatgttcttcaagtgccccagccctgagcccgcctccctgg
aagaactgcctgaggtgtaccctgagggcccctcttctctgcctgcctccctgagtctgtccgtgggcacctcttccgccaagctggaagccatcaacgagctgatcagattcgaccacatctacaccaagccc
ctggtgctggaaatcccctccgagacagagtcccaggccaacgtggtcgtgaagatcgaggaagcccccctgtcccctagcgagaacgaccaccctgagttcatcgtgtccgtgaaagaggaacccgtgga
agatgacctggtgcccgagctgggaatctccaacctgctgtcctccagccactgccccaagcctagctcctgtctgctggacgcctactccgactgtggctacggcggatctctgtcccccttctccgacatgtc
ctccctgctgggagtgaaccactcctgggaggacaccttcgccaatgagctgttcccccagctgatctcagtgtga!
YY1%
CHO!
1239!bp!
atggcatctggcgataccctgtatatcgccaccgacggctctgagatgcctgccgagattgtggaactgcacgagatcgaggtggaaacaatccccgtggaaaccatcgagacaaccgtcgtgggcgaaga
ggaagatgaggacgaagaggatgaagatggtggtggcggtggcggcggaggtggacatggacatgctggacaccatcaccatcatcatcaccaccatcaccatccacctatgatcgccctccagcctctg
gtcaccgatgatcctacacaggtgcaccaccaccaagaagtgatcctggtccagaccagagaggaagtcgtcggcggcgacgattctgatggactgagagctgaggacggcttcgaggaccagatcctga
ttcctgttcctgctccagccggcggagatgacgattatatcgagcagaccctcgtgaccgtggccgctgctggaaaatctggtggcggaggatctagttcctctggcggaggcagagtgaagaaaggcggcg
gaaagaagtccggcaagaagtcttatttgtctggcggtgctggtgcagcaggcggaggcggagctgatcctggaaacaagaagtgggagcagaagcaggtccagatcaagaccctggaaggcgagttct
ccgtgaccatgtggtcctccgacgagaagaaggacatcgaccacgagacagtggtggaagaacagatcatcggcgagaactccccacctgactactccgagtacatgacaggcaagaagctgcctcctgg
cggcatccctggaatcgacctgtctgatcctaagcagctggccgagttcgcccggatgaagcctagaaagatcaaagaggacgacgcccctcggacaatcgcttgtcctcataagggctgcaccaagatgtt
ccgggacaactccgccatgcggaaacatctgcacacccacggacctagagtgcacgtgtgcgctgagtgtggcaaggccttcgtggaatcctctaagctgaagcggcatcagctggtgcataccggcgaga
agcctttccagtgcacctttgaaggctgcggcaagcggttctccctggacttcaatctgagaacccacgtgcgcatccacaccggcgatagaccttacgtgtgccctttcgacggctgcaacaagaaattcgc
ccagtccaccaacctgaagtcccacatcctgacacacgccaaggccaagaacaaccagtga!
!
!
